Edgar Filing: OMEGA HEALTHCARE INVESTORS INC

AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 25, 2002

REGISTRATION NO. 333-72750
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

------------------------

POST-EFFECTIVE AMENDMENT NO. 2 TO
FORM S-11
REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

------------------------

OMEGA HEALTHCARE INVESTORS, INC.

(Exact name of Registrant as specified in its charter)

MARYLAND 6798 38-3041398
(State or Other Jurisdiction (Primary Standard Industrial (IRS Employer
of Classification Number) Identification Number)
Incorporation or Organization)

--------------------------

900 VICTORS WAY
SUITE 350
ANN ARBOR, MICHIGAN 48108
(734) 887-0200
(Address, including zip code, and telephone number, including
area code, of Registrant's principal executive offices)

--------------------------

C. TAYLOR PICKETT
CHIEF EXECUTIVE OFFICER
OMEGA HEALTHCARE INVESTORS, INC.
9690 DEERECO ROAD
SUITE 100
TIMONIUM, MARYLAND 21093
(410) 561-5726

(Name, address, including zip code, and telephone number,
including area code, of agent for service)

--------------------------

COPIES OF COMMUNICATIONS TO:

RICHARD H. MILLER, ESQ.
ELIOT W. ROBINSON, ESQ.
POWELL, GOLDSTEIN, FRAZER & MURPHY LLP
SIXTEENTH FLOOR
191 PEACHTREE STREET, N.E.
ATLANTA, GEORGIA 30303
(404) 572-6600

--------------------------

APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after the effective date of this Registration Statement.

--------------------------

If this form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. / /

If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. / /

If this form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration number of the earlier effective registration statement for the same
offering. / /

If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. / /

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

EXPLANATORY NOTE

This post-effective amendment reflects the elimination of the requirement
that stockholders who wish to exercise their rights hold the shares of common
stock to which the rights relate continuously from the record date through the
exercise date.

PROSPECTUS

OMEGA HEALTHCARE INVESTORS, INC.
[LOGO] NONTRANSFERABLE RIGHTS OFFERING
TO PURCHASE UP TO 9,350,000 SHARES OF
COMMON STOCK AT $2.92 PER SHARE

------------------

If you held our common stock on January 22, 2002, you will receive rights to
purchase additional shares of common stock for a subscription price of $2.92 per
share. You will receive one right for every 2.15 shares of common stock you held
on that date. Each right entitles you to purchase one share of common stock at
the subscription price. The number of rights allocated to you is based on the
percentage of our voting stock you own on the record date on an as converted
basis. These rights represent your pro rata portion of the aggregate
$50 million in new equity capital we propose to raise in this rights offering
together with a concurrent private placement. There is no minimum number of
shares that must be subscribed for by stockholders in the rights offering.

Explorer Holdings, L.P., which owns all of our outstanding Series C
preferred stock and 553,850 shares of our common stock, representing 47.1% of
our voting stock, will not purchase common stock in this rights offering.
Instead, Explorer has agreed to purchase $23.6 million of our stock in a private
placement concurrent with the closing of the rights offering at the same price
per common share as in this rights offering. The $23.6 million that Explorer has
agreed to invest represents its pro rata portion of the $50 million we seek to
raise, based on Explorer's ownership of our Series C preferred stock and common
stock. Explorer has also committed to invest in the concurrent private placement
an additional amount equal to the aggregate subscription price of the shares of
common stock that are not subscribed for by other stockholders in this rights
offering. As a result, we are assured of receiving an aggregate of $50 million
upon the completion of this rights offering and the private placement.

You may exercise your rights beginning on the date of this prospectus until
5:00 p.m., New York City time, on February 14, 2002. We can extend the
subscription period but in no event will the subscription period be extended
beyond February 28, 2002. However, we do not presently intend to extend the
subscription period. Rights not exercised by the end of the subscription period
will expire and have no value.

The closing of the rights offering and the issuance of the shares of common
stock are conditioned upon certain conditions. All subscriptions will be held in
escrow pending satisfaction of these conditions. If the conditions are not
satisfied on or before the expiration of the subscription period, as it may be
extended, we will terminate this offering. If we terminate the offering, we will
return your money to you, without interest, within approximately 10 business
days following termination.

We will not issue fractional rights or fractional shares, and you may not
exercise rights other than in whole numbers. If the number of shares of common
stock you held on the record date would result in your receipt of fractional
rights, the number of rights issued to you has been rounded up to the nearest
whole right.

Our common stock is traded on the New York Stock Exchange under the symbol
OHI. On January 23, 2002, the last reported sale price for our common stock was
$5.50 per share.

The rights generally may not be sold, transferred or assigned and will not
be listed for trading on any stock exchange, quotation system or the
over-the-counter market. Once you exercise your rights, you may not revoke or
change the exercise even if you later change your mind.
------------------------

INVESTING IN OUR COMMON STOCK INVOLVES RISKS. SEE "RISK FACTORS" BEGINNING
ON PAGE 8.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
------------------------

The shares of common stock are being offered for sale directly by us without
the services of an underwriter or selling agent. We expect to deliver the shares
as soon as practicable following the expiration of the subscription period.

The date of this prospectus is January 24, 2002

TABLE OF CONTENTS

PAGE
--------

Prospectus Summary.......................................... 1
Risk Factors................................................ 8
The Rights Offering......................................... 21
Use of Proceeds............................................. 29
Modification of Bank Credit Agreements...................... 30
Determination of Subscription Price......................... 31
Price Range of Common Stock and Dividend Policy............. 44
Modifications to Agreements with Explorer................... 46
Capitalization.............................................. 50
Selected Financial Data..................................... 51
Management's Discussion and Analysis of Financial Condition
and Results of Operations................................. 52
Business.................................................... 65
Management.................................................. 74
Executive Compensation...................................... 79
Principal Stockholders...................................... 87
Affiliate Relationships and Transactions.................... 89
Description of Capital Stock................................ 92
Material United States Federal Income Tax Considerations.... 109
Plan of Distribution........................................ 118
Legal Matters............................................... 118
Experts..................................................... 118
Where You Can Find More Information......................... 118
Forward-Looking Statements.................................. 119
Index to Consolidated Financial Statements.................. F-1
Annex A--Opinion of Shattuck Hammond Partners LLC........... A-1

------------------------

You should rely only on the information contained in this prospectus and the
information to which we have referred you. We have not authorized anyone else to
provide you with information different from the information contained in this
prospectus. If anyone provides you with different or inconsistent information,
you should not rely on it. You should not assume that the information in this
prospectus is accurate as of any date other than the date on the front page of
this prospectus. Also, you should not assume that there has been no change in
our business, financial position or results of operations since the date of this
prospectus.

No action is being taken in any jurisdiction outside the United States to
permit a public offering of any securities or possession or distribution of this
prospectus in that jurisdiction. Persons who come into possession of this
prospectus in jurisdictions outside the United States are required to inform
themselves about and to observe any restrictions as to this offering and the
distribution of this prospectus applicable in that jurisdiction.

PROSPECTUS SUMMARY

THIS SUMMARY HIGHLIGHTS IMPORTANT INFORMATION CONTAINED ELSEWHERE IN THIS
PROSPECTUS IN MORE DETAIL. YOU SHOULD READ THE ENTIRE PROSPECTUS CAREFULLY.

QUESTIONS AND ANSWERS ABOUT THE RIGHTS OFFERING

WHAT ARE THE RIGHTS AND TO WHAT DO THE RIGHTS ENTITLE ME?

The rights give you the opportunity to purchase additional shares of our
common stock for $2.92 per share. On January 17, 2002, the last reported sale
price for our common stock on the New York Stock Exchange was $5.74 per share.

The aggregate number of rights you are entitled to receive, if exercised by
you in full, represents your pro rata portion of the $50 million in additional
equity capital we are seeking to raise. Your pro rata portion is based on the
number of shares of common stock you owned on the record date assuming, solely
for this purpose, conversion of all of our outstanding Series C preferred stock,
all of which is held by Explorer. There is no minimum number of shares that must
be subscribed for by stockholders in the rights offering.

WILL I RECEIVE FRACTIONAL RIGHTS OR SHARES?

No. We are not issuing fractional rights or shares, and you may not exercise
rights in fractional amounts. If the number of shares of common stock you held
on the record date would result in your receipt of fractional rights, the number
of rights distributed to you has been rounded up to the nearest whole right.

WHY IS OMEGA DISTRIBUTING THE RIGHTS AND OFFERING STOCK?

We are distributing the rights to purchase common stock as part of our plan
to raise up to $50 million in additional equity capital to satisfy the
conditions to the modification of our credit facilities and to enhance our
ability to repay approximately $98 million in debt maturing during the first
half of 2002. The equity investment consists of two components--this rights
offering and a concurrent private placement of equity pursuant to our
October 29, 2001 investment agreement with Explorer. We are distributing the
rights to give all our common stockholders the opportunity to participate in our
issuance of $50 million in additional equity in proportion to their ownership
interest in our voting stock. The rights offering affords our existing common
stockholders an opportunity to subscribe for new shares of common stock, at the
same price per common share as the Explorer private placement, and to maintain
their proportionate interest in us. In addition, since no underwriting or sales
commission will be paid in respect of the shares purchased in the rights
offering, we believe the rights offering will be a low-cost method for raising
additional capital.

HOW DID OMEGA ARRIVE AT THE $2.92 PRICE PER SHARE?

Our Board of Directors sought and obtained a written opinion from Shattuck
Hammond Partners LLC, an independent financial advisor, that as of October 29,
2001, the date of their opinion, the financial terms of the investment agreement
with Explorer, taken as a whole, are fair to us from a financial point of view.
The subscription price to be paid by stockholders in the rights offering will be
the same price per common share paid by Explorer in the concurrent private
placement. For purposes of the opinion, our financial advisor assumed a
subscription price of $2.92 per share.

In recommending a price at which a share of common stock may be purchased in
this rights offering, a special committee of our Board of Directors, which did
not include affiliates of Explorer, considered several factors, including the
fairness opinion delivered by our financial advisor, the historic and current
market price of our common stock as of the date of the opinion, our financial
condition, challenges facing us, anticipated cash flows, general conditions in
the securities markets, our need for additional capital, available alternate
sources of financing, prices offered to stockholders in other rights offerings
and the need to offer the shares at a price that would be attractive to
investors relative to the then current trading price for our common stock, among
other things. Shattuck Hammond's opinion relates solely to the fairness to Omega
Healthcare of the financial terms of the investment agreement, and does not
address the fairness of either the investment agreement to unaffiliated
stockholders or the subscription price in the rights offering.

HAS THE BOARD OF DIRECTORS MADE A RECOMMENDATION REGARDING THE RIGHTS OFFERING?

Our Board of Directors is not making any recommendation about whether or not
you should exercise any rights. Although our Board of Directors has obtained a
fairness opinion and both the Board of Directors and the special committee
approved our proceeding with the rights offering, you should make your own
decision as to whether or not to exercise your rights and, if so, how many
rights to exercise. You should make this decision only after reading this entire
prospectus and consulting with your own financial advisors. Your decision should
be based upon your own assessment of your best interests.

HOW SOON MUST I ACT?

The rights expire on February 14, 2002, at 5:00 p.m., New York City time.
The subscription agent must actually receive all required documents and payments
before that date and time. We recommend that you send all of your subscription
documents, together with payment of the subscription price, to the subscription
agent several days in advance of the expiration date. Any personal checks used
to pay for shares must timely clear payment prior to the expiration date. The
clearing process can take five business days or more. We can extend the
expiration date, but in no event will the expiration date be extended beyond
February 28, 2002. We do not presently intend to extend the expiration date.

MAY I TRANSFER MY RIGHTS OR THE SHARES TO WHICH THEY RELATE?

No. The rights are nontransferable, even by gift. However, rights may be
transferred by will, devise or operation of law in the case of death,
dissolution, liquidation, or bankruptcy of the holder or pursuant to an order of
an appropriate court.

WILL I BE ENTITLED TO AN OVER-SUBSCRIPTION PRIVILEGE?

No stockholder will have an over-subscription privilege in the rights
offering. To the extent that shares of common stock are not subscribed for in
this offering, Explorer has committed to increase the size of its private
placement investment in our company by an additional amount equal to the
aggregate subscription price relating to the unsubscribed shares on the closing
of the rights offering.

WILL EXPLORER PARTICIPATE IN THE RIGHTS OFFERING OR OTHERWISE INVEST IN OMEGA?

No. Explorer will not purchase common stock in this rights offering.
Although Explorer will not participate in the rights offerings, Explorer has
agreed to purchase $23.6 million of our stock, in a private placement concurrent
with the closing of the rights offering, at the same price per common

share available in this rights offering. The amount that Explorer has agreed to
invest in the private placement represents its pro rata portion, based on
Explorer's ownership of our Series C preferred stock and common stock, of the
$50 million in additional equity capital we are seeking to raise. Explorer has
also agreed to increase the size of its private placement investment in our
company by an additional amount equal to the aggregate subscription price of any
shares that are not subscribed for in this offering. As a result of this
commitment, we are assured of receiving a total of $50 million in gross proceeds
upon the completion of the rights offering and Explorer's investment. The shares
to be issued to Explorer are not registered as part of the rights offering and
will be restricted securities under the Securities Act.

As a condition to Explorer's private placement investment, we have agreed to
amend certain of the agreements relating to Explorer's July 2000 investment in
our company effective as of the closing of Explorer's new investment. The effect
of these amendments is generally to remove those provisions in our agreements
that prohibit Explorer from voting in excess of 49.9% of our stock and from
taking certain actions without the prior approval of our Board. These agreements
are described in more detail under "Modifications to Agreements with Explorer"
on page 46 of this prospectus. The private placement to Explorer is subject to
the satisfaction of the same closing conditions to which the rights offering is
subject.

The rules of the New York Stock Exchange require that stockholders approve
the sale of voting capital stock to an affiliate such as Explorer. If the
issuance of common stock to Explorer has not been approved by our stockholders
at the time we close the rights offering and Explorer's investment, we will
issue to Explorer, in lieu of common stock, non-voting Series D preferred stock,
which will have greater rights and preferences than common stock. The Series D
preferred stock will automatically convert into common stock upon receipt of
stockholder approval or the waiver by the New York Stock Exchange of its
stockholder approval requirement.

We have scheduled a special meeting of stockholders to be held on
February 18, 2002 at which stockholders will be asked to vote on a proposal to
approve the issuance of common stock to Explorer. Explorer has committed to vote
its existing shares, representing 47.1% of our voting capital stock, in favor of
this proposal. We will provide separate proxy solicitation materials to our
stockholders in connection with the special meeting. We recommend that you read
both the prospectus and the proxy materials completely. Your vote will not
affect your ability to exercise rights received in this offering. Stockholders
may vote to approve the issuance of the shares of common stock to Explorer and
still decline to exercise their subscription rights. Conversely, stockholders
can vote against the issuance of shares to Explorer yet still exercise their
subscription rights if the closing conditions to which the rights offering is
subject are met. This prospectus relates solely to the rights offering and is
not a solicitation for proxies. The proxy solicitation will only be made
pursuant to the separate proxy materials that you will receive.

AM I REQUIRED TO PARTICIPATE IN THE RIGHTS OFFERING?

No. You are not required to exercise any rights, purchase any new shares, or
otherwise take any action in response to this rights offering.

WHAT WILL HAPPEN IF I DO NOT EXERCISE MY RIGHTS?

If you do not exercise any rights, the number of shares you own will not
change, but your percentage ownership of our total outstanding common stock will
decline following the rights offering and Explorer's investment. There is no
minimum number of shares that must be subscribed for by stockholders in the
rights offering. If no other stockholders subscribe for shares in the rights
offering, Explorer has committed to invest $50 million if the closing conditions
are satisfied.

IS THE RIGHTS OFFERING SUBJECT TO ANY CLOSING CONDITIONS?

Yes, the closing of the rights offering is subject to conditions relating to
modifications to our credit facilities and the absence of any governmental order
or litigation that is reasonably likely to render it impossible or unlawful to
complete the rights offering and/or Explorer's investment, or that could
reasonably be expected to have a material adverse effect on our business,
results of operations, or financial condition, or materially restrict the the
rights of Explorer under the documents relating to its investment.

We have entered into amendments to our credit facilities that are
satisfactory to us and Explorer that become effective concurrently with the
closing of the rights offering. We believe that these amendments will satisfy
the closing conditions relating to our credit facilities. See "Modification of
Bank Credit Agreements." While there currently exists no governmental order or
litigation with respect to this offering, we cannot assure you that such
governmental order or litigation will not arise prior to closing the rights
offering. If a governmental order or litigation arises prior to the closing of
the rights offering, we may not be able to complete the rights offering and/or
the private placement to Explorer.

If these conditions are not satisfied by the expiration of the subscription
period, as it may be extended by us from time to time, in our sole discretion,
we will terminate the rights offering. All subscriptions will be held in escrow
pending satisfaction of these conditions. If we terminate the rights offering,
we will return your money to you, without interest, within approximately 10
business days following termination.

HOW DO I EXERCISE MY RIGHTS?

You must properly complete and sign the enclosed subscription agreement and
deliver it, together with payment in full for the rights you are exercising, to
the subscription agent before expiration of the subscription period. For the
address to which the subscription agreement should be mailed and payment
forwarded, see "The Rights Offering--Procedures To Exercise Rights."

AFTER I EXERCISE MY RIGHTS, CAN I CHANGE MY MIND?

No. Once you send in your subscription agreement and payment, you may not
revoke the exercise of your rights, even if you later learn information about us
that you consider to be unfavorable, or if our stock price declines. You should
not exercise your rights unless you are certain that you wish to purchase
additional shares of our common stock in this rights offering.

IS THERE RISK IN OWNING OUR COMMON STOCK?

Yes. Exercising your rights means making a decision to make an additional
investment in our common stock. You should carefully consider this decision as
you would any other equity investment. Among other things, you should carefully
consider the risks described under "Risk Factors" beginning on page 8 of this
prospectus.

CAN OMEGA TERMINATE THE RIGHTS OFFERING?

Yes. We may terminate the rights offering at any time before the expiration
of the subscription period for any reason or promptly following expiration of
the subscription period if the closing conditions are not satisfied at
expiration. If we terminate the rights offering, your money will be refunded,
without interest, within approximately 10 business days following termination.

WHAT SHOULD I DO IF I WANT TO PARTICIPATE IN THE RIGHTS OFFERING, BUT MY COMMON
STOCK IS HELD IN THE NAME OF MY BROKER, DEALER OR OTHER NOMINEE?

If you hold your shares of our common stock through a broker, dealer or
other nominee, for example, through a custodian bank, then your broker, dealer
or other nominee is the record holder of

the shares you own. This record holder must exercise the rights on your behalf
for shares you wish to purchase. Therefore, you will need to have your broker,
dealer or other nominee act for you.

If you wish to participate in the rights offering and purchase new shares,
please promptly contact the record holder of your shares. To indicate your
decision with respect to your rights, you should follow the instructions
provided by your broker, dealer or other nominee. You should receive these
instructions from the record holder with the other rights offering materials.

WHAT FEES OR CHARGES APPLY IF I PURCHASE SHARES?

We are not charging any fee or sales commission to issue rights to you or to
issue shares to you if you exercise rights. If you exercise rights through a
record holder of your shares, you are responsible for paying any fees that the
record holder may charge you.

WHAT ARE THE FEDERAL INCOME TAX CONSEQUENCES OF EXERCISING MY SUBSCRIPTION
RIGHTS?

The receipt and exercise of your subscription rights are intended to be
nontaxable. However, you should seek specific tax advice from your personal tax
advisor with respect to your particular circumstances and tax situation. See
"Material United States Federal Income Tax Considerations."

HOW MANY SHARES OF COMMON STOCK WILL BE OUTSTANDING AFTER THE RIGHTS OFFERING
AND THE EXPLORER INVESTMENT? HOW MUCH OF OMEGA WILL EXPLORER OWN?

Following the rights offering and Explorer's investment, we will have
53,897,075 shares of common stock outstanding assuming the conversion of the
Series C preferred stock and assuming we issue shares of common stock to
Explorer in connection with its investment. If, at the time of Explorer's
investment, we have not obtained the requisite stockholder approval to issue
common stock to Explorer, Explorer will instead purchase shares of Series D
preferred stock rather than common stock, and the number of shares of common
stock outstanding would be reduced by the number of shares of common stock
reserved for issuance upon conversion of the Series D preferred stock. The
number of additional shares to be purchased by Explorer depends on the number of
shares that are purchased by other stockholders in the rights offering. If no
shares are subscribed for in the rights offering, following completion of the
rights offering and the concurrent private placement Explorer would own
approximately 63.9% of our voting stock on an as converted basis. If all of the
shares are subscribed for in the rights offering, Explorer would continue to own
approximately 47.1% of our voting stock on an as converted basis.

WHO IS THE SUBSCRIPTION AGENT?

EquiServe Trust Company, N.A. is the subscription agent for this rights
offering. EquiServe is also the transfer agent for our common stock.

WHAT IF MY PAYMENT IS INCONSISTENT WITH THE NUMBER OF RIGHTS BEING EXERCISED?

If you send a payment that is insufficient to purchase the number of shares
for which you are exercising rights, or if the number of shares is not indicated
in the forms you return, the subscription agent will apply the payment received
to exercise rights on your behalf up to the amount of the payment received. If
your payment exceeds the subscription price for the maximum number of rights
that you are eligible to exercise, the excess will be refunded to you, without
interest within approximately 10 business days following the expiration date.

WILL MANAGEMENT PARTICIPATE IN THE RIGHTS OFFERING?

Our executive officers and directors that own shares of our common stock
have indicated that they intend to participate in the rights offering, although
they are not bound to do so and may change their mind at any time. These
executive officers and directors are eligible to subscribe for an aggregate of
448,950 additional shares of our common stock in the rights offering.

WHEN WILL SHARES BE ISSUED?

Shares of common stock purchased in the rights offering will be issued as
soon as practicable after satisfaction of the closing conditions, not to exceed
10 business days after the expiration date.

WHAT SHOULD I DO IF I HAVE OTHER QUESTIONS?

If you have questions, need additional copies of offering documents or
otherwise need assistance, you should contact Georgeson Shareholder
Communications, Inc. Georgeson's address and phone number appear on page 28. You
may also contact us at the address and telephone number shown on page 7. We also
file annual and quarterly reports and other information with the Securities and
Exchange Commission. You may obtain copies of these reports by contacting us,
the Securities and Exchange Commission or the New York Stock Exchange, as
applicable, as described in "Where You Can Find More Information" also on
page 118.

OUR COMPANY

We are a self-administered real estate investment trust, or REIT, investing
in and providing financing to the long-term care industry in the United States.
At September 30, 2001, we owned or had mortgages on 246 skilled nursing and
assisted living facilities with approximately 25,400 beds located in 29 states
and operated by 32 independent healthcare operating companies.

We have historically financed investments through borrowings under our
revolving credit facilities, private placements or public offerings of debt or
equity securities, the assumption of secured debt or a combination of these
methods. We also finance acquisitions through the exchange of properties or the
issuance of shares of our capital stock when the transactions otherwise satisfy
our investment criteria.

We prefer to make equity investments in our properties. We do this by
purchasing the property and leasing it back to the operator. However, due to
regulatory, tax or other considerations, we sometimes pursue alternative
investment structures, including convertible participating and participating
mortgages, that we believe achieve returns comparable to equity investments. We
also provide traditional fixed-rate mortgages.

We are currently unable to borrow under our revolving credit facilities
because we are not in compliance with certain financial covenants contained in
the loan agreements relating to our two revolving credit facilities. On
December 21, 2001, we reached agreements with the bank groups under both of our
revolving credit facilities. These agreements include modifications and/or
waivers to the financial covenants with which we were not in compliance. In
addition, certain other financial covenants will be either modified or
eliminated going forward. The effectiveness of these agreements is subject to
the completion of the rights offering and private placement to Explorer. See
"Modifications of Bank Credit Agreements."
--------------

Our executive offices are located at 9690 Deereco Road, Suite 100, Timonium,
Maryland 21093. Our telephone number is (410) 561-5726.

We also maintain a website at www.omegahealthcare.com. However, the
information on our website is not part of this prospectus and you should
consider only the information contained in this prospectus when making a
decision as to whether or not to exercise your rights.

RISK FACTORS

You should carefully consider the risks described below and the other
information in this prospectus before deciding to purchase shares in the rights
offering. Many factors, including the risks described below and other risks we
have not recognized, could cause our operating results to be different from our
current expectations and plans.

RISKS RELATED TO THE RIGHTS OFFERING

YOU CANNOT REVOKE YOUR EXERCISE OF SUBSCRIPTION RIGHTS FOR ANY REASON.

You may not revoke or change your exercise of rights after you send your
subscription forms and payment to the subscription agent. If you later learn
information about us that you consider to be unfavorable, if our stock price
declines, or if you simply change your mind, you will not be entitled to revoke
your subscription or obtain a refund of your subscription price. If we terminate
the rights offering, you are only entitled to a refund of your subscription
price. We will not pay any interest on the subscription price while it is held
in escrow. If the market value of your shares declines during the period in
which you are required to hold the shares, you will not receive any compensation
for such loss in market value.

IF YOU DO NOT EXERCISE YOUR RIGHTS, YOUR PERCENTAGE OWNERSHIP INTEREST WILL BE
DILUTED.

If you choose not to exercise your subscription rights in full, your
percentage ownership interest will be diluted following the rights offering and
private placement to Explorer. In addition, because the subscription price
represents a discount from the prevailing market price of our common stock,
stockholders who choose not to exercise their subscription rights will
experience dilution of their economic interest in us.

THE SUBSCRIPTION RIGHTS ARE NONTRANSFERABLE.

Only our stockholders of record as of the record date may exercise rights.
You may not sell, give away, or otherwise transfer your rights. However, rights
may be transferred by will, devise or operation of law in the case of death,
dissolution, liquidation or bankruptcy of the holder or pursuant to an order of
an appropriate court.

YOU NEED TO ACT PROMPTLY AND FOLLOW SUBSCRIPTION INSTRUCTIONS.

If you decide to exercise your rights, you will need to follow the
instructions contained in this prospectus and the subscription agreement. If you
do not, your subscription may be rejected. Stockholders who desire to purchase
shares in the rights offering must act promptly to ensure that all required
forms and payments are actually received by EquiServe, the subscription agent,
prior to the expiration date. If you fail to complete and sign the required
subscription forms, send an incorrect payment amount, or otherwise fail to
follow the subscription procedures we may, depending on the circumstances,
reject your subscription or accept it to the extent of the payment received.
Neither we nor EquiServe undertakes to contact you concerning, or to attempt to
correct, an incomplete or incorrect subscription form. We have the sole
discretion to determine whether a subscription exercise properly follows the
subscription procedures.

In addition, any personal check used to pay for shares must clear prior to
the expiration date, and the clearing process may require five or more business
days.

THE SERIES D PREFERRED STOCK THAT MAY BE ISSUED TO EXPLORER WILL HAVE GREATER
RIGHTS, PREFERENCES AND PRIVILEGES THAN THOSE ALLOCATED TO OUR COMMON STOCK.

If we have not obtained the approval of our stockholders to issue common
stock to Explorer as required by the rules of the New York Stock Exchange prior
to the closing of the private placement to Explorer, we will issue to Explorer a
new series of preferred stock that will have greater rights, preferences and
privileges than our common stock, although this preferred stock would be
non-voting. The Series D preferred stock has dividend rights and rights upon
liquidation, dissolution or winding up of our company that rank senior to our
common stock. Accordingly, if Explorer receives Series D preferred stock and it
cannot be converted into common stock, Explorer will have, in some instances,
greater rights, preferences and privileges than the holders of our common stock.

YOUR SUBSCRIPTION PRICE WILL BE RETURNED WITHOUT INTEREST IF THE RIGHTS OFFERING
IS NOT COMPLETED.

If we terminate the rights offering, you are only entitled to a refund of
your subscription price. We will not pay any interest on the subscription price
while it is held in escrow. If the market value of your shares declines during
the period in which you are required to hold the shares, you will not receive
any compensation for such loss in market value.

The closing of the rights offering is subject to conditions relating to
modifications to our credit facilities and the absence of any governmental order
or litigation that is reasonably likely to render it impossible or unlawful to
complete the rights offering and/or Explorer's investment, or that could
reasonably be expected to have a material adverse effect on our business,
results of operations, or financial condition, or materially restrict the rights
of Explorer under the documents relating to its investment.

We have entered into amendments to our credit facilities that are
satisfactory to us and Explorer that become effective concurrently with the
closing of the rights offering. We believe that these amendments will satisfy
the closing conditions relating to our credit facilities. While there currently
exists no governmental order or litigation with respect to this offering, we
cannot assure you that such governmental order or litigation will not arise
prior to closing the rights offering. If a governmental order or litigation
arises prior to the closing of the rights offering, we may not be able to
complete the rights offering and/or the private placement to Explorer. As a
result, we cannot assure you that the rights offering will be completed.

RISKS RELATED TO OUR COMMON STOCK

THE PRICE OF OUR COMMON STOCK MAY DECLINE BELOW THE SUBSCRIPTION PRICE.

The subscription price in this rights offering represents a discount to the
market price of our common stock on the date it was determined. The trading
price for our common stock may decline below the subscription price during or
after the rights offering. We cannot assure you that the subscription price will
remain below the trading price for our common stock.

THE FUTURE MARKET PRICE OF OUR COMMON STOCK MAY FLUCTUATE SUBSTANTIALLY.

Future prices of our stock may be affected positively or negatively by our
future revenues and earnings, changes in estimates by analysts, our ability to
meet analysts' estimates, speculation in the trade or business press about our
company, and overall conditions affecting our business, economic trends and the
securities markets.

In addition, the stock market has recently experienced significant price and
volume fluctuations, which have been further exacerbated by the events of
September 11, 2001. We cannot assure you that the market for our common stock
will not continue to be volatile or that any additional terrorist attacks would
not further disrupt the market generally or our common stock in particular.

ALTHOUGH OUR COMMON STOCK IS LISTED ON THE NEW YORK STOCK EXCHANGE, IT IS THINLY
TRADED. OUR STOCK PRICE MAY FLUCTUATE MORE THAN THE STOCK MARKET AS A WHOLE.

As a result of the thin trading market or "float" for our stock, the market
price for our common stock may fluctuate significantly more than the stock
market as a whole. In addition, sales of a substantial amount of common stock in
the public market, or the perception that these sales may occur, could adversely
affect the market price of our common stock. Explorer owns approximately 47.1%
of our voting stock and will likely acquire additional shares as a result of its
new investment and stockholders not exercising their rights in the rights
offering. Without a large float, our common stock is less liquid than the stock
of companies with broader public ownership, and as a result, the trading prices
for our common stock may be more volatile. Among other things, trading of a
relatively small volume of our common stock may have a greater impact on the
trading price for our stock than would be the case if our public float were
larger. Explorer has the right to require us to register for resale the shares
of our capital stock that it owns and can transfer any or all of its shares
without our consent. As a result, Explorer has the ability to sell a substantial
amount of our stock. Sales by Explorer, or the perception that such sales may
occur, could negatively impact the market for and trading price of our common
stock.

RISKS RELATED TO OUR COMPANY

OUR SUBSTANTIAL INDEBTEDNESS COULD ADVERSELY AFFECT OUR FINANCIAL CONDITION.

We have substantial indebtedness and will continue to have substantial
indebtedness after the completion of the rights offering. In addition, we may
increase our indebtedness in the future. Our level of indebtedness could have
important consequences to our stockholders. For example, it could:

- make us more vulnerable to economic downturns;

- potentially limit our ability to withstand competitive pressures;

- impair our ability to obtain additional financing in the future for
working capital, capital expenditures, acquisitions or general corporate
purposes; and

- make us more susceptible to the above risks because borrowings under our
credit facilities will bear interest at fluctuating rates.

We are dependent on third party financing for our investments. We have
historically obtained such financing by accessing the public and private debt
capital markets. Cash provided by our operating activities and/or proceeds from
asset sales or additional equity issuances may be insufficient to meet required
payments of principal and interest. In addition, we are also subject to risks
related to rising interest rates on our floating rate debt that is not hedged,
and our ability to repay or refinance existing indebtedness, which generally
will not have been fully amortized at maturity and the terms of which may not be
as favorable as the terms of existing indebtedness. In the event we are unable
to refinance outstanding indebtedness as it matures on acceptable terms, we
might be forced to dispose of properties upon disadvantageous terms, which might
result in losses to us, or to obtain financing at unfavorable terms either of
which might adversely affect the cash flow available to meet debt service
obligations. In addition, if a property or properties are mortgaged to secure
payment of indebtedness and we are unable to meet required mortgage payments,
the mortgage securing the property could be foreclosed upon by, or the property
could be otherwise transferred to, the mortgagee with a consequent loss of
income and asset value to us.

At September 30, 2001, on a consolidated basis, we had outstanding
indebtedness of approximately $426.0 million, and the ratio of our debt to total
assets was 46.7%. On a pro forma basis at September 30, 2001, after giving
effect to the rights offering, Explorer's investment and the application

of the estimated net proceeds therefrom and certain other adjustments, we would
have had outstanding indebtedness of approximately $381.0 million and had a
ratio of debt to total assets of 41.8%.

OUR FAILURE TO COMPLY WITH CERTAIN FINANCIAL COVENANTS IN OUR TWO CREDIT
FACILITIES CURRENTLY PREVENTS US FROM BORROWING UNDER THOSE FACILITIES AND COULD
CAUSE THAT AND OTHER DEBT TO BECOME IMMEDIATELY PAYABLE.

We are currently unable to borrow under our revolving credit facilities
because we are not in compliance with certain of the financial covenants
contained in the loan documents relating to our two revolving credit facilities.
These covenant violations currently prevent us from drawing upon the remaining
availability under these credit facilities.

On December 21, 2001 we reached agreements with the bank groups amending
both of our revolving credit facilities. These agreements include modifications
and/or waivers to certain financial covenants with which we were not in
compliance. In addition, certain other financial covenants will be either
modified or eliminated going forward.

Each of the amendments to our credit facilities is conditioned upon the
closing of the rights offering and Explorer's investment. If the rights offering
does not close, both amendments will be null and void and we will remain in
violation of our credit facilities. These violations would permit the lenders to
declare any or all of the amounts due under the respective credit facilities to
be immediately due and payable. If the lenders declare such amounts due and
payable, we will not have sufficient funds to repay the borrowings or other debt
obligations that may come due in the near future.

THE SALE OF UNSUBSCRIBED SHARES IN THE RIGHTS OFFERING TO EXPLORER OR FUTURE
STOCK PURCHASES BY EXPLORER MAY VEST CONTROL OF OUR COMPANY IN EXPLORER.

Explorer presently owns 47.1% of our voting stock through the ownership of
our Series C preferred stock and 553,850 shares of common stock. The number of
additional shares Explorer has agreed to purchase in the concurrent private
placement depends on how many rights are exercised in the rights offering. If
all of the rights are exercised by our stockholders in the rights offering,
Explorer would continue to own 47.1% of our voting stock following the rights
offering and private placement to Explorer. If none of the rights are exercised,
Explorer would own 63.9% of our voting stock following the rights offering and
private placement to Explorer.

As a condition to the private placement to Explorer, we have agreed to amend
the agreements we have with Explorer to remove restrictions that currently limit
the right of Explorer to purchase additional shares of our stock or to vote
shares of our stock that it owns in excess of 49.9% of our total voting stock.
As a result, if Explorer acquires beneficial ownership of more than 50% of our
common stock, Explorer will have the right to designate a majority of our
directors and the voting power to cause the election of all our directors.
Explorer will be able to control, through our Board, the management and affairs
of our company. It will also be able to control the vote on all matters
submitted to our stockholders, including transactions involving an actual or
potential change in our control. This could prevent transactions in which the
holders of our common stock might otherwise receive a premium for their shares
over then current market prices. The interests of Explorer may not coincide with
the interests of the other holders of our common stock.

OUR ASSETS MAY NOT BE ADEQUATE TO SATISFY OUR DEBT OBLIGATIONS IN THE EVENT OF A
LIQUIDATION AND WE MAY NOT HAVE ANY ASSETS AVAILABLE FOR DISTRIBUTION TO
STOCKHOLDERS.

If the lenders under our credit facilities were to declare any or all of the
amounts outstanding under those facilities to be immediately payable, we will
not have sufficient funds to repay the borrowings or other debt obligations that
may come due in the near future. In the event of a

bankruptcy or liquidation of our company, the lenders under our credit
facilities and the holders of our debt securities would be entitled to payment
of all amounts due to them before the holders of our common stock would receive
anything. In addition, the holders of our preferred stock are entitled to
liquidation preferences. We cannot assure you that the value of our assets will
be sufficient to meet all of our obligations. If they are not sufficient, the
holders of our common stock may not receive anything in the event of a
liquidation or reorganization of our company.

WE HAVE SIGNIFICANT PRINCIPAL AND DIVIDEND PAYMENTS COMING DUE; WE MAY BE UNABLE
TO PAY THESE AMOUNTS OR REFINANCE MATURING INDEBTEDNESS.

We have significant principal and dividend payments due on our indebtedness
and preferred stock over the next several years. We are presently required to
make the following principal payments on our current outstanding debt:

- $99.4 million in 2002;

- $131.0 million in 2003;

- $2.2 million in 2004; and

- $180.5 million thereafter.

Additionally, dividends on Series A, B and C preferred stock accrue at
$20.1 million annually. As of December 31, 2001, we had $19.9 million of
accumulated and unpaid preferred dividends.

Although we intend to use a portion of the proceeds of this offering to
repay our indebtedness, it will not be enough to satisfy all of these
obligations. Our ability to meet these obligations will depend upon our future
operating performance and our ability to dispose of properties currently held
for sale, which in turn will be subject to general economic conditions, industry
cycles and financial, business and other factors affecting our operations, many
of which are beyond our control.

We cannot assure you that our business will continue to generate sufficient
cash flow from operations or that there will be sufficient proceeds from asset
sales or additional equity issuances to repay our substantial indebtedness. If
we are unable to generate sufficient cash from these sources, we may be required
to sell additional assets, to refinance all or a portion of our indebtedness or
to obtain additional financing. We cannot assure you that any such refinancing
will be possible or that any additional financing will be available on terms
acceptable to us.

OUR DEBT AGREEMENTS IMPOSE SIGNIFICANT OPERATING AND FINANCIAL RESTRICTIONS,
WHICH MAY PREVENT US FROM CAPITALIZING ON BUSINESS OPPORTUNITIES.

Our debt agreements impose significant operating and financial restrictions
on us. These restrictions affect, and in certain cases limit, among other
things, our ability to:

- incur additional indebtedness and liens;

- make capital expenditures;

- make investments and acquisitions and sell assets; or

- consolidate, merge or sell all or substantially all of our assets.

We cannot assure you that these restrictions will not adversely affect our
ability to finance our future operations or capital needs or to engage in other
business activities that may be in the interest of stockholders.

OUR INDUSTRY IS SUBJECT TO SIGNIFICANT GOVERNMENT REGULATION.

Nearly all of our properties are used as healthcare facilities; therefore,
we are directly affected by the risks associated with the healthcare industry.
The healthcare industry is highly regulated by federal, state and local laws,
rules and regulations and is directly affected by state and local licensure,
fines and loss of certification to participate in the Medicare and Medicaid
programs, as well as potential criminal penalties. These laws, rules and
regulations are complex and constantly evolving, and subject to considerable
interpretation and discretion on the part of regulators and courts. We cannot
assure you that government investigations will not result in interpretations
that are inconsistent with industry practices.

The Balanced Budget Act of 1997 enacted a number of anti-fraud and abuse
provisions and contains civil monetary penalties for an operator's violation of
the anti-kickback laws. The Balanced Budget Act also imposes an affirmative duty
on operators to ensure they do not employ or contract with persons excluded from
the Medicare or other governmental programs. It also provides a minimum ten-year
period for exclusion from participation in federal healthcare programs for
operators convicted of a prior healthcare offense. Additionally, the Health
Insurance Portability and Accountability Act of 1996, which became effective
January 1, 1997, broadened the scope of fraud and abuse laws, such as the
anti-kickback law, and related enforcement activities.

Governmental investigations and enforcement of healthcare laws have
increased dramatically and are expected to continue to increase. There are
heightened coordinated civil and criminal enforcement efforts by both federal
and state government agencies relating to the healthcare industry, including the
skilled nursing segment. There is increasing scrutiny by law enforcement
authorities, the Office of Inspector General, the Department of Health and Human
Services, the U.S. Department of Justice, the courts and Congress of
arrangements between healthcare providers and potential referral sources to
ensure that arrangements are not designed as a mechanism to exchange
remuneration for patient care referrals and opportunities. Investigators have
also demonstrated a willingness to look behind the formalities of a business
transaction to determine the underlying purpose of payments between healthcare
providers and potential referral sources. Additionally, federal and state
enforcement authorities have used the federal False Claims Act with increasing
frequency in quality of care cases. In addition to investigations and
enforcement actions initiated by governmental agencies, healthcare companies may
also be the subject of qui tam or whistleblower actions brought under the False
Claims Act by private individuals on behalf of the government. Whistleblowers
receive a portion of any amounts collected by the government in those types of
actions as a reward for bringing the action to the government's attention.
Actions under the False Claims Act are generally filed under seal to allow the
government adequate time to investigate and determine whether or not it will
intervene in the lawsuit, and defendant healthcare providers are often without
knowledge of these actions until the government has completed its investigation
and the seal is lifted. This process can take several years. Over the past few
years, a number of False Claims Act or fraud and abuse suits have been brought
against nursing home facilities or operators based on quality of care issues,
staffing levels, submitting falsely inflated costs reports, billing for services
never rendered, billing of labor costs, and upcoding of claims.

The increase in governmental investigations, the Balanced Budget Act, Health
Insurance Portability and Accountability Act, future healthcare legislation or
other changes in administration or interpretation of governmental healthcare
programs may have a material adverse effect on the amounts we receive with
respect to our owned and operated portfolio and the liquidity, financial
condition or results of operations of our operators, which could also have a
material adverse effect on their ability to make rent and interest payments to
us.

OUR LESSEES/MORTGAGORS RELY ON THIRD PARTY PAYORS FOR PAYMENT.

Based on information provided by the operators of our facilities, the
following table sets forth the approximate payor mix for our facilities for the
most recently reported twelve-month period:

Medicaid.................................................... 52.5%
Medicare.................................................... 22.5
Private..................................................... 12.0
Other....................................................... 13.0
-----
Total....................................................... 100.0%
=====

Our lessees and mortgagors, as well as the facilities owned and operated for
our account, derive a substantial portion of their net operating revenues from
third-party payors, including the Medicare and Medicaid programs. These programs
are highly regulated and subject to frequent and substantial changes. The
Balanced Budget Act significantly reduced spending levels for the Medicare and
Medicaid programs. Due to the implementation of the terms of the Balanced Budget
Act, effective July 1, 1998, the majority of skilled nursing facilities shifted
from payments based on reimbursable cost to a prospective payment system for
services provided to Medicare beneficiaries. Under the prospective payment
system, skilled nursing facilities are paid on a per diem prospective case mix
adjusted payment basis for all covered services. Implementation of the
prospective payment system has affected each long-term care facility to a
different degree depending upon the amount of revenue it derives from Medicare
patients. Long-term care facilities have had to attempt to restructure their
operations to operate profitably under the new Medicare prospective payment
system reimbursement policies. Although Congress amended the Balanced Budget Act
in 1999 and 2000 to restore some monies to skilled nursing facilities that were
cut as a result of the implementation of the Balanced Budget Act, we cannot
assure you that there will be any future legislation to increase payment rates
for skilled nursing facilities. If payment rates for skilled nursing facilities
are not increased in the future, our lessees and mortgagors may have difficulty
meeting their payment obligations to us.

Each state has its own Medicaid program that is funded jointly by the state
and federal government. Federal law governs how each state manages its Medicaid
program, but there is wide latitude for states to customize Medicaid programs to
fit the needs and resources of its citizens. The Balanced Budget Act repealed
the federal payment standard, also known as the Boren Amendment, for hospitals
and nursing facilities under Medicaid, increasing states' discretion over the
administration of Medicaid programs. A number of states are considering
legislation designed to reduce their Medicaid expenditures which could result in
decreased revenues for our lessees and mortgagors.

In addition, private payors, including managed care payors, are increasingly
demanding discounted fee structures and the assumption by healthcare providers
of all or a portion of the financial risk of operating a healthcare facility.
Efforts to impose greater discounts and more stringent cost controls are
expected to continue. Any changes in reimbursement policies which reduce
reimbursement levels could adversely affect the amounts we receive with respect
to our owned and operated portfolio and the revenues of our lessees and
mortgagors and thereby adversely affect those lessees' and mortgagors' abilities
to make their monthly lease or debt payments to us.

OUR LESSEES/MORTGAGORS MAY NOT GENERATE SUFFICIENT INCOME TO MEET THEIR PAYMENT
OBLIGATIONS TO US.

changes in governmental regulation, such as zoning laws, general or local
economic conditions, such as fluctuations in interest rates and adequacy of
local labor supply, the available local supply and demand for improved real
estate, a reduction in rental income as the result of an inability to maintain
occupancy levels, natural disasters, such as earthquakes and floods or similar
factors.

Other changes in the healthcare industry that may adversely affect the
incomes of lessees and mortgagors include continuing trends toward shorter
lengths of stay, increased use of outpatient services, increased federal, state
and third-party regulation and oversight of healthcare company operations and
business practices and increased demand for capitated healthcare services,
defined as the delivery of services at a fixed price per capita basis to a
defined group of covered parties. The entrance of insurance companies into
managed care programs is also accelerating the introduction of managed care in
new localities, and states and insurance companies continue to negotiate
actively the amounts they will pay for services. Moreover, the percentage of
healthcare services that are reimbursed under Medicare and Medicaid programs
continues to increase as the population ages and as states expand their Medicaid
programs. Continued eligibility to participate in these programs is crucial to a
provider's financial strength. Finally, healthcare regulation through
Certificates of Need has tended to limit construction of new long-term care
facilities in many states because states that have enacted Certificate of Need
legislation require the issuance of a Certificate of Need prior to the
construction of a new healthcare facility. A Certificate of Need is issued by
the applicable health planning agency in a state only after the health planning
agency makes a determination that a need exists in a particular area in the
state for a particular service or facility. Several states in which we have
investments have repealed Certificates of Need legislation, including California
and Texas, opening up opportunities for additional competition for our
facilities. As a result of the foregoing, the revenues and margins of the
operators of our facilities may decrease, resulting in a reduction of our
rent/interest coverage from investments.

OUR LESSEES/MORTGAGORS MAY EXPERIENCE A REDUCTION IN REVENUES DUE TO HEALTHCARE
REFORM.

The Health Insurance Portability and Accountability Act, enacted in 1996,
focused on assuring portability of employee healthcare benefits and increasing
enforcement powers of federal agencies that investigate and prosecute fraud and
abuse in federally funded healthcare programs. Ongoing federal budget
constraints will continue to place priority on the need to slow the growth rate
in federal healthcare expenditures. We anticipate that further debate on overall
structural reform of federal healthcare programs will affect additional
legislative action on cost-containment. We also anticipate that private payor
efforts to contain or reduce healthcare costs will continue. These trends are
likely to lead to reduced or slower growth in reimbursement for certain services
provided by some of our lessees and mortgagors. We cannot assure you that the
implementation of any reforms will not have a material adverse effect on our
financial condition or results of operations.

Additionally, portions of the Health Insurance Portability and
Accountability Act required the Department of Health and Human Services to adopt
standards governing electronic transmission of healthcare information. The
purpose of this law is to promote efficiency and effectiveness in the healthcare
system through the establishment of standards and requirements for the
electronic transmission of certain healthcare information. The entities covered
under this law are health plans, healthcare clearinghouses, and healthcare
providers that transmit health information electronically. Pursuant to this
authority, the Department of Health and Human Services published final
regulations on August 17, 2000 setting standardized transaction forms and code
sets for several common healthcare transactions, including healthcare claims,
remittance advice, coordination of benefits, referral certification and
authorization, health plan enrollments and disenrollments, health plan premium
payments, and health plan eligibility. The use of these standardized formats for
the covered transactions is expected to be mandated within 24 months of the
effective date of these regulations for

providers such as our lessees and mortgagors that engage in these types of
transactions through electronic transmissions.

Pursuant to other Administrative Simplification provisions of the Health
Insurance Portability and Accountability Act, the Department of Health and Human
Services published final regulations governing privacy and security of health
information on December 28, 2000, which became effective April 14, 2001. These
privacy regulations will likely require substantial review of and revisions to
our lessees' and mortgagors' current policies and procedures regarding the
storage, use and disposition of health information, as well as require them to
engage in "business partners" agreements regarding these practices with any
third party to which they disclose health information in order to carry out
their business and operate their facilities. These privacy regulations would
also require publication of our lessees' and mortgagors' policies regarding
privacy of health information and would confer enumerated rights upon residents
with respect to access to their own health information, requests to correct such
information, and accounting for particular disclosures of the information by our
lessees and mortgagors, and under our agreements with business partners.

Compliance with the regulations issued by the Department of Health and Human
Services under the Administrative Simplification provisions of the Health
Insurance Portability and Accountability Act will require our lessees and
mortgagors to assure that their information systems, as well as their operating
policies and procedures, are sufficient to accommodate the final standardized
transactions and code sets, as well as the security and privacy standards in the
privacy regulations published by the Department of Health and Human Services. As
a result of compliance with the foregoing, the revenues and margins of the
operators of our facilities may decrease, resulting in a reduction of our
rent/interest coverage from investments.

MEDICAID MAY NOT ADEQUATELY REIMBURSE US OR OUR LESSEES AND MORTGAGORS WHICH
COULD IMPACT THEIR ABILITY TO MEET THEIR PAYMENT OBLIGATIONS TO US.

We cannot assure you that the Medicaid reimbursement programs in each of the
states where we own and operate facilities or where our lessees' and mortgagors'
facilities are located will adequately reimburse us for our operating costs or
the rent or interest costs of our lessees and mortgagors. Failure by these state
Medicaid programs to provide reimbursement at current or increased levels could
have an adverse effect upon the cash flow of the facilities and, hence, on the
ability of our lessees and mortgagors to meet their respective payment
obligations to us. Additionally, Medicare regulations provide that, effective
December 1, 1997, when a facility changes ownership, by sale or under certain
lease transactions, reimbursement for depreciation and interest will be based on
the cost to the owner of record as of August 5, 1997, less depreciation allowed.
Previously, the buyer would use its cost of purchase up to the original owner's
historical cost before depreciation. Such changes could adversely affect the
resale value of our healthcare facilities.

THE LONG-TERM CARE INDUSTRY MAY EXPERIENCE INCREASED LIABILITY COSTS.

General liability and professional liability costs in the long-term care
industry have significantly increased over the past several years, with
increases in the number and average size of claims. Excluding Florida, where
recent experience is materially inconsistent with most other states, the number
of claims in the long-term care industry has been increasing annually at a rate
of approximately 8%, while the size of such claims has increased 14%. In
Florida, the number of claims has been increasing annually at a rate of
approximately 23%, while the size of such claims has increased 18%. The
increased frequency and magnitude of losses have led a number of insurance
companies to exit from the long-term care industry, resulting in dramatically
increased premiums and increased difficulties in obtaining coverage.

WE MAY BE EXPOSED TO UNINSURED LOSSES.

We currently require, and it is our intention to continue to require, all
lessees and mortgagors to secure adequate comprehensive property and liability
insurance that covers us as well as the lessee and mortgagor. Certain risks may,
however, be uninsurable or not economically insurable and we cannot assure you
that we or a lessee will have adequate funds to cover all contingencies.

OUR REAL ESTATE INVESTMENTS ARE RELATIVELY ILLIQUID.

Real estate investments are relatively illiquid and, therefore, tend to
limit our ability to vary our portfolio promptly in response to changes in
economic or other conditions. All of our properties are "special purpose"
properties that could not be readily converted to general residential, retail or
office use. Healthcare facilities that participate in Medicare or Medicaid must
meet extensive program requirements, including physical plant and operational
requirements, which are revised from time to time. Such requirements may include
a duty to admit Medicare and Medicaid patients, limiting the ability of the
facility to increase its private pay census beyond certain limits. Medicare and
Medicaid facilities are regularly inspected to determine compliance, and may be
excluded from the programs--in some cases without a prior hearing--for failure
to meet program requirements. Transfers of operations of nursing homes and other
healthcare-related facilities are subject to regulatory approvals not required
for transfers of other types of commercial operations and other types of real
estate. Thus, if the operation of any of our properties becomes unprofitable due
to competition, age of improvements or other factors such that our lessee or
mortgagor becomes unable to meet its obligations on the lease or mortgage loan,
the liquidation value of the property may be substantially less, particularly
relative to the amount owing on any related mortgage loan, than would be the
case if the property were readily adaptable to other uses. The receipt of
liquidation proceeds or the replacement of an operator that has defaulted on its
lease or loan could be delayed by the approval process of any federal, state or
local agency necessary for the transfer of the property or the replacement of
the operator licensed to manage the facility. In addition, certain significant
expenditures associated with real estate investment, such as real estate taxes
and maintenance costs, are generally not reduced when circumstances cause a
reduction in income from the investment. Should such events occur, our income
and cash flows from operations would be adversely affected.

AS AN OWNER OR LENDER WITH RESPECT TO REAL PROPERTY, WE MAY BE EXPOSED TO
POSSIBLE ENVIRONMENTAL LIABILITIES.

Under various federal, state and local environmental laws, ordinances and
regulations, an owner of real property or a secured lender, such as us, may be
liable in certain circumstances for the costs of removal or remediation of
certain hazardous or toxic substances at, under or disposed of in connection
with such property, as well as certain other potential costs relating to
hazardous or toxic substances, including government fines and damages for
injuries to persons and adjacent property. Such laws often impose liability
without regard to whether the owner knew of, or was responsible for, the
presence or disposal of such substances and liability may be imposed on the
owner in connection with the activities of an operator of the property. The cost
of any required remediation, removal, fines or personal or property damages and
the owner's liability therefore could exceed the value of the property, and/or
the assets of the owner. In addition, the presence of such substances, or the
failure to properly dispose of or remediate such substances, may adversely
affect the owner's ability to sell or rent such property or to borrow using such
property as collateral which, in turn, would reduce our revenues.

Although our leases and mortgage loans require the lessee and the mortgagor
to indemnify us for certain environmental liabilities, the scope of such
obligations may be limited, and we cannot assure you that any such borrower or
lessee would be able to fulfill its indemnification obligations.

WE RELY ON THIRD PARTY OPERATORS OF HEALTHCARE FACILITIES.

As of September 30, 2001, our portfolio of domestic investments consisted of
246 facilities located in 29 states and operated by 32 independent healthcare
operating companies. Our gross investments in these facilities totalled
$887.2 million at September 30, 2001. This portfolio is made up of 129 long-
term care facilities and two rehabilitation hospitals owned and leased to third
parties, fixed rate, participating and convertible participating mortgages on 55
long-term healthcare facilities and 48 long-term care facilities that were
recovered from customers and are currently operated through third-party
management contracts for our own account. In addition, 12 facilities are subject
to third-party leasehold interests. Approximately 73.7% of our real estate
investments were operated by seven public companies, including Sun Healthcare
Group, Inc. (24.6%), Integrated Health Services, Inc. (18.1%, including 10.7% as
the manager for and 50% owner of Lyric Health Care LLC), Advocat Inc. (12.0%),
Mariner Post-Acute Network, Inc. (6.7%), Kindred Healthcare, Inc. (formerly
known as Vencor Operating, Inc.) (5.7%), Alterra Healthcare Corporation (3.8%)
and Genesis Health Ventures, Inc. (2.8%). Kindred and Genesis manage facilities
for our own account, including "owned and operated" assets. The two largest
private operators represent 3.5% and 2.5%, respectively, of investments. No
other operator represents more than 2.5% of investments. The three largest
states in which we had investments were Florida (16.0%), California (7.5%) and
Illinois (7.5%).

WE ARE EXPOSED TO POTENTIAL RISKS FROM BANKRUPTCIES OF OUR LESSEES AND
MORTGAGORS.

Our financial position and our ability to service our debt may be adversely
affected by financial difficulties experienced by any of our operators and the
related potential for a bankruptcy filing.

Our lease arrangements with operators who operate more than one of our
facilities are generally made pursuant to a single master lease covering all of
that operator's facilities. Although each lease or master lease provides that we
may terminate the master lease upon the bankruptcy or insolvency of the tenant,
the Bankruptcy Reform Act of 1978 provides that a trustee in a bankruptcy or
reorganization proceeding under the Bankruptcy Act, or a debtor-in-possession in
a reorganization, has the power and the option to assume or reject the unexpired
lease obligations of a debtor-lessee. In the event that the unexpired lease is
assumed on behalf of the debtor-lessee, all the rental obligations thereunder
generally would be entitled to a priority over other unsecured claims. However,
the court also has the power to modify a lease if a debtor-lessee in a
reorganization were required to perform certain provisions of a lease that the
court determined to be unduly burdensome. It is not possible to determine at
this time whether or not any of our leases or master lease contains any such
provision. If a lease is rejected, the lessor has a general unsecured claim
limited to any unpaid rent already due plus an amount equal to the rent reserved
under the lease, without acceleration, for the greater of one year or 15% of the
remaining term of such lease, not to exceed three years.

Generally, with respect to our mortgage loans, the imposition of an
automatic stay under the Bankruptcy Act precludes us from exercising foreclosure
or other remedies against the debtor. Pre-petition creditors generally do not
have rights to the cash flows from the properties underlying the mortgages. The
timing of the collection from mortgagors in bankruptcy depends on negotiating an
acceptable settlement with the mortgagor (and subject to approval of the
bankruptcy court) or the order of the bankruptcy court in the event a negotiated
settlement cannot be achieved. A mortgagee also is treated differently from a
landlord in three key respects. First, the mortgage loan is not subject to
assumption or rejection because it is not an executory contract or a lease.
Second, the mortgagee's loan may be divided into (1) a secured loan for the
portion of the mortgage debt that does not exceed the value of the property and
(2) a general unsecured loan for the portion of the mortgage debt that exceeds
the value of the property. A secured creditor such as ourselves is entitled to
the recovery of interest and costs only if and to the extent that the value of
the collateral exceeds the amount owed. If the value of the collateral exceeds
the amount of the debt, interest and allowed costs may not be paid during the
bankruptcy proceeding but accrue until confirmation of a plan of reorganization
or such

other time as the court orders. If the value of the collateral held by a senior
creditor is less than the secured debt, interest on the loan for the time period
between the filing of the case and confirmation may be disallowed. Finally,
while a lease generally would either be rejected or assumed with all of its
benefits and burdens intact, the terms of a mortgage, including the rate of
interest and timing of principal payments, may be modified if the debtor is able
to effect a "cramdown" under the Bankruptcy Act.

The receipt of liquidation proceeds or the replacement of an operator that
has defaulted on its lease or loan could be delayed by the approval process of
any federal, state or local agency necessary for the transfer of the property or
the replacement of the operator licensed to manage the facility. In addition,
some significant expenditures associated with real estate investment such as
real estate taxes and maintenance costs are generally not reduced when
circumstances cause a reduction in income from the investment. In order to
protect our investments, we may take possession of a property or even become
licensed as an operator, which might expose us to successorship liability to
government programs or require us to indemnify subsequent operators to whom we
might transfer the operating rights and licenses. Third party payors may also
suspend payments to us following foreclosure until we receive the required
licenses to operate the facilities. Should these events occur, our income and
cash flows from operations would be adversely affected.

WE ARE EXPOSED TO POTENTIAL RISKS RELATED TO OWNED AND OPERATED ASSETS.

As a consequence of the financial difficulties encountered by a number of
our operators, we have recovered various long-term care assets, pledged as
collateral for the operators' obligations, either in connection with a
restructuring or settlement with certain operators or pursuant to foreclosure
proceedings. During 2000, $24.3 million of assets previously classified as held
for sale were reclassified to "owned and operated assets" as the timing and
strategy for sale or, alternatively, re-leasing, were revised in light of then
prevailing market conditions.

We are typically required to hold applicable licenses and are responsible
for the regulatory compliance at our owned and operated facilities. Our
management contracts with third party operators for these properties provide
that the third party operator is responsible for regulatory compliance, but we
could be sanctioned for violation of regulatory requirements. In addition, the
risk of third party claims such as patient care and personal injury claims may
be higher with respect to our owned and operated properties as compared to the
our leased and mortgaged assets.

THE INDUSTRY IN WHICH WE OPERATE IS HIGHLY COMPETITIVE. THIS COMPETITION MAY
PREVENT US FROM RAISING PRICES AT THE SAME PACE AS OUR COSTS INCREASE.

We compete for additional healthcare facility investments with other
healthcare investors, including other real estate investment trusts. The
operators of the facilities compete with other regional or local nursing care
facilities for the support of the medical community, including physicians and
acute care hospitals, as well as the general public. Some significant
competitive factors for the placing of patients in skilled and intermediate care
nursing facilities include quality of care, reputation, physical appearance of
the facilities, services offered, family preferences, physician services and
price.

WE ARE SUBJECT TO SIGNIFICANT ANTI-TAKEOVER PROVISIONS.

In addition to the potential anti-takeover effects resulting from Explorer's
significant investment in our company, our certificate of incorporation and
bylaws contain various procedural and other requirements which could make it
difficult for stockholders to effect certain corporate actions. Our Board of
Directors also has the authority to issue additional shares of preferred stock
and to fix the preferences, rights and limitations of the preferred stock
without stockholder approval. We have also adopted a stockholders rights plan
which provides for share purchase rights to become exercisable at a discount if
a person or group, other than Explorer and its affiliates, acquires more than
9.9% of our

common stock or announces a tender offer for more than 9.9% of our common stock.
These provisions could discourage unsolicited acquisition proposals or make it
more difficult for a third party to gain control of us, which could adversely
affect the market price of our common stock.

WE MAY CHANGE OUR INVESTMENT STRATEGIES AND POLICIES AND CAPITAL STRUCTURE.

Our Board of Directors, without the approval of our stockholders, may alter
our investment strategies and policies if it determines in the future that a
change is in our and our stockholders' best interests. The methods of
implementing our investment strategies and policies may vary as new investments
and financing techniques are developed.

WE ARE ORGANIZED AS A SELF-ADMINISTERED REAL ESTATE INVESTMENT TRUST.

We were organized to qualify for taxation as a real estate investment trust,
or REIT, under Sections 856 through 860 of the Internal Revenue Code. We believe
we have conducted, and we intend to continue to conduct, our operations so as to
qualify as a REIT. Qualification as a REIT involves the satisfaction of numerous
requirements, some on an annual and some on a quarterly basis, established under
highly technical and complex provisions of the Internal Revenue Code for which
there are only limited judicial and administrative interpretations and involve
the determination of various factual matters and circumstances not entirely
within our control. For example, in order to qualify as a REIT, each year we
must distribute to our stockholders at least 90% (95% for taxable years before
2001) of our taxable income, other than any net capital gain. We cannot assure
you that we will at all times satisfy these rules and tests.

If we were to fail to qualify as a REIT in any taxable year, as a result of
a determination that we failed to meet the annual distribution requirement or
otherwise, we would be subject to federal income tax, including any applicable
alternative minimum tax, on our taxable income at regular corporate rates.
Moreover, unless entitled to relief under certain statutory provisions, we also
would be disqualified from treatment as a REIT for the four taxable years
following the year during which qualification is lost. This treatment would
reduce our net earnings and cash flow available for investment, debt service or
distribution to stockholders because of our additional tax liability for the
years involved. In addition, distributions to stockholders would no longer be
required to be made.

THE RIGHTS OFFERING

THE RIGHTS

If you owned our common stock as of 5:00 p.m. on January 22, 2002, you will
receive one right for every 2.15 shares of common stock owned by you at that
time. Each right entitles you to purchase one share of common stock at the
subscription price. For example, if you owned 100 shares of common stock on the
record date, you would have the right to purchase 47 additional shares of common
stock for $2.92 per share. The aggregate number of rights you are entitled to
receive, if exercised by you in full, represents your pro rata portion of the
$50 million in additional equity capital we are seeking to raise in the rights
offering and private placement. Your pro rata portion is based on the number of
shares of common stock you owned on the record date, assuming solely for this
purpose the conversion of all of our outstanding Series C preferred stock, all
of which is held by Explorer. There is no minimum number of shares that must be
subscribed for by stockholders in the rights offering. If no stockholders
subscribe for shares in the rights offering, Explorer will purchase $50 million
of additional equity assuming the closing conditions are satisfied.

We will not issue fractional rights, and you may not exercise rights other
than in whole numbers. If the number of shares of common stock you held on the
record date would result in your receipt of fractional rights, the number of
rights distributed to you has been rounded up to the nearest whole right.

EXPIRATION TIME AND DATE

The rights expire on February 14, 2002, at 5:00 p.m., New York City time.
Our subscription agent must actually receive all required documents and payments
before that date and time. We recommend that you send all of your subscription
documents, together with payment of the subscription price, to the subscription
agent several days in advance of the expiration date. We can extend the
expiration date, but in no event will the date be extended beyond February 28,
2002. We do not presently intend to extend the expiration date. Rights not
exercised by the expiration date will be null and void and will have no value,
and the shares of common stock associated with those rights will not be issued.

SUBSCRIPTION PRICE

The subscription price is $2.92 per share, payable in cash. All payments
must clear on or before the expiration date. The market price of our common
stock may increase or decrease during the rights offering. On January 17, 2002,
the last reported sale price for our common stock on the New York Stock Exchange
was $5.74 per share.

The subscription price is the same price that is being offered to Explorer
in the private placement concurrent with this offering. Our Board of Directors
sought and obtained a written opinion from Shattuck Hammond Partners LLC, an
independent financial advisor, that as of October 29, 2001, the date of their
opinion, the financial terms of the investment agreement with Explorer taken as
a whole are fair to Omega from a financial point of view. For purposes of the
opinion, our financial advisor assumed a subscription price of $2.92 per share.

We have attached the full text of Shattuck Hammond's opinion as Annex A to
this prospectus. You should read the entire opinion to understand the
assumptions made, matters considered and limitations on the review undertaken by
our financial advisor. The opinion does not constitute a recommendation as to
whether you should exercise your rights in the rights offering. Shattuck
Hammond's opinion relates solely to the fairness to Omega Healthcare of the
financial terms of the investment agreement, and does not address the fairness
of either the investment agreement to unaffiliated stockholders or the
subscription price in the rights offering. A summary of the opinion is also set
forth below under "Determination of Subscription Price."

In determining whether to pursue the rights offering as well as setting the
price at which a share of common stock may be purchased in this rights offering,
a special committee of our Board of Directors, which did not include affiliates
of Explorer, considered several factors, including the fairness

opinion delivered by our financial advisor, the historic and current market
price of our common stock as of the date of the opinion, our financial
condition, challenges facing us, anticipated cash flows, general conditions in
the securities markets, our need for additional capital, available alternate
sources of financing, prices offered to stockholders in other rights offerings
and the need to offer the shares at a price that would be attractive to
investors relative to the then current trading price for our common stock, among
other things.

CLOSING CONDITIONS

The closing of the rights offering is subject to conditions relating to
modifications to our credit facilities and the absence of any governmental order
or litigation that is reasonably likely to render it impossible or unlawful to
complete the rights offering and/or Explorer's investment, or that could
reasonably be expected to have a material adverse effect on our business,
results of operations, or financial condition, or materially restrict the the
rights of Explorer under the documents relating to its investment.

We have entered into amendments to our credit facilities that are
satisfactory to us and Explorer that become effective concurrently with the
closing of the rights offering. See "Modification of Bank Credit Agreements" for
a discussion of the general terms of the proposed amendment to our two credit
facilities and any conditions to the effectiveness of such amendments. We
believe that these amendments will satisfy the closing conditions relating to
our credit facilities. While there currently exists no governmental order or
litigation with respect to this offering, we cannot assure you that such
governmental order or litigation will not arise prior to closing the rights
offering. If a governmental order or litigation arises prior to the closing of
the rights offering, we may not be able to complete the rights offering and/or
the private placement to Explorer.

All subscriptions will be held in escrow until expiration of the
subscription period and the satisfaction of the closing conditions. If the
closing conditions are not satisfied on or before expiration of the subscription
period as it may be extended by us, we will terminate the rights offering and
return your money to you, without interest, within approximately 10 business
days following the termination.

ESCROW ARRANGEMENT

Until the closing conditions have been satisfied and the expiration of the
subscription period, your money will be held in a non-interest-bearing account
maintained by Bank One Trust Company, NA, the escrow agent. If we terminate the
offering, we will return your money to you, without interest, within
approximately 10 business days following termination. We will pay the fees and
expenses of the escrow agent, which we estimate to be approximately $4,000.

EXPLORER PRIVATE PLACEMENT

Explorer Holdings, L.P., which owns all of our outstanding Series C
preferred stock and 553,850 shares of our common stock, representing 47.1% of
our voting stock, will not purchase common stock in this rights offering.
Although Explorer will not participate in the rights offering, Explorer has
agreed to purchase $23.6 million of our stock in a private placement concurrent
with the closing of the rights offering, at the same price per common share as
in this rights offering. The amount that Explorer has committed to invest in the
private placement represents its pro rata portion, with respect to shares of our
Series C preferred stock and common stock it holds, of the $50 million in
additional equity capital we are seeking to raise. Explorer has also agreed to
increase the size of its private placement investment in our company by an
additional amount equal to the aggregate subscription price of any shares that
are not subscribed for in this offering. As a result of this commitment, we are
assured of receiving a total of $50 million in gross proceeds upon the
completion of the rights offering and the private placement to Explorer. The
shares to be issued to Explorer are not registered as a part of the rights
offering and will be restricted securities under the Securities Act of 1933.

As a condition to Explorer's private placement investment, we have agreed to
amend certain of the agreements relating to Explorer's July 2000 investment in
our company effective as of the closing of

Explorer's new investment. The effect of these amendments is generally to remove
those provisions in our agreements that prohibit Explorer from voting in excess
of 49.9% of our stock and from taking certain actions without the prior approval
of our Board. These agreements are described in more detail under "Modifications
to Agreements with Explorer" on page 46 of this prospectus. The private
placement to Explorer is subject to the satisfaction of the same closing
conditions to which the rights offering is subject. In addition, prior to the
closing of the rights offering, the private placement to Explorer is subject to
the condition that our existing stockholder rights plan has not been triggered
and that the amendment to the stockholder rights plan in connection with the
Explorer investment remains in effect.

We have scheduled a special meeting of stockholders to be held on
February 18, 2002 at which stockholders will be asked to vote on a proposal to
approve the issuance of common stock to Explorer. We will provide separate proxy
solicitation materials to stockholders in connection with the special meeting.
We recommend that you read both the prospectus and the proxy materials
completely. Your vote will not affect your ability to exercise rights received
in this offering. Stockholders may vote to approve the issuance of the shares of
common stock to Explorer and still decline to exercise their subscription
rights. Conversely, stockholders can vote against the issuance of shares to
Explorer yet still exercise their subscription rights if the closing conditions
to which the rights offering is subject are met. This prospectus relates solely
to the rights offering and is not a solicitation for proxies. The proxy
solicitation is made pursuant to the separate proxy materials that you will
receive.

REASONS FOR THE RIGHTS OFFERING

The rights offering affords our existing stockholders an opportunity to
subscribe for new shares of common stock, at the same price per common share as
the Explorer private placement, and to maintain their proportionate interest in
us. Some of the factors considered by our Board of Directors in deciding to
proceed with the rights offering include:

- our need for capital;

- the alternative methods available to us for raising capital;

- the pro rata nature of a rights offering to our stockholders;

- the terms of the investment agreement with Explorer;

- the time period available in which to raise the needed capital and the
uncertainty of closure associated with various alternative methods for
raising capital;

- the market price of our common stock; and

- conditions of the capital markets in general.

In addition, since no underwriting or sales commission will be paid in respect
of the shares purchased in the rights offering, we believe the rights offering
will be a low-cost method for raising additional capital.

NO BOARD INVESTMENT RECOMMENDATION TO STOCKHOLDERS

Our Board of Directors is not making any recommendation to you about whether
or not you should exercise any rights. Although our Board of Directors has
obtained a fairness opinion and the Board of Directors approved proceeding with
the rights offering based on the recommendation of the special committee, you
should make your own decision as to whether or not to exercise your rights and,
if so, how many rights to exercise. You should make this decision only after
reading this entire prospectus and consulting with your own financial advisors.
Your decision should be based upon your own assessment of your best interests.

CONSEQUENCES OF FAILURE TO EXERCISE RIGHTS

If you choose not to exercise your subscription rights in full, your
relative percentage ownership interest will be diluted. There is no minimum
number of shares that must be subscribed for by stockholders in the rights
offering. If no other stockholders subscribe for shares in the rights offering,
Explorer has committed to invest $50 million if the closing conditions are
satisfied.

NO REVOCATION

You may not revoke or change your exercise of rights after you send in your
subscription agreement and payment even if you later learn information about us
that you deem to be unfavorable, or if our stock price declines. You should not
exercise your rights unless you are certain that you wish to purchase additional
shares of our common stock in this rights offering.

OVER-SUBSCRIPTION PRIVILEGE

There will be no over-subscription privilege for unexercised rights. To the
extent that shares of common stock are not subscribed for in this offering,
Explorer has committed to increase the size of its private placement investment
in our company by an amount equal to the aggregate subscription price relating
to the unsubscribed shares on the closing of the rights offering.

EXTENSION, WITHDRAWAL AND AMENDMENT

We have the option of extending the rights offering and the period for
exercising your rights until February 28, 2002 (but not beyond February 15, 2002
without Explorer's written consent), although we presently do not intend to do
so.

We also reserve the right to terminate the rights offering at any time for
any reason including the failure of the closing conditions to occur. In the
event that the offering is terminated, money received from subscriptions will be
returned, without interest.

We reserve the right to amend the terms of the rights offering. If we make
an amendment that we consider significant, we will:

- mail notice of the amendment to all stockholders of record as of the
record date;

- extend the expiration date by at least ten days; and

- offer all subscribers no less than ten days to revoke any subscription
already submitted.

The extension of the expiration date will not, in and of itself, be treated
as a significant amendment for these purposes.

MAILING OF SUBSCRIPTION AGREEMENTS AND EXERCISE OF RIGHTS

We are sending a subscription agreement and the proxy statement to each
record holder as of the record date along with this prospectus and related
instructions. To exercise rights, you must complete and sign the subscription
agreement and deliver it, along with full payment for the shares to be
purchased, to EquiServe before the expiration of the subscription period. See
"--Procedures to Exercise Rights."

SHARES HELD FOR OTHERS

Only holders of record of common stock at the close of business on the
record date may exercise rights. You are a record holder for this purpose only
if your name is registered as a stockholder with our transfer agent, EquiServe,
as of the record date.

A depository bank, trust company or securities broker or dealer which is a
record holder for more than one beneficial owner of shares may divide or
consolidate subscription agreements to represent shares held on the record date
by their beneficial owners, upon proper showing to EquiServe.

If you own shares held in a brokerage, bank or other custodial or nominee
account, you should promptly send the proper instruction form to the person
holding your shares in order to exercise your rights. Your broker, dealer,
depository or custodian bank or other person holding your shares is the record
holder of your shares and will have to act on your behalf in order for you to
exercise rights. We have asked your broker, dealer or other nominee holders of
our stock to contact the beneficial owners to obtain instructions concerning
rights the beneficial owners are entitled to exercise.

RIGHT TO BLOCK EXERCISE DUE TO REGULATORY ISSUES

We do not anticipate that the laws of any state or local U.S. jurisdiction
will restrict the exercise of rights or require any prior clearance or approval.
However, holders in non-U.S. jurisdictions who receive rights may not be
eligible to exercise their rights and participate in the offer if applicable law
in such non-U.S. jurisdiction restricts or regulates such exercise.

We reserve the right to refuse the exercise of rights by any holder of
rights who would, in our opinion, be required to obtain prior clearance or
approval from any regulatory authorities for the exercise of rights or ownership
of additional shares if, at the expiration date, this clearance or approval has
not been obtained. We are not undertaking to pay any expenses incurred in
seeking that clearance or approval.

PROCEDURES TO EXERCISE RIGHTS

Rights may be exercised by delivering to EquiServe, the subscription agent,
on or prior to 5:00 p.m., New York City time, on February 14, 2002, the properly
completed and executed subscription agreement, together with payment in full of
the exercise price for each right exercised. Please do not send subscription
agreements or related forms to us. The subscription price may be paid by:

- a personal check, which must have timely cleared payment on or before
expiration of the subscription period; or

- a certified or cashier's check or bank draft drawn upon a U.S. bank or a
U.S. postal money order.

FUNDS PAID BY UNCERTIFIED PERSONAL CHECK MAY TAKE AT LEAST FIVE BUSINESS
DAYS TO CLEAR. ACCORDINGLY, IF YOU PAY THE SUBSCRIPTION PRICE BY MEANS OF
UNCERTIFIED PERSONAL CHECK, YOU SHOULD MAKE PAYMENT SUFFICIENTLY IN ADVANCE OF
THE EXPIRATION TIME TO ENSURE THAT YOUR CHECK ACTUALLY CLEARS AND THE PAYMENT IS
RECEIVED BEFORE THAT TIME. WE ARE NOT RESPONSIBLE FOR ANY DELAY IN PAYMENT BY
YOU AND SUGGEST THAT YOU CONSIDER PAYMENT BY MEANS OF CERTIFIED OR CASHIER'S
CHECK, MONEY ORDER OR WIRE TRANSFER OF FUNDS.

All subscription agreements, payments of the subscription price and nominee
holder certifications, to the extent applicable to your exercise of rights, must
be delivered to EquiServe as follows:

By Regular Mail: By Overnight Courier:
EquiServe Trust Company, N.A. EquiServe Trust Company, N.A.
P.O. Box 43025 40 Campanelli Drive
Providence, RI 02940-3025 Braintree, MA 02184

By Hand:
EquiServe Trust Company, N.A.
c/o Securities Transfer and Reporting Services, Inc.
100 William Street--Galleria
New York, NY 10038

Eligible institutions may also deliver documents by facsimile transaction.
EquiServe's facsimile number is (781) 575-4826 or (781) 575-4827. You should
confirm receipt of all facsimiles by calling (781) 575-4816.

You should read carefully the forms of subscription agreement and related
instructions and forms which accompany this prospectus. You should call
Georgeson Shareholder Communications, Inc. at (800) 223-2064 promptly with any
questions you may have.

INCOMPLETE FORMS; INSUFFICIENT PAYMENT

If you do not specify the number of rights being exercised in your
subscription agreement, or do not forward sufficient payment to pay for the
number of rights that you indicate are being exercised, then we will accept the
subscription forms and payment only for the maximum number of rights that may be
exercised based on the amount of the payment received. If you do not forward
sufficient payment and as a result not all of your rights are exercised, your
relative percentage ownership interest will be diluted. If your payment exceeds
the aggregate subscription price for the number of common shares indicated on
your subscription agreement or the maximum number of common shares for which you
are eligible to subscribe, your payment will be applied to the maximum number of
common shares for which you are eligible to subscribe. We will return any
payment not applied to the purchase of shares under the rights offering
procedures to those who made these payments as soon as practicable by mail.
Interest will not be payable on amounts refunded.

INSTRUCTIONS TO NOMINEE HOLDERS

If you are a broker, trustee or depository for securities or other nominee
holder of common stock for beneficial owners of the stock, we are requesting you
to contact the beneficial owners as soon as possible to obtain instructions and
related certifications concerning their rights. Our request to you is further
explained in the suggested form of letter of instructions from nominee holders
to beneficial owners accompanying this prospectus.

To the extent so instructed, nominee holders should complete appropriate
subscription agreements on behalf of beneficial owners and submit them on a
timely basis to EquiServe with the proper payment.

RISK OF LOSS ON DELIVERY OF SUBSCRIPTION AGREEMENT FORMS AND PAYMENTS

Each holder of rights bears all risk of the method of delivery to EquiServe
of subscription agreements and payments of the subscription price.

IF SUBSCRIPTION AGREEMENTS AND PAYMENTS ARE SENT BY MAIL, YOU ARE URGED TO
SEND THESE BY REGISTERED MAIL, PROPERLY INSURED, WITH RETURN RECEIPT REQUESTED,
AND TO ALLOW A SUFFICIENT NUMBER OF DAYS TO ENSURE DELIVERY TO EQUISERVE AND
CLEARANCE OF PAYMENT PRIOR TO THE EXPIRATION TIME.

BECAUSE UNCERTIFIED PERSONAL CHECKS MAY TAKE AT LEAST FIVE BUSINESS DAYS TO
CLEAR, YOU ARE STRONGLY URGED TO PAY, OR ARRANGE FOR PAYMENT, BY MEANS OF
CERTIFIED OR CASHIER'S CHECK, MONEY ORDER OR WIRE TRANSFER OF FUNDS.

PROCEDURES FOR DTC PARTICIPANTS

If you hold your shares of common stock through the Depository Trust Company
or one if its participants, you may exercise your rights through the facilities
of the Depository Trust Company. You should contact the Depository Trust Company
or the participant through which you hold your shares for further instructions.

TRANSFERABILITY OF RIGHTS

The rights may not be sold, transferred or assigned, even by gift. However,
rights may be transferred by will, devise or by operation of law in the case of
death, dissolution, liquidation, or bankruptcy of the holder, or pursuant to an
order of an appropriate court. Rights that are forfeited due to improper
transfer will be null and void and no shares will be issued in respect thereof.
If your rights are forfeited, your relative percentage ownership interest will
be diluted.

HOW PROCEDURAL AND OTHER QUESTIONS ARE RESOLVED

We are entitled to resolve all questions concerning the timeliness,
validity, form and eligibility of any exercise of rights and our determinations
of such questions will be final and binding. We, in our sole discretion, may
waive any defect or irregularity, or permit a defect or irregularity to be
corrected within such time as we may determine, or reject the purported exercise
of any right because of any defect or irregularity in the exercise.

Subscription agreements will not be deemed to have been received or accepted
until all irregularities have been waived or cured within such time as we
determine, in our sole discretion. Neither we nor EquiServe will have any duty
to notify you of any defect or irregularity in connection with the submission of
subscription agreements or any other required document and neither we nor
EquiServe will incur any liability for failure to so notify you.

We reserve the right to reject any exercise of rights if the exercise does
not comply with the terms of this rights offering or is not in proper form or if
the exercise of rights would be unlawful or materially burdensome.

MANAGEMENT PARTICIPATION

FEDERAL INCOME TAX CONSIDERATIONS

For United States federal income tax purposes, we believe that holders of
our common stock will not recognize taxable income upon receipt or exercise of
the rights. If you sell the common stock you acquire upon exercise of your
rights, you will recognize gain or loss equal to the difference between the
amount realized and your basis in the common stock. You should consult your own
tax advisor concerning the tax consequences of this offering with respect to
your particular circumstances and tax situation.

ISSUANCE OF STOCK CERTIFICATES

Stock certificates for shares of common stock purchased in the rights
offering will be issued as soon as practicable after the expiration date.
EquiServe will deliver subscription payments to us at the same time as it
delivers stock certificates to those exercising rights. Unless otherwise
instructed in your

subscription agreement form, shares purchased by the exercise of rights will be
registered in the name of the person exercising the rights.

SUBSCRIPTION AGENT

EquiServe is the subscription agent for the rights offering. It is also the
transfer agent for our common stock. We will pay the fees and expenses of
EquiServe, which we estimate to be approximately $37,500. We have also agreed to
indemnify EquiServe from any liability which it may incur in connection with the
rights offering.

QUESTIONS AND ANSWERS CONCERNING THE RIGHTS

You should direct any questions, requests for assistance concerning the
rights or requests for additional copies of this prospectus to:

Georgeson Shareholder Communications, Inc.
17 State Street
New York, New York 10004

Banks and brokers......................... (212) 440-9800
All others................................ (800) 223-2064

USE OF PROCEEDS

We estimate that the net proceeds of this offering and Explorer's investment
will be approximately $48 million. We intend to use the proceeds to repay a
portion of our outstanding debt maturing in 2002, as well as for debt service,
working capital needs and other general corporate purposes. We have not
determined the exact amount of proceeds that we will use for each of these
purposes. The allocation of the net proceeds for a particular purpose, including
a determination as to which outstanding debt we repay, is subject to numerous
factors, which can be expected to change over the short term. These factors
include:

- economic conditions generally and in the healthcare industry in
particular, including the financial situation of our operators and the
resulting effect on our revenues and cash flows;

- our ability to negotiate appropriate modifications to the terms of our
credit facilities;

- developments in the capital markets affecting our ability to refinance all
or a portion of our outstanding debt;

- our ability to dispose of assets held for sale and other property at
appropriate prices;

- re-leasing of owned and operated assets and recoupment of working capital
investments; and

- the other factors discussed under "Risk Factors," which begin on page 8.

We will have broad discretion over the use of proceeds. Pending application,
we intend to invest the net proceeds from this offering and Explorer's
investment in interest-bearing deposit accounts, certificates of deposit,
government securities or short-term and investment-grade financial instruments
of varying maturities.

As of the date of this prospectus, we had approximately $129 million of
loans outstanding under one of our secured revolving credit facilities, which
bears interest at a weighted average rate of 6.72% at that date. As of the date
of this prospectus, we had approximately $64.6 million of loans outstanding
under our other senior revolving credit facility, which bears interest at a
weighted average rate per annum of 6.88% at that date. Our 6.95% senior notes
also mature in June 2002. As of the date of this prospectus, we had
approximately $97.5 million aggregate principal amount of these notes
outstanding. We are currently unable to borrow under our revolving credit
facilities because we are not in compliance with certain financial covenants
contained in the loan agreements relating to our two revolving credit
facilities. See "Modification of Bank Credit Agreements."

MODIFICATION OF BANK CREDIT AGREEMENTS

On December 21, 2001, we reached agreements with the bank groups under both
of our revolving credit facilities. These agreements include modifications
and/or waivers to certain financial covenants with which we were not in
compliance. In addition, certain other financial covenants will be either
modified or eliminated going forward. The effectiveness of these agreements is
subject to the completion of the rights offering and private placement to
Explorer, which we anticipate to occur within 10 business days of the expiration
of the rights offer. Explorer has approved the amendments, and therefore the
effectiveness of the amendments will satisfy the conditions to the rights
offering and Explorer investment related to our credit facilities. See "The
Rights Offering--Closing Conditions."

For the quarter ended June 30, 2001, we were not in compliance with the
maximum leverage covenant ratio of funded indebtedness to earnings before
interest, taxes, depreciation and amortization, or EBITDA, in each of our credit
facilities. For the quarter ended September 30, 2001, we were not in compliance
with the maximum leverage covenant and the minimum EBITDA to interest expense
covenants in each of our credit facilities. Recent amendments to our credit
facilities waive these covenant violations and will modify the following
covenants effective as of the closing of the rights offering and the private
placement to Explorer:

- The minimum tangible net worth covenant will be reduced from $445 million
plus 50% of net proceeds from any equity issuances to $425 million
(increasing to $430 million in the third quarter of 2002) plus 50% of
proceeds from any equity issuances (after reflecting the rights offering
and the private placement to Explorer).

- Minimum EBITDA/interest expense covenant will be increased from 200% to
225% beginning in the second quarter of 2002, 250% in the fourth quarter
of 2002 and 275% thereafter.

- The requirement for no loss in a fiscal year beginning December 31, 2001
has been removed.

- The maximum leverage ratio covenant has been reduced to 5.0 times EBITDA
in the second quarter of 2002 and 4.75 times EBITDA thereafter.

In addition, adjusted EBITDA under the loan agreements has been redefined to
exclude certain one-time charges including, but not limited to, the $10 million
litigation settlement recognized in June 2001 and associated legal fees of up to
$1 million and up to $5 million for relocation of our corporate headquarters to
Maryland, for which we recognized a charge of $4.3 million in September 2001.

As of the closing of the rights offering and the private placement to
Explorer and the effectiveness of the amendments, we will be in compliance with
all covenants under our credit facilities as amended.

As part of the amendment regarding our $75 million revolving credit facility
we prepaid $10 million originally scheduled to mature in March 2002. This
voluntary prepayment results in a permanent reduction in the total commitment,
thereby reducing the credit facility to $65 million. The agreement regarding our
$175 million revolving credit facility includes a one-year extension in maturity
from December 31, 2002 to December 31, 2003, and a reduction in the total
commitment from $175 million to $160 million. Amounts up to $150 million may be
drawn upon to repay the maturing 6.95% Notes due in June 2002.

The effectiveness of these amendments as of the completion of the rights
offering will reduce our outstanding debt maturing in 2002 to $97.5 million.
Upon completion of the private placement and rights offering, we expect to have
approximately $17.7 million available to draw upon under our revolving credit
facilities.

DETERMINATION OF SUBSCRIPTION PRICE

The subscription price is $2.92 per share, payable in cash. Our Board of
Directors sought and obtained a written opinion from Shattuck Hammond Partners
LLC, an independent financial advisor, that as of October 29, 2001, the date of
their opinion, the financial terms of the investment agreement with Explorer,
taken as a whole, are fair to Omega from a financial point of view. We have
attached the full text of their opinion as Annex A to this prospectus. You
should read the entire opinion to understand the assumptions made, matters
considered and limitations on the review undertaken by our financial advisor.
The opinion does not constitute a recommendation as to whether you should
exercise your rights in the rights offering. Shattuck Hammond's opinion relates
solely to the fairness to Omega Healthcare of the financial terms of the
investment agreement, and does not address the fairness of either the investment
agreement to unaffiliated stockholders or the subscription price in the rights
offering.

In recommending a price at which a share of common stock may be purchased in
this rights offering, a special committee of our Board of Directors, which did
not include affiliates of Explorer, considered several factors, including the
fairness opinion delivered by our financial advisor, the historic and current
market price of our common stock, our financial condition, challenges facing us,
anticipated cash flows, general conditions in the securities markets, our need
for additional capital, available alternate sources of financing, prices offered
to stockholders in other rights offerings, and the need to offer the shares at a
price that would be attractive to investors relative to the then current trading
price for our common stock, among other things. Our Board of Directors
established $2.92 as the maximum subscription price based upon a 6% discount
from the average closing price of $3.10 for our common stock over a 20
consecutive trading day period ending on October 26, 2001.

Based on the $2.92 subscription price, up to 9,350,000 shares of common
stock will be offered to stockholders who own our common stock on the
January 22, 2002 record date. These shares represent 52.9% of the total equity
capital we seek to raise. The remaining 47.1% of the equity capital sought will
be invested by Explorer, plus an amount equal to the aggregate subscription
price for all rights not exercised by common stockholders.

OPINION OF FINANCIAL ADVISOR TO THE SPECIAL COMMITTEE OF INDEPENDENT DIRECTORS
AND THE BOARD OF DIRECTORS

Our Board of Directors asked a special committee, composed solely of
directors who are unaffiliated with Explorer, to evaluate any proposals received
from Explorer and make a recommendation to the full Board of Directors regarding
what action, if any, our company should take with respect to such proposals. The
special committee engaged Shattuck Hammond Partners LLC on October 15, 2001 as
the committee's financial advisor to (i) review and analyze potential financing
alternatives for our company as well as financing proposals we received; and
(ii) if requested, render an opinion to the Board of Directors regarding the
fairness from a financial point of view of a financing contemplated by us
involving, among other things, an investment by Explorer, a 45.5% owner of our
common stock on an as converted basis as of the date of the fairness opinion,
and a rights offering to our stockholders other than Explorer. Prior to being
engaged by us as the financial advisor to the special committee, Shattuck
Hammond had no professional relationship with us nor Explorer.

The amount, terms and structure of the proposed financing were determined
through a negotiated process between the special committee and Explorer and are
set forth in an investment agreement dated as of October 29, 2001 between us and
Explorer. Shattuck Hammond did not participate directly in the negotiation of
the terms of the investment agreement. Pursuant to the investment agreement,
among other things, Explorer commits to invest, subject to certain closing
conditions being satisfied or waived, up to $50 million in payment for our
common stock or Series D preferred stock. The actual amount of Explorer's
investment will be equal to the difference between $50 million and the gross
proceeds received by us through a rights offering to our common stockholders
other than Explorer, defined as the "unsubscribed purchase amount." If all
rights offered in the rights offering are exercised,

it was Shattuck Hammond's understanding that the proportional ownership of our
stock by stockholders other than Explorer and by Explorer on an as converted
basis would, upon Explorer's payment of the unsubscribed purchase amount and the
issuance to it of shares of our common stock, remain approximately the same as
of the date of Shattuck Hammond's opinion.

It was also Shattuck Hammond's understanding that the subscription price per
common share in the rights offering and the price per common share or the
conversion price of the Series D preferred to be paid by Explorer would be the
same. For purposes of their opinion Shattuck Hammond assumed that the
subscription price was $2.92, the maximum price approved by our Board of
Directors.

Shattuck Hammond rendered an oral opinion to the special committee and our
Board of Directors on October 23, 2001, subject to review of definitive
documentation that was in the process of being negotiated, and a written opinion
addressed to the special committee and our Board of Directors on October 29,
2001, in each case to the effect that, as of such date and subject to the
assumptions made, matters considered and the limitations set forth in its
opinion, the financial terms of the investment agreement taken as a whole,
defined as the "financial terms of the investment agreement" as described more
fully in its opinion, are fair to us from a financial point of view. The full
text of Shattuck Hammond's written opinion is attached as Annex A to this
prospectus and is incorporated herein by reference. Shattuck Hammond's opinion
sets forth the assumptions made, the matters considered and limits on the review
undertaken by Shattuck Hammond in connection with its engagement. The following
summary of Shattuck Hammond's opinion is qualified in its entirety by reference
to the full text of such opinion. Shattuck Hammond's opinion is directed only to
the fairness to us, from a financial point of view, of the financial terms of
the investment agreement taken as a whole and does not address any other aspect
of the investment by Explorer or the rights offering or any other transaction to
which Explorer and our company are parties. Shattuck Hammond's opinion was
provided for the information and assistance of the special committee and the
Board of Directors in connection with their consideration of the financing
proposal put forward by Explorer and is not a recommendation of any action that
the special committee, the Board of Directors or any of our stockholders should
take.

It was Shattuck Hammond's further understanding that the investment
agreement included, among other things, the various financial terms that are
specifically identified in Shattuck Hammond's fairness opinion set forth in
Annex A (see pages A-1 to A-2) to this prospectus.

In connection with preparing its opinion, Shattuck Hammond reviewed a
variety of materials including those specifically identified in its fairness
opinion set forth in Annex A (see pages A-2 to A-4) to this prospectus and made
such investigations as it deemed appropriate. Shattuck Hammond did not
independently verify any of the information it obtained for the purposes of its
opinion. Instead, Shattuck Hammond assumed the accuracy and completeness of all
such information. Shattuck Hammond relied upon assurances by our management that
all forward-looking information concerning us reflected the best currently
available judgments and estimates of management as to our likely future
financial performance and capital requirements. Shattuck Hammond assumed that
the financing will be consummated in accordance with the terms of the investment
agreement. Shattuck Hammond did not make an independent inspection, evaluation
or appraisal of our assets or liabilities, nor did anyone furnish Shattuck
Hammond with any such evaluation or appraisal. The Shattuck Hammond opinion is
based on market, economic and other conditions as they existed and could be
evaluated at the time their fairness opinion was rendered.

No limitations were imposed by the special committee, the Board of Directors
or us on the scope of Shattuck Hammond's investigation or the procedures
Shattuck Hammond followed in rendering its opinion. The terms of Shattuck
Hammond's engagement, however, did not include soliciting interest in an
investment transaction from investors, and Shattuck Hammond made no such
solicitation.

In evaluating the fairness, from a financial point of view, of the financial
terms of the investment agreement taken as a whole to us, Shattuck Hammond
employed a variety of analyses and reviews

which it believes were appropriate for preparing its opinion. The preparation of
a fairness opinion involves various determinations of the most appropriate and
relevant methods of financial analyses and review and the application of those
methods to the particular circumstances. Therefore such an opinion is not
necessarily susceptible to partial analysis or summary description. Shattuck
Hammond believes that its analyses and reviews must be considered as a whole and
that selection of portions of its analyses and reviews and of the factors
considered by it, without considering all of the factors and analyses and
reviews, would create a misleading view of the processes underlying its opinion.
In arriving at its opinion, Shattuck Hammond did not attribute any particular
weight to any particular analysis, review or factor considered by it, but rather
made qualitative judgments about the significance and relevance of each
analysis, review and factor.

In performing its analyses and reviews, Shattuck Hammond made numerous
assumptions with respect to industry performance, general business and economic
conditions and other matters, many of which are beyond our control. The analyses
and reviews performed by Shattuck Hammond do not purport to be an appraisal and
are not necessarily indicative of actual values or actual future results that
might be achieved, all of which may be significantly more or less favorable than
suggested by Shattuck Hammond's analyses and reviews.

In connection with its analyses and reviews, Shattuck Hammond utilized
estimates and forecasts of our future operating results contained in or derived
from projections developed and supplied by our management. Analyses based on
forecasts of future results are not necessarily indicative of actual future
results, which may be significantly more or less favorable than the forecasts.
Such analyses are inherently subject to uncertainty, being based on numerous
factors or events beyond our control, and are susceptible to interpretations and
periodic revision based on actual experience and business and economic
developments after the date they were prepared. Therefore, future results or
actual values may be materially different from these forecasts or assumptions.

The following is a brief summary of material analyses and reviews performed
by Shattuck Hammond in connection with the preparation of Shattuck Hammond's
fairness opinion delivered to the special committee and our Board of Directors
on October 29, 2001. The following analyses and reviews reflect substantially
the same methodologies used by Shattuck Hammond in its preliminary oral
presentation to the special committee and our Board of Directors on October 23,
2001, but updated and confirmed in writing to reflect financial information and
market data that was available as of October 26, 2001 as well as a review of the
definitive documentation executed in connection with Explorer's investment.

ALTERNATIVE FINANCING STRUCTURES REVIEW

GENERAL. Shattuck Hammond reviewed a number of financing alternatives to
Explorer's investment including:

- equity financing (secondary public offering, private investment into
public equity, private placement);

- debt financing (subordinated debt, collateralized mortgage backed
securitization, Health and Urban Development insured and senior
unsecured); and

- other financings (asset sales, sale or merger of our company).

Shattuck Hammond's review was based on a number of theoretical criteria
including pricing, completion risk, timing, deleveraging of balance sheet,
governance and approval requirements, fees and other factors. Based on its
review and the criteria cited, Shattuck Hammond was of the view that no other
financing alternative was clearly better than Explorer's investment. In this
regard, Shattuck Hammond noted that, among other things:

- Explorer did not require any additional due diligence;

- Explorer and our company were willing to enter into agreements on terms
that were substantially similar to the definitive documentation related to
Explorer's investment in our Series C preferred stock;

- the views of our management regarding the potential consequences if we did
not reach an agreement with its banks for covenant waivers by mid
December, 2001, including, without limitation, interest rate increases and
other penalties and possible acceleration of its senior debt;

- the requirement of our banks that there be an infusion of equity or other
junior capital in connection with any covenant waivers and possible term
extensions;

- Explorer's commitment to purchase our common stock at a fixed price per
share determined under the investment agreement irrespective of the actual
price of our common stock at the time Explorer makes its investment;

- the structure of the Explorer investment as an investment in our common
stock or Series D preferred stock to convert into our common stock thereby
eliminating the potential need to pay dividends or interest that other
investments might require (assuming that Series D preferred stock is not
issued or, if issued, is outstanding for only a short period of time);

- an investment of equity would deleverage our balance sheet;

- the World Trade Center attack on September 11, 2001 negatively impacted
the financing markets; and

- a rights offering is "democratic" from the perspective that all
stockholders can participate based on their proportional ownership.

MARKET VALUATION OF OMEGA PUBLICLY-TRADED SENIOR UNSECURED DEBT AND
SERIES A AND B PREFERRED STOCK. Shattuck Hammond noted that our senior
unsecured debt and Series A and B preferred stock were trading at significant
discounts to their respective par values. Moreover, Shattuck Hammond further
noted that our unsecured debt has a below investment grade rating and that the
Series A and B preferred stock have had their dividends suspended. Shattuck
Hammond concluded that our below investment grade rating on our debt, dividend
suspension on our preferred stock and relative trading values of such securities
to their par amounts were indicative of the challenges we would face in
attempting to complete an alternative financing to Explorer's investment.

OMEGA SENIOR UNSECURED DEBT

PRICE YTM S&P RATING
-------- -------- ----------

Omega 6.95%; 6/15/02................................. 85 35.8% CCC+
Omega 6.95%; 8/01/07................................. 60 18.5% CCC+

OMEGA SERIES A AND SERIES B PREFERRED (ACTUAL DOLLARS)

CURRENT DISCOUNT TO
LIQUIDATION PRICE AS OF LIQUIDATION DIVIDEND
PREFERENCE 10/26/01 PREFERENCE YIELD
----------- ----------- ----------- --------

Series A Preferred.................. $25.00 $14.51 58.0% NA (1 )
Series B Preferred.................. $25.00 $13.70 54.8% NA (2 )

(1) DIVIDEND SUSPENDED; ACCRUES AT RATE OF 9.250%.

(2) DIVIDEND SUSPENDED; ACCRUES AT RATE OF 8.625%.

EXPLORER PRO FORMA OWNERSHIP ANALYSIS

Shattuck Hammond noted that Explorer's current ownership of 45.5% of our
voting capital stock and the ability to designate four out of nine Board seats
(and approve an independent director) provided Explorer with significant control
of our company. Based on the $50 million financing and an

assumed subscription price of $2.92, depending on the number of our stockholders
other than Explorer who exercise their rights, Explorer's ownership of our
voting capital stock could exceed 50% on an as converted basis.

The table below presents Explorer and non-Explorer ownership of our common
stock on an as converted basis based on different assumed levels of non-Explorer
stockholder participation in the rights offering:

OWNERSHIP ANALYSIS (SHARES IN MILLIONS)

COMMON SHARES ON AN AS CONVERTED BASIS(1)
------------------------------------------------------------------------------
NON-
EXPLORER
PARTICIPATION TOTAL TOTAL
IN RIGHTS SHARES PERCENTAGE SHARES PERCENTAGE TOTAL
EXPLORER OWNERSHIP LEVEL OFFERING NON-EXPLORER NON-EXPLORER EXPLORER EXPLORER SHARES
------------------------ ------------- ------------ ------------ -------- ---------- --------

High.................................. 0% 20.1 37.2% 33.9 62.8% 54.0
Medium................................ 50% 24.7 45.8% 29.2 54.2% 54.0
Low................................... 100% 29.4 54.5% 24.6 45.5% 54.0

(1) EXCLUDES OPTIONS AND WARRANTS AND 553,850 SHARES OF OUR COMMON STOCK
ACQUIRED BY EXPLORER SUBSEQUENT TO OCTOBER 29, 2001.

Shattuck Hammond further noted that in the event that upon consummation of
the rights offering and transactions contemplated by the investment agreement,
Explorer were to beneficially own more than 50% of our voting securities,
Explorer would have voting control of our company through its unrestricted right
to vote our voting capital stock and the power to designate a majority of our
Board of Directors subject to the following restrictions imposed by the
investment agreement and any other limitation or restriction imposed by law:

- a limitation on the number of our Board of Directors which Explorer could
designate;

- so long as Explorer holds at least 15% of our voting securities, a
commitment by Explorer to vote in favor of the election of three directors
who are both "independent" under the rules of the New York Stock Exchange
and unaffiliated with Explorer and, upon the increase in the number of
directors to ten, one additional person who is unaffiliated with Explorer;
and

- except for a transaction approved by a committee of our Board of Directors
comprised entirely of independent directors and under certain other
limited circumstances, a prohibition against Explorer acquiring beneficial
ownership of more than 80% of our voting securities.

RIGHTS OFFERING ANALYSIS

Shattuck Hammond reviewed 31 rights offerings, excluding rights offerings
involving closed end funds and American Depositary Receipts, that have been
completed since January 1, 2001. Shattuck Hammond noted that rights offerings
are:

- in many instances used by financially troubled companies, and
approximately 61% of the companies in the sample involved companies with
share prices less than $5.00 per share;

- all of the rights offerings in the sample for which information was
available had over-subscription rights available to all stockholders;

- approximately 41% of such rights offerings for which information was
available had a large investor that was willing to purchase all or a large
part of any rights which were not exercised;

- approximately 36% of the rights offerings in the sample for which
information was available had rights that were transferable; and

- approximately 86% of the sample for which information was available were
priced based on intangible factors that may have had no relation to the
value of the companies' assets, operating performance or share price.

Shattuck Hammond also reviewed the relative share price performance of the
sample group based on the date of announcement and ex dividend date, and
concluded that rights offerings typically have relatively little impact on a
company's share price.

RIGHTS OFFERING ANALYSIS

ANALYSIS BY ANNOUNCEMENT DATE

WEEK DAY ON ONE ONE
BEFORE BEFORE DAY OF DAY AFTER WEEK AFTER
--------------------- -------- -------- --------- ----------

1.00 0.99 1.00 0.97 0.93

ANALYSIS BY EX DATE

WEEK DAY ON ONE ONE
BEFORE BEFORE DAY OF DAY AFTER WEEK AFTER
--------------------- -------- -------- --------- ----------

1.13 1.13 1.00 0.98 1.05
---- ---- ---- ----

OMEGA FLOAT COMPARISON

Based on information provided by Bloomberg Investor Services, Shattuck
Hammond compared our public float (common shares not owned by management or
other affiliates) with the public float of a select group of publicly-traded
financially stable healthcare REITs, which consisted of Health Care Property
Investors, Inc., Health Care REIT, Inc., Healthcare Realty Trust, Inc.,
Nationwide Health Properties, Inc. and Senior Housing Properties Trust, and a
select group of publicly-traded financially distressed REITs, which consisted of
LTC Properties, Inc. and National Health Investors, Inc. The REITs in each group
were selected because their healthcare focus and mix of assets were reasonably
similar to those of our company. The general criteria used to distinguish
between a stable and distressed REIT is that stable REITs generally have
stronger financial performance, fewer operators who are in bankruptcy, and pay a
dividend to their common shareholders. Shattuck Hammond considered our company
to be a distressed REIT.

The public float for the stable REITs ranged from 16.4 million shares to
54.7 million shares and averaged 37.9 million shares. The public float for the
distressed REITs, excluding our company, ranged from 20.2 million shares to
21.8 million shares and averaged 21.0 million shares. Shattuck Hammond noted
that a larger float generally increases the trading liquidity of a stock and may
enhance the ability to undertake a reverse split to increase share price. In
this regard, if any non-Explorer stockholders, other than management and other
affiliates, exercised their rights, our float would increase.

The table below presents the pro forma impact on our float based on
different levels of assumed participation in the rights offering by our
stockholders other than Explorer:

OMEGA PRO FORMA FLOAT ANALYSIS (SHARES IN MILLIONS)

HIGH MEDIUM LOW
-------- -------- --------

Omega Float............................................ 19.2 19.2 19.2
Non-Explorer Rights Participation...................... 100% 50% 0%
New Shares Issued (1).................................. 9.3 4.7 0.0
Total Pro Forma Float.................................. 28.5 23.9 19.2
% Increase in Float.................................... 48% 24% 0%

(1) ASSUMES $27.3 MILLION RIGHTS OFFERING PRICED AT $2.92 PER SHARE REPRESENTING
A 6% DISCOUNT TO AVERAGE CLOSING PRICE FOR 20 TRADING DAY PERIOD ENDED
OCTOBER 26, 2001.

PRO FORMA DEBT TO CAPITALIZATION ANALYSIS

Shattuck Hammond analyzed the debt to capitalization of the stable REITs and
the distressed REITs (excluding our company) and compared them to our company.
Debt/capitalization is calculated as (long-term debt + short-term
debt)/(long-term debt + short-term debt + preferred stock + equity value). The
debt/capitalization of the stable REITs ranged from 14.2% to 56.7% and from
30.8% to 38.5% for the distressed REITs. Shattuck Hammond noted that a
$50 million equity financing and additional subsequent repayment of debt through
cash flow from operations would significantly lower our debt/capitalization
ratio and bring such ratio into closer proximity with the ratios of the
distressed REITs and stable REITs.

The table presents our capitalization at June 30, 2001 and as adjusted on a
pro forma basis for a $50 million equity investment that is assumed will be used
to repay debt, and for an assumed further $73.5 million reduction in debt
through cash flow from operations:

OMEGA PRO FORMA DEBT TO CAPITALIZATION ANALYSIS (DOLLARS IN MILLIONS)

PRO FORMA
JUNE 30, EQUITY PRO FORMA FURTHER JUNE 30,
2001 INVESTMENT WITH EQUITY REDUCTION 2001
-------- ---------- ----------- --------- ---------

DEBT
Total Debt (1)............. $425.6 (50.0) $375.6 (73.5) $302.1
EQUITY
Preferred.................. $212.3 $212.3 $212.3
Other...................... 247.4 50.0 297.4 297.4
------ ------ ------ ------ ------
Total Equity........... $459.7 50.0 $509.7 $509.7
DEBT TO CAPITALIZATION: 48.1% 42.4% 37.2%
MEAN (2)
Distressed REITs........... 34.7% 34.7% 34.7%
Stable REITs............... 42.5% 42.5% 42.5%
MEDIAN (2)
Distressed REITs........... 34.7% 34.7% 34.7%
Stable REITs............... 40.3% 40.3% 40.3%

(1) ASSUMES ADDITIONAL $10.0 MILLION OF DEBT IS REPAID FROM PROCEEDS IN EXCESS
OF $113.5 DUE IN MARCH AND JUNE OF 2002.

(2) MEAN AND MEDIAN FOR DISTRESSED REITS EXCLUDE OMEGA. MEAN AND MEDIAN FOR
STABLE REITS EXCLUDE SENIOR HOUSING PROPERTIES TRUST.

OMEGA SHARE PRICE ANALYSIS

Shattuck Hammond compared our share price performance to an index created by
Shattuck Hammond of the share price performances of the stable REITs and the
distressed REITs. Shattuck Hammond noted that we under-performed both indices
for the five year period and twelve month period ended October 26, 2001.
Shattuck Hammond also noted that for the three months ended October 26, 2001, we
outperformed the stable REIT index and improved relative to the distressed REIT
index.

Shattuck Hammond calculated our average share price based on the daily close
for our common stock for the five year, twelve month and three month period
ended October 26, 2001. Such averages were $20.26, $3.03 and $3.03,
respectively. Shattuck Hammond noted that the maximum rights offering price of
$2.92 was 94% of the average price for both the twelve month and three month
period.

COMPARABLE COMPANY ANALYSIS

In its comparable company analysis, Shattuck Hammond derived various
valuation and leverage multiples as well as leverage and operating margins for
our company and compared them to similar multiples and margins for the stable
REITs and the distressed REITs. As previously discussed, the REITs in each group
were selected because their healthcare focus and mix of assets were reasonably
similar to our company. Shattuck Hammond focused the comparable company analysis
on:

- the common share price to funds from operations multiple defined as
"Price/FFO" where FFO is defined as net income available to common
stockholders plus depreciation and amortization less any gains or losses
on sales of assets, and adjusted for any items deemed extraordinary or
"one-time" items; and

- the Debt/Capitalization ratio. See "Omega Pro Forma Debt to Capitalization
Analysis" above.

Shattuck Hammond noted that Omega's Price/FFO multiple was below the median and
mean multiples for the distressed and stable REITs. Shattuck Hammond further
noted that completion of the Explorer investment and rights offering could
result in an increase in our Price/FFO multiple.

The table below presents the mean and median price to FFO multiples for the
periods shown:

COMPARABLE PUBLIC COMPANIES' PRICE/FFO MULTIPLES

SIX
MONTHS
LTM ANNUALIZED 2001 2002
6/30/01 6/30/01 ESTIMATED PROJECTED
-------- ---------- --------- ---------

STABLE REITS
Mean......................................... 10.4x 10.5x 9.6x 9.2x
Median....................................... 10.4x 10.4x 10.2x 9.8x
DISTRESSED REITS
Mean (1)..................................... 5.6x 6.0x 7.0x 7.0x
Median (1)................................... 5.6x 6.0x 7.0x 7.0x
OMEGA (2) (3)................................ 3.2X 3.1X 3.9X 4.4X

(1) MEAN AND MEDIAN EXCLUDES OMEGA.

(2) 2001E AND 2002P ASSUME FULL CONVERSION OF SERIES C PREFERRED STOCK, AND
INCLUDES ADDITIONAL STOCK IN 2002 DUE TO PROPOSED $50 MILLION FINANCING.

(3) OUR FFO PER SHARE INCLUDES ADD-BACK OF ONE-TIME ITEMS AND CERTAIN
ADJUSTMENTS RELATED TO 2002 FINANCING.

In addition to the foregoing, Shattuck Hammond reviewed certain other
valuation and leverage multiples as well as leverage and operating margins,
including:

COMPARABLE PUBLIC COMPANIES' EQUITY VALUE AS A PERCENTAGE OF TOTAL ENTERPRISE
VALUE.

Shattuck Hammond calculated the Equity Value, or EV, for each of the stable
REITs and the distressed REITs by multiplying the fully-diluted number of shares
outstanding by the share price at October 26, 2001 and dividing the result by
the Total Enterprise Value, or TEV. TEV is defined as EV plus long and
short-term debt, plus other long-term liabilities, plus preferred stock, less
all cash and cash equivalents.

Shattuck Hammond noted that compared to all of the comparable REITs, the EV
of Omega is small relative to TEV. Shattuck Hammond further noted that as a
result, an increase in Omega's share price has a significant impact on
increasing Omega's Price/FFO multiple, but little impact on Omega's TEV to
Earnings Before Interest, Taxes, Depreciation and Amortization, or EBITDA,
multiple or TEV/EBITDA. This is the primary reason why Shattuck Hammond focused
its comparable company analysis on the Price/FFO multiple.

The table below presents the EV as a percentage of TEV for the period shown:

COMPARABLE PUBLIC COMPANIES' EV AS A % OF TEV

AS OF
OCTOBER, 26
2001
-----------

STABLE REITS
Mean........................................................ 62.4%
Median...................................................... 55.6%
DISTRESSED REITS
Mean (1).................................................... 31.4%
Median (1).................................................. 25.4%
OMEGA....................................................... 9.2%

(1) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

COMPARABLE PUBLIC COMPANIES' TEV/EBITDA MULTIPLE. Shattuck Hammond noted
that Omega's TEV/EBITDA multiple is greater than the mean and median multiples
of the distressed REITs and less than the mean and median multiples of the
stable REITs.

The table below presents mean and median TEV/EBITDA multiples for the
periods shown:

COMPARABLE PUBLIC COMPANIES' TEV/EBITDA

6 MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

STABLE REITS
Mean...................................................... 10.5x 10.7x
Median.................................................... 10.6x 10.7x
DISTRESSED REITS
Mean (1).................................................. 7.9x 8.4x
Median (1)................................................ 7.8x 8.6x
OMEGA (2)................................................. 8.7X 9.0X

(1) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

(2) OMEGA EBITDA ADJUSTED TO REFLECT ADD-BACK AND REDUCTION OF CERTAIN ONE-TIME
ITEMS.

COMPARABLE PUBLIC COMPANIES' FFO AS A PERCENTAGE OF DEBT. Shattuck Hammond
noted that Omega's FFO as a percentage of debt, or FFO/Debt, was below the
median and mean percentages for the distressed and stable REITs.

The table below presents the mean and median FFO/Debt percentages for the
periods shown:

COMPARABLE PUBLIC COMPANIES' FFO/DEBT

6 MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

STABLE REITS
Mean (1).................................................. 17.2% 17.2%
Median (1)................................................ 17.8% 17.9%
DISTRESSED REITS
Mean (2).................................................. 15.4% 14.6%
Median (2)................................................ 12.8% 11.1%
OMEGA (3)................................................. 4.8% 4.9%

(1) SENIOR HOUSING PROPERTY TRUST EXCLUDED FROM MEAN AND MEDIAN AS AN OUTLIER.

(2) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

(3) OMEGA FFO ADJUSTED TO REFLECT ADD-BACK AND REDUCTION OF CERTAIN ONE-TIME
ITEMS.

COMPARABLE PUBLIC COMPANIES' DEBT TO EBITDA MULTIPLE. Shattuck Hammond
noted that Omega's Debt to EBITDA, or Debt/EBITDA, multiple was greater than the
mean and median multiples for the distressed REITs and the stable REITs.

The table below presents the mean and median Debt/EBITDA multiples for the
periods shown:

COMPARABLE PUBLIC COMPANIES' DEBT/EBITDA

6 MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

STABLE REITS
Mean (1).................................................. 3.6x 3.7x
Median (1)................................................ 3.5x 3.5x
DISTRESSED REITS
Mean (2).................................................. 3.6x 3.8x
Median (2)................................................ 3.3x 3.6x
OMEGA (3)................................................. 5.2X 5.4X

(1) SENIOR HOUSING PROPERTY TRUST EXCLUDED FROM MEAN AND MEDIAN AS AN OUTLIER.

(2) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

(3) OMEGA EBITDA ADJUSTED TO REFLECT ADD-BACK AND REDUCTION OF CERTAIN ONE-TIME
ITEMS.

COMPARABLE PUBLIC COMPANIES' EBITDA TO INTEREST MULTIPLE. Shattuck Hammond
noted that Omega's EBITDA to Interest, or EBITDA/Interest, multiple was less
than the mean and median multiples for the distressed REITs and the stable
REITs.

The table below presents the mean and median EBITDA/Interest multiples for
the periods shown:

COMPARABLE PUBLIC COMPANIES' EBITDA/INTEREST

6 MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

STABLE REITS
Mean (1).................................................. 3.5x 3.5x
Median (1)................................................ 3.5x 3.7x
DISTRESSED REITS
Mean (2).................................................. 2.7x 2.8x
Median (2)................................................ 2.8x 2.8x
OMEGA (3)................................................. 2.1X 2.1X

(1) SENIOR HOUSING PROPERTY TRUST EXCLUDED FROM MEAN AND MEDIAN AS AN OUTLIER.

(2) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

(3) OMEGA EBITDA ADJUSTED TO REFLECT ADD-BACK AND REDUCTION OF CERTAIN ONE-TIME
ITEMS.

COMPARABLE PUBLIC COMPANIES' EBITDA AS A PERCENTAGE OF REVENUES. Shattuck
Hammond noted that Omega's EBITDA as a percentage of revenue, or EBITDA/Revenue,
was less than the mean and median percentages for the distressed REITs and the
stable REITs.

The table below presents the mean and median EBITDA/Revenue percentages for
the periods shown:

COMPARABLE PUBLIC COMPANIES' EBITDA/REVENUE

6 MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

STABLE REITS
Mean (1).................................................. 89.7% 90.1%
Median (1)................................................ 89.7% 90.5%
DISTRESSED REITS
Mean (2).................................................. 59.8% 58.8%
Median (2)................................................ 59.1% 57.4%
OMEGA (3)................................................. 28.8% 29.1%

(1) SENIOR HOUSING PROPERTY TRUST EXCLUDED FROM MEAN AND MEDIAN AS AN OUTLIER.

(2) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

(3) OMEGA EBITDA ADJUSTED TO REFLECT ADD-BACK AND REDUCTION OF CERTAIN ONE-TIME
ITEMS.

COMPARABLE PUBLIC COMPANIES' NET INCOME AS A PERCENTAGE OF
REVENUE. Shattuck Hammond noted that Omega's Net Income as a percentage of
revenue, or Net Income/Revenue, was less than the mean and median percentages
for the distressed REITs and the stable REITs.

The table below presents the mean and median Net Income/Revenue percentages
for the periods shown:

COMPARABLE PUBLIC COMPANIES' NET INCOME/REVENUE

6 MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

STABLE REITS
Mean (1).................................................. 41.6% 41.0%
Median (1)................................................ 40.1% 40.0%
DISTRESSED REITS
Mean (2).................................................. 29.7% 26.5%
Median (2)................................................ 29.7% 30.2%
OMEGA..................................................... 7.1% 7.4%

(1) SENIOR HOUSING PROPERTY TRUST EXCLUDED FROM MEAN AND MEDIAN AS AN OUTLIER.

(2) MEAN AND MEDIAN FOR DISTRESSED REITS INCLUDE OMEGA.

NET ASSET VALUE ANALYSIS

Shattuck Hammond performed a net asset value analysis that compared the
estimated net asset value per fully-diluted common share to our actual share
price at October 26, 2001. A similar comparative analysis was done with respect
to the stable REITs and the distressed REITs. The analysis was based on
financial results for the latest twelve months ended June 30, 2001 and the six
months ended June 30, 2001 annualized. The net asset value calculation was based
on determining a value for owned properties and other income and then adjusting
this combined value for various balance sheet related items such as cash, debt
and preferred stock. The value of owned properties was determined by multiplying
property cash flow by a multiple. Property cash flow was assumed to be equal to
real estate operating revenue less direct real estate operating costs. Other
income is assumed to consist primarily of interest income and excludes income or
losses related to sales of assets. The value of other income is determined by
multiplying other income for the period by a multiple. For the stable REITs, the

property cash flow multiple and other income multiple utilized is 10.0x and
6.0x, respectively. For the distressed REITs, the property cash flow multiple
and other income multiple utilized is 8.0x and 5.5x, respectively.

The table below presents the calculation of our net asset value, the median
and mean net asset values per share for the stable REITs and the distressed
REITs and the premium or discount of the actual share prices to the net asset
value per share for each group of REITs and our company at October 26, 2001:

SUMMARY NET ASSET VALUE PER SHARE (ACTUAL DOLLARS)

SIX MONTHS
LTM PREMIUM/ ANNUALIZED PREMIUM/
6/30/01 (DISCOUNT) 6/30/01 (DISCOUNT)
-------- ---------- ---------- ----------

STABLE REITS
Mean.................................. $ 25.5 (6.8)% $ 25.0 (4.7)%
Median................................ $ 24.8 (3.7)% $ 24.8 (2.2)%
DISTRESSED REITS
Mean (1).............................. $13.31 (22.9)% $11.95 (8.3)%
Median (1)............................ $13.31 (22.9)% $11.95 (8.3)%
OMEGA................................. $ 2.97 7.2% $ 2.39 33.2%

(1) DISTRESSED REITS EXCLUDE OMEGA.

CALCULATION OF OMEGA'S NET ASSET VALUE (DOLLARS IN MILLIONS)

SIX MONTHS
LTM ANNUALIZED
6/30/01 6/30/01
-------- ----------

Real Estate Operating Revenue........................... $ 251.6 $ 241.1
Direct Operating Expenses............................... 191.2 180.3
-------- -------
Property Cash Flow.................................... $ 60.4 $ 60.8
Applied Market Multiple................................. 8.0x 8.0x
Property Asset Value.................................. $ 483.4 $ 486.7
Other Income............................................ $ 31.3 $ 28.6
Applied Market Multiple................................. 5.5x 5.5x
Other Income for NAV Purposes......................... $ 172.3 $ 157.2

BALANCE SHEET (6/30/01)
Property Asset Value.................................... $ 483.4 $ 486.7
Other Income............................................ 172.3 157.2
Plus: Land.............................................. 32.1 32.1
Plus: Cash.............................................. 10.8 10.8
Less: Debt.............................................. (425.7) (425.7)
Less: Preferred......................................... (212.3) (212.3)
-------- -------
Net Asset Value....................................... $ 60.5 $ 48.7
SHARES OUTSTANDING (MILLIONS)........................... 20.4 20.4
NET ASSET VALUE PER SHARE............................... $ 2.97 $ 2.39
CURRENT SHARE PRICE (10/26/01).......................... $ 3.18 $ 3.18
SHARE PRICE RELATIVE TO NAV............................. 7.16% 33.17%

SELECTION AND ENGAGEMENT OF SHATTUCK HAMMOND

The Board of Directors authorized the special committee to engage a
financial advisor to provide financial advice and issue a fairness opinion with
respect to the rights offering. The special committee solicited proposals from
several investment banking firms. After careful consideration, the special
committee elected to engage Shattuck Hammond based on a number of factors
including the firm's experience in the healthcare sector as well as the
competitive terms of its fee proposal. As part of its

investment banking business, Shattuck Hammond is continually engaged in the
valuation of businesses and their securities in connection with mergers and
acquisitions, negotiated underwritings, secondary distributions of securities,
private placements and other purposes. Shattuck Hammond acted as financial
advisor to the special committee in connection with a review of other financing
alternatives that might be available to us and a review of any proposals related
to Explorer and will receive a fee from us for such services and an additional
fee upon the delivery of its opinion.

As compensation for its services as financial advisor to the special
committee, pursuant to a letter agreement dated October 15, 2001, we agreed to
pay Shattuck Hammond $250,000 in cash as follows:

- a retainer of $50,000;

- $50,000 upon the submission of a written report to the Board of Directors
which addressed a review and analysis of potential financing alternatives
for us as well as a review and analysis of financing proposals received by
us; and

- $250,000 (less any fees previously received) upon the earlier of the
completion of a financing or the delivery of a written opinion as to the
fairness of such financing from a financial point of view.

On October 29, 2001, the October 15, 2001 agreement was amended in
recognition of the increased time requirement of Shattuck Hammond, to provide
for Shattuck Hammond to receive a fee of $400,000 (instead of $250,000) less any
fees received, upon the earlier of the completion of a financing and the
delivery of its written opinion. In addition, Shattuck Hammond agreed to pay for
all of its out-of-pocket expenses.

PRICE RANGE OF COMMON STOCK AND DIVIDEND POLICY

Our common stock is listed on the NYSE under the symbol "OHI." On
January 17, 2002, there were approximately 2,050 registered holders of the
common stock, and the closing price per share of the common stock as listed on
the NYSE composite tape was $5.74.

In prior years, we historically distributed to stockholders a large portion
of the cash available from operations. Cash dividends paid totaled $1.00 per
common share for 2000, compared with $2.80 per common share for the year ended
December 31, 1999. Our historical policy had been to make distributions on our
common stock of approximately 80% of funds from operations. The dividend payout
ratio, that is the ratio of per common share amounts for dividends paid to the
diluted per common share amounts of funds from operations, was approximately
238% for 2000 and 84.3% for 1999. Excluding the provision for loss on mortgages
and notes receivable and severance and consulting agreement costs, the dividend
payout ratio for 2000 was approximately 73.0%. Cash dividends paid totaled $1.00
per common share during 2000 and $0.75 for the nine-month period ended
September 30, 2000. No common dividends were paid during the first three
quarters of 2001.

In November 2000, Explorer agreed to defer receipt until April 2, 2001 of
$4.7 million in dividends declared in the third quarter of 2000 on the Series C
preferred stock. We requested this deferral in light of the maturity in February
2001 of $16.6 million of subordinated debentures. In February 2001, we suspended
payment of all common and preferred cash dividends. This action was intended to
preserve cash to facilitate our ability to obtain financing to fund the 2002
debt maturities. Additionally, on March 30, 2001, we exercised our option to pay
the $4,666,667 Series C preferred stock dividend deferred from November 15, 2000
and the associated deferral fee by issuing 48,420 Series C preferred shares to
Explorer on April 2, 2001, which are convertible into 774,722 shares of our
common stock at $6.25 per share. We do not know when or if we will resume
dividend payments on our common stock and preferred stock or, if resumed, what
the amount or timing of any dividend will be. We do not anticipate paying
dividends on any class of capital stock at least until our $98 million of debt
maturing in the first half of 2002 has been repaid. All accumulated and unpaid
dividends on our Series A, B and C preferred stock, which totalled
$19.9 million at December 31, 2001, must be paid in full before dividends on our
common stock can be resumed.

Our current revolving credit facilities limit our ability to pay and declare
dividends to the maximum of 95% of our earnings before interest, taxes,
depreciation and amortization, except that we are permitted to declare and pay
any amount of dividends as may be required to be paid by us to maintain our
status as a real estate investment trust. If the maturity of a material amount
of our indebtedness is accelerated, we would be unable to pay dividends.

We have made sufficient distributions to satisfy the distribution
requirements under the REIT rules of the Internal Revenue Code of 1986 to
maintain our REIT status for 2000 and intend to satisfy the requirements under
the REIT rules for 2001.

On March 30, 2001 our Board of Directors approved payment of the accrued
Series C dividend from November 15, 2000 and the associated waiver fee by
issuing 48,420 shares of Series C preferred Stock to Explorer on April 2, 2001.
Dividends paid in stock to a specific class of stockholders, such as our payment
of our Series C preferred stock in April 2001, constitute dividends eligible for
the 2001 dividends paid deduction. Additionally, and as specifically authorized
by the Internal Revenue Code, dividends declared by September 15, 2002 and paid
by December 31, 2002 may be elected to be treated as a distribution of 2001
taxable income.

The following table sets forth the high and low closing prices of the common
stock as reported on the NYSE composite tape, together with the amount of cash
dividends declared per common share for each quarter for 2001 and 2000.

2002 2001 2000
------------------------------------------------------ ---------------------------------------------- -----------------------
DIVIDENDS DIVIDENDS
PER PER
QUARTER HIGH LOW SHARE QUARTER HIGH LOW SHARE QUARTER HIGH
------- -------- -------- --------- ------- -------- -------- --------- ------- --------

First (through First........ 4.7188 1.7500 $0.00 First........ $12.8125
1/14/2002)......... 6.1700 5.7400 Second....... 3.3906 1.3438 0.00 Second....... 7.0625
Third........ 3.6406 2.4531 0.00 Third........ 6.6875
Fourth....... 6.1563 2.9375 0.00 Fourth....... 6.2500

2000
--------------------- --------------------
DIVIDENDS
PER
QUARTER LOW SHARE
------- -------- ---------

First (through $5.8125 $0.50
1/14/2002)......... 4.5156 0.00
4.5625 0.25
3.3750 0.25

MODIFICATIONS TO AGREEMENTS WITH EXPLORER

Explorer has agreed to purchase $23.6 million of our stock in a private
placement concurrent with the closing of the rights offering, at the same price
per share as in this rights offering. The shares that Explorer has agreed to
purchase represent its pro rata portion, with respect to the shares of our
Series C preferred stock and common stock it holds, of the $50 million in
additional equity capital we are seeking to raise. Explorer has also committed
to increase the size of its private placement investment in our company by an
additional amount equal to the aggregate subscription price of any shares that
are not subscribed for in this offering. As a result of this commitment, we are
assured of receiving a total of $50 million in gross proceeds upon completion of
the rights offering and Explorer's investment. The shares to be issued to
Explorer are not registered as a part of the rights offering and will be
restricted securities under the Securities Act of 1933.

As a condition to Explorer's investment, we have agreed to amend certain of
the agreements relating to Explorer's July 2000 investment in our company
effective as of the closing of Explorer's new investment. The effect of these
amendments generally will be to remove those provisions in our agreements that
prohibit Explorer from voting in excess of 49.9% of our stock and from taking
certain actions without the prior approval of our Board of Directors.

EXISTING AGREEMENTS IN CONNECTION WITH JULY 2000 EXPLORER INVESTMENT

STOCKHOLDERS AGREEMENT. In connection with Explorer's July 2000 investment
in our company, we entered into a stockholders agreement dated July 14, 2000
under which Explorer is entitled to designate up to four members of our Board of
Directors depending on the percentage of total voting securities, consisting of
common stock and Series C preferred stock, acquired from time to time by
Explorer. Explorer is entitled to designate at least one director to our Board
of Directors as long as it owns at least 5% of the total voting power of our
company and to approve one "independent" director as long as it owns at least
25% of the shares it acquired at the initial closing or our common stock issued
upon conversion of those preferred shares. The right to designate directors will
terminate on July 14, 2010.

Explorer is permitted to transfer its Series C preferred stock to large
institutional investors if either (i) the total amount of voting securities
represented by the Series C preferred stock does not exceed 9.9% of the total
voting power of our voting securities or (ii) the investor becomes a party to
the standstill agreement contained in the stockholders agreement. Explorer has
the right, up to five times, to request us to register its shares for resale,
subject to customary conditions and limitations on such registration requests.
Any transfer of voting securities by Explorer or its affiliates (other than in
connection with the exercise of registration rights) is subject to a right of
first offer that can be exercised by us or any other purchaser that we may
designate. These transfer restrictions terminate on July 14, 2005.

Under the terms of the standstill provisions in the stockholders agreement,
Explorer agreed that, until July 14, 2005, it will not acquire, without the
prior approval of our Board of Directors, beneficial ownership of any voting
securities, other than acquisitions of not more than 5% of our voting
securities. In addition, without the prior approval of our Board of Directors,
Explorer is restricted from soliciting proxies from our other stockholders in
opposition to a recommendation of the Board of Directors, joining a "group"
within the meaning of Section 13(d)(3) of the Exchange Act with respect to our
securities, depositing our securities into a voting trust, or tendering our
securities in a tender offer not approved by the Board. Explorer and its
affiliates currently cannot exercise more than 49.9% of our total voting power
due to the terms of the Series C preferred stock, which provide that no holder
of Series C preferred stock will be entitled to vote any shares of Series C
preferred stock that would result in such holder, together with its affiliates,
voting in excess of 49.9% of the then outstanding voting power. In addition,
shares of Series C preferred stock cannot be converted to the extent that

such conversion would cause the converting stockholder to beneficially own in
excess of 49.9% of the then outstanding voting power.

SERIES C INVESTMENT AGREEMENT. Under the terms of an investment agreement
dated May 11, 2000 between us and Explorer in connection with Explorer's
purchase of Series C preferred stock, we agreed to reimburse Explorer for its
out-of-pocket expenses, up to a maximum amount of $2.5 million, incurred in
connection with the Series C investment. To date, we have reimbursed Explorer
for approximately $1.6 million of these expenses.

ADVISORY AGREEMENT. Under the terms of an amended and restated advisory
agreement dated October 4, 2000 between us and Hampstead, we have agreed to pay
Explorer an advisory fee if Hampstead provides assistance to us in connection
with the evaluation of growth opportunities or other financing matters. On
June 1, 2001, in connection with Hampstead's agreement to provide certain
specified financial advisory, consulting and operational services, including but
not limited to assistance in our efforts to refinance, repay or extend certain
indebtedness and assist in efforts to manage our capitalization and liquidity,
we agreed to pay Hampstead a fee equal to 1% of the aggregate amount of our
indebtedness that is refinanced, repaid or extended, based on the maximum amount
available to be drawn in the case of revolving credit facilities, up to a
maximum fee of $3.1 million. The advisory fee was payable five business days
following the completion of the refinancing, repayment or extension of any of
our indebtedness, but as amended no fee will be payable prior to December 31,
2001. Upon the closing of the rights offering and Explorer investment, Hampstead
will have fulfilled all of its obligations under the agreement, but the advisory
fee will only be payable at such time as all of the conditions to payment of the
advisory fee contained in the advisory agreement are met.

DIVIDEND AND GOVERNANCE RIGHT DEFERRAL. We and Explorer entered into a
dividend deferral letter agreement dated November 15, 2000 relating to the
extension of the dividend payment payable in connection with our Series C
preferred stock for the dividend period ended October 31, 2000. The deferral
period expired on April 2, 2001. The amount of the deferred dividend payment is
$4.667 million representing the total unpaid preferential cumulative dividend
for the October 2000 dividend. In exchange for the deferral, we also agreed to
pay Explorer a fee equal to 10% of the daily unpaid principal balance of the
unpaid dividend amount from November 15, 2000 until the dividend was paid. Under
certain circumstances, the portion of the unpaid dividend amount and fee which
is not paid in cash may be payable with additional shares of Series C preferred
stock. Shares of Series C preferred stock issued pursuant to this agreement are
valued at $100 per share, the stated per share liquidation preference, and are
convertible into our common stock at $6.25 per share. In consideration of the
payment of the deferral fee, Explorer agreed that the deferral of the subject
dividend would not be considered an unpaid dividend and, as a result, the
October 31, 2000 dividend period will not be included in the determination of
when Explorer's right to elect additional directors will vest.

By letter dated January 31, 2001, Explorer has waived its right to elect
additional preferred stock directors through December 31, 2002 provided that the
dividends on any shares of Series C preferred stock would not be in arrears for
six or more dividend periods from January 31, 2001 through and including
December 31, 2002.

In full payment of our obligations under the dividend deferral letter
agreement, we issued 48,420 shares of Series C preferred stock to Explorer on
April 2, 2001.

AGREEMENTS RELATED TO CURRENT EXPLORER INVESTMENT COMMITTMENT

AMENDED AND RESTATED STOCKHOLDERS AGREEMENT. We will enter into an amended
and restated stockholders agreement at the closing of Explorer's investment. If
Explorer owns securities representing more than 50% of our common stock,
Explorer would be able to elect all of the members of the Board of Directors.
However, pursuant to the amended and restated stockholders agreement, Explorer
will be

entitled to designate to our Board of Directors that number of directors that
would generally be proportionate to Explorer's ownership of voting securities of
our company, not to exceed five directors (six following increase in the size of
the Board of Directors to ten directors). We will limit the number of directors
on our Board so as not exceed nine without the consent of Explorer (ten
following stockholder approval of the increase in the size of the Board of
Directors to ten). We will also take such action to ensure generally that
Explorer's representation on all committees of the Board is proportionate to its
representation on the entire Board other than any special committee established
to consider transactions in which Explorer or any of its affiliates may have a
conflict of interest.

Explorer will, so long as it owns at least 15% of our voting securities,
vote its shares in favor of three "independent directors" as defined under the
rules of the New York Stock Exchange who are not affiliates of Explorer. Upon
the increase of the size of the Board to ten members, Explorer will vote its
shares in accordance with the previous sentence in favor of an additional
director who is not affiliated with Explorer. Upon the increase of the size of
the Board to ten members, we will appoint C. Taylor Pickett, our Chief Executive
Officer, as a new director. Mr. Pickett will then constitute the fourth non-
Explorer director.

Pursuant to the amended stockholders agreement, Explorer will no longer be
subject to certain restrictions under the prior stockholders agreement
preventing it from acquiring more than an additional 5% of our voting securities
without prior board approval, but Explorer will be restricted from acquiring
beneficial ownership of more than 80% of our voting securities without the
approval of a committee of the Board consisting entirely of independent
directors. Other restrictions on Explorer under the prior stockholders
agreement, including the agreement of Explorer not to solicit proxies in
opposition to, or prior to the issuance of a recommendation by, the Board; not
to join, form or participate in a group relating to the ownership or voting of
our securities or control of our company; not to deposit any securities in a
voting trust or other voting arrangement; and not to tender any securities in a
tender offer not approved by the Board will also no longer apply to Explorer.
Explorer will also no longer be subject to the right of first offer transfer
restrictions in the prior stockholders agreement.

Pursuant to the amended stockholders agreement, Explorer will not transfer
our voting securities to a transferee who, as a result of such transfer, would
beneficially own 10% or more of our outstanding voting securities unless such
transferee agrees to be bound by certain provisions of the amended stockholders
agreement including those relating to the election of independent directors.

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT. Pursuant to an amended
and restated registration rights agreement, we have agreed, subject to certain
limitations and under certain circumstances, to register for sale any shares of
our stock held by Explorer. We will enter into the amended and restated
registration rights agreement with Explorer at the closing of Explorer's
investment.

AMENDED SERIES C ARTICLES SUPPLEMENTARY. Pursuant to our investment
agreement with Explorer, we are required to seek the approval of our
stockholders to amend the Series C articles supplementary for the Series C
preferred stock presently owned by Explorer. Pursuant to the amended Series C
articles supplementary, the terms of the Series C preferred stock will be
amended to:

(i) remove the restriction that prevents the voting or conversion of the
Series C preferred stock in excess of 49.9% of our voting securities
owned by Explorer;

(ii) provide that if we fail to pay dividends owed upon the Series C
preferred stock or the Series D preferred stock for a period of time,
the holders of the Series C preferred stock and the Series D preferred
stock, voting together as a single class, will be entitled to designate
two additional directors to our Board;

(iii) provide that the subscription price in the rights offering will not
result in an adjustment to the conversion price of our Series C
preferred stock; and

(iv) make other technical changes to reflect the existence of the Series D
preferred stock.

The above amendments will not be effective unless approved by our stockholders.
We intend to seek stockholder approval for these amendments at the special
meeting of our stockholders scheduled for February 18, 2002. Explorer has
committed to vote its shares, representing approximately 47.1% of our voting
shares, in favor of these amendments. We will file an amended Series C articles
supplementary with the State Department of Assessments and Taxation of the State
of Maryland following receipt of stockholder's approval and the closing of
Explorer's investment.

STOCKHOLDERS RIGHTS PLAN AMENDMENT. Pursuant to our investment agreement
with Explorer, we have amended our stockholders rights plan to provide that
neither Explorer nor its affiliates will be an "acquiring person" for purposes
of activating the rights that were issued pursuant to our stockholders rights
plan. The amendment also exempts direct and indirect transferees of Explorer,
other than in transfers through an underwriter or national securities exchange,
from the definition of an "acquiring person." We will enter into the amendment
to our stockholders rights plan at the closing of Explorer's investment.

ADVISORY AGREEMENT SIDE LETTER. We have agreed that upon the closing of the
rights offering The Hampstead Group, L.L.C., an affiliate of Explorer, will have
fulfilled all of its obligations under the amended and restated advisory
agreement between us and Hampstead to provide certain specified financial
advisory, consulting and operational services, including, but not limited to,
assistance in our efforts to refinance, repay or extend certain indebtedness and
assistance in efforts to manage our capitalization and liquidity. As a result,
the advisory fee payable to Hampstead under the advisory agreement will be
earned but only becomes payable when all of the conditions to payment of the
advisory fee contained in the advisory agreement are met. These conditions
include the extension, repayment or refinancing of the outstanding balances of
our senior unsecured notes maturing on June 15, 2002 as well as the extension,
refinancing or repayment of our $175 million senior secured revolving credit
facility. The advisory fee that will be payable is equal to 1% of the amount of
refinanced indebtedness (based on the maximum amount available to be drawn in
the case of revolving credit facilities) up to a maximum fee of $3.1 million.
Following the completion of the rights offering and the effectiveness of the
agreements with our bank groups, the full $3.1 million advisory fee will have
been earned. However, Hampstead has agreed to defer payment of this fee until
all the company indebtedness maturing in 2002 has been repaid, refinanced or
extended. If Hampstead provides additional services, we will be required to pay
them a customary advisory fee.

OCTOBER 2001 INVESTMENT AGREEMENT. As part of our investment agreement with
Explorer dated October 29, 2001 in connection with the rights offering and
Explorer's investment, we have agreed to reimburse Explorer for its out of
pocket expenses in connection with its new investment.

CAPITALIZATION

The following table shows, as of September 30, 2001, our historical
capitalization and our capitalization as adjusted for the rights offering and
Explorer's investment, including the application of the proceeds, assuming net
proceeds of $48 million. For purposes of this table, we have assumed that all of
the rights will be exercised in full by stockholders in the rights offering and
that we will issue Series D preferred stock to Explorer at the closing of the
rights offering. If stockholders approve Explorer's investment before the
closing of the rights offering, Explorer will be issued a number of shares of
common stock equal to the number of shares of common stock that would otherwise
have been issuable upon conversion of the Series D preferred stock in lieu of
the Series D preferred stock. To the extent stockholders do not exercise all of
the rights, the amount of Series D preferred stock or common stock issued to
Explorer will increase. For purposes of our capitalization as adjusted, we have
assumed a subscription price of $2.92 per share.

UNAUDITED
------------------------------
HISTORICAL AS ADJUSTED
---------- --------------
(IN THOUSANDS)

Debt:
Revolving lines of credit................................. $ 203,641 $ 203,641
Other secured borrowings.................................. 18,595 18,595
Unsecured borrowings:
6.95% Notes Due June 2002(1)............................ 99,641 51,641
6.95% Notes Due August 2007............................. 100,000 100,000
Other unsecured borrowings.............................. 4,160 4,160
--------- ---------
Total Debt................................................ 426,037 378,037

Stockholders' Equity:
Preferred Stock $1.00 par value:
Authorized--10,000 Shares
Issued and Outstanding--2,300 shares Series A with an
aggregate liquidation preference of $57,500............ 57,500 57,500
Issued and Outstanding--2,000 shares Series B with an
aggregate liquidation preference of $50,000............ 50,000 50,000
Issued and Outstanding--1,048 shares Series C with an
aggregate liquidation preference of $104,842........... 104,842 104,842
Issued and Outstanding--228 shares Series D with an
aggregate liquidation preference of $22,808(2)......... -- 22,808

Common Stock $.10 par value:
Authorized--100,000 shares
Issued and Outstanding--20,076(2)....................... 2,008 --
Issued and Outstanding--37,199.......................... -- 3,720
Additional paid-in capital.............................. 438,384 461,864
Cumulative net earnings................................. 171,272 171,272
Cumulative dividends paid............................... (365,654) (365,654)
Unamortized restricted stock awards....................... (202) (202)
Accumulated other comprehensive income.................... (1,491) (1,491)
--------- ---------
Total Stockholders' Equity................................ 456,659 504,659
--------- ---------
Total Capitalization...................................... $ 882,696 $ 882,696
========= =========

------------------------------

(1) For purposes of our capitalization, as adjusted, we have assumed that the
net proceeds from this offering and the Explorer investment will be
approximately $48 million and that we used those proceeds to repay notes
due June 2002. We have not determined the actual allocation of proceeds
from this offering and the Explorer investment and management will have
broad discretion in making that determination. See "Use of Proceeds."

(2) If none of the subscription rights are exercised by stockholders,
20,076,024 shares of common stock and 500,000 shares of Series D preferred
stock with a liquidation preference of $50 million will be outstanding
following the closing of the rights offering and Explorer's investment as
adjusted. Upon stockholder approval of Explorer's investment, all the
outstanding Series D preferred stock will automatically be converted into
17,123,288 shares of common stock.

SELECTED FINANCIAL DATA

The historical operating data set forth below for the nine months ended
September 30, 2000 and 2001 and the balance sheet data as of September 30, 2001
are derived from our unaudited consolidated financial statements and notes
included in this prospectus and, in the opinion of our management, include all
adjustments, consisting of only normal recurring adjustments, considered
necessary for a fair presentation. Interim results are not necessarily
indicative of the results that can be expected for a full fiscal year. The
historical operating data set forth below for each of the years in the
three-year period ended December 31, 2000 and the balance sheet data as of
December 31, 2000 and 1999 are derived from our audited consolidated financial
statements and notes included in this prospectus, which have been audited by
Ernst & Young LLP, independent auditors. The historical operating data set forth
below for each of the years in the two-year period ended December 31, 1997 and
the balance sheet data as of December 31, 1998, 1997 and 1996 are derived from
our audited consolidated financial statements and notes, which have not been
included in this prospectus but which we have previously filed with the
Securities and Exchange Commission and have been audited by Ernst & Young LLP,
independent auditors. The following selected financial data have been derived
from and should be read in conjunction with our consolidated financial
statements and the related notes and "Management's Discussion and Analysis of
Financial Condition and Results of Operations."

NINE MONTHS
ENDED
SEPTEMBER 30, YEAR ENDED DECEMBER 31,
------------------- ----------------------------------------------------
2001 2000 2000 1999 1998 1997 1996
-------- -------- -------- -------- -------- -------- --------
(UNAUDITED) (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

OPERATING DATA
Revenues(1).......................................... $201,666 $195,673 $275,793 $148,129 $109,314 $90,820 $73,127
Net Earnings (Loss) Available to Common (before
gain/loss on assets sold and provision for
impairment in 2001, 2000, 1999 and 1998 and gain
from early extinguishment of debt in 2001)......... (19,951) (13,500) (14,784) 40,047 41,777 41,305 34,590
Net Earnings (Loss) Available to Common.............. (26,242) (57,507) (66,485) 10,040 68,015 41,305 34,590
Per Share Amounts:
Net Earnings (Loss) (before gain/loss on assets
sold and provision for impairment in 2001, 2000,
1999 and 1998 and gain from early extinguishment
of debt in 2001):
Basic............................................ (1.00) (0.67) $ (0.74) $ 2.01 $ 2.09 $ 2.16 $ 2.01
Diluted.......................................... (1.00) (0.67) (0.74) 2.01 2.08 2.16 2.01
Net Earnings (Loss) Available to Common:
Basic............................................ (1.31) (2.87) (3.32) 0.51 3.39 2.16 2.01
Diluted.......................................... (1.31) (2.87) (3.32) 0.51 3.39 2.16 2.01
Net Earnings (Loss) before gain on early
extinguishment of debt:
Basic............................................ (1.46) (2.87) (3.32) 0.51 3.39 2.16 2.01
Diluted.......................................... (1.46) (2.87) (3.32) 0.51 3.39 2.16 2.01
Dividends, Common Stock(2)......................... -- 0.75 1.00 2.80 2.68 2.58 2.48
Dividends, Series A Preferred(2)................... -- 1.73 2.31 2.31 2.31 1.16
Dividends, Series B Preferred(2)................... -- 1.62 2.16 2.16 1.08
Dividends, Series C Preferred(3)................... -- -- 0.25
Weighted Average Common Shares Outstanding, Basic.... 20,032 20,058 20,052 19,877 20,034 19,085 17,196
Weighted Average Common Shares Outstanding,
Diluted............................................ 20,032 20,058 20,052 19,877 20,041 19,137 17,240

NINE MONTHS
ENDED
SEPTEMBER 30, DECEMBER 31,
-------------- --------------------------------------------------------
2001 2000 1999 1998 1997 1996
-------------- -------- ---------- ---------- -------- --------
(UNAUDITED)

BALANCE SHEET DATA
Gross Investments.................................... $944,148 $974,507 $1,072,398 $1,069,646 $839,927 $643,261
Total Assets......................................... 911,265 948,451 1,038,731 1,037,207 816,108 634,836
Revolving Lines of Credit............................ 203,641 185,641 166,600 123,000 58,300 6,000
Other Long-Term Borrowings........................... 222,396 249,161 339,764 342,124 208,966 135,659
Subordinated Convertible Debentures.................. -- 16,590 48,405 48,405 62,485 94,810
Stockholders' Equity................................. 456,659 464,313 457,081 505,762 468,221 383,007

------------------------------

(1) Revenues for the nine months ended September 2001 and 2000 and the years
ended December 2000 and December 1999 include $133,613, $123,461, $175,559,
and $26,223, respectively, of revenues from nursing home operations from
facilities recovered from customers and managed for our own account.

(2) Dividends per share are those declared and paid during each period.

(3) Dividends per share are those declared during each period, based on the
number of shares of common stock issuable upon conversion of the outstanding
Series C. See Note 15 to our December 31, 2000 consolidated financial
statements included in this prospectus.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THE FOLLOWING DISCUSSION CONTAINS FORWARD-LOOKING STATEMENTS. THESE
STATEMENTS RELATE TO OUR EXPECTATIONS, BELIEFS, INTENTIONS, PLANS, OBJECTIVES,
GOALS, STRATEGIES, FUTURE EVENTS, PERFORMANCE AND UNDERLYING ASSUMPTIONS AND
OTHER STATEMENTS OTHER THAN STATEMENTS OF HISTORICAL FACTS. IN SOME CASES YOU
CAN IDENTIFY FORWARD-LOOKING STATEMENTS BY THE USE OF FORWARD-LOOKING
TERMINOLOGY INCLUDING "MAY" "WILL" "ANTICIPATES" "EXPECTS" "BELIEVES" "INTENDS"
"SHOULD" OR COMPARABLE TERMS OR THE NEGATIVE THEREOF. THESE STATEMENTS ARE BASED
ON INFORMATION AVAILABLE ON THE DATE OF THIS PROSPECTUS AND ONLY SPEAK AS OF THE
DATE HEREOF AND NO OBLIGATION TO UPDATE SUCH FORWARD-LOOKING STATEMENTS SHOULD
BE ASSUMED. OUR ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE REFLECTED IN THE
FORWARD-LOOKING STATEMENTS CONTAINED HEREIN AS A RESULT OF A VARIETY OF FACTORS,
INCLUDING THOSE DISCUSSED UNDER "FORWARD-LOOKING STATEMENTS" AND "RISK FACTORS."

OVERVIEW

The long-term care industry has experienced unprecedented financial
challenges in the recent past that have had an adverse impact on us during 2000
and 2001. These challenges are due principally to the Balanced Budget Act of
1997 which introduced the prospective payment system for the reimbursement of
Medicare patients in skilled nursing facilities, implementing an acuity-based
reimbursement system in lieu of the cost-based reimbursement system historically
used. The prospective payment system significantly reduced payments to nursing
home operators. That reduction, in turn, has negatively affected the revenues of
our nursing home facilities and the ability of our nursing home operators to
service their capital costs to us. Many nursing home operators, including a
number of our large nursing home operators, have sought protection under
Chapter 11 of the Bankruptcy Act.

In response to the adverse impact of the prospective payment system
reimbursement cuts, the Federal government passed the Balanced Budget Refinement
Act of 1999 and the Benefits Improvement and Protection Act of 2000, both of
which increase payments to nursing home operators. These increases have
positively affected the revenues of our nursing home facilities and the ability
of our nursing home operators to service their capital costs to us. In addition,
the facilities that we own and currently operate for our own account have been
likewise positively affected by the Balanced Budget Refinement Act and Benefits
Improvement and Protection Act.

The initial impact of the prospective payment system negatively affected our
financial results and our access to capital sources to fund growth and refinance
existing indebtedness. To obtain sufficient liquidity to enable us to address
the maturity in July 2000 and February 2001 of indebtedness totaling
$129.8 million, we issued $100.0 million of Series C preferred stock to Explorer
in July 2000 as described in more detail in Note 10 to our audited consolidated
financial statements included in this prospectus. Simultaneously with the
issuance of the Series C preferred stock, we also refinanced our then existing
credit facilities.

As a consequence of the financial difficulties encountered by a number of
our nursing home operators, we have recovered various long-term care assets
pledged as collateral for the operators' obligations either in connection with a
restructuring or settlement with certain operators or pursuant to foreclosure
proceedings. Under normal circumstances, we would classify such assets as
"assets held for sale" and seek to re-lease or otherwise dispose of such assets
as promptly as practicable. However, a number of companies were actively
marketing portfolios of similar assets and, in light of the market conditions in
the long-term care industry generally, it had become more difficult both to sell
these properties and for potential buyers to obtain financing to acquire them.
As a result, during 2000, $24.3 million of assets previously classified as held
for sale were reclassified to "owned and operated assets" as the timing and
strategy for sale or, alternatively, re-leasing, were revised in light of
prevailing market conditions.

As of September 30, 2001, we owned 60 long-term healthcare facilities that
had been recovered from customers and are currently operated for our own
account. During 1999, 2000 and 2001, we experienced a significant increase in
nursing home revenues attributable to the increase in owned and operated assets.
In addition, in connection with the recovery of these assets, we often fund
working capital and deferred capital expenditure needs for a transitional period
until license transfers and other regulatory matters are completed and
reimbursement from third-party payors recommences. Our management intends to
sell or re-lease these assets as promptly as possible consistent with achieving
valuations that reflect our management's estimate of fair realizable value of
the assets. We do not know, however, if or when the dispositions will be
completed or whether the dispositions will be completed on terms that will
enable us to realize the fair value of such assets.

In November 2000, Explorer agreed to defer receipt until April 2, 2001 of
$4.7 million in dividends declared in October 2000 on the Series C preferred
stock. We requested this deferral in light of the maturity in February 2001 of
$16.6 million of subordinated debentures. In February 2001, we suspended payment
of all dividends on all common and preferred stock. This action was intended to
preserve cash to facilitate our ability to obtain financing to fund debt
maturing in 2002. Additionally, on March 30, 2001, we exercised our option to
pay the deferred Series C preferred stock dividend and associated deferral fee
by issuing 48,420 additional shares of Series C preferred stock to Explorer.
These shares are convertible into 774,722 shares of our common stock at $6.25
per share. We do not know when or if we will resume dividend payments on our
common stock or, if resumed, what the amount or timing of any dividend will be.
We do not anticipate paying dividends on any class of capital stock at least
until our $98 million of debt maturing in the first half of 2002 has been
repaid, and in any event, all accrued and unpaid dividends on our Series A, B
and C preferred stock must be paid in full before dividends on our common stock
can be resumed. We have made sufficient distributions to satisfy the
distribution requirements under the REIT rules of the Internal Revenue Code of
1986 to maintain our REIT status for 2000 and intend to satisfy the requirements
under the REIT rules for 2001.

In August 2001, we paid $10 million to settle a lawsuit brought against us
by Karrington Health, Inc. The recognition of this non-recurring expense
associated with the settlement has resulted in violations of certain financial
covenants in the loan agreements relating to our revolving credit facilities. We
previously obtained a waiver from the lenders under our two revolving credit
facilities through September 14, 2001 in respect of our default under these
covenants. The lenders under our $175 million credit facility have granted us a
waiver through December 13, 2001. The waiver granted by our lenders under our
$75 million secured credit facility has expired and discussions regarding an
extension are continuing.

The following is our discussion of the consolidated results of operations,
financial position and liquidity and capital resources, which should be read in
conjunction with our consolidated financial statements and accompanying notes.

RESULTS OF OPERATIONS

YEAR ENDED DECEMBER 31, 2000 COMPARED TO YEAR ENDED DECEMBER 31, 1999

Our revenues for the year ended December 31, 2000 totaled $275.8 million, an
increase of $127.7 million over 1999 revenues. This increase is principally due
to the inclusion of revenue from nursing home operations for assets owned and
operated for our account recovered pursuant to foreclosure and settlements with
troubled operators in 2000 and revenues associated with foreclosure assets that
were previously classified as "assets held for sale" and reclassified to "owned
and operated assets" during the third quarter of 2000. Excluding nursing home
revenues of owned and operated assets, revenues were $96.8 million for the
twelve-month period ended December 31, 2000, a decrease of $26.1 million from
the comparable prior year period.

Our rental income for the year ended December 31, 2000 totaled
$67.3 million, a decrease of $9.1 million over 1999 rental income. The decrease
is due to $8.7 million from reductions in lease revenue due to foreclosures,
bankruptcies and restructurings, and $4.9 million from reduced investments
caused by 1999 and 2000 asset sales. These decreases are offset by $2.4 million
in additional revenue from 1999 investments held for a full year, $1.3 million
relating to contractual increases in rents that became effective in 2000 as
defined under the related agreements and $0.8 million from a mortgage that
converted to a lease in 1999.

Our mortgage interest income for the year ended December 31, 2000 totaled
$24.1 million, decreasing $12.2 million over 1999 mortgage interest income. The
decrease is due to $7.3 million from reductions due to foreclosures,
bankruptcies and restructurings, $4.7 million from reduced investments caused by
the payoffs of mortgages and $0.8 million reduction from a mortgage that
converted to a lease in 1999. These decreases are offset by $0.5 million
relating to contractual increases in interest income that became effective in
2000 as defined under the related agreements.

Our nursing home revenues of owned and operated assets for the year ended
December 31, 2000 totaled $175.6 million, increasing $149.3 million over 1999
nursing home revenues. The increase is due to the increased number of facilities
classified as owned and operated assets in 2000 as a result of bankruptcies,
foreclosures and restructurings.

Our expenses for the year ended December 31, 2000 totaled $335.3 million,
increasing approximately $217.4 million over expenses of $117.9 million for
1999.

Our nursing home expenses for owned and operated assets increased to
$179.0 million from $25.2 million in 1999 due to the increase in the number of
nursing homes operated for our account.

Our interest expense for the year ended December 31, 2000 was approximately
$42.4 million, compared with $42.9 million for 1999. The decrease in 2000 is
primarily due to lower average outstanding borrowings during the 2000 period,
partially offset by higher average interest rates.

The 2000 provision for depreciation and amortization of real estate totaled
$23.3 million, decreasing $0.9 million over 1999. The decrease primarily
consists of $2.0 million depreciation expense for properties sold or held for
sale and a reduction in amortization of non-compete agreements of $0.8 million
offset by $1.6 million additional depreciation expense from properties
previously classified as mortgages and new investments placed in service in 1999
and 2000.

Our general and administrative expenses for 2000 totaled $6.4 million as
compared to $5.2 million for 1999, an increase of $1.2 million or 22.8%. The
increase is due in part to the incremental administrative costs incurred in 2000
to manage the owned and operated assets, $0.5 million of non-cash compensation
expense relating to the dividend equivalent rights granted to management, and
increased consulting costs related to the foreclosure assets.

Our legal expenses for 2000 totaled $2.5 million as compared to
$0.4 million in 1999. The increase is largely attributable to legal costs
associated with the operator bankruptcy filings and negotiations with our
troubled operators.

We recognized a $4.7 million charge for severance payments in 2000. The
charges are comprised of severance and consulting payments to our former Chief
Executive Officer and former Chief Financial Officer.

We also recognized a provision for loss on mortgages and notes receivable of
$15.3 million in 2000, adjusting the carrying value of mortgages and notes
receivable to their net realizable value.

A provision for impairment of $61.7 million is included in expenses for
2000. This provision included $14.4 million for assets held for sale to reduce
properties to fair value less cost to dispose, $43.0 million for facilities
recovered from operators and now held as owned and operated assets to fair

value, $1.9 million for other real estate assets and $2.4 million of goodwill
which, due to the diminished value of the related real estate assets, our
management has determined is impaired.

During 2000, we sold certain of our core and other assets realizing proceeds
of $34.7 million, resulting in a gain of $10.0 million. During 1999, we
completed asset sales yielding net proceeds of $18.2 million, realizing losses
of $10.5 million.

Our funds from operations for the year ended December 31, 2000 on a fully
diluted basis totaled $19.2 million, a decrease of $52.6 million as compared to
the $71.9 million for 1999 due to factors mentioned above. After adjusting for
the non-recurring provision for loss on mortgages and notes receivable and
severance and consulting costs, funds from operations for the year was
$39.3 million, a decrease of $32.6 million from the year ended December 31,
1999. Funds from operations is net earnings available to common stockholders,
excluding any gains or losses from debt restructuring and the effects of asset
dispositions, plus depreciation and amortization associated with real estate
investments. Diluted funds from operations is the lower of funds from operations
and funds from operations adjusted for the assumed conversion of Series C
Preferred Stock and Subordinated Convertible Debentures and the exercise of
in-the-money stock options. We consider funds from operations to be one
performance measure which is helpful to investors of real estate companies
because, along with cash flows from operating activities, financing activities
and investing activities, it provides investors an understanding of our ability
to incur and service debt and to make expenditures. Funds from operations in and
of itself does not represent cash generated from operating activities in
accordance with generally accepted accounting principles and therefore should
not be considered an alternative to net earnings as an indication of operating
performance, or to net cash flow from operating activities as determined by
generally accepted accounting principles in the United States, as a measure of
liquidity and is not necessarily indicative of cash available to fund cash
needs.

No provision for federal income taxes has been made since we continue to
qualify as a REIT under the provisions of Sections 856 through 860 of the
Internal Revenue Code of 1986, as amended. Accordingly, we have not been subject
to federal income taxes on amounts distributed to stockholders, as we have
distributed at least 95% of our REIT taxable income for taxable years before
2001 and have met certain other conditions. In 2001, and future taxable years,
we are required to distribute at least 90% of our REIT taxable income.

YEAR ENDED DECEMBER 31, 1999 COMPARED TO YEAR ENDED DECEMBER 31, 1998

Revenues for the year ended December 31, 1999 totaled $148.1 million,
increasing $38.8 million over 1998 revenues.

Our rental income for the year ended December 31, 1999 totaled
$76.4 million, an increase of $4.3 million over 1998 rental income. The 1999
revenue growth stems primarily from $11.7 million in revenue from additional
investments during 1999 and a full year of revenue from investments made in
1998, $1.2 million relating to contractual increases in rents that became
effective in 1999 as defined under the related agreements, and $1.3 million from
mortgages that converted to leases in 1999. These increases are offset by
$9.9 million from reductions in lease revenue due to foreclosure, bankruptcy and
asset sales.

Our mortgage interest income for the year ended December 31, 1999 totaled
$36.4 million, an increase of $6.0 million over 1998 mortgage interest income.
The 1999 revenue growth stems primarily from $9.3 million in revenue from
additional investments during 1999 and a full year of revenue from investments
made in 1998, and $0.3 million relating to contractual increases in mortgage
interest that became effective in 1999 as defined under the related agreements.
These increases are offset by $2.4 million from reductions in interest revenue
due to the payment of mortgages and $1.3 million from mortgages that converted
to leases in 1999.

Our nursing home revenues of owned and operated assets for the year ended
December 31, 1999 totaled $26.2 million. This is due to the consolidation of
nursing home revenues for owned and operated assets as a result of foreclosures
occurring in 1999.

Our expenses for the year ended December 31, 1999 totaled $117.9 million,
increasing approximately $51.8 million over expenses of $66.1 million for 1998.

Our nursing home expenses attributable to owned and operated assets
increased $25.2 million due to recovery of nursing homes operated for our own
account.

The 1999 provision for depreciation and amortization of real estate totaled
$24.2 million, increasing $2.7 million over 1998. This increase stems from a
full year provision for 1998 investments, plus a partial year provision for 1999
investments.

Our interest expense for the year ended December 31, 1999 was approximately
$42.9 million, compared with $32.4 million for 1998. The increase in 1999 is
primarily due to higher average outstanding borrowings during the 1999 period,
partially offset by lower average interest rates.

During 1999, we completed asset sales yielding net proceeds of
$18.2 million, realizing losses of $10.5 million. In addition, our management
initiated a plan in the 1999 fourth quarter for additional asset sales to be
completed in 2000. The additional assets identified as assets held for sale had
a cost of $33.8 million, a net carrying value of $28.6 million and annualized
revenue of approximately $3.4 million. As a result of this review, we recorded a
provision for impairment in 1999 of $19.5 million to adjust the carrying value
of assets held for sale to their fair value, less cost of disposal.

During 1998, we initiated a plan to dispose of certain properties judged to
have limited long-term potential and to re-deploy the proceeds. Following a
review of the portfolio, assets identified for sale in 1998 had a cost of
$95.0 million, a net carrying value of $83.0 million, and annualized revenues of
approximately $11.4 million. In 1998, we recorded a provision for impairment of
$6.8 million to adjust the carrying value of those assets judged to be impaired
to their fair value, less cost of disposal. During 1998, we completed sales of
two groups of assets, yielding sales proceeds of $42.0 million. Gains realized
in 1998 from the dispositions approximated $2.8 million.

Our funds from operations for the year ended December 31, 1999 on a fully
diluted basis totaled $71.9 million, an increase of $2.1 million over the
$69.8 million for 1998. The 1999 increase in funds from operations is primarily
due to new additions to investments, offset by early payment of mortgages and
disposition of real estate assets.

No provision for Federal income taxes has been made since we continue to
qualify as a real estate investment trust under the provisions of Sections 856
through 860 of the Internal Revenue Code of 1986, as amended.

THREE- AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2001 COMPARED TO THREE- AND
NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2000

Revenues for the three-month and nine-month periods ended September 30, 2001
totaled $66.8 million and $201.7 million, respectively, a decrease of
$1.2 million and an increase of $6.0 million, respectively, over the periods
ending September 30, 2000. Excluding nursing home revenues of owned and operated
assets, revenues were $23.0 million and $68.1 million, respectively, for the
three-month and nine-month periods ended September 30, 2001, an increase of
$1.0 million and a decrease of $4.2 million, respectively, from the comparable
prior year periods.

Rental income for the three-month and nine-month periods ended
September 30, 2001 totaled $14.9 million and $45.7 million, respectively, a
decrease of $0.6 million and $4.0 million, respectively, over the same periods
in 2000. The three-month decrease is due to $1.5 million from reductions in
lease revenue due to foreclosures, bankruptcies and restructurings. This
decrease is offset by

$0.3 million relating to contractual increases in rents that became effective in
2001 and $0.2 million relating to assets previously classified as owned and
operated. The nine-month decrease is due to $3.8 million from reductions in
lease revenue due to foreclosures, bankruptcies and restructurings, and
$1.8 million from reduced investments resulting from the sale of assets in 2000.
These decreases are offset by $0.9 million relating to contractual increases in
rents that became effective in 2001 as defined under the related agreements and
$0.2 million relating to assets previously classified as owned and operated.

Mortgage interest income for the three-month and nine-month periods ended
September 30, 2001 totaled $5.1 million and $16.3 million, respectively,
decreasing $0.8 million and $1.5 million, respectively, from the same periods in
2000. The three-month decrease is due to reduced investments resulting from the
payoff of mortgage notes. The nine-month decrease is due to reductions from
foreclosures, bankruptcies and restructurings ($0.5 million) and reduced
investments resulting from the payoffs of mortgage notes ($1.2 million). These
decreases are partially offset by contractual increases in interest income that
became effective in 2001 as defined under the related agreements.

Nursing home revenues of owned and operated assets for the three-month and
nine-month periods ended September 30, 2001 totaled $43.8 million and
$133.6 million, respectively, decreasing $2.1 million and increasing
$10.2 million, respectively, over the same periods in 2000. The decrease for the
three-month period is due to a decreased number of operated facilities versus
the same three-month period in 2000 as a result of the closure of certain
facilities and their reclassification to assets held for sale as well as the
re-lease of three facilities during 2001 to a new operator. The increase in the
nine-month period is primarily due to the inclusion of 30 facilities formerly
operated by RainTree Healthcare Corporation for the full nine-month period ended
September 30, 2001 versus seven months during the nine-month period ended
September 30, 2000.

Expenses for the three-month and nine-month periods ended September 30, 2001
totaled $67.4 million and $215.0 million, respectively, decreasing approximately
$65.6 million and $38.0 million, respectively, over expenses of $133.0 million
and $253.0 million for the three-month and nine-month periods ended
September 30, 2000.

Nursing home expenses for owned and operated assets for the three-month
period and nine-month periods ended September 30, 2001 decreased by
$4.1 million and increased by $8.1 million, respectively, from $48.6 million and
$126.4 million for same periods in 2000. The decrease in the three-month period
is due to a decreased number of facilities versus the same three-month period in
2000 as a result of the closure of certain facilities and their reclassification
to assets held for sale as well as the re-lease of three facilities during 2001
to a new operator. The increase in the nine-month period is primarily due to the
inclusion of 30 facilities formerly operated by RainTree Healthcare Corporation
for the full nine-month period ended September 30, 2001 versus seven months
during the three-month period ended September 30, 2000.

The provision for depreciation and amortization totaled $5.5 million and
$16.6 million, respectively, during the three-month and nine-month periods ended
September 30, 2001. This is a decrease of $0.1 million and $0.8 million,
respectively, over the same periods in 2000. The decrease is primarily due to
assets sold in 2000, lower depreciable values due to impairment charges on owned
and operated properties and a reduction in the amortization of goodwill and
non-compete agreements.

Interest expense for the three-month and nine-month periods ended
September 30, 2001 was approximately $9.1 million and $28.0 million, compared
with $9.8 million and $32.2 million, respectively, for the same periods in 2000.
The decrease in 2001 is primarily due to lower average outstanding borrowings
during the 2001 period, partially offset by slightly higher average interest
rates due to increased rate spreads under our credit facilities versus last
year.

General and administrative expenses for the three-month and nine-month
periods ended September 30, 2001 totaled $2.2 million and $7.7 million,
respectively, as compared to $1.8 million and

$4.6 million, respectively, for the same periods in 2000, an increase of
$0.4 million and $3.1 million. The increase is due primarily to consulting costs
related to the efforts associated with the business objective of re-leasing our
owned and operated assets, restructuring activities and other non-recurring
expenses including executive recruiting fees.

Legal expenses for the three-month and nine-month periods ended
September 30, 2001 totaled $1.1 million and $2.9 million, respectively, an
increase of $0.7 million and $1.9 million, respectively, over the same periods
in 2000. The increase is largely attributable to legal costs associated with the
foreclosure of assets and other negotiations with our troubled operators as well
as the defense of various lawsuits to which we are party.

The nine-month period ended September 30, 2001 included a $10 million
litigation settlement expense related to a suit brought against us by Karrington
Health, Inc. which was recorded in the quarter ended June 30, 2001.

Expenses for the nine-month period ended September 30, 2001 included a
provision for impairment of $8.4 million. This provision was recorded to reduce
the cost basis of assets recovered from a defaulting operator to their fair
value less costs of disposal, since these assets are being marketed for sale. A
provision for impairment of $54.3 million was recognized in the 2000 period,
including $41.1 million related to foreclosure assets operated for our own
account, $11.3 million related to assets held for sale and $1.9 million related
to a leased asset doubtful of recovery.

Charges totalling $0.7 million for provision for uncollectible accounts were
taken during the nine-month period ended September 30, 2001 relating to
write-off of rents due from and funds advanced to the defaulting operator. A
provision for uncollectible accounts of $12.1 million was recognized in the 2000
periods, including a provision for loss on mortgages of $4.9 million and notes
receivable of $7.2 million.

Severance, moving and consulting agreement costs of $4.3 million were
recorded in the three-month period ended September 30, 2001, in connection with
our planned relocation to Maryland. The nine-month period ended September 30,
2001 also includes $0.5 million related to the termination of an employment
contract with an officer of our company. Severance and consulting agreement
costs of $4.7 million were recognized during the same period in 2000.

We disposed of one healthcare facility during the three-month period ended
September 30, 2001, resulting in a loss on sale of $1.5 million. The loss on
sale of $0.9 million for the nine-month period ended September 30, 2001 includes
the gain on sale of $0.6 million from the sale of three healthcare facilities.
For the nine-month period ended September 30, 2000, a gain of $10.3 million was
recognized on the disposal of real estate. The net gain was comprised of a
$10.9 million gain on the sale of four facilities previously leased to Tenet
Healthsystem Philadelphia, Inc., offset by a loss of $0.6 million on the sale of
a healthcare facility.

Funds from operations for the three-month and nine-month periods ended
September 30, 2001 were $0.5 million and a deficit of $2.3 million,
respectively, an increase of approximately $15.7 million and a decrease of
$6.2 million, respectively, as compared to the deficit of $15.2 million and
positive $3.9 million for the same periods in 2000 due to factors mentioned
above. Diluted funds from operations amounts were a $3.1 million and
$5.5 million, respectively, for the three-month and nine-month periods ended
September 30, 2001, as compared to the deficit of $11.0 million and positive
$10.2 million for the same period in 2000 due to factors mentioned above. Funds
from operations is defined as net earnings available to common stockholders,
excluding any gains or losses from debt restructuring and the effects of asset
dispositions, plus depreciation and amortization associated with real estate
investments. Diluted funds from operations is the lower of funds from operations
and funds from operations adjusted for the assumed conversion of Series C
Preferred Stock and Subordinated Convertible Debentures and the exercise of
in-the-money stock options. We consider funds from operations to be one
performance measure which is helpful to investors of real estate companies

because, along with cash flows from operating activities, financing activities
and investing activities, it provides investors an understanding of our ability
to incur and service debt, to make capital expenditures and to pay dividends to
our stockholders. Funds from operations in and of itself does not represent cash
generated from operating activities in accordance with generally accepted
accounting principles and therefore should not be considered an alternative to
net earnings as an indication of operating performance or to net cash flow from
operating activities as determined by generally accepted accounting principles
as a measure of liquidity and is not necessarily indicative of cash available to
fund cash needs.

RECENT DEVELOPMENTS

MARINER AND PROFESSIONAL HEALTHCARE SETTLEMENT. We have entered into a
comprehensive settlement with Mariner Post-Acute Network, Inc. resolving all
outstanding issues relating to our loan to Professional Healthcare
Management Inc., a subsidiary of Mariner. Pursuant to the settlement, the
Professional Healthcare loan is secured by a first mortgage on 12 skilled
nursing facilities owned by Professional Healthcare with 1,668 operating beds.
Professional Healthcare will remain obligated on the total outstanding loan
balance as of January 18, 2000, the date Mariner filed for protection under
Chapter 11 of the Bankruptcy Act, and is to pay us our accrued interest at a
rate of approximately 11% for the period from the filing date until
September 1, 2001. Monthly payments with interest at the rate of 11.57% per
annum resumed October 1, 2001. The settlement agreement was approved by the
United States Bankruptcy Court in Wilmington, Delaware on August 22, 2001, and
became effective as of September 1, 2001.

On February 1, 2001, four Michigan facilities, previously operated by
Professional Healthcare and subject to our pre-petition mortgage, were
transferred by Professional Healthcare to a new operator who paid for the
facilities by execution of a promissory note that has been assigned to us.
Professional Healthcare was given a $4.5 million credit on February 1, 2001 and
an additional $3.5 million credit as of September 1, 2001, both against the
Professional Healthcare loan balance in exchange for the assignment of the
promissory note to us. The promissory note is secured by a first mortgage on the
four facilities.

Following the closing under the settlement agreement, the outstanding
principal balance on the Professional Healthcare loan is approximately
$59,700,000. The Professional Healthcare loan term will be ten years with
Professional Healthcare having the option to extend for an additional ten years.
Professional Healthcare will also have the option to prepay the Professional
Healthcare loan between February 1, 2005 and July 31, 2005.

OTHER OPERATORS. In Note 15 to our Form 10-K for the year ended December
31, 2000, we announced continuing discussions with several of our lessees to
resolve payment issues, including Alterra Healthcare Corp., Lyric Healthcare
LLC, Alden Management Services, Inc. and TLC Healthcare Inc.

Alterra Healthcare Corp. has been making reduced payments of their monthly
rent since March 2001. Monthly rent payments of $306,138 were not paid for March
through June; $100,000 was paid in each of the July and August months; and
$185,097 was paid each month from September through December. All shortfalls
were funded from Alterra's security deposit. Accordingly, revenues were
recognized on the full contractual rent of $306,138 per month. A term sheet has
been executed with Alterra whereby we would take back two facilities, receive a
fee of approximately $1.1 million, and monthly rent payments of $187,000 in 2002
increasing to $268,000 per month in 2003. However, final documentation of this
agreement has not been completed. The total gross investment in the properties

leased to Alterra is $34.1 million, including $6.2 million for the two
facilities that are to be taken back. These two facilities will be leased to a
new operator or marketed for sale.

Integrated Health Services, Inc. filed for Chapter 11 bankruptcy protection
in February 2000. With the exception of a small portion of prepetition interest
(approximately $63,000), IHS paid its contractual mortgage interest from its
bankruptcy filing in February 2000 until October 2001. In November 2001, IHS
informed us that it did not intend to pay future rent and mortgage interest due.
We hold three mortgages on properties owned by IHS: a $37.5 million mortgage
collateralized by seven facilities located in Florida and Texas; a $12 million
mortgage, collateralized by two facilities located in Georgia; and a
$4.9 million mortgage collateralized by one facility located in Florida. Annual
contractual interest income on each of the mortgages is approximately
$3.96 million, $1.25 million and $0.55 million, respectively. We also have a
lease with IHS for one property in the state of Washington, representing an
investment of $10 million and annualized contractual revenue of $1.45 million.
IHS rejected this lease on November 9, 2001.

We are currently negotiating with IHS to reach a permanent restructuring
agreement or to transition the facilities to a new operator or operators. Rent
under the lease was paid for November, but no payments were made on the October
mortgage interest due November 1. As of the date of this filing, no further
payments have been made. Accordingly, no revenue was recorded for the mortgage
for October and November. Current appraisals of the properties underlying the
mortgage loans indicate collateral value in excess of the mortgage loan
balances. Accordingly, we do not expect to record any reserves relative to these
loans at this time. See "Risk Factors--We Are Exposed To Potential Risks From
Bankruptcies Of Our Lessees and Mortgagors" on page 18.

We entered into a forbearance agreement with Lyric Healthcare LLC through
August 31, 2001, whereby the Company received $541,266 of the $860,000 monthly
rent due under the Lyric leases through November 2001. On November 7, we were
notified by Lyric that we would no longer be receiving payments. As of the date
of this filing Lyric had not made their December rent payments to us. Revenue
has been recorded as received since April 2001. We will continue to record
revenue in this manner until a resolution with Lyric is finalized. Discussions
are continuing with Lyric to reach a permanent restructuring agreement or to
transition the facilities to a new operator or operators. Our original
investment in the ten facilities covered under the lease is $95.4 million, with
annual contractual rent of $10.3 million.

On March 30, 2001, we announced that affiliates of Alden Management, Inc.
were delinquent in paying their lease and escrow payments on the four facilities
they lease from us. During the month of April, Alden resumed regularly scheduled
lease payments to us, and began making payments on a schedule designed to bring
their past due amounts current by August 2001. The facilities which Alden leases
are located in the state of Illinois and derive approximately 90% of their
revenues from Illinois Medicaid. Alden adhered to the schedule and was current
with their rental payments to us through November. However, Alden has indicated
to us that the State of Illinois has been behind in processing reimbursements
under the Medicaid system.

In April 2001 we were informed by TLC Healthcare, Inc. that it could no
longer meet its payroll and other operating obligations. We had leases and
mortgages with TLC representing eight properties with 1,049 beds and an initial
investment of $27.5 million. As a result of this action, one facility in Texas
with an initial investment of $2.5 million was leased to a new operator, Lamar
Healthcare, Inc. and four properties in Illinois, Indiana and Ohio, with an
initial investment of $13.5 million, were taken back and placed under management
agreements with Atrium Living Centers and Nexion Health Management, Inc. and are
now operated for our own account and classified as Owned and Operated Assets.
The remaining three properties, located in Texas, were closed and are being
marketed for sale. These three facilities are classified as Assets Held for Sale
and have been reduced to their fair value, less cost of disposal. Amounts due
from TLC that were not collected were written off as bad debt expense during
2001.

In several instances we hold security deposits that can be applied in the
event of lease and loan defaults, subject to applicable limitations under
bankruptcy law with respect to operators seeking protection under Chapter 11 of
the Bankruptcy Act.

OFFICE RELOCATION. We are relocating our corporate offices effective as of
January 1, 2002 and have entered into a lease of office space in Timonium,
Maryland, a suburb of Baltimore. All of our current employees either have an
employment agreement or are otherwise entitled to incentives if they remain
employed with us in their current positions during the transitional period
expected to be completed by January 31, 2002.

LIQUIDITY AND CAPITAL RESOURCES

At September 30, 2001, we had total assets of $911.3 million, stockholders'
equity of $456.7 million, and long-term debt of $426.0 million, representing
approximately 46.7% of total capitalization. In addition, as of September 30,
2001, we had an aggregate of $238.6 million of outstanding debt which matures in
2002, including $99.6 million of 6.95% Notes due June 2002 and $139 million on
our two credit facilities maturing during 2002.

BANK CREDIT FACILITIES

On July 17, 2000, we replaced our $200 million unsecured revolving credit
facility with a new $175 million secured revolving credit facility that expires
on December 31, 2002. Borrowings under this facility bear interest based on the
London Interbank Offered Rate, or LIBOR, plus a margin based on our consolidated
debt/EBITDA ratio, which resulted in a weighted-average rate of 6.73% at
September 30, 2001, and 10.00% at December 31, 2000. Borrowings under our prior
credit facility bore interest at a weighted-average rate of 7.30% at December
31, 1999. Real estate investments with a gross book value of approximately
$240 million are pledged as collateral for this credit facility.

On August 16, 2000, we replaced our $50 million secured revolving credit
facility with a new $75 million secured revolving credit facility that expires
on March 31, 2002 as to $10 million and June 30, 2005 as to $65 million.
Borrowings under this facility bear interest based on LIBOR plus a margin based
on our consolidated debt/EBITDA ratio, which resulted in a weighted average rate
of 8.06% at September 30, 2001, and 9.77% at December 31, 2000. Borrowings under
our prior credit facility bore interest at a weighted average rate of 8.44% at
December 31, 1999. Real estate investments with a gross book value of
approximately $90 million are pledged as collateral for this credit facility.

The settlement of the lawsuit with Karrington Health, Inc. in August 2001
fixed the amount of expense associated with this claim against us at
$10 million and was therefore recorded at June 30, 2001. The recognition of this
non-recurring expense resulted in certain violations of financial covenants
contained in the loan agreements relating to our revolving credit facilities.
For the quarter ended June 30, 2001, we were not in compliance with the maximum
leverage covenant ratio of funded indebtedness to earnings before interest,
taxes, depreciation and amortization, or EBITDA, in each of our credit
facilities. For the quarter ended September 30, 2001, we were not in compliance
with the maximum leverage covenant and the minimum EBITDA to interest expense
covenants in each of our credit facilities. We previously obtained a waiver from
the lenders under both credit facilities through September 14, 2001. The lenders
under our $175 million secured credit facility extended their waiver through
December 13, 2001, and the lenders under our $75 million secured credit facility
extended their waiver through December 15, 2001. These covenant violations have
been waived pursuant to the agreements described below, but currently prevent us
from drawing upon the remaining availability under both credit facilities.

MODIFICATION OF BANK CREDIT AGREEMENTS

On December 21, 2001, we reached agreements with the bank groups under both
of our revolving credit facilities. These agreements include modifications
and/or waivers to certain financial covenants with which we were not in
compliance. In addition, certain other financial covenants will be either
modified or eliminated going forward. The effectiveness of these agreements is
subject to the completion of the rights offering and private placement to
Explorer. Explorer has approved the amendments, and therefore the effectiveness
of the amendments will satisfy the conditions to the rights offering and
Explorer investment related to our credit facilities. See "The Rights
Offering--Closing Conditions."

These amendments to our credit facilities waive the covenant violations
described above and will modify the following covenants effective as of the
closing of the rights offering and the private placement to Explorer:

- Minimum EBITDA/interest expense covenant will be increased from 200% to
225% beginning in the second quarter of 2002, 250% in the fourth quarter
of 2002 and 275% thereafter.

- The requirement for no loss in a fiscal year beginning December 31, 2001
has been removed.

- The maximum leverage ratio covenant has been reduced to 5.0 times EBITDA
in the second quarter of 2002 and 4.75 times EBITDA thereafter.

DIVIDENDS

In prior years, we historically distributed to stockholders a large portion
of the cash available from operations. Our historical policy has been to make
distributions on common stock of approximately 80% of funds from operations, but
on February 1, 2001, we announced the suspension of all common and preferred
dividends. This action is intended to preserve cash to facilitate our ability to
obtain financing to fund the 2002 debt maturities. Additionally, on March 30,
2001, we exercised our option to pay the accrued $4,666,667 Series C preferred
stock dividend from November 15, 2000 and the

associated waiver fee by issuing 48,420 Series C preferred shares to Explorer on
April 2, 2001, which are convertible into 774,722 shares of our common stock at
$6.25 per share.

Cash dividends paid totaled $0.25 per common share and $0.75 per common
share for the three-month and nine-month periods ended September 30, 2000,
respectively. No common dividends were paid during 2001 nor during the second
quarter of 2000. Cash dividends paid totaled $1.00 per common share for 2000,
compared with $2.80 per common share for the year ended December 31, 1999. The
dividend payout ratio, that is the ratio of per common share amounts for
dividends paid to the diluted per common share amounts of funds from operations,
was approximately 238% for 2000 and 84.3% for 1999. Excluding the provision for
loss on mortgages and notes receivable and severance and consulting agreement
costs, the dividend payout ratio for 2000 was approximately 73.0%.

We do not know when or if we will resume dividend payments on our common
stock or, if resumed, what the amount or timing of any dividend will be. We do
not anticipate paying dividends on any class of capital stock at least until our
$108 million of debt maturing in the first half of 2002 has been repaid and, in
any event, all accrued and unpaid dividends on our Series A, B and C preferred
stock must be paid in full before dividends on our common stock can be resumed.
We have made sufficient distributions to satisfy the distribution requirements
under the REIT rules to maintain our REIT status for 2000 and expect to satisfy
the requirements under the REIT rules for 2001.

On March 30, 2001 our Board of Directors approved payment of the accrued
Series C dividend from November 15, 2000 and the associated waiver fee by
issuing 48,420 shares of Series C preferred stock to Explorer on April 2, 2001.
Dividends paid in stock to a specific class of stockholders, such as our payment
of our Series C preferred stock in April 2001, constitute dividends eligible for
the 2001 dividends paid deduction. Additionally, and as specifically authorized
by the Internal Revenue Code, dividends declared by September 15, 2002 and paid
by December 31, 2002 may be elected to be treated as a distribution of 2001
taxable income.

The table below sets forth information regarding arrearages in payment of
preferred stock dividends:

ANNUAL ARREARAGE AS OF
DIVIDEND PER SEPTEMBER 30,
TITLE OF CLASS SHARE 2001
-------------- ------------ ---------------

9.25% Series A Cumulative Preferred Stock.................. $ 2.3125 $ 3,989,063
8.625% Series B Cumulative Preferred Stock................. $ 2.1563 3,234,375
Series C Convertible Preferred Stock....................... $10.0000 7,660,493
-----------
Total.................................................. $14,883,931
===========

LIQUIDITY

We have entered into an investment agreement with Explorer under which
Explorer has committed to purchase, on the closing of the rights offering, at
the same price per share available in the rights offering, shares of our stock.
The shares that Explorer has committed to purchase represent its pro rata
portion of the $50 million in additional capital we are seeking to raise, plus
an additional amount equal to the aggregate subscription price for the shares
that are not subscribed for in the rights offering. As a result of Explorer's
commitment, we are assured of receiving a total of $50 million in gross proceeds
from the rights offering and Explorer's investment assuming they are both
completed.

Assuming we complete the rights offering and Explorer's investment and the
amendments to our credit facilities become effective, management believes our
liquidity and various sources of available capital, including funds from
operations and expected proceeds from planned asset sales, are adequate to
finance operations, meet recurring debt service requirements including our 2002
debt maturities and fund future investments through the next 12 months. From
time to time, we explore alternative

financing arrangements and opportunities and may continue to do so in the
future. However, we cannot assure you that we will be successful in obtaining
alternative financing arrangements or regarding the terms thereof.

As a result of the ongoing financial challenges facing long-term care
operators, the availability of the external capital sources historically used by
us has become extremely limited and expensive. Therefore, if the rights offering
and Explorer investment are not completed, we could not assure you that we would
be able to replace or extend our debt maturing in 2002, or that any refinancing
or replacement financing would be on terms favorable to us. There also can be no
assurance that we will be able to complete the rights offering and Explorer
investment as planned, and in such event our agreements with the lenders under
our credit facilities would not become effective. If we were unable to refinance
this debt or other indebtedness on acceptable terms, we might be forced to
dispose of properties on disadvantageous terms, which might result in losses to
us and might adversely affect the cash available for distribution to
stockholders, or to pursue additional dilutive equity financing. If interest
rates or other factors at the time of the refinancing result in higher interest
rates upon refinancing, our interest expense would increase, which might affect
our ability to make distributions to our stockholders.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

We are exposed to various market risks, including the potential loss arising
from adverse changes in interest rates. We do not enter into derivatives or
other financial instruments for trading or speculative purposes, but we seek to
mitigate the effects of fluctuations in interest rates by matching the term of
new investments with new long-term fixed rate borrowing to the extent possible.

The market value of our long-term fixed rate borrowings and mortgages are
subject to interest rate risks. Generally, the market value of fixed rate
financial instruments will decrease as interest rates rise and increase as
interest rates fall. The estimated fair value of our total long-term borrowings
at September 30, 2001 was $396 million. A one percent increase in interest rates
would result in a decrease in the fair value of long-term borrowings by
approximately $5.3 million.

We are subject to risks associated with debt or preferred equity financing,
including the risk that existing indebtedness may not be refinanced or that the
terms of such refinancing may not be as favorable as the terms of current
indebtedness. If we were unable to refinance our 2002 debt maturities or other
indebtedness on acceptable terms, we might be forced to dispose of properties on
disadvantageous terms, which might result in losses to us and might adversely
affect the cash available for distribution to stockholders, or to pursue
dilutive equity financing. If interest rates or other factors at the time of the
refinancing result in higher interest rates upon refinancing, our interest
expense would increase, which might affect our ability to make distributions to
our stockholders.

We utilize interest rate swaps to fix interest rates on variable rate debt
and reduce certain exposures to interest rate fluctuations. At September 30,
2001, we had two interest rate swaps with notional amounts of $32 million each,
based on 30-day LIBOR. Under the first $32 million agreement, we receive
payments when LIBOR interest rates exceed 6.35% and pay the counterparties when
LIBOR rates are under 6.35%. The amounts exchanged are based on the notional
amounts. The $32 million agreement expires in December 2002.

Under the terms of the second agreement, which expires in December 2002, we
receive payments when LIBOR rates exceed 4.89% and pay the counterparties when
LIBOR rates are under 4.89%. The combined fair value of the interest rate swaps
at September 30, 2001 was a deficit of $2,006,297.

BUSINESS

OVERVIEW

We were incorporated in the State of Maryland on March 31, 1992. We are a
self-administered real estate investment trust, or REIT, investing in
income-producing healthcare facilities, principally long-term care facilities
located in the United States. We provide lease or mortgage financing to
qualified operators of skilled nursing facilities and, to a lesser extent,
assisted living and acute care facilities. We have historically financed
investments through borrowings under our revolving credit facilities, private
placements or public offerings of debt or equity securities, the assumption of
secured indebtedness, or a combination of these methods. We also finance
acquisitions through the exchange of properties or the issuance of shares of our
capital stock when the transactions otherwise satisfy our investment criteria.

As of September 30, 2001, our portfolio of domestic investments consisted of
246 healthcare facilities, located in 29 states and operated by 32 third-party
operators. Our gross investments in these facilities totaled $887.2 million at
September 30, 2001. This portfolio is made up of:

- 129 long-term healthcare facilities and two rehabilitation hospitals owned
and leased to third parties;

- fixed rate, participating and convertible participating mortgages on 55
long-term healthcare facilities; and

- 48 long-term healthcare facilities that were recovered from customers and
are currently operated through third-party management contracts for our
own account.

In addition, we have 12 facilities subject to third-party leasehold
interests. We also hold miscellaneous investments and closed healthcare
facilities held for sale of approximately $55.2 million at September 30, 2001,
including $22.3 million related to two non-healthcare facilities leased by the
United States Postal Service, a $7.7 million investment in Omega Worldwide,
Principal Healthcare Finance Limited, and Principal Healthcare Finance Trust,
and $14.3 million of notes receivable.

Approximately 73.7% of our real estate investments were operated by seven
public companies, including Sun Healthcare Group, Inc. (24.6%), Integrated
Health Services, Inc. (18.1%, including 10.7% as the manager for and 50% owner
of Lyric Health Care LLC), Advocat Inc. (12.0%), Mariner Post-Acute
Network, Inc. (6.7%), Kindred Healthcare, Inc. (formerly known as Vencor
Operating, Inc.) (5.7%), Alterra Healthcare Corporation (3.8%) and Genesis
Health Ventures, Inc. (2.8%). Kindred and Genesis manage facilities for our own
account, including "owned and operated" assets. The two largest private
operators represent 3.5% and 2.5%, respectively, of our investments. No other
operator represents more than 2.5% of our investments.

The following tables summarize our net revenues and real estate assets by
asset category for 2000, 1999 and 1998, setting forth the effect of the results
of operations of property recovered as a result of foreclosure and settlements
with troubled operators that are held for sale or operated on an interim basis
for our own account until such time as the properties are sold or re-leased.
Historical information for 1999 and 1998 is reclassified, for comparative
purposes, to the presentation for 2000.

NET REVENUES BY ASSET CATEGORY
(IN THOUSANDS)

YEARS ENDED DECEMBER 31,
------------------------------
2000 1999 1998
-------- -------- --------

Core Assets:
Lease Rental Income....................................... $67,308 $ 76,389 $ 72,072
Mortgage Interest Income.................................. 24,126 36,369 30,399
------- -------- --------
Total Core Asset Revenues............................. 91,434 112,758 102,471
Owned and Operated Assets Net Revenue (Loss)................ (3,416) 1,050 --
Other Asset Revenue......................................... 6,594 6,814 5,971
Miscellaneous Income........................................ 2,206 2,334 872
------- -------- --------
Total Net Revenue..................................... $96,818 $122,956 $109,314
======= ======== ========

REAL ESTATE ASSETS BY ASSET CATEGORY
(IN THOUSANDS)

AS OF DECEMBER 31,
----------------------------------
2000 1999 1998
-------- ---------- ----------

Core Assets:
Leased Assets............................................ $579,941 $ 686,105 $ 643,378
Mortgaged Assets......................................... 206,710 213,617 340,455
-------- ---------- ----------
Total Core Assets.................................... 786,651 899,722 983,833
Owned and Operated and Held for Sale Assets................ 134,614 97,216 35,289
Other Assets............................................... 53,242 75,460 41,753
-------- ---------- ----------
Total Real Estate Assets................................... $974,507 $1,072,398 $1,060,875
======== ========== ==========

INVESTMENT STRATEGIES

INVESTMENT POLICIES. We maintain a diversified portfolio of long-term
healthcare facilities and mortgages on healthcare facilities located in the
United States. In making investments, we generally have focused on established,
creditworthy, middle-market healthcare operators that meet our standards for
quality and experience of management. We have sought to diversify our
investments in terms of geographic locations, operators and facility types. As a
consequence of our current financial condition and upcoming debt maturities, we
have not recently made investments and do not intend to make investments unless
and until we address our $98 million of debt maturing in the first half of 2002.

In evaluating potential investments, we consider such factors as:

- the quality and experience of management and the credit worthiness of the
operator of the facility;

- the facility's historical, current and forecasted cash flow and its
adequacy to meet operational needs, capital expenditures and lease or debt
service obligations, providing a competitive return on investment to us;

- the construction quality, condition and design of the facility;

- the geographic area and type of facility;

- the tax, growth, regulatory and reimbursement environment of the community
in which the facility is located;

- the occupancy and demand for similar healthcare facilities in the same or
nearby communities; and

- the payor mix of private, Medicare and Medicaid patients.

One of our fundamental investment strategies is to obtain contractual rent
escalations under long-term, non-cancelable, "triple-net" leases and revenue
participation through participating mortgage loans, and to obtain substantial
liquidity deposits. Additional security is typically provided by covenants
regarding minimum working capital and net worth, liens on accounts receivable
and other operating assets, and various provisions for cross-default,
cross-collateralization and corporate/personal guarantees, when appropriate.

We prefer to invest in equity ownership of properties. Due to regulatory,
tax or other considerations, we sometimes pursue alternative investment
structures, including convertible participating and participating mortgages,
that achieve returns comparable to equity investments. The following summarizes
the four primary investment structures currently used by us. Average annualized
yields reflect existing contractual arrangements and an estimate of restructured
arrangements for one of

our troubled operators. However, in view of the ongoing financial challenges in
the long-term care industry, we cannot assure you that the operators of our
facilities will meet their payment obligations in full or when due. Certain
operators have recently indicated to us that they intend to delay or reduce the
payment of their contractual obligations to us, and therefore the annualized
yields as of January 1, 2001 set forth below are not necessarily indicative of
or a forecast of actual yields, which may be lower.

PURCHASE/LEASEBACK. In a Purchase/Leaseback transaction, we purchase the
property from the operator and lease it back to the operator over terms
ranging from 8 to 17 years, plus renewal options. The leases originated
by us generally provide for minimum annual rentals which are subject to
annual formula increases based upon such factors as increases in the
consumer price index, or CPI, or increases in the revenue streams
generated by the underlying properties, with certain fixed minimum and
maximum levels. Generally, the operator holds an option to repurchase the
property at set dates at prices based on specified formulas. The average
annualized yield from leases was 11.19% at January 1, 2001.

CONVERTIBLE PARTICIPATING MORTGAGE. Convertible participating mortgages
are secured by first mortgage liens on the underlying real estate and
personal property of the mortgagor. Interest rates are usually subject to
annual increases based upon increases in the consumer price index or
increases in the revenues generated by the underlying long-term care
facilities, with certain maximum limits. Convertible participating
mortgages afford us the option to convert our mortgage into direct
ownership of the property, generally at a point six to nine years from
inception. If we exercise our purchase option, we are obligated to lease
the property back to the operator for the balance of the originally
agreed term and for the originally agreed participations in revenues or
consumer price index adjustments. This allows us to capture a portion of
the potential appreciation in value of the real estate. The operator has
the right to buy out our option at prices based on specified formulas.
The average annualized yield on these mortgages was approximately 12.99%
at January 1, 2001.

PARTICIPATING MORTGAGE. Participating mortgages are similar to
convertible participating mortgages except that we do not have a purchase
option. Interest rates are usually subject to annual increases based upon
increases in the consumer price index or increases in revenues of the
underlying long-term care facilities, with certain maximum limits. The
average annualized yield on these investments was approximately 13.26% at
January 1, 2001.

FIXED-RATE MORTGAGE. These mortgages have a fixed interest rate for the
mortgage term and are secured by first mortgage liens on the underlying
real estate and personal property of the mortgagor. The average
annualized yield on these investments was 11.20% at January 1, 2001.

The following table identifies the years of expiration of the payment
obligations due to us under existing contractual obligations as of January 1,
2001, or in the case of one of our troubled operators, under an estimated
restructured arrangement. This information is provided solely to indicate the
scheduled expiration of payment obligations due to us, and is not a forecast of
expected revenues.

MORTGAGE
RENT INTEREST TOTAL %
-------- -------- -------- --------
(IN THOUSANDS)

2001..................................................... $ -- $ 1,746 $ 1,746 1.92%
2002..................................................... 215 15 230 0.25
2003..................................................... 1,128 4,049 5,177 5.69
2004..................................................... 1,263 572 1,835 2.02
2005..................................................... 805 588 1,393 1.53
Thereafter............................................... 61,476 19,117 80,593 88.59
------- ------- ------- ------
Total.............................................. $64,887 $26,087 $90,974 100.00%
======= ======= ======= ======

BORROWING POLICIES. We may incur additional indebtedness and have
historically sought to maintain a long-term debt-to-total capitalization ratio
in the range of 40% to 50%. Total capitalization is total stockholders equity
plus long-term debt. We intend to review periodically our policy with respect to
our debt-to-total capitalization ratio and to modify the policy as our
management deems prudent in light of prevailing market conditions. Our strategy
generally has been to match the maturity of our indebtedness with the maturity
of our investment assets, and to employ long-term, fixed-rate debt to the extent
practicable in view of market conditions in existence from time to time.

We may use proceeds of any additional indebtedness to provide permanent
financing for investments in additional healthcare facilities. We may obtain
either secured or unsecured indebtedness, and may obtain indebtedness which may
be convertible into capital stock or be accompanied by warrants to purchase
capital stock. Where debt financing is present on terms deemed favorable, we
generally may invest in properties subject to existing loans, secured by
mortgages, deeds of trust or similar liens on properties.

Industry turmoil and continuing adverse economic conditions have caused the
terms on which we can obtain additional borrowings to become unfavorable. If we
need capital to repay indebtedness as it matures, we may be required to
liquidate investments in properties at times which may not permit realization of
the maximum recovery on these investments. This also could result in adverse tax
consequences to us. We may also be required to issue additional equity interests
in our company, which could dilute your investment in our company.

FEDERAL INCOME TAX CONSIDERATIONS. We intend to make and manage our
investments, including the sale or disposition of property or other investments,
and to operate in such a manner as to qualify as a REIT under the Internal
Revenue Code, unless, because of changes in circumstances or changes in the
Internal Revenue Code, our Board of Directors determines that it is no longer in
our best interest to qualify as a REIT. As a REIT, we generally will not pay
federal income taxes on the portion of our income which is distributed to
stockholders. See "Material United States Federal Income Tax Considerations."

SECURITIES OR INTEREST IN PERSONS PRIMARILY ENGAGED IN REAL ESTATE ACTIVITIES.

In November 1997, we formed Omega Worldwide, Inc., a company which provides
asset management services and management advisory services, as well as equity
and debt capital to the healthcare industry, particularly residential healthcare
services to the elderly. On April 2, 1998, we contributed substantially all of
our assets in Principal Healthcare Finance Limited, an Isle of Jersey (United
Kingdom) company, to Omega Worldwide in exchange for approximately 8.5 million
shares of Omega Worldwide common stock and 260,000 shares of Series B preferred
stock. Of the 8,500,000 shares of Omega Worldwide common stock we received,
approximately 5,200,000 were distributed on April 2, 1998 to our stockholders,
and we sold 2,300,000 shares on April 3, 1998. As of September 30, 2001, the
carrying value of our investment in Omega Worldwide is $4.9 million represented
by 1,163,000 shares of common stock and 260,000 shares of preferred stock. We
also have entered into a services agreement with Omega Worldwide which provides
for an allocation of the indirect costs incurred by us to Omega Worldwide. See
"Affiliate Relationships and Transactions." We also hold a $1.6 million
investment in Principal Healthcare Finance Limited and a $1.3 million investment
in the Principal Healthcare Finance Trust, an Australian Unit Trust.

POLICIES WITH RESPECT TO CERTAIN ACTIVITIES

If our Board of Directors determines that additional funding is required, we
may raise such funds through additional equity offerings, debt financing,
retention of cash flow (subject to provisions in the

Internal Revenue Code concerning taxability of undistributed REIT taxable
income) or a combination of these methods.

In the event that our Board of Directors determines to raise additional
equity capital, it has the authority, without stockholder approval, to issue
additional common stock or preferred stock in any manner and on such terms and
for such consideration it deems appropriate, including in exchange for property.
In July 2000, we issued shares of our Series C Convertible Preferred Stock to
Explorer in exchange for an investment of $100.0 million.

Borrowings may be in the form of bank borrowings, secured or unsecured, and
publicly or privately placed debt instruments, purchase money obligations to the
sellers of assets, long-term, tax-exempt bonds or other publicly or privately
placed debt instruments, financing from banks, institutional investors or other
lenders, securitizations, any of which indebtedness may be unsecured or may be
secured by mortgages or other interests in the asset. Such indebtedness may be
recourse to all or any part of our assets or may be limited to the particular
asset to which the indebtedness relates.

The agreement regarding our $175 million revolving credit facility includes
a one-year extension in maturity from December 31, 2002 to December 31, 2003,
and a reduction in the total commitment from $175 million to $160 million.
Amounts up to $150 million may be drawn upon to repay the maturing 6.95% Notes
due in June 2002.

The effectiveness of these amendments as of the completion of the rights
offering will reduce our oustanding debt maturing in 2002 to $97.5 million. Upon
completion of the private placement and rights offering, we expect to have
approximately $17.7 million available to draw upon under our revolving credit
facilities.

We have authority to offer our common stock or other equity or debt
securities in exchange for property and to repurchase or otherwise reacquire our
shares or any other securities and may engage in such activities in the future.
Similarly, we may offer additional interests in our operating partnership that
are exchangeable into common shares or, at our option, cash, in exchange for
property. We also may make loans to our subsidiaries.

Subject to the percentage of ownership limitations and gross income and
asset tests necessary for REIT qualification, we may invest in securities of
other REITS, other entities engaged in real estate activities or securities of
other issuers, including for the purpose of exercising control over such
entities.

We may engage in the purchase and sale of investments. We do not underwrite
the securities of other issuers.

We make annual and quarterly reports to our stockholders pursuant to the
requirements of the Exchange Act on Forms 10-K and 10-Q. We may elect to deliver
other forms of reports to stockholders from time to time.

Our officers and directors may change any of these policies without a vote
of our stockholders.

In the opinion of our management, our properties are adequately covered by
insurance.

PROPERTIES

At September 30, 2001, our real estate investments include long-term care
facilities and rehabilitation hospital investments, either in the form of
purchased facilities which are leased to operators, mortgages on facilities
which are operated by the mortgagors or their affiliates and facilities owned
and operated for our account, including facilities subject to leasehold
interests. The facilities are located in 29 states and are operated by 32
unaffiliated operators. The following table summarizes our property investments
as of September 30, 2001:

GROSS
NO. OF NO. OF OCCUPANCY INVESTMENT
INVESTMENT STRUCTURE/OPERATOR BEDS/UNITS FACILITIES PERCENTAGE(1) (IN THOUSANDS)
----------------------------- ---------- ---------- ------------- --------------

PURCHASE/LEASEBACK
Sun Healthcare Group, Inc..................... 5,408 50 88 $218,985
Integrated Health Services, Inc............... 1,573 11 81 105,400
Advocat, Inc.................................. 3,055 29 78 89,647
Alterra Healthcare Corporation................ 361* 10 75 34,085
Alden Management Services, Inc................ 868 4 62 31,306
Roncalli Health Center........................ 312 3 95 22,163
USA Healthcare, Inc........................... 668 8 76 17,213
Washington N&R, LLC........................... 286 2 87 12,152
Peak Medical of Idaho, Inc.................... 224 2 76 10,500
HQM of Floyd County, Inc...................... 283 3 96 10,250
Safe Harbor Florida Healthcare Properties,
Inc......................................... 300 1 85 8,151
Liberty Assisted Living Centers, LP........... 120 1 88 5,995
Meadowbrook Healthcare of N.C................. 192 2 75 5,561
Eldorado Care Center, Inc. & Magnolia
Manor, Inc.................................. 167 2 59 5,100
Lamar Healthcare, Inc......................... 102 1 49 2,540
Kansas & Missouri, Inc........................ 102 1 75 2,500
Lakeland Diversified.......................... 118 1 62 80
------ --- -- --------
14,139 131 81 581,628
OWNED AND OPERATED ASSETS--FEE
Kindred Healthcare, Inc....................... 1,436 14 80 48,495
Genesis Health Ventures, Inc.................. 767 7 86 25,062
Atrium Living Centers, Inc.................... 1,049 22 78 21,721
Pinon Management, Inc......................... 181 3 85 14,287
Nexion Health Management, Inc................. 197 2 81 6,437
------ --- -- --------
3,630 48 81 116,002
OWNED AND OPERATED ASSETS--LEASEHOLD INTEREST
Kindred Healthcare, Inc....................... 896 10 69 1,761
Pinon Management, Inc......................... 175 2 72 358
------ --- -- --------
1,071 12 70 2,119
CONVERTIBLE PARTICIPATING MORTGAGES
Senior Care Properties, Inc................... 150 2 59 6,184
Integrated Health Services, Inc............... 180 1 62 4,903
------ --- -- --------
330 3 60 11,087

PARTICIPATING MORTGAGES
Mariner Post-Acute Network, Inc............... 1,679 12 90 59,688
Integrated Health Services, Inc............... 1,144 9 91 49,500
Midtown Real Estate Company, LLC.............. 552 4 61 8,900
Advocat, Inc.................................. 120 1 57 2,000
------ --- -- --------
3,495 26 84 102,088
FIXED RATE MORTGAGES
Essex Healthcare Corporation.................. 633 6 70 15,821
Advocat, Inc.................................. 423 4 73 14,785
Parthenon Healthcare, Inc..................... 300 2 83 11,003
Texas Health Enterprises/HEA Mgmt. Group,
Inc......................................... 594 4 57 5,557
Tiffany Care Centers, Inc..................... 319 5 79 4,892
Covenant Care, Inc............................ 150 1 50 1,922
Rocky Mountain Health Care.................... 100 1 50 1,851
BNS, Inc...................................... 80 1 93 1,515
Integrated Health Services, Inc............... 164 2 84 1,080
------ --- -- --------
2,763 26 70 58,426
------ --- -- --------
Total..................................... 25,428 246 80 $889,350
====== === == ========

------------------------
(1) Generally represents data for the twelve-month period ending June 30, 2001.

* Represents Assisted Living Units. Occupancy percentage for these facilities
excludes 216 units that are in fill-up.

The following table presents the concentration of our facilities by state as
of September 30, 2001:

NUMBER TOTAL % OF
OF TOTAL INVESTMENT TOTAL
FACILITIES BEDS/UNITS(1) (IN THOUSANDS) INVESTMENT
---------- ------------- -------------- ----------

Florida........................................ 29 3,439 $142,544 16.0%
California..................................... 19 1,545 66,922 7.5
Illinois....................................... 13 1,732 66,386 7.5
Ohio........................................... 11 1,282 55,887 6.3
Michigan....................................... 13 1,784 50,909 5.7
Texas.......................................... 16 1,976 50,273 5.7
North Carolina................................. 10 1,346 45,950 5.2
Indiana........................................ 32 1,806 41,105 4.6
Arkansas....................................... 12 1,281 39,325 4.4
Alabama........................................ 12 1,431 36,362 4.1
Massachusetts.................................. 7 772 33,153 3.7
West Virginia.................................. 7 734 30,579 3.4
Kentucky....................................... 7 757 26,963 3.0
Connecticut.................................... 4 442 22,373 2.5
Washington..................................... 3 354 21,574 2.4
Tennessee...................................... 6 636 21,553 2.4
Iowa........................................... 10 898 20,650 2.3
Pennsylvania................................... 2 413 19,900 2.2
Arizona........................................ 8 894 18,150 2.0
Colorado....................................... 6 393 17,228 1.9
Missouri....................................... 7 605 17,044 1.9
Georgia........................................ 2 304 12,000 1.4
Idaho.......................................... 3 264 11,100 1.3
Kansas......................................... 2 136 5,919 0.7
New Hampshire.................................. 1 68 5,800 0.7
Louisiana...................................... 1 131 4,603 0.5

NUMBER TOTAL % OF
OF TOTAL INVESTMENT TOTAL
FACILITIES BEDS/UNITS(1) (IN THOUSANDS) INVESTMENT
---------- ------------- -------------- ----------

Oklahoma....................................... 1 32 3,178 0.4
Utah........................................... 1 100 1,851 0.2
Nevada......................................... 1 73 71 --
--- ------ -------- ----
Total...................................... 246 25,428 $889,350 100%
=== ====== ======== ====

------------------------
(1) Beds include a total of 361 assisted living units.

Our core portfolio consists of long-term lease and mortgage agreements.
However, there are risks associated with this segment. See "Risks Related to Our
Company."

Our leased real estate properties are leased under provisions of master
leases with initial terms typically ranging from 10 to 16 years, plus renewal
options. Substantially all of the master leases provide for minimum annual
rentals which are subject to annual increases based upon increases in the
Consumer Price Index or increases in revenues of the underlying properties, with
certain limits. Under the terms of the leases, the lessee is responsible for all
maintenance, repairs, taxes and insurance on the leased properties.

Our owned and operated facilities, like those of our lessees and mortgagees,
are subject to government regulation and derive a substantial portion of their
net operating revenues from third-party payors, including the Medicare and
Medicaid programs. See "Risks Related to Our Company."

Our owned and operated facilities are managed by independent third parties
under management contracts. These managers are responsible for the day-to-day
operation of the facilities, including, among other things, patient care,
staffing, billing and collection of patient accounts and facility-level
financial reporting. For their services, the managers are paid a management fee,
typically based on a percentage of nursing home revenues.

As a consequence of the financial difficulties encountered by a number of
our operators, we have recovered various long-term care assets pledged as
collateral for the operators' obligations either in connection with a
restructuring or settlement with certain operators or pursuant to foreclosure
proceedings. Under normal circumstances, we would seek to re-lease or otherwise
dispose of such assets as promptly as practicable. When we adopt a plan to sell
a property, the property is classified as Assets Held for Sale. However, a
number of companies are actively marketing portfolios of similar assets and, in
light of the current conditions in the long-term care industry generally, it has
become more difficult both to sell such properties and for potential buyers to
obtain financing to acquire such properties.

As of the date of this prospectus, there are eight properties in assets held
for sale, representing a total investment, net of impairment of $7.1 million. Of
these eight properties, three are under contract for sale. However, no assurance
can be given that the sales will be realized, as there are financing and other
contingencies on these contracts.

COMPETITION

EMPLOYEES

As of September 30, 2001, we had 29 full-time employees and 5 part-time
employees. On October 9, 2001, we announced that we are relocating our corporate
offices effective as of January 1, 2002 to Timonium, Maryland, a suburb of
Baltimore. All of our current employees either have an employment agreement or
are otherwise entitled to incentives if they remain employed with us in their
current positions during the transitional period, which is expected to be
completed by January 31, 2002.

LEGAL PROCEEDINGS

We are subject to various legal proceedings, claims and other actions
arising out of the normal course of business. While any legal proceeding or
claim has an element of uncertainty, we believe that the outcome of each lawsuit
claim or legal proceeding that is pending or threatened, or all of them
combined, will not have a material adverse effect on our consolidated financial
position or results of operations.

On June 21, 2000, we were named as a defendant in certain litigation brought
against us by Madison/OHI Liquidity Investors, LLC, a customer that claims that
we have breached and/or anticipatorily breached a commercial contract.
Ronald M. Dickerman and Bryan Gordon are partners in Madison and limited
guarantors of Madison's obligations to us. Madison claims damages as a result of
the alleged breach of approximately $700,000. Madison seeks damages as a result
of the claimed anticipatory breach in the amount of $15 million or, in the
alternative, Madison seeks specific performance of the contract as modified by a
course of conduct that Madison alleges developed between Madison and us. We
contend that Madison is in default under the contract in question. We believe
that the litigation is meritless. We continue to vigorously defend the case and
have filed counterclaims against Madison and the guarantors, seeking repayment
of approximately $9.4 million, excluding default interest, that Madison owes us.
The trial in this matter is currently set for February 2002.

On December 29, 1998, Karrington Health, Inc. brought suit against us in the
Franklin County, Ohio, Common Pleas Court (subsequently removed to the U.S.
District Court for the Southern District of Ohio, Eastern Division) alleging
that we repudiated and ultimately breached a financing contract to provide
$95 million of financing for the development of 13 assisted living facilities.
Karrington was seeking recovery of approximately $34 million in damages it
alleged to have incurred as a result of the breach. On August 13, 2001, we paid
Karrington $10 million to settle all claims arising from the suit, but without
our admission of any liability or fault, which liability is expressly denied.
Based on the settlement, the suit has been dismissed with prejudice. The
settlement was recorded in the quarter ended June 30, 2001.

MANAGEMENT

Under the terms of our Articles of Incorporation, our Board of Directors is
classified into three classes. Each class of directors serves for a terms of
three years, with one class being elected each year. As of the date of this
prospectus, there are nine directors, with three directors in each class.

Our directors and executive officers are listed below.

TERM AS DIRECTOR
NAME AGE POSITION EXPIRES
---- -------- -------- ----------------

C. Taylor Pickett................ 40 Chief Executive Officer --
Daniel J. Booth.................. 38 Chief Operating Officer --
R. Lee Crabill, Jr............... 48 Vice-President of Operations --
Robert O. Stephenson............. 38 Chief Financial Officer --
Daniel A. Decker(1).............. 49 Director, Chairman of the Board 2002
Thomas W. Erickson(1)............ 50 Director 2002
Thomas F. Franke................. 72 Director 2003
Harold J. Kloosterman............ 59 Director 2003
Bernard J. Korman................ 70 Director 2003
Edward Lowenthal................. 57 Director 2004
Christopher W. Mahowald(1)....... 40 Director 2004
Donald J. McNamara(1)............ 48 Director 2002
Stephen D. Plavin(2)............. 42 Director 2004

------------------------

(1) Designated by Explorer pursuant to our stockholders agreement with Explorer.

(2) Independent Director designated pursuant to our stockholders agreement with
Explorer.

C. TAYLOR PICKETT is the Chief Executive Officer and has served in this
capacity since June 12, 2001. Prior to joining our company, Mr. Pickett served
as the Executive Vice President and Chief Financial Officer from January 1998 to
June 2001 of Integrated Health Services, Inc., a public company specializing in
post-acute healthcare services. He also served as Executive Vice President of
mergers and acquisitions from May 1997 to December 1997 of Integrated Health
Services. Prior to his roles as Chief Financial Officer and Executive Vice
President of mergers and acquisitions, Mr. Pickett served as the President of
Symphony Health Services, Inc. from January 1996 to May 1997.

DANIEL J. BOOTH is the Chief Operating Officer and has served in this
capacity since October 15, 2001. Prior to joining our company, Mr. Booth served
as a member of Integrated Health Services, Inc.'s management team since 1993,
most recently serving as Senior Vice President, Finance. Prior to joining
Integrated Health Services, Mr. Booth was Vice President in the Healthcare
Lending Division of Maryland National Bank (now Bank of America).

R. LEE CRABILL, JR. is the Senior Vice-President of Operations of our
company and has served in this capacity since July 30, 2001. Mr. Crabill served
as a Senior Vice-President of Operations at Mariner Post-Acute Network from 1997
through 2000. Prior to that, he served as an Executive Vice-President of
Operations at Beverly Enterprises.

ROBERT O. STEPHENSON is the Chief Financial Officer and has served in this
capacity since August 1, 2001. Prior to joining our company, Mr. Stephenson
served for five years from 1996 to July 1, 2001 as the Senior Vice President and
Treasurer of Integrated Health Services, Inc., a public company specializing in
post-acute healthcare services. Prior to Integrated Health Services,
Mr. Stephenson served in management roles at CSX Intermodal, Martin Marietta
Corporation and Electronic Data Systems.

DANIEL A. DECKER is Chairman of the Board and has served in this capacity
since July 17, 2000. Mr. Decker also served as Executive Chairman from
March 2001 until June 12, 2001 when Mr. Pickett

joined us as Chief Executive Officer. Mr. Decker has been an officer of The
Hampstead Group, L.L.C., a privately-held equity investment firm based in
Dallas, Texas, since 1990. Mr. Decker has previously served as a director of
various other public companies, including Bristol Hotel Company (NYSE), Wyndham
Hotel Company (NYSE), Malibu Entertainment International Inc., and the Forum
Group (NASDAQ).

THOMAS W. ERICKSON is a Director and has served in this capacity since
July 17, 2000. Mr. Erickson served as our Interim Chief Executive Officer from
October 1, 2000 until June 12, 2001. Mr. Erickson has served as President and
Chief Executive Officer of CareSelect Group, Inc., an operator of physician
clinics, since 1994 and ECG Ventures, Inc., a healthcare venture capital firm,
since 1987.

THOMAS F. FRANKE is a Director and has served in this capacity since
March 31, 1992. Mr. Franke is Chairman and principal owner of Cambridge
Partners, Inc., an owner, developer and manager of multifamily housing in Grand
Rapids and Ann Arbor, Michigan. He is also the principal owner of private
healthcare firms operating in the United States and the United Kingdom and is a
principal owner of a private hotel firm in the United Kingdom. Mr. Franke is a
director of Principal Healthcare Finance Limited and Omega Worldwide, Inc.

HAROLD J. KLOOSTERMAN is a Director and has served in this capacity since
September 1, 1992. Mr. Kloosterman has served as President since 1985 of
Cambridge Partners, Inc., a company he formed in 1985. He has been involved in
the development and management of commercial, apartment and condominium projects
in Grand Rapids and Ann Arbor, Michigan and in the Chicago area.
Mr. Kloosterman was formerly a Managing Director of Omega Capital from 1986 to
1992. Mr. Kloosterman has been involved in the acquisition, development and
management of commercial and multifamily properties since 1978. He has also been
a senior officer of LaSalle Partners, Inc.

BERNARD J. KORMAN is a Director and has served in this capacity since
October 19, 1993. Mr. Korman is Chairman of the Board of Trustees of
Philadelphia Health Care Trust, a private healthcare foundation, since December
1995. He formerly was President, Chief Executive Officer and Director of MEDIQ
Incorporated (health care services) from 1977 to 1995. Mr. Korman also is a
director of the following public companies: The New America High Income
Fund, Inc. (financial services), The Pep Boys, Inc. (auto supplies), Kramont
Realty Trust (real estate investment trust), NutraMax Products, Inc. (consumer
health care products), and Omega Worldwide, Inc.

EDWARD LOWENTHAL is a Director and has served in this capacity since
October 17, 1995. Mr. Lowenthal is President and Chief Executive Officer of
Wellsford Real Properties, Inc. (AMEX:WRP), a real estate Merchant bank since
1997, and was President of the predecessor of Wellsford Real Properties, Inc.
since 1986. Mr. Lowenthal also serves as a director of United American Energy
Corporation (a developer, owner and operator of energy facilities), Corporate
Renaissance Group, Inc. (a mutual fund), Equity Residential Properties Trust,
and Great Lakes REIT.

CHRISTOPHER W. MAHOWALD is a Director and has served in this capacity since
October 17, 2000. Mr. Mahowald has served as President of EFO Realty since
January 1997 where he is responsible for the origination, analysis, structuring
and execution of new investment activity and asset management relating to EFO
Realty's existing real estate assets.

DONALD J. MCNAMARA is a Director and has served in this capacity since
October 17, 2000. Mr. McNamara is the founder of The Hampstead Group, L.L.C., a
privately-held equity investment firm based in Dallas, Texas, and has served as
its Chairman since its inception in 1989. He has served as Chairman of the Board
of Directors of FelCor Lodging Trust (NYSE:FCH) since its merger with Bristol
Hotel Company in July 1998. Mr. McNamara has also served as a director of
Franklin Covey Co. (NYSE:FC) since May 1999. Mr. McNamara also currently serves
as a trustee of St. Mark's School in Texas and a trustee of the Virginia Tech
Foundation.

STEPHEN D. PLAVIN is a Director and has served in this capacity since
July 17, 2000. Mr. Plavin is Chief Operating Officer of Capital Trust, Inc., a
New York City-based specialty finance and investment

management company and has served in this capacity since 1998. In this role,
Mr. Plavin is responsible for all of the lending, investing and portfolio
management activities of Capital Trust, Inc.

RIGHT OF EXPLORER TO APPOINT DIRECTORS

Pursuant to the existing stockholders agreement executed in connection with
Explorer's investment in our Series C preferred stock in July 2000, Explorer is
entitled to designate up to four members of our Board of Directors depending on
the percentage of total voting securities, consisting of common stock and
Series C preferred stock, acquired from time to time by Explorer. Explorer is
entitled to designate at least one director as long as it owns at least 5% of
the total outstanding voting power and to approve one "independent director" as
long as it owns at least 25% of the shares it acquired in July 2000, or common
stock issued upon the conversion of the Series C preferred stock acquired by
Explorer at that time. The holders of the Series C preferred stock are entitled
to elect a majority of the members of the Board of Directors at such time as
their dividends are in arrears for four or more dividend periods. The dividends
are currently in arrears for more than four periods, but Explorer has waived its
right to appoint a majority of our directors through December 31, 2002, provided
that dividends on the Series C preferred stock are not in arrears for six or
more dividend periods from January 1, 2001 through December 31, 2002. Explorer's
right to appoint directors under the existing stockholders agreement expires
July 14, 2010.

As a condition to the closing of Explorer's new investment, we have agreed
to amend and restate our stockholders agreement with Explorer and to seek
stockholder approval to increase the maximum size of our Board of Directors so
that C. Taylor Pickett, our Chief Executive Officer, can be appointed to the
Board of the Directors. Under the new stockholders agreement to be executed at
the closing of Explorer's investment, Explorer would be entitled to designate a
number of directors that would generally be proportionate to Explorer's
ownership of voting securities, not to exceed five directors, six following any
increase in the size of the Board to nine directors. Under the new stockholders
agreement, the number of directors on the Board may not exceed nine without the
consent of Explorer (ten following stockholder approval of the increase in the
size of the Board to ten). We have agreed to take appropriate action to ensure
generally that Explorer's representation on all committees of the Board is
proportionate to its representation on the entire board, other than any special
committee established to consider transactions in which Explorer or any of its
affiliates may have a conflict of interest.

The new stockholders agreement will require Explorer to vote its shares in
favor of three independent directors, as defined under the rules of the New York
Stock Exchange, who are not affiliated with Explorer so long as it owns at least
15.0% of our voting securities. Upon the increase of the size of the Board to
ten directors, Explorer will vote its shares in favor of a fourth director who
is not affiliated with Explorer. The fourth director will be
C. Taylor Pickett, our Chief Executive Officer. The new stockholders agreement
expires on October 29, 2006.

The rules of the New York Stock Exchange require us to seek stockholder
approval before an affiliate such as Explorer can invest in our common stock. We
intend to seek this approval and Explorer has agreed that it will vote its share
in favor of the proposal. The terms of the Series D preferred stock to be issued
to Explorer if stockholders have not approved Explorer's investment before
closing will provide that the holders of the Series D preferred stock, voting
together as a single class with the holders of the Series C preferred stock,
will have the right to elect two additional directors if dividends on the
Series D preferred stock are in arrears for four or more dividend periods.

BOARD COMMITTEES AND MEETINGS

The Board of Directors held 24 meetings during 2000. Henry H. Greer, a
former member of our Board of Directors, attended 11 of the 21 meetings held
during the time he was director. All other

members of the Board of Directors attended more than 75% of the Board or
committee meetings held during 2000.

The Board of Directors has established an audit committee consisting of
Messrs. Korman, Kloosterman and Plavin, a compensation committee consisting of
Messrs. Kloosterman, McNamara and Franke, an independent directors committee
consisting of Messrs. Franke, Kloosterman, Korman and Lowenthal, and an
executive committee consisting of Messrs. Decker and Korman.

The Board of Directors does not presently have a standing nominating
committee and the functions that would typically be performed by a nominating
committee are performed by the entire Board of Directors, except that each
nominee that is not designated by Explorer pursuant to the stockholders
agreement are designated by the independent directors committee. In connection
with the closing of the rights offering and Explorer's investment, the Board of
Directors intends to reconstitute the nominating committee with two independent
directors, and one Explorer designee. Recommendations of the nominating
committee must be approved by the entire Board of Directors.

The audit committee met twice in 2000. Its primary function is to assist the
Board of Directors in fulfilling its oversight responsibilities with respect to:

- the annual financial information to be provided to stockholders and the
Securities and Exchange Commission;

- the system of internal controls that management has established; and

- the external audit process.

In addition, the audit committee provides an avenue for communication
between the independent accountants, financial management and the Board.

The compensation committee met three times during 2000 and is responsible
for the compensation of directors and key management personnel and the
administration of our 2000 Stock Incentive Plan and our 1993 Deferred
Compensation Plan. The compensation committee also administered our Amended and
Restated Stock Option and Restricted Stock Plan prior to the plan's termination
in 2000.

The independent directors committee, which did not meet during 2000, is
responsible for passing upon those issues with respect to which a conflict may
exist between us and Explorer and its affiliates, including issues with respect
to the allocation of costs between us and Explorer pursuant to the advisory
agreement between us and The Hampstead Group L.L.C., an affiliate of Explorer.
See "Affiliate Relationships and Transactions--Advisory Agreement" below.

The executive committee, which met four times during 2000, is responsible
for acting on behalf of the entire Board of Directors in between meetings of the
Board of Directors.

COMPENSATION OF DIRECTORS

For the year ended December 31, 2000, we paid each non-employee director a
fee of $20,000 per year for services as a director, plus $3,000 for services as
a committee chairperson and $500 for attendance at a meeting of the Board of
Directors, or of any committee during the first and second quarters of fiscal
year 2000 and $1,000 for attendance at a meeting during the third and fourth
quarters of fiscal year 2000, as well as $500 for participation in each
teleconference meeting. In addition, we reimbursed the directors for travel
expenses incurred in connection with their duties as directors. Employee
directors received no compensation for service as directors. The cash
compensation, not including reimbursement for expenses, paid by us in
consideration of Mr. Decker's and Mr. McNamara's service on the Board of
Directors as Explorer designees was paid directly to Hampstead under the
advisory agreement.

The compensation committee changed the manner in which non-employee
directors are awarded cash compensation for 2001 and thereafter. Commencing in
2001, each non-employee director will

receive a cash payment equal to $10,000 per year, payable in quarterly
installments of $2,500. Each non-employee director will receive a grant of
shares of common stock equal to the number of shares determined by dividing the
sum of $2,500 by the fair market value of the common stock on the date of each
quarterly grant, currently set at February 15, May 15, August 15, and
November 15. In addition, each non-employee director is entitled to receive fees
equal to $1,000 per meeting for attendance at each regularly scheduled meeting
of the Board of Directors. For each teleconference or called special meeting of
the Board of Directors, each non-employee director will receive $1,000 for
meetings with a duration in excess of 15 minutes and $500 for meetings with a
duration of less than 15 minutes. We will also continue to reimburse directors
for travel expenses incurred in connection with their duties as directors. In
addition, we expect to continue paying this cash compensation and expense
reimbursement in connection with Mr. Decker's and Mr. McNamara's service on the
Board of Directors as Explorer designees directly to Hampstead.

Mr. Erickson is compensated through payments made to an entity controlled by
him under a management services agreement. Under the management services
agreement, Mr. Erickson may also receive awards of stock options and dividend
equivalent rights. See "Executive Compensation--Management Services Agreement."

Robert L. Parker, one of our former directors, provided ongoing consulting
services to us during the time he served as a director. Mr. Parker received
$3,000 per month up until the time of his resignation from the Board of
Directors on July 14, 2000.

Directors are eligible to participate in our 2000 Stock Incentive Plan.
Directors received option grants under our amended and restated plan prior to
its termination in 2000. Each non-employee director was awarded options with
respect to 10,000 shares at the date the plan was adopted or on his or her
subsequent election as a director, and each non-employee director will be
granted an additional option grant with respect to 1,000 shares on January 1 of
each year they serve as a director. On July 17, 2000, Messrs. Decker, Erickson,
Mahowald and Plavin each received their initial award of an option to purchase
10,000 shares of our common stock. Mr. McNamara received his initial award of an
option to purchase 10,000 shares of our common stock on October 17, 2000. All
grants have been and will be at an exercise price equal to 100% of the fair
market value of our common stock on the date of the grant. Non-employee director
options vest one third after each year for three years.

During the year ended December 31, 2000, Messrs. Franke, Kloosterman, Korman
and Lowenthal were each awarded a grant of 300 shares of restricted stock, which
vested six months after the date of grant.

In addition, a borrowing program was adopted to enable directors and
employees to borrow funds from us with which to purchase shares of our common
stock pursuant to the exercise of stock options. See "Affiliate Relationships
and Transactions--Borrowing Program."

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

Mr. Decker, the Chairman of the Board, and Mr. Erickson were previously
members of our compensation committee. Both Mr. Decker and Mr. Erickson have
resigned from the compensation committee as of March 30, 2001. Mr. McNamara is
currently a member of the compensation committee. Messrs. Decker and McNamara
are affiliates of Explorer and Hampstead, and therefore may be deemed to have an
interest in the investment to be made by Explorer contemporaneously with the
closing of the rights offering, as well as the agreements and transactions
described under "Affiliate Relationships and Transactions--Explorer."
Mr. Erickson can be deemed to have an interest in payments made by us under the
terms of the management services agreement, the terms of which are described
under "Executive Compensation--Management Services Agreement."

EXECUTIVE COMPENSATION

COMPENSATION OF EXECUTIVE OFFICERS

The following table sets forth, for the years ended December 31, 2001, 2000,
and 1999, the compensation for services in all capacities to our company of each
person who served as chief executive officer during the year ended December 31,
2001 the four most highly compensated executive officers serving at
December 31, 2001, and two former executive officers.

LONG-TERM COMPENSATION
----------------------------------
AWARD(S) PAYOUTS
----------------------- --------
ANNUAL RESTRICTED SECURITIES ALL
COMPENSATION STOCK UNDERLYING LTIP OTHER
NAME AND -------------------- AWARD(S) OPTIONS/ PAYOUTS COMPENSATION
PRINCIPAL POSITION YEAR SALARY($) BONUS($) ($) SARS(#) ($) ($)(1)
------------------------------------ -------- --------- -------- ---------- ---------- -------- -------------

C. Taylor Pickett................... 2001 250,673 --(2) 116,000(3) 1,120,000 -- --
Chief Executive Officer

Thomas W. Erickson.................. 2001 507,044(4) 250,000(4) -- 51,000(5) -- 31,499 (6)
Interim Chief Executive Officer 2000 127,055(4) -- -- 45,000(7) -- 12,000 (6)
(10/1/2000 through 6/12/2001)

Daniel J. Booth..................... 2001 58,349 --(2) -- 350,000 -- --
Chief Operating Officer

R. Lee Crabill...................... 2001 91,237 --(2) -- 245,000 -- 21,851 (8)
Vice President

Robert O. Stephenson................ 2001 89,583 --(2) -- 325,000 -- --
Chief Financial Officer

Richard M. FitzPatrick.............. 2001 322,866(9) --(2) -- -- -- --
Chief Financial Officer (7/14/2000 2000 139,634(10) -- -- -- -- --
through 7/31/2001)

F. Scott Kellman.................... 2001 300,000 150,000(12) -- -- -- 386,230 (13)
Chief Operating Officer (prior to 2000 266,651 325,000(14) 212,400(15) 500,000(16) -- 10,743
10/15/2001)(11) 1999 245,000 55,000 55,000(15) 27,500 -- (19,559)

Laurence D. Rich.................... 2001 175,000 117,500(12) -- -- -- 119,426 (18)
Vice President 2000 139,833 115,000(14) 104,000(17) 227,500(16) -- 3,239
1999 120,000 27,500 27,500(17) 15,000 -- 9,664

------------------------------

(1) Consists of our contributions to our 401(k) Profit-Sharing Plan and
provisions for each participant under our 1993 Deferred Compensation Plan,
except as follows or as otherwise noted in footnotes appearing in this
column: with respect to Mr. Kellman, such amount includes a payment of
$8,036 for consideration of acceleration of certain options in 1999.

(2) Bonus amounts for 2001, payable in 2002, have not yet been determined.

(3) Represents a restricted stock award of 50,000 shares of our common stock to
Mr. Pickett on June 12, 2001, with shares vesting on June 12, 2003.

(4) Represents amounts paid to a company controlled by Mr. Erickson pursuant to
the terms of the Management Services Agreement in consideration of the
services performed by Mr. Erickson as our Interim Chief Executive Officer.
See "Thomas W. Erickson Management Services Agreement."

(5) Includes 50,000 shares subject to an option granted to Mr. Erickson under
the terms of the Management Services Agreement and 1,000 shares subject to
an option granted to Mr. Erickson as a director. See "Thomas W. Erickson
Management Services Agreement."

(6) Includes stock grants for payment of director fees in 2001 and cash payments
for director fees of $21,500 in 2001 and $12,000 in 2000.

(7) Includes 35,000 shares subject to an option granted to Mr. Erickson under
the terms of the Management Services Agreement and 10,000 shares subject to
an option granted to Mr. Erickson in consideration of becoming a director.
See "Thomas W. Erickson Management Services Agreement."

(8) Represents compensation to Mr. Crabill for reimbursement of moving expenses.

(9) Includes amounts payable to Mr. FitzPatrick by The Hampstead Group, LLC in
consideration of Mr. FitzPatrick serving as our Chief Financial Officer from
January 1, 2001 through April 30, 2001. Pursuant to the Advisory Agreement,
we agreed to reimburse Explorer for the services provided to us by
Mr. FitzPatrick. See "Certain Transactions--Advisory Agreement."

(10) Represents compensation payable to Mr. FitzPatrick by Hampstead in
consideration of Mr. FitzPatrick serving as our Chief Financial Officer
through December 31, 2000. Pursuant to the Advisory Agreement, we agreed to
reimburse Explorer for the services provided to us by Mr. FitzPatrick. See
"Certain Transactions--Advisory Agreement."

(11) See "F. Scott Kellman Retention, Severance and Release Agreement" below.

(12) Represents minimum cash bonuses payable under a Severance and Release
Agreement.

(13) Consists of $250,000 settlement of dividend equivalent rights in connection
with the cancellation of options, $131,130 payment under our 1993 Deferred
Compensation Plan and contributions to our 401(k) Profit-Sharing Plan for
Mr. Kellman.

(14) Includes a special bonus paid in connection with the Series C Investment
pursuant to a compensation agreement entered into between the named
individuals and us. See "Compensation Agreements with Management."

(15) Represents restricted stock awards of 35,258 shares and 7,097 shares of our
common stock made to Mr. Kellman on February 10, 2000 and January 31, 2000,
respectively. The February 10, 2000 award was a prospective award for
service in fiscal 2000. The January 31, 2000 award represents compensation
earned in fiscal 1999. With respect to the February 10, 2000 grant, 25% of
the shares vested 180 days following the grant date and 25% of the shares
vest on each anniversary of the grant date for the next three years. Under
the February 10, 2000 award, 17,629 shares were awarded subject to the price
of our common stock meeting certain performance hurdles. The price of our
common stock did not satisfy the required performance hurdles, and the
17,629 shares referred to above were forfeited in accordance with the terms
of the grant. With respect to the January 31, 2000 grant, 50% of the shares
vested 180 days following the grant date, with the balance vesting on the
anniversary of the grant date. Mr. Kellman receives dividends on unvested
shares. The number of unvested shares and value of Mr. Kellman's restricted
stock awards at the end of last year were 647 shares and $3,895 of which all
were released in January 2002.

(16) Represents special grant of options in connection with the Series C
Investment pursuant to the terms of a Compensation Agreement between the
named individual and us. Such options were cancelled in 2001 and a payment
was made to the named individuals in settlement of dividend equivalent
rights in connection with the cancellation of these options. See Note (12).
Also see "Compensation Agreements with Management."

(17) Represents restricted stock awards of 17,269 shares and 3,548 shares of our
common stock made to Mr. Rich on February 10, 2000 and January 31, 2000,
respectively. The February 10, 2000 award was a prospective award for
service in fiscal 2000. The January 31, 2000 award represents compensation
earned in fiscal 1999. With respect to the February 10, 2000 grant, 25% of
the shares vested 180 days following the grant date and 25% of the shares
vest on each anniversary of the grant date for the next three years. Under
the February 10, 2000 award, 8,634 shares were awarded subject to the price
of our common stock meeting certain performance hurdles. The price of our
common stock did not satisfy the required performance hurdles, and the 8,634
shares referred to above were forfeited in accordance with the terms of the
grant. With respect to the January 31, 2000 grant, 50% of the shares vested
180 days following the grant date, with the balance vesting on the
anniversary of the grant date. Mr. Rich receives dividends on unvested
shares. The number of unvested shares and value of Mr. Rich's restricted
stock awards at the end of the last year were 215 shares and $1,294 of which
all were released in January 2002.

(18) Consists of $113,750 settlement of dividend equivalent rights in connection
with the cancellation of options, provisions under our 1993 Deferred
Compensation Plan and contributions to our 401(k) Profit-Sharing Plan for
Mr. Rich.

OPTION GRANTS/SAR GRANTS

The following table sets forth certain information concerning options and
stock appreciation rights, or SARs, granted during 2001 to Messrs. Pickett,
Erickson, Booth, Crabill and Stephenson. Messrs. FitzPatrick and Kellman did not
receive any option grants during 2001 and therefore do not appear in the table
below.

INDIVIDUAL GRANTS
------------------------------- POTENTIAL REALIZABLE VALUE
NUMBER OF % OF TOTAL AT ASSUMED ANNUAL RATES
SECURITIES OPTIONS/SARS EXERCISE OF STOCK PRICE APPRECIATION
UNDERLYING GRANTED TO OR BASE FOR OPTION TERM(1)
OPTIONS/SARS EMPLOYEES IN PRICE EXPIRATION ---------------------------
NAME GRANTED(2) FISCAL YEAR ($/SHARE) DATE 5%($) 10%($)
---- ------------ ------------ --------- ---------- ------------ ------------

C. Taylor Pickett.......... 800,000(3) $ 2.3200 06/12/11 $1,168,000 $2,960,000
320,000(4) 3.1700 10/25/11 636,800 1,616,000
--------- ---------- ----------
1,120,000 49.89% 1,804,800 4,576,000
========= ========== ==========
Thomas W. Erickson......... 1,000(5) 3.8125 01/01/12 2,400 6,080
50,000(6) 2.1500 11/01/05 27,000 59,000
--------- ---------- ----------
51,000 2.27% 29,400 65,080
========= ========== ==========
Daniel J. Booth............ 250,000(7) 3.0000 10/15/11 472,500 1,195,000
100,000(4) 3.1700 10/25/11 199,000 505,000
--------- ---------- ----------
350,000 15.59% 671,500 1,700,000
========= ========== ==========
R. Lee Crabill............. 175,000(8) 3.0000 07/30/11 330,750 836,500
70,000(4) 3.1700 10/25/11 139,300 353,500
--------- ---------- ----------
245,000 10.91% 470,050 1,190,000
========= ========== ==========
Robert O. Stephenson....... 200,000(9) 2.7600 08/30/11 348,000 880,000
125,000(4) 3.1700 10/25/11 248,750 631,250
--------- ---------- ----------
325,000 14.48% 596,750 1,511,250
========= ========== ==========

------------------------

(1) The assumed annual rates of appreciation of 5% and 10% would result in the
price of our stock increasing, at the expiration date of the options, to
between $0.54 and $2.40 at the 5% rate and between $1.18 and $6.08 at the
10% rate for the various grants. We cannot assure you that our stock price
will appreciate at such rates.

(2) Represents grants of incentive and non-qualified options which expire
10 years after the date of grant.

(3) As to 627,587 options, options are exercisable as to 50% of the award after
optionee has performed two years of service (June 12, 2003) and the
remaining 50% will become exercisable ratably over the 24 months of
optionee's service following the second anniversary of the grant date. As to
172,413 options, options are exercisable as to 43,103 shares on
December 31, 2002, as to 43,103 shares on June 12, 2003, as to 43,103 shares
ratably over the twelve months of service in 2004 and as to the remaining
43,104 shares ratably over the first six months of service in 2005.

(4) Vests as to 50% after the optionee has performed two years of service, and
the remaining 50% ratably over the twenty-four months of optionee's service
following the second anniversary of the grant date.

(5) Vests in equal increments of 1/3rd on each anniversary of the grant date of
January 2, 2001.

(6) Shares vested December 31, 2001 pursuant to the management services
agreement.

(7) As to 166,666 options, options are exercisable as to 33,333 shares on each
of December 31, 2002, October 1, 2004, October 1, 2005 and January 1, 2006
and 116,668 on October 1, 2003.

(8) Options are exercisable as to 33,333 shares on each of December 31, 2002,
August 1, 2003, August 1, 2004 and August 1, 2005 and 41,667 on July 30,
2003.

(9) Options are exercisable as to 36,231 on December 31, 2002; 55,076 on
August 1, 2003; 36,231 on August 1, 2004; 36,231 on August 1, 2005 and
36,231 on January 1, 2006.

AGGREGATED OPTIONS/ SAR EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END
OPTION/ SAR VALUES

The following table summarizes options and stock appreciation rights
exercised during 2001 and presents the value of unexercised options and stock
appreciation rights held by the named executive officers at December 31, 2001.
Mr. FitzPatrick did not have any outstanding options or stock appreciation
rights at December 31, 2001 and therefore does not appear in the table below.

NUMBER OF SECURITIES IN-THE-MONEY
SHARES UNDERLYING UNEXERCISED OPTIONS/SARS AT
ACQUIRED OPTIONS/ SARS AT FISCAL
ON VALUE FISCAL YEAR-END(#) YEAR-END($)
EXERCISE REALIZED UNEXERCISABLE(U) UNEXERCISABLE(U)
NAME (#) ($) EXERCISABLE(E) EXERCISABLE(E)
---- -------- -------- ---------------------- ----------------

C. Taylor Picket......................... -- -- 1,120,000(U) $ 3,872,000(U)
Thomas W. Erickson....................... -- -- 7,667(U) $ 2,208(U)
-- -- 88,333(E) $ 193,500(E)
Daniel J. Booth.......................... -- -- 350,000(U) $ 1,040,000(U)
R. Lee Crabill........................... -- -- 245,000(U) $ 728,000(U)
Robert O. Stephenson..................... -- -- 325,000(U) $ 1,008,250(U)
F. Scott Kellman......................... -- -- 27,880(E) --(E)

LONG-TERM INCENTIVE PLAN

For the period from August 14, 1992, the date of commencement of our
operations, through December 31, 2000, we have had no long-term incentive plans.

C. TAYLOR PICKETT EMPLOYMENT AGREEMENT

We entered into an employment agreement with C. Taylor Pickett dated as of
June 12, 2001, to be our Chief Executive Officer. The term of the agreement
expires on June 12, 2005.

Mr. Pickett's base salary is $450,000 per year, subject to increase by us
and provides that he will be eligible for an annual bonus of up to 100% of his
base salary based on criteria determined by the compensation committee of our
Board of Directors. We issued Mr. Pickett 50,000 shares of our restricted common
stock on June 12, 2001, which vest after he has completed two years of service.
Additionally, Mr. Pickett was granted an incentive stock option to purchase
172,413 shares of our common stock and a nonqualified stock option to purchase
627,587 shares of our common stock. The incentive stock option will be vested as
to 25% of the shares on December 31, 2002; as to an additional 25%, after
Mr. Pickett completes two years of service; as to an additional 25%, ratably on
a monthly basis in 2004; and as to the final 25%, ratably on a monthly basis in
the first six months of 2005, in each case provided Mr. Pickett continues to
work for us on the applicable vesting date. The nonqualified stock option will
become vested as to 50% of the shares after Mr. Pickett completes two years of
service and will become ratably vested as to the remainder of the shares on a
monthly basis over the next 24 months of service following that two year
anniversary.

If we terminate Mr. Pickett's employment without cause or if he resigns for
good reason, he will be entitled to payment of his base salary for a period of
12 months or, if shorter, for the remainder of the term of the agreement.
Additionally, Mr. Pickett will be entitled to payment of an amount equal to

the bonus paid in the prior year, payable in 12 monthly installments.
Mr. Pickett is required to execute a release of claims against us as a condition
to the payment of severance benefits. The vesting of Mr. Pickett's options may
be subject to acceleration upon the occurrence of certain events such as
termination without cause or resignation for good reason and will become fully
vested if, within one year following a change of control, he is terminated
without cause or resigns for good reason.

Mr. Pickett is restricted from using any of our confidential information
during his employment and for two years thereafter or from using any trade
secrets during his employment and for as long thereafter as permitted by
applicable law. Mr. Pickett is subject to covenants which prohibit him from
competing with us and from soliciting our customers or employees while he is
employed by us and for 12 months following his termination of employment.

DANIEL J. BOOTH EMPLOYMENT AGREEMENT

We entered into an employment agreement with Daniel J. Booth effective as of
October 15, 2001, to be our Chief Operating Officer. The term of the agreement
expires on January 1, 2006.

Mr. Booth's base salary is $275,000 per year, subject to increase by us, and
he is eligible for an annual bonus of up to 50% of his base salary based on
criteria determined by the compensation committee. Mr. Booth was granted an
incentive stock option to purchase 166,666 shares of our common stock and a
nonqualified stock option to purchase 83,334 shares of our common stock. The
incentive stock option will vest as to 20% of the shares on each of
December 31, 2002, October 1, 2003, October 1, 2004, October 1, 2005, and
January 1, 2006 and the nonqualified stock option will vest on January 1, 2003,
provided Mr. Booth continues to work for us on the applicable vesting date.

Our agreement with Mr. Booth contains severance and accelerated option
vesting provisions similar to those in Mr. Pickett's agreement described above.
Mr. Booth is required to execute a release of claims against us as a condition
to the payment of severance benefits. He is also subject to restrictions on his
use of confidential information and our trade secrets that are the same as those
in our agreement with Mr. Pickett described above.

ROBERT O. STEPHENSON EMPLOYMENT AGREEMENT

We entered into an employment agreement with Robert O. Stephenson effective
as of August 30, 2001, to be our Chief Financial Officer. The term of the
agreement expires on January 1, 2006.

Mr. Stephenson's base salary is $215,000 per year, subject to increase by
us, and he is eligible for an annual bonus of up to 50% of his base salary based
on criteria determined by the compensation committee. Mr. Stephenson was granted
an incentive stock option to purchase 181,155 shares of our common stock and a
nonqualified stock option to purchase 18,845 shares of our common stock. The
incentive stock option will vest as to 20% of the shares on each of
December 31, 2002, August 1, 2003, August 1, 2004, August 1, 2005, and
January 1, 2006 and the nonqualified stock option will vest on August 1, 2003,
provided Mr. Stephenson continues to work for us on the applicable vesting date.

Our agreement with Mr. Stephenson contains severance and accelerated option
vesting provisions similar to those in Mr. Pickett's agreement described above.
Mr. Stephenson is required to execute a release of claims against us as a
condition to the payment of severance benefits. He is also subject to
restrictions on his use of confidential information and our trade secrets that
are the same as those in our agreement with Mr. Pickett described above.

R. LEE CRABILL, JR. EMPLOYMENT AGREEMENT

We entered into an employment agreement with R. Lee Crabill, Jr. effective
as of July 30, 2001, to be our Senior Vice President of Operations. The term of
the agreement expires on July 30, 2005.

Mr. Crabill's base salary is $215,000 per year, subject to increase by us,
and he is eligible for an annual bonus of up to 50% of his base salary based on
criteria determined by the compensation committee. Mr. Crabill was granted an
incentive stock option to purchase 133,333 shares of our common stock and a
nonqualified stock option to purchase 41,667 shares of our common stock. The
incentive stock option will vest as to 25% of the shares on each of
December 31, 2002, August 1, 2003, August 1, 2004, and August 1, 2005, and the
nonqualified stock option will vest as to 50% of the shares after Mr. Crabill
completes two years of service and will become ratably vested as to the
remainder of the shares on a monthly basis over the next twenty-four
(24) months of service following that two year anniversary, provided
Mr. Crabill continues to work for us on the applicable vesting date.

Our agreement with Mr. Crabill contains severance and accelerated option
vesting provisions similar to those in Mr. Pickett's agreement described above.
Mr. Crabill is required to execute a release of claims against us as a condition
to the payment of severance benefits. He is also subject to restrictions on his
use of confidential information and our trade secrets that are the same as those
in our agreement with Mr. Pickett described above.

THOMAS W. ERICKSON MANAGEMENT SERVICES AGREEMENT

We entered into a management services agreement with ECG Ventures, Inc.
dated as of October 1, 2000, to obtain the services of Thomas W. Erickson as our
interim Chief Executive Officer. Mr. Erickson continued to provide services
following the appointment of Mr. Pickett as Chief Executive Officer to
facilitate a transition. The term of the agreement expires on the earlier of
(i) December 31, 2001 or (ii) the later of (x) the date we determine that
Mr. Erickson's services are no longer necessary, or (y) three months following
the hiring of a new Chief Executive Officer.

We pay ECG Ventures $41,667 per month and granted them an option to purchase
50,000 shares of our common stock which will be fully vested on December 31,
2001. We also reimburse ECG Ventures for the premiums for healthcare coverage
for Mr. Erickson and his dependents. We agreed to pay ECG Ventures $250,000 if
Mr. Erickson continues to provide transitional services through the earlier of
December 31, 2001, or the date we determine that his services are no longer
necessary. Mr. Erickson and ECG Ventures are subject to customary restrictions
on their use of our confidential information and trade secrets.

RICHARD M. FITZPATRICK EMPLOYMENT AGREEMENT

We entered into an employment agreement with Richard M. FitzPatrick
effective as of May 1, 2001, to be our interim Chief Financial Officer. The term
of the agreement expires on the earlier of January 31, 2002 or the date we
determine his services are no longer necessary.

Mr. FitzPatrick's base salary was $250,000 per year and provides that he was
eligible for an annual bonus of up to 100% of his base salary based on criteria
determined by the compensation committee. We agreed to pay Mr. FitzPatrick an
amount equal to $125,000 plus 50% of his actual bonus for 2001 if he continues
to work for us for three months following the expiration of his agreement to
facilitate a transition to Mr. Stephenson. We also reimbursed The Hampstead
Group, L.L.C. for the amount of Mr. FitzPatrick's annual compensation paid by
Hampstead during the period from January 1, 2001 to May 1, 2001, since
Mr. FitzPatrick worked as our interim Chief Financial Officer on a full-time
basis during that period prior to the effectiveness of his employment agreement.
Following termination of Mr. FitzPatrick's employment, Mr. FitzPatrick has
agreed to provide consulting services to us for a period of three months, and in
consideration for such services, we will pay to Mr. FitzPatrick an amount equal
to his base salary and bonus on a pro rata basis.

If Mr. FitzPatrick's employment is terminated by us without cause or if he
resigns for good reason, in either event before January 31, 2002, he will be
entitled to payment of his base salary through January 31, 2002.
Mr. FitzPatrick is required to execute a release of claims against us as a
condition to

the payment of severance benefits and his use of our confidential information
and trade secrets is subject to customary restraints.

F. SCOTT KELLMAN RETENTION, SEVERANCE AND RELEASE AGREEMENT

We entered into a retention, severance and release agreement with F. Scott
Kellman, our former Chief Operating Officer, effective as of October 9, 2001,
which provides that Mr. Kellman will continue his employment with us until
January 31, 2002 or such earlier date specified by us. Mr. Kellman's employment
will end on this resignation date. Mr. Kellman will be paid his regular base
salary through January 31, 2002, and if he remains employed through the
resignation date, he will receive a minimum cash bonus of $150,000 payable on
February 1, 2002, that may be increased by an additional $150,000 if specified
performance objectives are reached. In addition, if Mr. Kellman remains employed
through the resignation date he will also receive a retention bonus of $930,000
to be paid on February 1, 2002. We will pay Mr. Kellman's premiums for eligible
health care insurance benefits, less required employee contributions for
premiums, through December 31, 2002. As a condition to payment of the amounts
under the retention grant, Mr. Kellman is required to execute a comprehensive
release of claims against us. If we terminate Mr. Kellman for cause, he will not
be entitled to any payments under the agreement.

If any of the payments to Mr. Kellman are subject to an excise tax on
"excess parachute payments" under the Internal Revenue Code, he will be entitled
to receive a payment in an amount that puts him in the same after-tax position
as if no excise tax had been imposed. Mr. Kellman has agreed to maintain the
confidentiality of our information for a period of two (2) years after the
resignation date.

LAURENCE D. RICH RETENTION, SEVERANCE AND RELEASE AGREEMENT

We entered into a retention, severance and release agreement with Laurence
D. Rich effective as of August 1, 2001, which provides that Mr. Rich will
continue his employment until January 31, 2002 or such earlier date specified by
us. Mr. Rich's employment will end on this resignation date. Mr. Rich will be
paid his regular base salary through January 31, 2002, and, if he remains
employed through the resignation date, he will receive a minimum cash bonus of
$117,500 payable on February 1, 2002, that may be increased by an additional
$87,500 if specified performance objectives are reached. In addition, if
Mr. Rich remains employed through the resignation date he will also receive a
retention bonus of $530,000 to be paid on February 1, 2002. We will pay
Mr. Rich's premiums for eligible heath care insurance benefits, less required
employee contributions for premiums, through December 31, 2002. As a condition
to payment of the amounts under the retention agreement, Mr. Rich is required to
execute a comprehensive release of claims against us. If we terminate
Mr. Rich's employment for cause, he will not be entitled to any payments under
the agreement.

If any of the payments to Mr. Rich are subject to an excise tax on "excess
parachute payments" under the Internal Revenue Code, he will be entitled to
receive a payment in an amount that puts him in the same after-tax position as
if no excise tax had been imposed. Mr. Rich has agreed to maintain the
confidentiality of our information for a period of two (2) years after his
termination of employment.

RETENTION, SEVERANCE, AND RELEASE AGREEMENTS FOR OTHER EMPLOYEES

In August, 2001, we entered into retention, severance, and release
agreements with a total of 24 of our employees (excluding Mr. Kellman and
Mr. Rich) who were not expected to work for us in our new headquarters in
Maryland. Pursuant to these agreements, each employee agrees to continue his or
her employment with us until January 31, 2002, or such earlier date as we
specify. Each such employee's employment will end on his or her respective
resignation date. Pursuant to the agreement, each employee will be paid his or
her regular base salary through January 31, 2002, and, if he or she

remains employed though the resignation date, the employee will receive a
specified minimum cash bonus payable on February 1, 2002, that may be increased
by a specified amount if performance objectives are satisfied. In addition, if
the employee remains employed through the resignation date, the employee will
also receive a specified retention bonus to be paid in equal monthly
installments beginning on February 1, 2002 over a specified retention bonus
period. The maximum total amount of all mandatory bonuses, performance bonuses,
and retention bonuses are $275,785, $243,935, and $495,490, respectively.

During the retention bonus period, we will pay the employee's premiums for
eligible health care insurance benefits, less required employee contributions
for premiums, and we will also provide outplacement services for a reasonable
period of time after the resignation date. As a condition to the payment of
these severance benefits, the employee is required to execute a comprehensive
release of claims against us. If we terminate the employee's employment for
cause, the employee will not be entitled to any severance benefits under the
agreement.

PRINCIPAL STOCKHOLDERS

The following table sets forth information regarding beneficial ownership of
our common stock as of December 31, 2001 by:

- each of our directors and the named executive officers appearing in the
table under "Executive Compensation--Compensation of Executive Officers,"
except for those executive officers no longer employed by the Company;

- each of the four new executive officers who have joined the Company since
June 2001;

- all directors and executive officers as a group, except for those
executive officers no longer employed by the Company; and

- all persons known to us to be the beneficial owner of more than 5% of our
outstanding common stock.

Except as indicated in the footnotes to this table, the persons named in the
table have sole voting and investment power with respect to all shares of our
common stock shown as beneficially owned by them, subject to community property
laws where applicable. The business address of the directors and executive
officers is 9690 Deereco Road, Suite 100, Timonium, Maryland 21093.

COMMON STOCK
-------------------------------------------------------
AFTER THE RIGHTS
BEFORE THE RIGHTS OFFERING AND
OFFERING AND EXPLORER
EXPLORER INVESTMENT INVESTMENT(15) SERIES A PREFERRED
----------------------------- ----------------------- -----------------------
NUMBER OF PERCENT OF NUMBER OF PERCENT OF NUMBER OF PERCENT OF
BENEFICIAL OWNER SHARES CLASS(1) SHARES CLASS(16) SHARES CLASS(18)
--------------------------------------- ---------- ---------- ---------- ---------- ---------- ----------

DIRECTORS AND EXECUTIVE OFFICERS:
C. Taylor Pickett...................... 50,000(2) 0.1% 73,256 0.1% -- --
Robert O. Stephenson................... 1,000 * 1,466 * -- --
Daniel J. Booth........................ -- * -- * -- --
R. Lee Crabill......................... -- * -- * -- --
Thomas W. Erickson..................... 54,407(3) 0.1% 56,302 0.1% -- --
Richard M. FitzPatrick................. -- * -- * -- --
F. Scott Kellman....................... 39,888(4)(5) 0.1% 58,442 0.1% -- --
Laurence D. Rich....................... 13,114(6) * 19,214 * -- --
Thomas F. Franke....................... 39,682(7)(8) 0.1% 57,985 0.1% 4,000 *
Harold J. Kloosterman.................. 64,837(8)(9) 0.2% 94,840 0.2% -- --
Bernard J. Korman...................... 366,307(8) 1.0% 536,528 1.0% 200 *
Edward Lowenthal....................... 8,707(8)(10) * 12,602 * -- --
Christopher W. Mahowald................ 4,407(8) * 6,302 * -- --
Donald J. McNamara..................... 17,695,627(8)(11)(12) 48.1% 25,934,794 48.1% 3,600(17) *
Daniel A. Decker....................... 17,332,977(8)(12) 47.1% 25,403,467 47.1% -- --
Stephen D. Plavin...................... 4,407(8) * 6,302 * -- --
Directors and executive officers as 18,346,790(13) 49.9% 26,864,335 49.8% 7,800 *
a group (16 persons).................

5% BENEFICIAL OWNERS:
Merrill Lynch & Co. Inc.
(on behalf of Merrill Lynch Asset
Management Group)
World Financial Center,
North Tower
250 Vesey Street
New York, NY 10381................... 1,136,750(14) 3.1% 1,665,471 3.1%

Hampstead Investment Partners III, L.P.
(through Explorer Holdings, L.P.)
4200 Texas Commerce Tower West
2200 Ross Avenue
Dallas, TX 75201..................... 17,328,570(12) 47.1% 25,139,563 46.6%

SERIES B PREFERRED
-----------------------
NUMBER OF PERCENT OF
BENEFICIAL OWNER SHARES CLASS(19)
--------------------------------------- ---------- ----------

DIRECTORS AND EXECUTIVE OFFICERS:
C. Taylor Pickett...................... -- --
Robert O. Stephenson................... -- --
Daniel J. Booth........................ -- --
R. Lee Crabill......................... -- --
Thomas W. Erickson..................... -- --
Richard M. FitzPatrick................. -- --
F. Scott Kellman....................... -- --
Laurence D. Rich....................... -- --
Thomas F. Franke....................... -- --
Harold J. Kloosterman.................. -- --
Bernard J. Korman...................... 1,300 *
Edward Lowenthal....................... -- --
Christopher W. Mahowald................ -- --
Donald J. McNamara..................... 4,300 *
Daniel A. Decker....................... -- --
Stephen D. Plavin...................... -- --
Directors and executive officers as 5,600 *
a group (16 persons).................
5% BENEFICIAL OWNERS:
Merrill Lynch & Co. Inc.
(on behalf of Merrill Lynch Asset
Management Group)
World Financial Center,
North Tower
250 Vesey Street
New York, NY 10381...................
Hampstead Investment Partners III, L.P.
(through Explorer Holdings, L.P.)
4200 Texas Commerce Tower West
2200 Ross Avenue
Dallas, TX 75201.....................

------------------------------

* Less than 0.10%

(1) Based on 36,773,618 shares of our common stock outstanding as of
December 31, 2001, including 16,774,722 shares of our common stock issuable
upon conversion of Series C preferred stock. See note (12) below.

(2) Represents unvested shares of Restricted Stock granted in July 2001.

(3) Includes stock options that are exercisable within 60 days to acquire
50,333 shares.

(4) Includes shares owned jointly by Mr. Kellman and his wife, plus 171 shares
held solely in Mrs. Kellman's name. Mr. Kellman disclaims any beneficial
interest in the shares held solely by Mrs. Kellman.

(5) Includes 647 unvested shares of Restricted Stock granted in January 1999.

(6) Includes 215 unvested shares of Restricted Stock granted in January 1999.

(7) Includes 26,037 shares owned by a family limited liability company (Franke
Family LLC) of which Mr. Franke is a Member.

(8) Includes stock options that are exercisable within 60 days to acquire 333
shares.

(9) Includes shares owned jointly by Mr. Kloosterman and his wife, and 23,269
shares held solely in Mrs. Kloosterman's name.

(10) Includes 1,000 shares held in a private profit sharing plan for the
benefit of Mr. Lowenthal.

(11) Includes 251,000 shares held by a partnership established by Mr. McNamara
for the benefit of certain members of Mr. McNamara's family, 5,150 shares
held by a charitable foundation established by Mr. McNamara, and 1,000
shares held by a trust established by Mr. McNamara for non-family members
of which Mr. McNamara is the trustee. Mr. McNamara disclaims any
beneficial ownership of the shares held by the partnership, the foundation
and the trust.

(12) Based on Amendment No. 4 to Schedule 13D filed by Hampstead Investment
Partners III, L.P. on November 29, 2001. Represents shares of our common
stock issuable upon conversion of 1,048,420 shares of Series C preferred
stock and 553,850 shares of common stock owned by Explorer. Hampstead
holds the ultimate controlling interest in Explorer. Messrs. McNamara and
Decker disclaim beneficial ownership of the Series C preferred stock and
the common stock, which they may be deemed to beneficially own because of
their ownership interests in Hampstead, which holds the ultimate
controlling interest in Explorer.

(13) Includes options that are exercisable within 60 days to acquire 52,997
shares. Also includes 50,862 unvested shares of restricted stock. Includes
shares of our common stock issuable upon conversion of Series C preferred
stock and shares of common stock owned by Explorer. See Note 12.

(14) Based on the Schedule 13G filed by Merrill Lynch & Co., Inc. with the
Securities and Exchange Commission on February 7, 2000.

(15) Assumes full exercise of subscription rights by each stockholder in the
rights offering. If none of the subscription rights are exercised in the
rights offering, Explorer would beneficially own 34,451,860 shares, or
63.9%, of our common stock, represented by 553,850 shares of common stock,
1,048,420 shares of Series C preferred stock and 500,000 shares of
Series D preferred stock, depending on whether or not we have obtained
shareholder approval for Explorer's investment at the time of the
investment.

(16) Based on 53,896,906 shares of our common stock, including 17,123,288
issued pursuant to this offering and private placement and
16,774,722 shares of our common stock issuable upon conversion of our
Series C preferred stock. See Note (12).

(17) Includes 800 shares held by a trust established by Mr. McNamara for
non-family members of which Mr. McNamara is the trustee. Mr. McNamara
disclaims any beneficial ownership of the shares held by the trust.

(18) Based on 2,300,000 shares of Series A preferred stock outstanding on
December 31, 2001.

(19) Based on 2,000,000 shares of Series B preferred stock outstanding on
December 31, 2001.

AFFILIATE RELATIONSHIPS AND TRANSACTIONS

EXPLORER

Hampstead, through its affiliate Explorer, indirectly owns 1,048,722 shares
of Series C preferred stock and 553,850 shares of our common stock, representing
47.1% of our outstanding voting power. Daniel A. Decker, our Chairman of the
Board, is a member of Hampstead. Donald J. McNamara, the Chairman of Hampstead,
is one of our directors. In connection with this rights offering and Explorer's
investment, we have agreed to amend certain documents currently in effect
between Explorer and us. For a description of our existing agreements with
Explorer and proposed modifications, see "Modifications to Agreements with
Explorer" beginning on page 46.

OMEGA WORLDWIDE

FLEET CREDIT GUARANTY. We guaranteed repayment of borrowings of our
affiliate, Omega Worldwide, Inc., pursuant to a revolving credit facility with a
bank group, of which Fleet Bank, N.A. acts as agent in exchange for an initial
1% fee and an annual facility fee of 0.25%. At December 31, 2000, borrowings of
$2,850,000 were outstanding under Omega Worldwide's revolving credit facility.
Omega Worldwide's credit agreement required scheduled payments to be made until
fully repaid in June 2001. Under this agreement, no further borrowings may be
made by Omega Worldwide under its revolving credit facility. We were required to
provide collateral in the amount of up to $8,800,000 related to the guarantee of
Omega Worldwide's obligations. Upon repayment by Omega Worldwide of the
remaining outstanding balance under its revolving credit facility, the subject
collateral was released in connection with the termination of our guarantee.

OPPORTUNITY AGREEMENT. We and Omega Worldwide have entered into an
opportunity agreement to provide each other with rights to participate in
transactions and make investments. The opportunity agreement provides that each
company will offer the other a right of first refusal to participate in
transactions or investments of which it becomes aware. In addition, both
companies agree to jointly pursue certain transactions and investments upon the
request of either company. The terms upon which each of us elect to participate
in any transaction or investment will be negotiated in good faith and must be
mutually acceptable to our respective boards of directors, with the affirmative
votes of the independent directors of each of the boards of directors. The
opportunity agreement has a term of ten years and automatically renews for
successive five-year terms, unless terminated.

SERVICES AGREEMENT. We and Omega Worldwide have entered into a services
agreement which provides for the allocation of indirect costs incurred by us to
Omega Worldwide. The allocation of indirect costs has been based on the
relationship of assets under our management to the combined total of those
assets and assets under Omega Worldwide's management. Upon expiration of this
agreement on June 30, 2000, we entered into a new agreement requiring quarterly
payments from Omega Worldwide of $37,500 for the use of offices and
administrative and financial services provided by us. Upon the reduction of our
accounting staff, the service agreement was renegotiated again on November 1,
2000 requiring quarterly payments from Omega Worldwide of $32,500. Costs
allocated to Omega Worldwide for 2000 and 1999 were $404,000 and $754,000,
respectively. The former services agreement has expired and Omega Worldwide is
paying monthly invoices for services rendered.

OTHER

BORROWING PROGRAM. On January 14, 1998, the Board of Directors adopted a
program pursuant to which we agreed to lend funds to employees and directors to
enable them to purchase our common stock through the exercise of stock options.
The goal of the borrowing program was to increase ownership of our common stock
by employees and directors, and, as a result, to foster a proprietary feeling
among employees and directors and to further align the interests of employees
and directors with those of our other stockholders. The maximum amount that an
employee was permitted to borrow under the borrowing program depended on the
employee's salary level, with the maximum loan amount

for employees at the lower end of the salary range being $20,000, and the
maximum loan amount for employees at the upper end of the salary range being
$300,000. The maximum loan amount for directors was $300,000. Each loan carried
interest at our borrowing cost, as determined by our management. Interest was
payable quarterly, and all principal and accrued and unpaid interest was due
five years from the date of the loan. Upon receipt by an employee of a cash
bonus from us, the employee was obligated to make a principal reduction payment
equal to 10% of the amount of the cash bonus. The loans are secured by pledges
of the stock purchased with the proceeds of the loans. As long as a loan is not
in default, the borrower may vote the shares purchased and is entitled to
receive all dividends paid on the shares. At January 1, 2000, the following
loans were outstanding to executive officers and non-employee directors:

NAME OF DIRECTOR AMOUNT BORROWED AS OF
OR EXECUTIVE OFFICER JANUARY 1, 2000
-------------------- ---------------------

Essel W. Bailey, Jr...................................... $195,707
James E. Eden............................................ $262,587
James P. Flaherty........................................ $262,632
Thomas F. Franke......................................... $262,587
Harold J. Kloosterman.................................... $262,587
Bernard J. Korman........................................ $300,000
Edward Lowenthal......................................... $187,472
Robert L. Parker......................................... $299,955
David A. Stover.......................................... $296,847

As of January 1, 2000, the outstanding aggregate principal balance of loans
made under the borrowing program to employees who are not directors or executive
officers was $201,088. On July 31, 2000, Messrs. Bailey, Eden, Flaherty, Franke,
Kloosterman, Korman, Lowenthal, Parker and Stover each surrendered 7,664;
12,000; 8,333; 12,000; 12,000; 12,000; 6,999; 12,739; and 11,703 shares of
common stock, respectively in exchange for forgiveness of $191,803; $262,587;
$255,171; $262,587; $262,587; $300,000; $187,472; $299,955; and $294,118,
respectively, of debt, incurred by each of them under the borrowing program. As
of December 31, 2000, no loans were outstanding under the borrowing program for
our directors or executive officers. We do not currently expect that any loans
will be made pursuant to the borrowing program in the future.

LEASE FROM CIRCLE PARTNERS. We leased 5,823 square feet of office space at
905 West Eisenhower Circle, Suite 110, Ann Arbor, Michigan 48103, from Circle
Partners, a general partnership whose general partners are Essel W. Bailey, Jr.,
our former President and Chief Executive Officer, and Thomas F. Franke, a
director. During 1998, we moved our principal executive offices to 900 Victors
Way, Suite 350, Ann Arbor, Michigan 48108 and entered into a sublease agreement
with respect to 1,900 square feet of the Eisenhower space on December 14, 1998.
We entered into a second sublease agreement with respect to an additional 3,000
square feet of the Eisenhower space in July 1999. The lease expired,
concurrently with the expiration of the subleases, on October 31, 2000. Rent
payments totaling $77,198 were made to Circle Partners in 2000. Rent income on
the subleases in 2000 was $65,509.

RELOCATION LOAN. In connection with the 1994 relocation of F. Scott
Kellman, our former Chief Operating Officer, from the Philadelphia metropolitan
area to Ann Arbor, Michigan, we loaned him $220,000 to enable him to purchase a
home in Ann Arbor. At January 1, 2000 the outstanding principal balance on the
loan was $67,000. The loan was secured by a lien on Mr. Kellman's residence, and
bore interest at 7.05% per annum. Mr. Kellman paid the balance of the mortgage
in full on January 29, 2001.

LOAN TO OAKWOOD. On December 30, 1998, we made a $6,000,000 loan to Oakwood
Living Centers of Massachusetts, Inc., an affiliate of Oakwood Living
Centers, Inc., of which James E. Eden, a former director of our company, also is
Chairman and Chief Executive Officer. The loan is secured by

a second mortgage lien on six skilled nursing facilities located in
Massachusetts, bears interest at 14% per annum and currently is past due and the
borrower is paying interest at the default rate of 17%.

STOVER SEVERANCE AGREEMENT. On June 15, 2000, we entered into a consulting
and severance agreement with David A. Stover, our former Chief Financial
Officer, pursuant to which Mr. Stover resigned as an officer of our company.
Mr. Stover's resignation and severance agreement was effective as of June 15,
2000.

Under the terms of the severance agreement, Mr. Stover received payment of
his regular base salary for thirty days after the effective date of his
resignation and a lump-sum severance payment equal to $348,667. The agreement
provided that Mr. Stover was fully vested in his restricted stock awards for
which there were no performance requirements, stock options and deferred
compensation units. In addition, the dollar value of Mr. Stover's deferred
compensation units under our deferred compensation arrangement were to be paid
to Mr. Stover in a lump sum payment pursuant to the terms of the plan. The
severance agreement permitted Mr. Stover to transfer shares he purchased under
the borrowing program back to us in satisfaction of his debt under the borrowing
program.

Under the terms of the severance agreement, Mr. Stover will provide
consulting services to us for one year following his resignation in exchange for
compensation equal to $348,667 payable in twelve equal monthly installments.

DESCRIPTION OF CAPITAL STOCK

We are offering shares of our common stock, par value $0.10 per share, to be
issued upon the exercise of rights given to stockholders of record as of January
22, 2002.

Our authorized capital stock currently consists of 100,000,000 shares of our
common stock, par value $0.10 per share, 2,300,000 shares of Series A preferred
stock, par value $1.00 per share, 2,000,000 shares of Series B preferred stock,
par value $1.00 per share, 2,000,000 shares of Series C preferred stock, par
value $1.00 per share, and 1,000,000 shares of Series D preferred stock, par
value $1.00 per share. As of December 31, 2001, we have 19,998,896 shares of our
common stock, 2,300,000 shares of our Series A preferred stock, 2,000,000 shares
of our Series B preferred stock, 1,048,420 shares of our Series C preferred
stock, and no shares of our Series D preferred stock issued and outstanding. Our
common stock, Series A preferred stock and Series B preferred stock are listed
on the New York Stock Exchange. We intend to apply to list for trading on the
New York Stock Exchange any additional shares of our common stock which are
issued and sold hereunder.

COMMON STOCK

All shares of our common stock participate equally in dividends payable to
stockholders of our common stock when and as declared by our Board of Directors
and in net assets available for distribution to stockholders of our common stock
on liquidation or dissolution, have one vote per share on all matters submitted
to a vote of the stockholders and do not have cumulative voting rights in the
election of directors. All issued and outstanding shares of our common stock
are, and our common stock offered hereby will be upon issuance, validly issued,
fully paid and nonassessable. Holders of our common stock do not have
preference, conversion, exchange or preemptive rights. Our common stock is
listed on the New York Stock Exchange under the symbol "OHI."

DIVIDENDS ON COMMON STOCK. In February 2001, we suspended payment of all
dividends on all common stock and preferred stock. We do not know when or if we
will resume dividend payments on our common stock or, if resumed, what the
amount or timing of any dividend will be. We do not anticipate paying dividends
on any class of capital stock at least until our $108 million of debt maturing
in the first half of 2002 has been repaid, and in any event, all accrued and
unpaid dividends on our Series A, B and C preferred stock must be paid in full
before dividends on our common stock can be resumed. We have made sufficient
distributions to satisfy the distribution requirements under the REIT rules of
the Internal Revenue Code of 1986 to maintain our REIT status for 2000 and
expect to satisfy the requirements under the REIT rules for 2001.

SERIES A PREFERRED STOCK

The following description of the terms of the Series A preferred stock sets
forth certain general terms and provisions of the Series A preferred stock. The
description of certain provisions of the Series A preferred stock set forth
below does not purport to be complete and is subject to and qualified in its
entirety by reference to our Articles of Incorporation, as amended, and the
Board of Directors' resolutions or articles supplementary relating to the
Series A preferred stock.

GENERAL. Under the Articles of Incorporation, our Board of Directors is
authorized without further stockholder action to provide for the issuance of up
to an aggregate of 10,000,000 shares of our

preferred stock, in one or more series, with such designations, preferences,
powers and relative participating, optional or other special rights and
qualifications, limitations or restrictions thereon, including, but not limited
to, dividend rights, dividend rate or rates, conversion rights, voting rights,
rights and terms of redemption, including sinking fund provisions, the
redemption price or prices, and the liquidation preferences as will be stated in
the resolutions providing for the issuance of a series of such stock, adopted,
at any time or from time to time, by our Board of Directors. The shares of
Series A preferred stock are fully paid and nonassessable and have no preemptive
rights.

RANK. The Series A preferred stock will, with respect to dividend rights
and rights upon liquidation, dissolution or winding-up of our company, rank:

- senior to all classes or series of our common stock, and to all equity
securities ranking junior to the Series A preferred stock with respect to
dividend rights or rights upon liquidation, dissolution or winding-up of
our company;

- on a parity with the Series B preferred stock, the Series C preferred
stock, the Series D preferred stock, if issued, and all other equity
securities we issue, the terms of which specifically provide that such
equity securities rank on a parity with the Series A preferred stock with
respect to dividend rights or rights upon liquidation, dissolution or
winding-up of our company; and

- junior to all of our existing and future indebtedness.

ANTI-TAKEOVER PROVISIONS IN OUR ARTICLES OF INCORPORATION. See "Redemption
and Business Combination Provisions" for a description of certain provisions of
our Articles of Incorporation, including provisions relating to redemption
rights and provisions, which may have certain anti-takeover effects.

DIVIDEND RIGHTS. Holders of shares of the Series A preferred stock are
entitled to receive, when and as declared by our Board of Directors, or a duly
authorized committee, out of funds legally available for the payment of
dividends, preferential cumulative cash dividends at the rate of 9.25% per annum
of the liquidation preference discussed below per share, equivalent to a fixed
annual amount of $2.31 per share. Dividends on the Series A preferred stock are
cumulative from the date of original issue and are payable quarterly in arrears
for each quarterly dividend period ended April 30, July 31, October 31 and
January 31, on or before the 15th day of May, August, November and February
respectively of each year or, if not a business day, the next succeeding
business day. The first dividend was paid on August 15, 1997 with respect to the
period commencing on the date of issue and ending on July 31, 1997. Any dividend
payable on Series A preferred stock for any partial period will be computed on
the basis of a 360-day year consisting of twelve 30-day months. Dividends will
be payable to holders of record as they appear in our stock records at the close
of business on the applicable record date which will be the last day of the
preceding calendar month prior to the applicable payment date of the dividend or
such other date designated by our Board of Directors that is not more than 30
nor less than 10 days prior to the date of the dividend payment. No dividends on
shares of Series A preferred stock will be declared by our Board of Directors or
paid or set apart for payment by us at such time as the terms and provisions of
any of our agreements, including any agreement relating to our indebtedness,
prohibit such declaration, payment or setting apart for payment or provide that
such declaration, payment or setting apart for payment would constitute a breach
thereof or a default thereunder, or if such declaration or payment is restricted
or prohibited by law. Notwithstanding the foregoing, dividends on the Series A
preferred stock will accrue whether or not we have earnings, whether or not
there are funds legally available for payment on such dividends and whether or
not such dividends are declared. Accrued but unpaid dividends on the Series A
preferred stock will not bear interest and holders of the Series A preferred
stock will not be entitled to any distributions in excess of full cumulative
distributions described above. Except as set forth in the next sentence, no
dividends will be declared or paid or set apart for payment on any of our
capital stock or any other series of

preferred stock ranking, as to dividends, on a parity with or junior to the
Series A preferred stock other than a dividend in shares of our common stock or
in shares of any other class of stock ranking junior to the Series A preferred
stock as to dividends and upon liquidation for any period unless full cumulative
dividends have been or contemporaneously are declared and paid or declared and a
sum sufficient for the payment thereof is set apart for such payment on the
Series A preferred stock for past dividend periods and the then current dividend
period. When dividends are not paid in full, or a sum sufficient for such
payment is not so set apart, upon the Series A preferred stock and the shares of
any other series of preferred stock ranking on a parity as to dividends with
Series A preferred stock, all dividends declared upon the Series A preferred
stock and any other series of preferred stock ranking on a parity as to
dividends with the Series A preferred stock will be declared pro rata so that
the amount of dividends declared per share of Series A preferred stock and any
other series of preferred stock will in all cases bear to each other the same
ratio that the accrued dividends per share of the Series A preferred stock and
such other series of preferred stock bear to each other, but not including any
accrual in respect of unpaid dividends for prior dividend periods if the
preferred stock does not have a cumulative dividend bear to each other. Except
as provided above, unless full cumulative dividends on the Series A preferred
stock have been or contemporaneously are declared and paid or declared and a sum
sufficient for payment thereof is set apart for payment for all past dividend
periods and the then current dividend period, no dividend, other than in shares
of common stock or other shares of capital stock ranking junior to the Series A
preferred stock as to dividends and liquidation, will be declared or paid or set
aside for payment nor will any other distribution be declared or made upon the
common stock, or any other class or series of our capital stock ranking junior
to or on a parity with the Series A preferred stock as to dividends or upon
liquidation, nor will any shares of our common stock, or any other shares of our
capital stock ranking junior to or on a parity with the Series A preferred stock
as to dividends or upon liquidation be redeemed, purchased or otherwise acquired
for any consideration, or any monies paid to or made available for a sinking
fund for the redemption for any such shares, by us except by conversion into or
exchange for other capital stock ranking junior to the Series A preferred stock
as to dividends and upon liquidation or redemption or for the purpose of
preserving our qualification as a real estate investment trust under the
Internal Revenue Code. Holders of shares of Series A preferred stock will not be
entitled to any dividend, whether payable in cash, property or stock in excess
of full cumulative dividends on the Series A preferred stock as provided above.
Any dividend payment made on shares of Series A preferred stock will be first
credited against the earliest accrued but unpaid dividends due with respect to
such shares which remain payable.

LIQUIDATION PREFERENCE. In the event of any liquidation, dissolution or
winding up of our company, whether voluntary or involuntary, the holders of
Series A preferred stock will be entitled to receive out of our assets legally
available for distribution to stockholders, the amount of $25 per share, plus an
amount equal to any accrued and unpaid dividends to the date of payment, but
without interest, before any distribution of assets is made to holders of our
common stock or any other class or series of our capital stock that ranks junior
to the Series A preferred stock as to liquidation rights. If, upon any voluntary
or involuntary liquidation, dissolution or winding up our company, the amounts
payable with respect to the Series A preferred stock and any other shares of our
preferred stock ranking as to any such distribution on a parity with Series A
preferred stock are not paid in full, the holders of the Series A preferred
stock and of such other shares of our preferred stock will share ratably in any
such distribution of our assets in proportion to the full respective
preferential amounts and accrued and unpaid dividends to which they are
entitled. After payment to the holders of the preferred stock of each series of
the full preferential amounts of the liquidating distribution and accrued and
unpaid dividends to which they are entitled, the holders of each such series of
the preferred stock will be entitled to no further participation in any
distribution of our assets. If liquidating distributions have been made in full
to all holders of shares of Series A preferred stock, our remaining assets will
be distributed among the holders of junior stock, according to their respective
rights and preferences and

in each case according to their respective number of shares. For such purposes,
the consolidation or merger of us with or into any other corporation, or the
sale, lease or conveyance of all or substantially all of our property or
business, will not be deemed to constitute a liquidation, dissolution or winding
up of our company.

REDEMPTION. On and after July 1, 2002, Series A preferred stock may be
redeemed, in whole or from time to time in part, at our option and may not be
subject to mandatory redemption pursuant to a sinking fund or otherwise, in each
case upon terms, at the time and at a redemption price of $25 per share plus all
accrued and unpaid dividends thereon without interest. The shares of the
Series A preferred stock redeemed will be restored to the status of authorized
but unissued shares of our preferred stock. In the event that fewer than all of
the outstanding shares of Series A preferred stock are to be redeemed, whether
by mandatory or optional redemption, the number of shares to be redeemed will be
determined by lot or pro rata, subject to rounding to avoid fractional shares,
as we may determine or by any other method as we may determine in our sole
discretion to be equitable. From and after the redemption date, unless we
default in providing for the payment of the redemption price plus accumulated
and unpaid dividends, if any, dividends will cease to accumulate on the shares
of Series A preferred stock called for redemption and all rights of the holders
thereof, except the right to receive the redemption price plus accumulated and
unpaid dividends, if any, will cease. Unless full cumulative dividends on all
shares of Series A preferred stock will have been or contemporaneously are
declared and a sum sufficient for the payment thereof set apart for payment for
all past dividend periods and the then current dividend period, no shares of
Series A preferred stock will be redeemed unless all outstanding shares of
Series A preferred stock are simultaneously redeemed and we will not purchase or
otherwise acquire directly or indirectly any shares of Series A preferred stock,
except by exchange for our capital stock ranking junior to the Series A
preferred stock as to dividends and upon liquidation; provided, however, that
the foregoing will not prevent our purchase of excess shares in order to insure
that we continue to meet the requirements for qualification as a REIT, or the
purchase or acquisition of shares of Series A preferred stock pursuant to a
purchase or exchange offer made on the same terms to all holders of all
outstanding shares of Series A preferred stock. So long as no dividends are in
arrears, we will be entitled at any time to repurchase shares of Series A
preferred stock in open market transactions duly authorized by the Board of
Directors and in compliance with the applicable law.

CONVERSION RIGHTS. The shares of Series A preferred stock are not
convertible into common stock.

VOTING RIGHTS. Except as indicated below or except as required by law,
holders of the Series A preferred stock will not be entitled to vote for any
purpose. So long as any shares of Series A preferred stock remain outstanding,
we will not, without the affirmative vote or consent of the holders of at least
two-thirds of the shares of the Series A preferred stock outstanding at the
time, given in person or by proxy, either in writing or at a meeting, voting
separately as a class, amend, alter or repeal the provisions of the Articles of
Incorporation or the articles supplementary relating to the Series A preferred
stock, whether by merger, consolidation or otherwise so as to materially and
adversely affect any right, preference, privilege or voting power of the
Series A preferred stock or the holders thereof; including without limitation,
the creation of any series of preferred stock ranking senior to the Series A
preferred stock with respect to payment of dividends or the distribution of
assets upon liquidation, dissolution or winding up. However, so long as the
Series A preferred stock (or any equivalent class or series of stock issued by
the surviving corporation in any merger or consolidation to which we become a
party) remains outstanding with the terms thereof materially unchanged, the
occurrence of any such event will not be deemed to materially and adversely
affect such rights, preferences, privileges or voting power of holders of the
Series A preferred stock. Any increase in the amount of the authorized preferred
stock or the creation or issuance of any other series of preferred stock or any
increase in the amount of authorized shares of such series, in each case ranking
on a parity with or junior to the Series A preferred stock with respect to
payment of dividends or the distribution of assets upon

liquidation, dissolution or winding up, will not be deemed to materially and
adversely affect such rights, preferences, privileges or voting powers. Whenever
dividends on any shares of Series A preferred stock are in arrears for 18 or
more months, the number of directors then constituting the Board of Directors
will be increased by two, if not already increased by a reason of a similar
arrearage pursuant to similar rights of any other preferred stock on parity with
the Series A Preferred Stock. The holders of such shares of Series A preferred
stock, voting separately as a class with any other preferred stock on parity
with the Series A preferred stock, if such stock has like voting rights that are
then exercisable, will be entitled to vote separately as a class in order to
fill the vacancies thereby created for the election of a total of two additional
directors at a special meeting called by the holders of record of such stock,
and at each subsequent annual meeting until all dividends accumulated on such
shares of preferred stock for the past dividend period and the dividend for the
then current dividend period shall have been fully paid or declared and a sum
sufficient for the payment thereof set aside for payment. Each director elected
pursuant to these voting rights, as a qualification for election as such, and
regardless of how elected, must submit to our Board of Directors a duly
executed, valid, binding and enforceable letter of resignation from the Board of
Directors, to be effective upon the date upon which all dividends accumulated on
such shares of preferred stock for the past dividend periods and the dividend
for the then current dividend period have been fully paid or declared and a sum
sufficient for the payment thereof set aside for payment, whereupon the terms of
office of all persons elected pursuant to these voting rights will terminate
upon the effectiveness of their respective letters of resignation, and the
number of directors then constituting the Board of Directors will be reduced
accordingly. If and when all accumulated dividends and the dividend for the then
current dividend period on the Series A preferred stock have been paid in full
or declared and set aside for payment in full, the holders thereof will be
divested of the foregoing voting rights, subject to revesting in the event of
each and every Series A dividend default, and, if all accumulated dividends and
the dividend for the then current dividend period have been paid for all
preferred stock with like voting power in full or set aside for payment in full
the term of office of each director so elected will terminate. Any director
elected pursuant to these voting rights may be removed at any time with or
without cause by, and will not be removed otherwise than by the vote of, the
holders of record of a majority of the outstanding shares of the Series A
preferred stock when they have the voting rights described above, voting
separately as a class with other preferred stock on parity with the Series A
preferred stock with like voting rights that are then exercisable. So long as a
Series A dividend default continues, any vacancy in the office of a director
elected pursuant to these voting rights may be filled by written consent of the
director elected pursuant to these voting rights remaining in office, or if none
remains in office, by a vote of the holders of record of a majority of the
outstanding shares of Series A preferred stock when they have the voting rights
described above, voting separately as a class with other preferred stock on
parity with the Series A preferred stock with like voting rights that are then
exercisable. The directors elected pursuant to these voting rights will each be
entitled to one vote per director on any matter.

SERIES B PREFERRED STOCK

The following description of the terms of the Series B preferred stock sets
forth general terms and provisions of the Series B preferred stock. The
description of provisions of the Series B preferred stock set forth below does
not purport to be complete and is subject to and qualified in its entirety by
reference to our Articles of Incorporation, and the Board of Directors'
resolutions or Articles Supplementary relating to the Series B preferred stock.

the liquidation preferences as will be stated in the resolutions providing for
the issuance of a series of such stock, adopted, at any time or from time to
time, by our Board of Directors. The shares of Series B preferred stock are
fully paid and nonassessable and have no preemptive rights.

RANK. The Series B preferred stock will, with respect to dividend rights
and rights upon liquidation, dissolution or winding-up of our company, rank:

- senior to all classes or series of our common stock, and to all equity
securities ranking junior to the Series B preferred stock with respect to
dividend rights or rights upon liquidation, dissolution or winding-up of
our company;

- on a parity with the Series A preferred stock, the Series C preferred
stock, the Series D preferred stock, if issued, and all other equity
securities we issue, the terms of which specifically provide that such
equity securities rank on a parity with the Series B preferred stock with
respect to dividend rights or rights upon liquidation, dissolution or
winding-up of our company; and

- junior to all of our existing and future indebtedness.

DIVIDEND RIGHTS. Holders of shares of the Series B preferred stock are
entitled to receive, when and as declared by our Board of Directors, or a duly
authorized committee, out of funds legally available for the payment of
dividends, preferential cumulative cash dividends at the rate of 8.625% per
annum of the liquidation preference per share equivalent to a fixed annual
amount of $2.156 per share. Dividends on the Series B preferred stock are
cumulative from the date of original issue and are payable in arrears for each
period ended July 31, October 31, January 31, and April 30 on or before the 15th
day of August, November, February and May of each year, or, if not a business
day, the next succeeding business day. The first dividend was paid on
August 15, 1998 with respect to the period ending on July 31, 1998. Any dividend
payable on Series B preferred stock for any partial period will be computed on a
basis of a 360-day year consisting of twelve 30-day months. Dividends will be
payable to holders of record as they appear in our stock records at the close of
business on the applicable record date, which will be the last day of the
preceding calendar month prior to the applicable dividend payment date or such
other date designated by our Board of Directors that is not more than 30 days
nor less than 10 days prior to such dividend payment date. No dividends on
shares of Series B preferred stock will be declared by our Board of Directors or
paid or set apart for payment by us at such time as the terms and provisions of
any agreement of our company, including any agreement relating to our
indebtedness, prohibit such declaration, payment or setting apart for payments
or provide that such declaration, payment or setting apart for payment will
constitute a breach thereof or a default thereunder, or if such declaration or
payment is restricted or prohibited by law. Notwithstanding the foregoing,
dividends on the Series B preferred stock will accrue whether or not we have
earnings, whether or not there are funds legally available for the payment on
such dividends and whether or not such dividends are declared. Accrued but
unpaid dividends on the Series B preferred stock will not bear interest and
holders of the Series B preferred stock will not be entitled to any
distributions in excess of the full cumulative distributions described above.
Except as set forth in the next sentence, no dividends will be declared or paid
or set apart for payment on any of our capital stock or any of our other series
of preferred stock ranking, as to dividends, on a parity with or junior to the
Series B preferred stock (other than a dividend in shares of our common stock or
in shares of any other class of stock ranking junior to the Series B preferred
stock as to the dividends and upon liquidation) for any period unless full
cumulative dividends have been or contemporaneously are declared and paid or
declared and a sum sufficient for the payment thereof is set apart for such

payment on the Series B preferred stock for all past dividend periods and the
then current dividend period. When dividends are not paid in full, or a sum
sufficient for such full payment is not so set apart, upon the Series B
preferred stock and the shares of any other series of preferred stock ranking on
a parity as to dividends with the Series B preferred stock, all dividends
declared upon the Series B preferred stock and any other series of preferred
stock ranking on a parity as to dividends with the Series B preferred stock will
be declared pro rata so that the amount of dividends declared per share of
Series B preferred stock and such other series of preferred stock will in all
cases bear to each other the same ratio that accrued dividends per share of the
Series B preferred stock and such other series of preferred stock, which will
not include any accrual in respect of unpaid dividends for prior dividend
periods if such preferred stock does not have a cumulative dividend, bear to
each other. Except as provided above, unless full cumulative dividends on the
Series B preferred stock have been or contemporaneously are declared and paid or
declared in a sum sufficient for payment thereof is set apart for payment for
all past dividend periods and the then current dividend period, no dividend,
other than in shares of common stock or other shares of our capital stock
ranking junior to the Series B preferred stock as to dividends and upon
liquidation, will be declared or paid or set aside for payment nor shall any
other distribution be declared or made upon the common stock, or any other class
or series of our capital stock ranking junior to or on a parity with the
Series B preferred stock as to dividends or upon liquidation, nor will any
shares of our common stock, or any other shares of our capital stock ranking
junior to or on a parity with the Series B preferred stock as to dividends or
upon liquidation be redeemed, purchased or otherwise acquired for any
consideration or any monies to be paid to or made available for a sinking fund
for the redemption for such shares by us, except by conversion into or exchange
for other capital stock ranking junior to the Series B preferred stock as to
dividends and upon liquidation or redemption for the purposes of preserving our
qualification as a real estate investment trust under the Internal Revenue Code.
Holders of shares of Series B preferred stock will not be entitled to any
dividend, whether payable in cash, property or stock, in excess of full
cumulative dividends on the Series B preferred stock as provided above. Any
dividend payment made on shares of Series B preferred stock will be first
credited against the earliest accrued but unpaid dividends due with respect to
such shares which remain payable.

LIQUIDATION PREFERENCE. In the event of any liquidation, dissolution or
winding up of our company, whether voluntary or involuntary, the holders of
Series B preferred stock will be entitled to receive out of our assets legally
available for distribution to stockholders, the amount of $25 per share plus an
amount equal to any accrued and unpaid dividends to the date of payment, but
without interest, before any distribution of assets is made to holders of our
common stock or any other class or series of our capital stock that ranks junior
to the Series B preferred stock in liquidation rights. If, upon any voluntary or
involuntary liquidation, dissolution or winding up of our company, the amounts
payable with respect to the Series B preferred stock and any other shares of our
preferred stock ranking as to any such distribution on a parity with Series B
preferred stock are not paid in full, the holders of the Series B preferred
stock and of such other shares of our preferred stock will share ratably in any
such distribution of our assets in proportion to the full respective
preferential amounts and accrued and unpaid dividends to which they are
entitled. After payment to the holders of the preferred stock of each series of
the full preferential amounts of the liquidating distribution and accrued and
unpaid dividends to which they are entitled, the holders of each such series of
the preferred stock will be entitled to no further participation in any
distribution of our assets. If liquidating distributions have been made in full
to all holders of shares of our preferred stock, our remaining assets will be
distributed among the holders of junior stock, according to their respective
rights and preferences and in each case according to their respective number of
shares. For such purposes, the consolidation or merger of us with or into any
other corporation, or the sale, lease or conveyance of all or substantially all
of our property or business, will not be deemed to constitute a liquidation,
dissolution or winding up of our company.

REDEMPTION. On and after July 1, 2003, the Series B preferred stock may be
redeemed, in whole or from time to time in part, at our option, and may not be
subject to mandatory redemption pursuant to a sinking fund or otherwise, in each
case upon terms, at the time and a redemption price of $25 per share plus all
accrued and unpaid dividends thereon without interest. The shares of the
Series B preferred stock redeemed will be restored to the status of authorized
but unissued shares of our preferred stock. In the event that fewer than all of
the outstanding shares of Series B preferred stock are to be redeemed, whether
by mandatory or optional redemption, the number of shares to be redeemed will be
determined by lot or pro rata, subject to rounding to avoid fractional shares,
as we may determine or by any other method as we may determine in our sole
discretion to be equitable. From and after the redemption date, unless we
default in providing for the payment of the redemption price plus accumulated
and unpaid dividends, if any, dividends will cease to accumulate on the shares
of Series B preferred stock called for redemption and all rights of the holders
thereof, except the right to receive the redemption price plus accumulated and
unpaid dividends, if any, will cease. Unless full cumulative dividends on all
shares of Series B preferred stock will have been or contemporaneously are
declared and a sum sufficient for the payment thereof set apart for payment for
all past dividend periods and the then current dividend period, no shares of
Series B preferred stock will be redeemed unless all outstanding shares of
Series B preferred stock are simultaneously redeemed and we shall not purchase
or otherwise acquire directly or indirectly any shares of Series B preferred
stock except by exchange for our capital stock ranking junior to the Series B
preferred stock as to dividends and upon liquidation; provided, however, that
the foregoing will not prevent our purchase of shares of Series B preferred
stock in excess of 9.9% of the value of our outstanding capital stock in order
to insure that we continue to meet the requirements for qualification as a REIT,
or the purchase or acquisition of shares of Series B preferred stock pursuant to
a purchase or exchange offer made on the same terms to all holders of all
outstanding shares of Series B preferred stock. So long as no dividends are in
arrears, we will be entitled at any time to repurchase shares of Series B
preferred stock in open market transactions duly authorized by the Board of
Directors and in compliance with the applicable law.

CONVERSION RIGHTS. The shares of Series B preferred stock are not
convertible into common stock.

VOTING RIGHTS. Except as indicated below or except as required by law,
holders of the Series B preferred stock will not be entitled to vote for any
purpose. So long as any shares of Series B preferred stock remain outstanding,
we will not, without the affirmative vote or consent of the holders of at least
two-thirds of the shares of the Series B preferred stock outstanding at the
time, given in person or by proxy, either in writing or at a meeting, voting
separately as a class, amend, alter or repeal the provisions of the Articles of
Incorporation or the articles supplementary relating to the Series B preferred
stock, whether by merger, consolidation or otherwise so as to materially and
adversely affect any right, preference, privilege or voting power of the
Series B preferred stock or the holders thereof, including without limitation,
the creation of any series of preferred stock ranking senior to the Series B
preferred stock with respect to payment of dividends or the distribution of
assets upon liquidation, dissolution or winding up. However, so long as the
Series B preferred stock or any equivalent class or series of stock issued by
the surviving corporation in any merger or consolidation to which we becomes a
party remains outstanding with the terms thereof materially unchanged, the
occurrence of any such event will not be deemed to materially and adversely
affect such rights, preferences, privileges or voting power of holders of the
Series B preferred stock. Any increase in the amount of the authorized preferred
stock or the creation or issuance of any other series of preferred stock or any
increase in the amount of authorized shares of such series, in each case ranking
on a parity with or junior to the Series B preferred stock with respect to
payment of dividends or the distribution of assets upon liquidation, dissolution
or winding up, will not be deemed to materially and adversely affect such
rights, preferences, privileges or voting powers. Whenever dividends on any
shares of Series B preferred stock are in arrears for 18 or more months, the
number of directors then constituting the Board of Directors will be increased
by two if not already increased by a reason of a similar arrearage pursuant to
similar rights of any other preferred stock on parity with the Series B
preferred stock. The holders of such

shares of Series B preferred stock, voting separately as a class with any other
preferred stock on a parity with the Series A preferred stock, if such stock has
like voting rights that are then exercisable, will be entitled to vote
separately as a class, in order to fill the vacancies thereby created for the
election of a total of two additional directors at a special meeting called by
the holders of record of such stock, and at each subsequent annual meeting until
all dividends accumulated on such shares of preferred stock for the past
dividend period and the dividend for the then current dividend period shall have
been fully paid or declared and a sum sufficient for the payment thereof set
aside for payment. Each director elected pursuant to these voting rights, as a
qualification for election as such and regardless of how elected must submit to
our Board of Directors a duly executed, valid, binding and enforceable letter of
resignation from the Board of Directors, to be effective upon the date upon
which all dividends accumulated on such shares of preferred stock for the past
dividend periods and the dividend for the then current dividend period have been
fully paid or declared and a sum sufficient for the payment thereof set aside
for payment, whereupon the terms of office of all persons elected pursuant to
these voting rights will terminate upon the effectiveness of their respective
letters of resignation, and the number of directors then constituting the Board
of Directors will be reduced accordingly. If and when all accumulated dividends
and the dividend for the then current dividend period on the Series B preferred
stock shall have been paid in full or declared and set aside for payment in
full, the holders thereof will be divested of the foregoing voting rights
subject to revesting in the event of each and every Series B dividend default
and, if all accumulated dividends and the dividend for the then current dividend
period have been paid for all preferred stock with like voting power in full or
set aside for payment in full, the term of office of each director so elected
will terminate. Any director elected pursuant to these voting rights may be
removed at any time with or without cause by, and will not be removed otherwise
than by the vote of, the holders of record of a majority of the outstanding
shares of the Series B preferred stock when they have the voting rights
described above, voting separately as a class with other preferred stock on
parity with the Series A preferred stock with like voting rights that are then
exercisable. So long as a Series B dividend default shall continue, any vacancy
in the office of a director elected pursuant to these voting rights may be
filled by written consent of the director elected pursuant to these voting
rights remaining in office, or if none remains in office, by a vote of the
holders of record of a majority of the outstanding shares of Series B preferred
stock when they have the voting rights described above, voting separately as a
class with other preferred stock on parity with the Series A preferred stock
with like voting rights that are then exercisable. The directors elected
pursuant to these voting rights will each be entitled to one vote per director
on any matter.

SERIES C PREFERRED STOCK

The following description of the terms of the Series C preferred stock sets
forth the general terms and provisions of the Series C preferred stock. The
description of the provisions of the Series C preferred stock set forth below
does not purport to be complete and is subject to and qualified in its entirety
by reference to our Articles of Incorporation, and the Board of Directors'
resolutions or articles supplementary relating to the Series C preferred stock.
As part of Explorer's investment, our stockholders will be asked to approve the
adoption of Amended and Restated Articles Supplementary for Series C Convertible
Preferred Stock, which will alter certain terms and provisions of the Series C
preferred stock. The changes that would result from the adoption of the Amended
and Restated Articles Supplementary for Series C Convertible Preferred Stock are
described below but the description does not purport to be complete and is
subject to and qualified in its entirety to the Form of Amended and Restated
Articles Supplementary for Series C Convertible Preferred Stock.

100

including, but not limited to, dividend rights, dividend rate or rates,
conversion rights, voting rights, rights and terms of redemption, including
sinking fund provisions, the redemption price or prices, and the liquidation
preferences as will be stated in the resolutions providing for the issuance of a
series of such stock, adopted, at any time or from time to time, by our Board of
Directors. The shares of Series C preferred stock are fully paid and
nonassessable and have no preemptive rights. The articles supplementary relating
to the Series C preferred stock authorize us to issue up to 2,000,000 shares of
the Series C preferred stock at an original issuance price of $100 per share.
However, the number of authorized shares of Series C preferred stock may
increase automatically if we pay any dividend in shares of Series C preferred
stock.

RANK. The Series C preferred stock will, with respect to dividend rights
and rights upon liquidation, dissolution or winding up of our company, rank:
senior to our common stock and to all other equity securities that by their
terms rank junior to the Series C preferred stock with respect to dividend
rights or rights upon liquidation, dissolution or winding up of our company; on
a parity with our outstanding Series A preferred stock, Series B preferred
stock, Series D preferred stock, if issued, and any other equity securities that
may be issued by us that have terms which specifically provide that such equity
securities will rank on a parity with respect to dividend rights or rights upon
liquidation dissolution or winding up of our company; junior to all of our
existing and future indebtedness. Any of our convertible debt securities will
rank senior to the Series C preferred stock prior to conversion.

ANTI-TAKEOVER PROVISIONS IN OUR ARTICLES OF INCORPORATION. See "Redemption
and Business Combination Provisions" for a description of provisions of our
Articles of Incorporation, including provisions relating to redemption rights
and certain provisions, which may have anti-takeover effects.

DIVIDEND RIGHTS. Holders of shares of the Series C preferred stock are
entitled to receive dividends at the greater of:

- 10% per annum of the liquidation preference discussed below per share,
which is equivalent to a fixed annual amount of $10.00 per share; and

- the amount per share declared or paid by us on our common stock based on
the number of shares of common stock into which the shares of Series C
preferred stock are then convertible.

Assuming that quarterly dividends on our common stock are recommenced at the
rate of $0.25 per share, each share of Series C preferred stock would receive a
quarterly dividend of $4.00 or an annual dividend of $16.00. Dividends on each
share of the Series C preferred stock are cumulative commencing from the date of
issuance. Dividends are payable in arrears for each dividend period ended
July 31, October 31, January 31 and April 30 on or before the relevant dividend
payment date, which will be the 15th day of August, November, February and May
of each year. The first dividend was paid on November 15, 2000, with respect to
the period commencing on the date of first issuance of Series C preferred stock
and ending on October 31, 2000. Any dividend payable on shares of the Series C
preferred stock for any partial period will be prorated for the partial period
based on the actual number of days elapsed commencing with and including the
date of issuance of such shares through the end of the dividend period. For any
dividend periods ending after February 1, 2001, dividends are payable in cash.
Dividends on shares of Series C preferred stock will not be declared by the
Board of Directors or paid or set apart for payment if the terms of any
agreement to which we are a party, including any agreement relating to our
indebtedness, prohibit the declaration or payment of dividends on the Series C
preferred stock or provide that such declaration or payment would constitute a
breach or default under the agreement, or if the payment is restricted or
prohibited by law. Dividends on the Series C preferred stock will also accrue
whether or not we have earnings or other funds legally available for the payment
of such dividends and whether or not such dividends are declared. Accrued but
unpaid dividends on the Series C preferred stock will not bear interest. Except
as set forth in the next sentence, no dividends will be declared or paid or set
apart for payment on any of our capital stock or any other series of preferred
stock ranking, as to dividends, on a parity with or

101

junior to the Series C preferred stock, other than a dividend in shares of our
common stock or in shares of any other class of stock ranking junior to the
Series C preferred stock as to dividends and upon liquidation, for any period
unless full cumulative dividends have been or contemporaneously are declared and
paid or declared and a sum sufficient for the payment thereof is set apart for
such payment on the Series C preferred stock for all past dividend periods and
the then current dividend period. When dividends are not paid in full upon the
Series C preferred stock and the shares of any other series of preferred stock
ranking on a parity as to dividends with the Series C preferred stock, all
dividends declared upon the Series C preferred stock and any other series of
preferred stock ranking on a parity as to dividends with the Series C preferred
stock shall be declared pro rata so that the amount of dividends declared per
share of Series C preferred stock and such other series of preferred stock will
in all cases bear to each other the same ratio that accrued dividends per share
of the Series C preferred stock and such other series of preferred stock, bear
to each other, not including any accrual in respect of unpaid dividends for
prior dividend periods if such preferred stock does not have a cumulative
dividend, bear to each other. Unless full cumulative dividends on the Series C
preferred stock have been or contemporaneously are declared and paid in full or
declared and a sum sufficient for the payment thereof has been set aside, no
dividends, other than any other shares of our capital stock ranking junior to or
on a parity with the Series C preferred stock as to dividends or upon
liquidation, may be paid or declared upon the common stock or any other class or
series of our capital stock ranking junior to or on a parity with the Series C
preferred stock as to dividends, nor will any shares of common stock or any
other shares of our capital stock ranking junior to or on a parity with the
Series C preferred stock as to dividends or liquidation be redeemed, purchased
or otherwise acquired for any consideration or any monies be paid to or made
available for a sinking fund for the redemption of such shares by us, except for
certain limited exceptions such as dividends paid for the purpose of preserving
our qualification as a real estate investment trust under the Internal Revenue
Code. Any dividend payment made on shares of the Series C preferred stock will
first be credited against the earliest accrued but unpaid dividend due with
respect to such shares which remains payable.

LIQUIDATION PREFERENCE. Upon any voluntary or involuntary liquidation,
dissolution or winding up of our affairs, the holders of shares of Series C
preferred stock will be entitled to be paid the liquidation preference out of
our assets legally available for distribution to our stockholders before any
distribution of assets is made to holders of common stock or any other class or
series of our capital stock that ranks junior to the Series C preferred stock as
to liquidation rights. After payment of the full amount of the liquidation
preference, plus any accrued and unpaid dividends to which they are entitled,
the holders of Series C preferred stock will have no right or claim to any of
our remaining assets. The consolidation or merger of us with or into any other
corporation, trust or entity or of any other corporation with or into us in a
manner that constitutes a change in control, or the sale, lease or conveyance of
all or substantially all of our property or business, shall be deemed to
constitute a liquidation, dissolution or winding up of the company. The
"liquidation preference" with respect to each share of Series C preferred stock
means an amount equal to the original issue price ($100 per share), plus any
accrued but unpaid dividends.

REDEMPTION. The Series C preferred stock is not redeemable, subject,
however, to certain restrictions on transfer and ownership, described in
"Redemption and Business Combination Provisions." In any event, Series C
preferred stock may not be redeemed without the consent of the holders thereof.

VOTING RIGHTS. Each holder of shares of Series C preferred stock will be
entitled to a number of votes equal to the number of shares of common stock into
which the shares of Series C preferred stock held by such holder could then be
converted. The holders of Series C preferred stock will vote together as a
single class with holders of common stock, except as expressly required by law.
The holders of Series C preferred stock will have no separate class or series
vote on any matter except as expressly required by law or as otherwise set forth
in the articles supplementary related to the Series C preferred

102

stock. Whenever dividends on any shares of Series C preferred stock are in
arrears for four or more dividend periods, the number of directors then
constituting the Board of Directors will be increased, if necessary, by such
number that would, if the number were added to the number of directors already
designated by the holders of the Series C preferred stock, whether pursuant to
the Stockholders Agreement between us and Explorer or otherwise, constitute a
majority of the Board of Directors. The holders of the shares of Series C
preferred stock, voting separately as a class with any other preferred stock on
a parity with the Series C preferred stock, if such stock has like voting rights
that are then exercisable, will be entitled to vote separately as a class to
elect the additional preferred stock directors until such time as all dividends
accumulated on such shares of Series C preferred stock and any preferred stock
that ranks on a parity with the Series C preferred stock for the past dividend
periods and the dividend for the then current dividend period have been fully
paid, at which time the additional preferred stock directors elected pursuant to
the rights described above are required to resign. In any election of such
additional preferred stock directors, each holder of shares of Series C
preferred stock or shares of preferred stock that ranks on a parity with the
Series C preferred stock will be entitled to one vote for each $1.00 amount of
liquidation preference attributable to the shares of preferred stock held. So
long as any shares of Series C preferred stock remain outstanding, we will not,
without the affirmative vote or consent of the holders of at least two-thirds of
the shares of the Series C preferred stock outstanding at the time, voting
separately as a class together with any other classes of preferred stock
adversely affected in the same manner, amend, alter or repeal the provisions of
our Articles of Incorporation or the articles supplementary related to the
Series C preferred stock, whether by merger, consolidation or otherwise, so as
to materially and adversely affect any right, preference, privilege or voting
power of the Series C preferred stock, including the creation of any series of
preferred stock ranking senior to the Series C preferred stock with respect to
payment of dividends or the distribution of assets upon liquidation, dissolution
or winding up, but not including the creation or issuance of preferred stock
ranking on a parity with the Series C preferred stock. No holder of Series C
preferred stock will be entitled to vote any shares of Series C preferred stock
that would result in such holder and any of its affiliates or any group, as such
term is used in Section 13(d)(3) of the Exchange Act, of which any of them is a
member voting in excess of 49.9% of our then-outstanding voting stock. This
provision does not apply to situations when the Series C preferred stock is
entitled to vote separately as a class. ``Voting stock" means any shares of our
capital stock that have the power to vote for the election of directors. If the
Amended Series C Articles Supplementary are adopted, the holders of the
Series C preferred stock will no longer have the special rights upon dividend
defaults described above. Instead, whenever dividends on any shares of Series C
preferred stock are in arrears for four or more dividend periods, the Series C
preferred stock will have the same special board election rights as the
Series D preferred stock, described below. Under the amended Series C Articles
Supplementary, the restriction limiting a holder of Series C preferred stock
from voting in excess of 49.9% of our then outstanding voting stock will no
longer exist.

CONVERSION. The holders of Series C preferred stock have the following
conversion rights:

OPTIONAL CONVERSION. Subject to certain limitations, each share of
Series C preferred stock, including all accrued and unpaid dividends thereon,
may be converted at any time into common stock at the option of the holder of
shares of the Series C preferred stock.

CONVERSION PRICE. Subject to certain limitations, each share of Series C
preferred stock may be converted into the number of shares of common stock as is
equal to the quotient obtained by dividing the original issue price for such
share by the conversion price discussed below in effect at the time of
conversion. The conversion price initially will be equal to the $6.25 per share
of our common stock, subject to adjustment from time to time as provided in the
supplementary articles related to the Series C preferred stock. The conversion
price will be adjusted to reflect the economic impact of a stock split, stock
combination, certain dividends paid in common stock, the issuance of additional
common stock at a price less than the then fair market value and similar events.

103

SERIES D PREFERRED STOCK

The following description of the terms of the Series D preferred stock sets
forth the general terms and provisions of the Series D preferred stock. The
description of the provisions of the Series D preferred stock set forth below
does not purport to be complete and is subject to and qualified in its entirety
by reference to our Articles of Incorporation, and the Board of Directors'
resolutions or the Form of Articles Supplementary for Series D Convertible
Preferred Stock.

GENERAL. Under the Articles of Incorporation, our Board of Directors is
authorized without further stockholder action to provide for the issuance of up
to an aggregate of 10,000,000 shares of our preferred stock, in one or more
series, with such designations, preferences, powers and relative participating,
optional or other special rights, dividend rate or rates, conversion rights,
voting rights, rights and terms of redemption (including sinking fund
provisions), the redemption price or prices, and the liquidation preferences as
will be stated in the resolutions providing for the issuance of a series of such
stock, adopted, at any time or from time to time, by our Board of Directors. The
Series D Articles Supplementary authorize us to issue up to 1,000,000 shares of
the Series D preferred stock. Whether or not we file the Series D Articles
Supplementary with the Maryland State Department of Assessment and Taxation or
issue any shares of Series D preferred stock will depend on whether our
stockholders have approved the issuance of common stock upon conversion of the
Series D preferred stock prior to the closing of Explorer's investment in our
company.

RANK. The Series D preferred stock will, with respect to dividend rights
and rights upon liquidation, dissolution or winding up of our company, rank
(i) senior to our common stock and to all other equity securities that by their
terms rank junior to the Series D preferred stock with respect to dividend
rights or rights upon liquidation, dissolution or winding up of our company;
(ii) on a parity with our outstanding Series A preferred stock, Series B
preferred stock, Series C preferred stock and any other equity securities that
may be issued by our company that have terms which specifically provide that
such equity securities will rank on a parity with the Series D preferred stock;
and (iii) junior to all existing and future indebtedness of Omega. Any of our
Company's convertible debt securities will rank senior to the Series D preferred
stock prior to conversion.

ANTI-TAKEOVER PROVISIONS IN OUR ARTICLES OF INCORPORATION. See "Redemption
and Business Combination Provisions" for a description of certain provisions of
our Articles of Incorporation including provisions relating to redemption rights
and provisions, which may have certain anti-takeover effects.

DIVIDEND RIGHTS. If approval of our stockholders to permit the conversion
of Series D preferred stock into common stock is not received by February 28,
2002, holders of shares of the Series D preferred stock are entitled to receive
dividends at the greater of:

- 10% per annum of the liquidation preference, as discussed below, per
share; and

- the amount per share declared or paid by us on our common stock based on
the number of shares of common stock into which the shares of Series D
preferred stock are then convertible.

Dividends on each share of the Series D preferred stock will be cumulative
commencing from the date of issuance. Dividends are payable in arrears for each
dividend period ended July 31, October 31, January 31 and April 30 on or before
the relevant dividend payment date, which will be the 15th day of August,
November, February and May of each year. Any dividend payable on shares of the
Series D preferred stock for any partial period will be prorated for the partial
period based on the actual number of days elapsed commencing with and including
the date of issuance of such shares through the end of the dividend period.
Dividends will be payable at the election of the holders of a majority of the
Series D preferred stock with respect to any period after June 30, 2002, and at
the election of the Board of Directors with respect to any period on or prior to
June 30, 2002, (i) by the issuance as of the relevant dividend payment date of
additional shares of Series D preferred stock having an aggregate

104

liquidation preference equal to the amount of such accrued dividends, or
(ii) in cash. If dividends are paid in additional shares of Series D preferred
stock, the number of authorized shares of Series D preferred stock will be
deemed, without further action, to be increased by the number of shares so
issued. Dividends on shares of Series D preferred stock will not be declared by
the Board of Directors or paid or set apart for payment if the terms of any
agreement to which we are a party, including any agreement relating to our
indebtedness, prohibits the declaration or payment of dividends on the Series D
preferred stock or provides that such declaration, payment or setting aside for
payment would constitute a breach thereof or default thereunder; provided, that
in such case dividends on the Series D preferred stock will accrue. Dividends on
the Series D preferred stock will also accrue whether or not we have earnings or
other funds legally available for the payment of such dividends. Accrued but
unpaid dividends on the Series D preferred stock will not bear interest. Except
as set forth in the next sentence, no dividends will be declared or paid or set
apart for payment on any of our capital stock or any other series of preferred
stock ranking, as to dividends, on a parity with or junior to the Series D
preferred stock, other than a dividend in shares of our common stock or in
shares of any other class of stock ranking junior to the Series D preferred
stock as to dividends and upon liquidation, for any period unless full
cumulative dividends have been or contemporaneously are declared and paid or
declared and a sum sufficient for the payment thereof is set apart for such
payment on the Series D preferred stock for all past dividend periods and the
then current dividend period. When dividends are not paid in full upon the
Series D preferred stock and the shares of any other series of preferred stock
ranking on a parity as to dividends with the Series D preferred stock, all
dividends declared upon the Series D preferred stock and any other series of
preferred stock ranking on a parity as to dividends with the Series D preferred
stock will be declared pro rata so that the amount of dividends declared per
share of Series D preferred stock and such other series of preferred stock will
in all cases bear to each other the same ratio that accrued dividends per share
as the Series D preferred stock and such other series of preferred stock, which
shall not include any accrual in respect of unpaid dividends for prior dividend
periods if such preferred stock does not have a cumulative dividend, bear to
each other. Unless full cumulative dividends on the Series D preferred stock
have been or contemporaneously are declared and paid in full or declared and a
sum sufficient for the payment thereof is set apart for payment in full, no
dividends, other than certain dividends payable in our capital stock, may be
declared or paid upon our common stock, except for certain limited exceptions
such as dividends paid for the purpose of preserving our qualification as a real
estate investment trust under the Internal Revenue Code of 1986, as amended. Any
dividend payment made on shares of the Series D preferred stock will first be
credited against the earliest accrued but unpaid dividend due with respect to
such shares which remains payable.

LIQUIDATION PREFERENCE. Upon any voluntary or involuntary liquidation,
dissolution or winding up of our affairs, each holder of shares of Series D
preferred stock will, at the election of such holder, be entitled to be paid the
liquidation preference out of our assets legally available for distribution to
our stockholders before any distribution of assets is made to holders of common
stock or any other class or series of our capital stock that ranks junior to the
Series D preferred stock as to liquidation rights. After payment of the full
amount of the liquidation preference, plus any accrued and unpaid dividends and
interest thereon, if any, to which they are entitled, the holders of Series D
preferred stock will have no right or claim to any of our remaining assets. The
consolidation or merger of our Company with or into any other corporation, trust
or entity or of any other corporation with or into us in a manner that
constitutes a change in control, or the sale, lease or conveyance of all or
substantially all of our property or business will be deemed to constitute a
liquidation, dissolution or winding up of our company. The liquidation
preference for shares of Series D preferred stock is equal to the original issue
price of the Series D preferred stock plus any accrued and unpaid dividends.

REDEMPTION. The Series D preferred stock is not redeemable, subject,
however, to certain restrictions on transfer and ownership, described in
"Redemption and Business Combination

105

Provisions." In any event, Series D preferred stock may not be redeemed without
the consent of the holders thereof.

VOTING RIGHTS. Holders of Series D preferred stock will not have voting
rights, except as set forth below. Whenever dividends on any shares of Series D
preferred stock are in arrears for two or more dividend periods, the number of
directors then constituting the Board of Directors will be increased by two if
not already increased pursuant to a similar provision in the Amended and
Restated Articles Supplementary for Series C Convertible Preferred Stock, which
will become effective upon stockholder approval as set forth in the description
of the Series C preferred stock above. The holders of such shares of Series D
preferred stock and the holders of Series C preferred stock upon which like
voting rights have been conferred and are exercisable, voting together as a
single class, will be entitled to vote as a single class to elect the additional
preferred stock directors until such time as all dividends accumulated on such
shares of Series D preferred stock and Series C preferred stock for the past
dividend periods and the dividend for the then current dividend period shall
have been fully paid, at which time the directors elected pursuant to this right
are required to resign. In any vote to elect or remove such directors, each
holder of shares of Series D preferred stock and Series C preferred stock will
be entitled to one vote for each share held by such holder. So long as any
shares of Series D preferred stock remain outstanding, we will not, without the
affirmative vote or consent of the holders of at least two-thirds of the shares
of the Series D preferred stock outstanding at the time (voting as a single
class together with any other classes of preferred stock adversely affected in
the same manner), amend, alter or repeal the provisions of our charter or the
Series D Articles Supplementary, whether by merger, consolidation or otherwise,
so as to materially and adversely affect any right, preference, privilege or
voting power of the Series D preferred stock, including the creation of any
series of preferred stock ranking senior to the Series D preferred stock with
respect to payment of dividends or the distribution of assets upon liquidation,
dissolution or winding up, but not including the creation or issuance of
preferred stock ranking on a parity with the Series D preferred stock.

CONVERSION. The holders of Series D preferred stock have the following
conversion rights:

AUTOMATIC CONVERSION. Each share of Series D preferred stock will
automatically convert into shares of our common stock upon the earlier of:
(i) the date the holders of a majority of the shares of our common stock, giving
effect to the conversion of the Series C preferred stock, present and entitled
to vote at a duly convened meeting of our stockholders vote to approve the
conversion of the Series D preferred stock into common stock and the issuance of
common stock upon such conversion and (ii) the date the New York Stock Exchange
waives any requirement for stockholder approval of the conversion of the
Series D preferred stock into common stock under its rules and policies.

CONVERSION PRICE. Subject to certain limitations on conversion set forth in
the Series D Articles Supplementary, each share of Series D preferred stock will
be converted into the number of shares of our common stock as is equal to the
quotient obtained by dividing the original issue price for such share by the
conversion price, as discussed below, in effect at the time of conversion. The
conversion price will be adjusted to reflect the economic impact of a stock
split, stock combination, certain dividends paid on common stock, the issuance
of additional common stock at a price less than fair market value and similar
events.

REDEMPTION AND BUSINESS COMBINATION PROVISIONS

If our Board of Directors is, at any time and in good faith, of the opinion
that direct or indirect ownership of at least 9.9% or more of the voting shares
of capital stock has or may become concentrated in the hands of one beneficial
owner, our Board of Directors will have the power:

- by lot or other means deemed equitable by it, to call for the purchase
from any of our stockholders a number of voting shares sufficient, in the
opinion of our Board of Directors, to maintain or bring the direct or
indirect ownership of voting shares of capital stock of such

106

beneficial owner to a level of no more than 9.9% of our outstanding voting
shares of our capital stock, and

- to refuse to transfer or issue voting shares of our capital stock to any
person whose acquisition of such voting shares would, in the opinion of
our Board of Directors, result in the direct or indirect ownership by that
person of more than 9.9% of our outstanding voting shares of our capital
stock.

Further, any transfer of shares, options, warrants, or other securities
convertible into voting shares that would create a beneficial owner of more than
9.9% of the outstanding voting shares will be deemed void ab initio and the
intended transferee will be deemed never to have had an interest therein.
Subject to the rights of the preferred stock described below, the purchase price
for any voting shares of our capital stock so redeemed will be equal to the fair
market value of the shares reflected in the closing sales prices for the shares,
if then listed on a national securities exchange, or the average of the closing
sales prices for the shares if then listed on more than one national securities
exchange, or if the shares are not then listed on a national securities
exchange, the latest bid quotation for the shares if then traded
over-the-counter, on the last business day immediately preceding the day on
which we send notices of such acquisitions, or, if no such closing sales prices
or quotations are available, then the purchase price shall be equal to the net
asset value of such stock as determined by our Board of Directors in accordance
with the provisions of applicable law. The purchase price for shares of
Series A preferred stock, Series B preferred stock, Series C preferred stock and
Series D preferred stock will be equal to the fair market value of the shares
reflected in the closing sales price for the shares, if then listed on a
national securities exchange, or if the shares are not then listed on a national
securities exchange, the purchase price will, in the case of the Series A
preferred stock and Series B preferred stock, be equal to the redemption price
of such shares of Series A preferred stock and Series B preferred stock,
respectively, and, in the case of the Series C preferred stock and Series D
preferred stock, the purchase price will be equal to the liquidation preference
of such shares of Series C preferred stock and Series D preferred stock,
respectively. From and after the date fixed for purchase by our Board of
Directors, the holder of any shares so called for purchase will cease to be
entitled to distributions, voting rights and other benefits with respect to such
shares, except the right to payment of the purchase price for the shares.

Our Articles of Incorporation require that, except in certain circumstances,
business combinations between us and a beneficial holder of 10% or more of our
outstanding voting stock, a related person, be approved by the affirmative vote
of at least 80% of our outstanding voting shares.

A "business combination" is defined in the Articles of Incorporation as:

- any merger or consolidation of our company with or into a related person;

- any sale, lease, exchange, transfer or other disposition, including
without limitation a mortgage or any other security device, of all or any
"substantial part," as defined below, of our assets including, without
limitation, any voting securities of a subsidiary to a related person;

- any merger or consolidation of a related person with or into our Company;

- any sale, lease, exchange, transfer or other disposition of all or any
substantial part of the assets of a related person to our company;

- the issuance of any securities (other than by way of pro rata distribution
to all stockholders) of our company to a related person; and

- any agreement, contract or other arrangement providing for any of the
transactions described in the definition of business combination.

The term "substantial part" is defined as more than 10% of the book value of our
total assets as of the end of our most recent fiscal year ending prior to the
time the determination is being made.

107

The 80% voting requirement described above will not be applicable if
(i) our Board of Directors has unanimously approved in advance the acquisition
of our stock that caused a related person to become a related person or
(ii) the business combination is solely between us and a wholly owned
subsidiary. Our Board of Directors unanimously approved in advance Explorer's
acquisition of our Series C preferred stock, which made Explorer a related
person to us. Therefore, the 80% voting requirement is inapplicable to Explorer.

Under the terms of our Articles of Incorporation, our Board of Directors is
classified into three classes. Each class of directors serves for a term of
three years, with one class being elected each year. As of the date of this
prospectus, there are nine directors, with each class consisting of three
directors.

The foregoing provisions of the Articles of Incorporation and certain other
matters may not be amended without the affirmative vote of at least 80% of our
outstanding voting shares.

The foregoing provisions may have the effect of discouraging unilateral
tender offers or other takeover proposals which certain stockholders might deem
in their interests or in which they might receive a substantial premium. Our
Board of Directors' authority to issue and establish the terms of currently
authorized preferred stock, without stockholder approval, may also have the
effect of discouraging takeover attempts. The provisions could also have the
effect of insulating current management against the possibility of removal and
could, by possibly reducing temporary fluctuations in market price caused by
accumulation of shares, deprive stockholders of opportunities to sell at a
temporarily higher market price. However, our Board of Directors believes that
inclusion of the business combination provisions in the Articles of
Incorporation may help assure fair treatment of stockholders and preserve our
assets.

The foregoing summary of certain provisions of the Articles of Incorporation
does not purport to be complete or to give effect to provisions of statutory or
common law. The foregoing summary is subject to, and qualified in its entirety
by reference to, the provisions of applicable law and the Articles of
Incorporation, a copy of which is incorporated by reference as an exhibit to the
registration statement of which this prospectus is a part.

STOCKHOLDER RIGHTS PLAN

On May 12, 1999, our Board of Directors authorized the adoption of a
stockholder rights plan. The plan is designed to require a person or group
seeking to gain control of our company to offer a fair price to all of our
stockholders. The rights plan will not interfere with any merger, acquisition or
business combination that our Board of Directors finds is in our best interest
and the best interests of our stockholders.

In connection with the adoption of the stockholder rights plan, our Board of
Directors declared a dividend distribution of one right for each common share
outstanding on May 24, 1999. The stockholder protection rights will not become
exercisable unless a person acquires 10% or more of our common stock, or begins
a tender offer that would result in the person owning 10% or more of our common
stock. At that time, each stockholder protection right would entitle each
stockholder other than the person who triggered the rights plan to purchase
either our common stock or stock of an acquiring entity at a discount to the
then market price. The plan was not adopted in response to any specific attempt
to acquire control of our company. We amended the stockholder rights plan to
exempt Explorer and any of its transferees that become a party to the
stockholders' agreement we have with Explorer from being deemed an acquiring
person for purposes of the plan.

TRANSFER AGENT AND REGISTRAR

EquiServe Trust Company, N.A. is the transfer agent and registrar of the
common stock and preferred stock.

108

MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS

CONSEQUENCES OF THE RIGHTS OFFERING

Powell, Goldstein, Frazer & Murphy LLP has rendered its opinion with respect
to the material United States income tax consequences of the offering to the
holders of the common stock upon the distribution of rights and to the holders
of the rights upon their exercise, which opinion has been filed as an exhibit to
the registration statement of which this prospectus is a part.

This opinion is based on provisions of the Internal Revenue Code of 1986, as
amended, existing and proposed Treasury regulations promulgated thereunder and
administrative and judicial interpretations thereof, all as of the date hereof
and all of which are subject to change, possibly on a retroactive basis.

This opinion is limited to those who hold the common stock, and will hold
the rights and any shares acquired upon the exercise of rights as "capital
assets" within the meaning of section 1221 of the Code. This opinion does not
address all of the tax consequences that may be relevant to particular holders
in light of their personal circumstances, or to holders who are subject to
special rules under the federal income tax laws, (such as banks and other
financial institutions, broker-dealers, real estate investment trusts, regulated
investment companies, insurance companies, tax-exempt organizations and foreign
taxpayers). In addition, this opinion does not include any description of the
tax laws of any state, local or non-U.S. government that may be applicable to a
particular holder.

HOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS WITH RESPECT TO THE
PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES TO THEM OF THIS OFFERING, AS
WELL AS THE TAX CONSEQUENCES UNDER STATE, LOCAL, NON-U.S. AND OTHER TAX LAWS AND
THE POSSIBLE EFFECTS OF CHANGES IN TAX LAWS.

In the opinion of Powell, Goldstein, Frazer & Murphy LLP:

DISTRIBUTION OF RIGHTS. Holders of our common stock will not recognize
taxable income for federal income tax purposes upon distribution of the
rights.

STOCKHOLDER BASIS AND HOLDING PERIOD OF THE RIGHTS. Except as provided
in the following sentence, the basis of the rights received by a stockholder
as a distribution with respect to such stockholder's common stock will be
zero. If, however, either (i) the fair market value of the rights on their
date of distribution is 15% or more of the fair market value (on the date of
distribution) of the common stock with respect to which they are received or
(ii) the stockholder properly elects, in his or her federal income tax
return for the taxable year in which the rights are received, to allocate
part of the basis of such common stock to the rights, then upon exercise of
the rights, the stockholder's basis in such common stock will be allocated
between the common stock and the rights in proportion to the fair market
values of each on the date of distribution.

The holding period of a stockholder with respect to the rights received
as a distribution on such stockholder's common stock will include the
stockholder's holding period for the common stock with respect to which the
rights were distributed.

LAPSE OF THE RIGHTS. Holders who allow the rights received by them in
this offering to lapse will not recognize any gain or loss, and no
adjustment will be made to the basis of the common stock, if any, they own.

EXERCISE OF THE RIGHTS; BASIS AND HOLDING PERIOD OF THE COMMON
STOCK. Holders will not recognize any gain or loss upon the exercise of
rights. The basis of the shares acquired through exercise of the rights will
be equal to the sum of the subscription price for the rights and the

109

holder's basis in such rights, if any. The holding period for the shares
acquired through exercise of the rights will begin on the date the rights
are exercised.

SALE OF SHARES. The sale of shares acquired upon exercise of the rights
will result in the recognition of gain or loss to the stockholder in an
amount equal to the difference between the amount realized and the
stockholder's basis in the shares. Gain or loss upon the sale of the shares
will be long-term capital gain or loss if the holding period for the shares
is more than one year.

TAXATION OF THE COMPANY

GENERAL. We have elected to be taxed as a real estate investment trust, or
a REIT, under Sections 856 through 860 of the Code beginning with our taxable
year ended December 31, 1992. We believe that we have been organized and
operated in such a manner as to qualify for taxation as a REIT under the Code
and we intend to continue to operate in such a manner, but no assurance can be
given that we have operated or will be able to continue to operate in a manner
so as to qualify or remain qualified as a REIT.

The sections of the Code that govern the Federal income tax treatment of a
REIT are highly technical and complex. The following sets forth the material
aspects of those sections. This summary is qualified in its entirety by the
applicable Code provisions, rules and regulations promulgated thereunder, and
administrative and judicial interpretations thereof.

In the opinion of Argue Pearson Harbison & Myers, LLP whose opinion has been
filed as an exhibit to the registration statement of which this prospectus is a
part, we are organized in conformity with the requirements for qualification as
a REIT, and our current and proposed method of operation will enable us to
continue to meet the requirements for continued qualification and taxation as a
REIT under the Code. This opinion is based on various assumptions and is
conditioned upon certain representations made by us as to factual matters
concerning our business and properties. Moreover, such qualification and
taxation as a REIT depends upon our ability to meet, through actual annual
operating results, distribution levels and diversity of stock ownership, the
various qualification tests imposed under the Code discussed below, the results
of which will not be reviewed by Argue Pearson Harbison & Myers, LLP on an
ongoing basis. Accordingly, no assurance can be given that the various results
of our operation for any particular taxable year will satisfy such requirements.
Further, such requirements may be changed, perhaps retroactively, by legislative
or administrative actions at any time. We have neither sought nor obtained any
formal ruling from the Internal Revenue Service regarding our qualification as a
REIT and presently have no plan to apply for any such ruling. See "--Failure to
Qualify."

If we qualify for taxation as a REIT, we generally will not be subject to
Federal corporate income taxes on our net income that is currently distributed
to stockholders. This treatment substantially eliminates the "double taxation"
(that is, taxation at both the corporate and the stockholder level) that
generally results from investment in a corporation. However, we will be subject
to Federal income tax as follows: First, we will be taxed at regular corporate
rates on any undistributed REIT taxable income, including undistributed net
capital gains; provided, however, that if we have a net capital gain, we will be
taxed at regular corporate rates on our undistributed REIT taxable income,
computed without regard to net capital gain and the deduction for capital gains
dividends, plus a 35% tax on undistributed net capital gain, if our tax as thus
computed is less than the tax computed in the regular manner. Second, under
certain circumstances, we may be subject to the "alternative minimum tax" on our
items of tax preference that we do not distribute or allocate to our
stockholders. Third, if we have (i) net income from the sale or other
disposition of "foreclosure property" which is held primarily for sale to
customers in the ordinary course of business or (ii) other nonqualifying income
from foreclosure property, we will be subject to tax at the highest regular
corporate rate on such income. Fourth, if we

110

have net income from prohibited transactions (which are, in general, certain
sales or other dispositions of property (other than foreclosure property) held
primarily for sale to customers in the ordinary course of business by us, (i.e.,
when we are acting as a dealer)), such income will be subject to a 100% tax.
Fifth, if we should fail to satisfy the 75% gross income test or the 95% gross
income test (as discussed below), but have nonetheless maintained our
qualification as a REIT because certain other requirements have been met, we
will be subject to a 100% tax on an amount equal to (a) the gross income
attributable to the greater of the amount by which we fail the 75% or 95% test,
multiplied by (b) a fraction intended to reflect our profitability. Sixth, if we
should fail to distribute by the end of each year at least the sum of (i) 85% of
our REIT ordinary income for such year, (ii) 95% of our REIT capital gain net
income for such year, and (iii) any undistributed taxable income from prior
periods, we will be subject to a 4% excise tax on the excess of such required
distribution over the amounts actually distributed. Seventh, we will be subject
to a 100% excise on transactions with a taxable REIT subsidiary, or TRS that are
not conducted on an arm's-length basis. Eighth, if we acquire any asset, which
is defined as a "built-in gain asset" from a C corporation that is not a REIT
(i.e., generally a corporation subject to full corporate-level tax) in a
transaction in which the basis of the built-in gain asset in our hands is
determined by reference to the basis of the asset (or any other property) in the
hands of the C corporation, and we recognize gain on the disposition of such
asset during the 10-year period, which is defined as the "recognition period",
beginning on the date on which such asset was acquired by us, then, to the
extent of the built-in gain (i.e., the excess of (a) the fair market value of
such asset on the date such asset was acquired by us over (b) our adjusted basis
in such asset on such date), our recognized gain will be subject to tax at the
highest regular corporate rate. The results described above with respect to the
recognition of built-in gain assume we will make an election pursuant to
Treasury Regulations. Section 1.337(d)-SST.

REQUIREMENTS FOR QUALIFICATION. The Code defines a REIT as a corporation,
trust or association (1) which is managed by one or more trustees or directors;
(2) the beneficial ownership of which is evidenced by transferable shares, or by
transferable certificates of beneficial interest; (3) which would be taxable as
a domestic corporation, but for Sections 856 through 859 of the Code; (4) which
is neither a financial institution nor an insurance company subject to the
provisions of the Code; (5) the beneficial ownership of which is held by 100 or
more persons; (6) during the last half year of each taxable year not more than
50% in value of the outstanding stock of which is owned, actually or
constructively, by five or fewer individuals (as defined in the Code to include
certain entities); and (7) which meets certain other tests, described below,
regarding the nature of its income and assets and the amount of its annual
distributions to stockholders. The Code provides that conditions (1) to (4),
inclusive, must be met during the entire taxable year and that condition
(5) must be met during at least 335 days of a taxable year of twelve months, or
during a proportionate part of a taxable year of less than twelve months. For
purposes of conditions (5) and (6), pension funds and certain other tax-exempt
entities are treated as individuals, subject to a "look-through" exception in
the case of condition (6).

INCOME TESTS. In order to maintain our qualification as a REIT, we annually
must satisfy two gross income requirements. First, at least 75% of our gross
income (excluding gross income from prohibited transactions) for each taxable
year must be derived directly or indirectly from investments relating to real
property or mortgages on real property (including generally "rents from real
property," interest on mortgages on real property and gains on sale of real
property and real property mortgages, other than property described in
Section 1221 of the Code) and income derived from certain types of temporary
investments. Second, at least 95% of our gross income (excluding gross income
from prohibited transactions) for each taxable year must be derived from such
real property investments, dividends, interest and gain from the sale or
disposition of stock or securities other than property held for sale to
customers in the ordinary course of business.

Rents received by us will qualify as "rents from real property" in
satisfying the gross income requirements for a REIT described above only if
several conditions are met. First, the amount of the

111

rent must not be based in whole or in part on the income or profits of any
person. However, any amount received or accrued generally will not be excluded
from the term "rents from real property" solely by reason of being based on a
fixed percentage or percentages of receipts or sales. Second, the Code provides
that rents received from a tenant will not qualify as "rents from real property"
in satisfying the gross income tests if we, or an owner (actually or
constructively) of 10% or more of the value of our stock, actually or
constructively owns 10% or more of such tenant, which is defined as a related
party tenant. Third, if rent attributable to personal property, leased in
connection with a lease of real property, is greater than 15% of the total rent
received under the lease, then the portion of rent attributable to such personal
property will not qualify as "rents from real property." Finally, for rents
received to qualify as "rents from real property," we generally must not operate
or manage the property or furnish or render services to the tenants of such
property, other than through an independent contractor from which we derive no
revenue. We, however, directly perform certain services that are "usually or
customarily rendered" in connection with the rental of space for occupance only
and are not otherwise considered "rendered to the occupant" of the property. In
addition, we may provide a minimal amount of "non-customary" services to the
tenants of a property, other than through an independent contractor, as long as
our income from the services does not exceed 1% of our income from the related
property. Furthermore, we may own up to 100% of the stock of a TRS, which may
provide customary and noncustomary services to our tenants without tainting our
rental income from the related properties.

The term "interest" generally does not include any amount received or
accrued (directly or indirectly) if the determination of such amount depends in
whole or in part on the income or profits of any person. However, an amount
received or accrued generally will not be excluded from the term "interest"
solely by reason of being based on a fixed percentage or percentages of gross
receipts or sales. In addition, an amount that is based on the income or profits
of a debtor will be qualifying interest income as long as the debtor derives
substantially all of its income from the real property securing the debt from
leasing substantially all of its interest in the property, but only to the
extent that the amounts received by the debtor would be qualifying "rents from
real property" if received directly by a REIT.

If a loan contains a provision that entitles us to a percentage of the
borrower's gain upon the sale of the real property securing the loan or a
percentage of the appreciation in the property's value as of a specific date,
income attributable to that loan provision will be treated as gain from the sale
of the property securing the loan, which generally is qualifying income for
purposes of both gross income tests.

Interest on debt secured by mortgages on real property or on interests in
real property generally is qualifying income for purposes of the 75% gross
income test. However, if the highest principal amount of a loan outstanding
during a taxable year exceeds the fair market value of the real property
securing the loan as of the date we agreed to originate or acquire the loan, a
portion of the interest income from such loan will not be qualifying income for
purposes of the 75% gross income test, but will be qualifying income for
purposes of the 95% gross income test. The portion of the interest income that
will not be qualifying income for purposes of the 75% gross income test will be
equal to the portion of the principal amount of the loan that is not secured by
real property.

PROHIBITED TRANSACTIONS. We will incur a 100% tax on the net income derived
from any sale or other disposition of property, other than foreclosure property,
that we hold primarily for sale to customers in the ordinary course of a trade
or business. We believe that none of our assets is held for sale to customers
and that a sale of any of our assets would not be in the ordinary course of our
business. Whether a REIT holds an asset primarily for sale to customers in the
ordinary course of a trade or business depends, however, on the facts and
circumstances in effect from time to time, including those related to a
particular asset. Nevertheless, we will attempt to comply with the terms of

112

safe-harbor provisions in the federal income tax laws prescribing when an asset
sale will not be characterized as a prohibited transaction. We cannot assure
you, however, that we can comply with the safe-harbor provisions or that we will
avoid owning property that may be characterized as property that we hold
primarily for sale to customers in the ordinary course of a trade or business.

FORECLOSURE PROPERTY. We will be subject to tax at the maximum corporate
rate on any income from foreclosure property, other than income that otherwise
would be qualifying income for purposes of the 75% gross income test, less
expenses directly connected with the production of that income. However, gross
income from foreclosure property will qualify for purposes of the 75% and 95%
gross income tests. Foreclosure property is any real property, including
interests in real property, and any personal property incident to such real
property:

- that is acquired a REIT as the result of the REIT having bid in such
property at foreclosure, or having otherwise reduced such property to
ownership or possession by agreement or process of law, after there was a
default or default was imminent on a lease of such property or on
indebtedness that such property secured;

- for which the related loan or lease was acquired by the REIT at a time
when the default was not imminent or anticipated; and

- for which the REIT markets a proper election to treat the property as
foreclosure property.

Property generally ceases to be foreclosure property at the end of the third
taxable year following the taxable year in which the REIT acquired the property,
or longer if an extension is granted by the Secretary of the Treasury. This
grace period terminates and foreclosure property ceases to be foreclosure
property on the first day:

- on which a lease is entered into for the property that, by its terms, will
give rise to income that does not qualify for purposes of the 75% gross
income test, or any amount is received or accrued, directly or indirectly,
pursuant to a lease entered into on or after such day that will give rise
to income that does not qualify for purposes of the 75% gross income test;

- on which any construction takes place on the property, other than
completion of a building or any other improvement, where more than 10% of
the construction was completed before default became imminent; or

- which is more than 90 days after the day on which the REIT acquired the
property and the property is used in a trade or business which is
conducted by the REIT, other than through an independent contractor from
whom the REIT itself does not derive or receive any income.

Beginning on January 1, 2001, foreclosure property also includes any
"qualified health care property," as defined in Code Section 856(a)(b) acquired
by us as the result of the termination or expiration of a lease of such
property. We may operate a qualified health care facility, acquired in this
manner for two years or longer if an extension is granted. We own 34 properties
with respect to which we have made foreclosure property elections. Properties
that are taken back in a foreclosure or bankruptcy and operated for our own
account are treated as foreclosure properties for income tax purposes, pursuant
to Internal Revenue Code Section 856(e). Gross income from foreclosure
properties is "good income" for purposes of the annual REIT income tests. Once
this election is made on the tax return, it is "good" for a period of three
years, or until the properties are no longer operated for our own account. An
election to extend the foreclosure status period for an additional three years
can be made. In all cases of the foreclosure property, we utilize an independent
contractor to conduct day-to-day operations in order to maintain REIT status. In
certain cases we operate facilities through a taxable REIT subsidiary. For those
properties operated through the taxable REIT subsidiary, we utilize an eligible
independent contractor to conduct day-to-day operations to maintain REIT status.
As a

113

result of the foregoing, we do not believe that our participation in the
operation of nursing homes will increase the risk that we will fail to qualify
as a REIT. Through our 2000 taxable year, we have not paid any tax on our
foreclosure property because those properties have been producing losses.
However, in the future, our income from foreclosure property could be
significant and we could be required to pay a significant amount of tax on that
income.

HEDGING TRANSACTIONS. From time to time, we enter into hedging transactions
with respect to one or more of our assets or liabilities. Our hedging activities
may include entering into interest rate swaps, caps, and floors, options to
purchase these items, and futures and forward contracts. To the extent that we
enter into an interest rate swap or cap contract, option, futures contract,
forward rate agreement, or any similar financial instrument to hedge our
indebtedness incurred to acquire or carry "real estate assets," any periodic
income or gain from the disposition of that contract should be qualifying income
for purposes of the 95% gross income test, but not the 75% gross income test.
Accordingly, our income and gain from our interest rate swap agreements
generally is qualifying income for purpose, or the 95% gross income test, but
not the 75% gross income test. To the extent that we hedge with other types of
financial instruments, or in other situations, it is not entirely clear how the
income from those transactions will be treated for purposes of the gross income
tests. We have structured and intend to continue to structure any hedging
transactions in a manner that does not jeopardize our status as a REIT.

FAILURE TO SATISFY INCOME TESTS. If we fail to satisfy one or both of the
75% or 95% gross income tests for any taxable year, we may nevertheless qualify
as a REIT for such year if we are entitled to relief under certain provisions of
the Code. These relief provisions will be generally available if our failure to
meet such tests was due to reasonable cause and not due to willful neglect, we
attach a schedule of the sources of our income to our tax return, and any
incorrect information on the schedule was not due to fraud with intent to evade
tax. It is not possible, however, to state whether in all circumstances we would
be entitled to the benefit of these relief provisions. Even if these relief
provisions apply. we would incur a 100% tax on the gross income attributable to
the greater of the amounts by which we fail the 75% and 95% gross income tests,
multiplied by a fraction intended to reflect our profitability.

ASSET TESTS. At the close of each quarter of our taxable year, we must also
satisfy the following tests relating to the nature of our assets. First, at
least 75% of the value of our total assets must be represented by real estate
assets (including (i) our allocable share of real estate assets held by
partnerships in which we own an interest and (ii) stock or debt instruments held
for not more than one year purchased with the proceeds of a stock offering or
long-term (at least five years) debt offering of our company), cash, cash items
and government securities. Second, of our investments not included in the 75%
asset class, the value of our interest in any one issuer's securities may not
exceed 5% of the value of our total assets. Third, we may not own more than 10%
of the voting power or value of any one issuer's outstanding securities. Fourth,
no more than 20% of the value of our total assets may consist of the securities
of one or more TRSs. Fifth, no more than 25% of the value of our total assets
may consist of the securities of TRSs and other non-TRS taxable subsidiaries and
other assets that are not qualifying assets for purposes of the 75% asset test.

For purposes of the second and third asset tests, the term "securities" does
not include our stock in another REIT, our equity or debt securities of a
qualified REIT subsidiary or TRS, or our equity interest in any partnership. The
term "securities," however, generally includes our debt securities issued by
another REIT or a partnership, except that debt securities of a partnership are
not treated as securities for purposes of the 10% value test if we own at least
a 20% profits interest in the partnership.

114

We may own up to 100% of the stock of one or more TRSs beginning on
January 1, 2001. However, overall, no more than 20% of the value of our assets
may consist of securities of one or more TRSs, and no more than 25% of the value
of our assets may consist of the securities of TRSs and other non-TRS taxable
subsidiaries (including stock in non-REIT C Corporations) and other assets that
are not qualifying assets for purposes of the 75% asset test.

If the outstanding principal balance of a mortgage loan exceeds the fair
market value of the real property securing the loan, a portion of such loan
likely will not be a qualifying real estate asset under the federal income tax
laws. The non-qualifying portion of that mortgage loan will be equal to the
portion of the loan amount that exceeds the value of the associated real
property.

After initially meeting the asset tests at the close of any quarter, we will
not lose our status as a REIT for failure to satisfy any of the asset tests at
the end of a later quarter solely by reason of changes in asset values. If the
failure to satisfy the asset tests results from an acquisition of securities or
other property during a quarter, the failure can be cured by disposition of
sufficient nonqualifying assets within 30 days after the close of that quarter.
We have maintained and intend to continue to maintain adequate records of the
value of our assets to ensure compliance with the asset tests, and to take such
other action within 30 days after the close of any quarter as may be required to
cure any noncompliance.

ANNUAL DISTRIBUTION REQUIREMENTS. In order to qualify as a REIT, we are
required to distribute dividends (other than capital gain dividends) to our
stockholders in an amount at least equal to (A) the sum of (i) 90% of our "REIT
taxable income" (computed without regard to the dividends paid deduction and our
net capital gain) and (ii) 90% of the net income (after tax), if any, from
foreclosure property, minus (B) the sum of certain items of noncash income. In
addition, if we dispose of any built-in gain asset during a recognition period,
we will be required to distribute at least 90% of the built-in gain (after tax),
if any, recognized on the disposition of such asset. Such distributions must be
paid in the taxable year to which they relate, or in the following taxable year
if declared before we timely file our tax return for such year and paid on or
before the first regular dividend payment after such declaration. In addition,
such distributions are required to be made pro rata, with no preference to any
share of stock as compared with other shares of the same class, and with no
preference to one class of stock as compared with another class except to the
extent that such class is entitled to such a preference. To the extent that we
do not distribute all of our net capital gain or do distribute at least 90%, but
less than 100% of our "REIT taxable income," as adjusted, we will be subject to
tax thereon at regular ordinary and capital gain corporate tax rates.

Furthermore, if we fail to distribute during a calendar year, or by the end
of January following the calendar in the case of distributions with declaration
and record dates falling in the last three months of the calendar year, at least
the sum of:

- 85% of our REIT ordinary income for such year;

- 95% of our REIT capital gain income for such year; and

- any undistributed taxable income from prior periods,

we will incur a 4% nondeductible excise tax on the excess of such required
distribution over the amounts we actually distribute. We may elect to retain and
pay income tax on the net long-term capital gain we receive in a taxable year.
If we so elect, we will be treated as having distributed any such retained
amount for purposes of the 4% excise tax described above. We have made, and we
intend to continue to make, timely distributions sufficient to satisfy the
annual distribution requirements. We may also be entitled to pay and deduct
deficiency dividends in later years as a relief measure to correct errors in
determining our taxable income. Although we may be able to avoid income tax on
amounts

115

distributed as deficiency dividends, we will be required to pay interest to the
IRS based upon the amount of any deduction we take for deficiency dividends.

The availability to us of, among other things, depreciation deductions with
respect to our owned facilities depends upon the treatment by us as the owner of
such facilities for federal income tax purposes, and the classification of the
leases with respect to such facilities as "true leases" rather than financing
arrangements for federal income tax purposes. The questions of whether we are
the owner of such facilities and whether the leases are true leases for federal
tax purposes are essentially factual matters. We believe that we will be treated
as the owner of each of the facilities that we lease, and such leases will be
treated as true leases for federal income tax purposes. However, no assurances
can be given that the IRS will not successfully challenge our status as the
owner of our facilities subject to leases, and the status of such leases as true
leases, asserting that the purchase of the facilities by us and the leasing of
such facilities merely constitute steps in secured financing transactions in
which the lessees are owners of the facilities and we are merely a secured
creditor. In such event, we would not be entitled to claim depreciation
deductions with respect to any of the affected facilities. As a result, we might
fail to meet the 90% distribution requirement or, if such requirement is met, we
might be subject to corporate income tax or the 4% excise tax.

FAILURE TO QUALIFY

If we fail to qualify as a REIT in any taxable year, and the relief
provisions do not apply, we will be subject to tax (including any applicable
alternative minimum tax) on our taxable income at regular corporate rates.
Distributions to stockholders in any year in which we fail to qualify will not
be deductible and our failure to qualify as a REIT would reduce the cash
available for distribution by us to our stockholders. In addition, if we fail to
qualify as a REIT, all distributions to stockholders will be taxable as ordinary
income, to the extent of current and accumulated earnings and profits, and,
subject to certain limitations of the Code, corporate distributees may be
eligible for the dividends received deduction. Unless entitled to relief under
specific statutory provisions, we would also be disqualified from taxation as a
REIT for the four taxable years following the year during which qualification
was lost. It is not possible to state whether in all circumstances we would be
entitled to such statutory relief. Failure to qualify could result in our
incurring indebtedness or liquidating investments in order to pay the resulting
taxes.

OTHER TAX MATTERS

We own and operate a number of properties through qualified REIT
subsidiaries (the "QRSs"). The QRSs are treated as qualified REIT subsidiaries
under the Code. Code Section 856(i) provides that a corporation which is a
qualified REIT subsidiary shall not be treated as a separate corporation, and
all assets, liabilities, and items of income, deduction, and credit of a
qualified REIT subsidiary shall be treated as assets, liabilities and such items
(as the case may be) of the REIT. Thus, in applying the tests for REIT
qualification described in this Prospectus under the heading "Taxation of the
Company," the QRSs will be ignored, and all assets, liabilities and items of
income, deduction, and credit of such QRSs will be treated as our assets,
liabilities and items of income, deduction, and credit.

In the case of a REIT that is a partner in a partnership, the REIT is
treated as owning its proportionate share of the assets of the partnership and
as earning its allocable share of the gross income of the partnership for
purposes of the applicable REIT qualification tests. Thus, our proportionate
share of the assets, liabilities, and items of income of any partnership, joint
venture, or limited liability company that is treated as a partnership for
federal income tax purposes in which we own an interest, directly or indirectly,
will be treated as our assets and gross income for purposes of applying the
various REIT qualification requirements.

116

Tax legislation enacted in 1999 allows a REIT to own up to 100% of the stock
of one or more TRSs, beginning on January 1, 2001. A TRS may earn income that
would not be qualifying income if earned directly by the parent REIT. Both the
subsidiary and the REIT must jointly elect to treat the subsidiary as a TRS. A
corporation of which a TRS directly or indirectly owns more than 35% of the
voting power or value of the stock will automatically be treated as a TRS.
Overall, no more than 20% of the value of a REIT's assets may consist of
securities of one or more TRSs. However, a TRS does not include a corporation
which directly or indirectly (i) operates or manages a health care (or lodging)
facility, or (ii) provides to any other person (under a franchise, license, or
otherwise) rights to any brand name under which a health care (or lodging)
facility is operated. A TRS will pay income tax at regular corporate rates on
any income that it earns. In addition, the new rules limit the deductibility of
interest paid or accrued by a TRS to its parent REIT to assure that the TRS is
subject to an appropriate level of corporate taxation. The rules also impose a
100% excise tax on transactions between a TRS and its parent REIT or the REIT's
tenants that are not conducted on an arm's-length basis. We have made TRS
elections with respect to Bayside Street II, Inc. and one of our wholly-owned
subsidiaries that owns all of the preferred stock of Omega Worldwide. Those
entities will pay corporate income tax on their taxable income and their
after-tax next income will be available for distribution to us.

STATE AND LOCAL TAXES

We may be subject to state or local taxes in other jurisdictions such as
those in which we may be deemed to be engaged in activities or own property or
other interests. The state and local tax treatment of us may not conform to the
federal income tax consequences discussed above.

117

PLAN OF DISTRIBUTION

We are offering shares of our common stock directly to you pursuant to this
rights offering. We have not employed any brokers, dealers or underwriters in
connection with the solicitation or exercise of subscription privileges in this
rights offering and no commissions, fees or discounts will be paid in connection
with it.

We will pay the fees and expenses of EquiServe, the subscription agent, and
we have also agreed to indemnify the subscription agent from any liability it
may incur in connection with the rights offering. We will also pay the fees and
expenses of Bank One Trust Company, NA, the escrow agent and Georgeson
Shareholder Communications, Inc., the information agent.

As soon as practicable after the record date, we will distribute the rights
and copies of this prospectus to individuals who owned shares of our common
stock on the record date. If you wish to exercise your rights and subscribe for
new shares of common stock, you should follow the procedures described under
"The Rights Offering--Procedure to Exercise Rights." The subscription rights
generally are non-transferable; there are substantial restrictions on the
transfer of the rights, as described under "The Rights Offering--Restrictions on
Transferability of Rights."

Shares of Omega common stock received through the exercise of subscription
rights will be traded on the NYSE under the symbol "OHI."

LEGAL MATTERS

The validity of the issuance of the securities offered in this offering will
be passed upon for us by Powell, Goldstein, Frazer & Murphy LLP, Atlanta,
Georgia.

EXPERTS

Ernst & Young, LLP, independent auditors, have audited our consolidated
financial statements and schedules at December 31, 2000 and 1999, and for each
of the three years in the period ended December 31, 2000, as set forth in their
report. We have included our consolidated financial statements and schedules in
the prospectus and registration statement in reliance on the report of Ernst &
Young LLP, given on their authority as experts in accounting and auditing.

WHERE YOU CAN FIND MORE INFORMATION

We have filed a registration statement on Form S-11 to register with the
Commission the rights and the shares of our common stock to be issued upon the
exercise of the rights. This prospectus is part of that registration statement.
As allowed by the SEC's rules, this prospectus does not contain all of the
information you can find in the registration statement or the exhibits to the
registration statement.

We file annual, quarterly and other information with the SEC. You may read
and copy any reports, statements and other information we file at the SEC's
public reference room at 450 Fifth Street, N.W. Washington, D.C. 20549. Please
call (800) SEC-0330 for further information on the public reference rooms. Our
filings will also be available to the public from commercial document retrieval
services and at the web site maintained by the SEC at http://www.sec.gov.

Also, we will provide to you, free of charge, any of our documents filed
with the Securities and Exchange Commission. To get your free copies, please
call or write:

Omega Healthcare Investors, Inc.
9690 Deereco Road
Suite 100
Timonium, Maryland 21093
Attn: Corporate Secretary
(410) 561-5726

118

FORWARD-LOOKING STATEMENTS

This prospectus includes forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. All statements other than statements of historical facts
included in this prospectus may constitute forward-looking statements. We have
based these forward-looking statements on our current expectations and
projections about future events. Although we believe that our assumptions made
in connection with the forward-looking statements are reasonable, we cannot
assure you that our assumptions and expectations will prove to have been
correct. Important factors that could cause our actual results to differ
materially from our expectations are disclosed in this prospectus, including
factors disclosed under "Risk Factors" beginning on page 8. These
forward-looking statements are subject to various risks, uncertainties and
assumptions including, among other things:

- our ability to dispose of assets held for sale on a timely basis and at
appropriate prices;

- uncertainties relating to the operation of our owned and operated assets,
including those relating to reimbursement by third party payors,
regulatory matters and occupancy levels;

- the ability of our operators in bankruptcy to reject unexpired lease
obligations, modify the terms of our mortgages, and impede our ability to
collect unpaid rent or interest during the process of a bankruptcy
proceeding and retain security deposits for the debtors' obligations;

- our ability to negotiate appropriate modifications to the terms of our
credit facilities;

- the availability and cost of capital;

- regulatory and other changes in the healthcare sector;

- our ability to manage, re-lease, or sell our owned and operated
facilities;

- competition in the financing of healthcare facilities;

- the effect of economic and market conditions generally and, particularly,
in the healthcare industry;

- changes in interest rates;

- the amount and yield of any additional investments;

- changes in tax laws and regulations affecting real estate investment
trusts; and

- changes in the ratings of our debt securities.

119

OMEGA HEALTHCARE INVESTORS, INC.
INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS

PAGE
--------

AUDITED CONSOLIDATED FINANCIAL STATEMENTS

Independent Auditors' Report................................ F-2

Consolidated Balance Sheets at December 31, 1999 and 2000... F-3

Consolidated Statements of Operations for the three years
ended December 31, 2000................................... F-4

Consolidated Statements of Changes in Shareholders' Equity
for the three years ended
December 31, 2000......................................... F-5

Consolidated Statements of Cash Flows for the three years
ended December 31, 2000................................... F-7

Notes to the Consolidated Financial Statements.............. F-8

FINANCIAL STATEMENT SCHEDULES.

Schedule III--Real Estate and Accumulated Depreciation...... F-38

Schedule IV--Mortgage Loans on Real Estate.................. F-42

UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Condensed Consolidated Balance Sheets at December 31, 2000
and September 30, 2001.................................... F-43

Condensed Consolidated Statements of Operations for the
three months ended September 30, 2001 and 2000, and the
nine months ended September 30, 2001 and 2000............. F-44

Condensed Consolidated Statements of Cash Flows for the nine
months ended September 30, 2001 and 2000.................. F-45

Notes to the Unaudited Consolidated Financial Statements.... F-46

F-1

REPORT OF INDEPENDENT AUDITORS

Board of Directors
Omega Healthcare Investors, Inc.

We have audited the accompanying consolidated balance sheets of Omega
Healthcare Investors, Inc. and subsidiaries as of December 31, 2000 and 1999,
and the related consolidated statements of operations, stockholders' equity and
cash flows for each of the three years in the period ended December 31, 2000.
Our audit also included the financial statement schedules listed in the Index on
page F-1. These financial statements and schedules are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements and schedules based on our audits.

We conducted our audits in accordance with auditing standards generally
accepted in the United States. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. An
audit also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a reasonable basis
for our opinion.

In our opinion, the financial statements referred to above present fairly,
in all material respects, the consolidated financial position of Omega
Healthcare Investors, Inc. and subsidiaries at December 31, 2000 and 1999, and
the consolidated results of their operations and their cash flows for each of
the three years in the period ended December 31, 2000, in conformity with
accounting principles generally accepted in the United States. Also, in our
opinion, the related financial statement schedules, when considered in relation
to the basic financial statements taken as a whole, present fairly in all
material respects the information set forth therein.

/s/ Ernst & Young LLP

Chicago, Illinois
March 16, 2001, except
for the third and seventh paragraphs
of Note 15, as to which the
date is March 30, 2001.

F-2

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)

DECEMBER 31,
----------------------
2000 1999
--------- ----------

ASSETS
Real estate properties
Land and buildings at cost................................ $ 710,542 $ 746,915
Less accumulated depreciation............................. (89,870) (67,929)
--------- ----------
Real estate properties--net............................. 620,672 678,986
Mortgage notes receivable--net............................ 206,710 213,617
--------- ----------
827,382 892,603
Other investments--net...................................... 53,242 75,460
--------- ----------
880,624 968,063
Assets held for sale--net................................... 4,013 36,406
--------- ----------
Total Investments......................................... 884,637 1,004,469
Cash and cash equivalents................................... 7,172 4,105
Accounts receivable......................................... 10,497 9,664
Other assets................................................ 9,338 10,845
Operating assets for owned properties....................... 36,807 9,648
--------- ----------
Total Assets.............................................. $ 948,451 $1,038,731
========= ==========

LIABILITIES AND SHAREHOLDERS' EQUITY
Liabilities:
Revolving lines of credit................................. $ 185,641 $ 166,600
6.95% Unsecured Notes due 2002............................ 125,000 125,000
6.95% Unsecured Notes due 2007............................ 100,000 100,000
Unsecured Notes due 2000.................................. -- 81,381
Other long-term borrowings................................ 24,161 33,383
Subordinated convertible debentures....................... 16,590 48,405
Accrued expenses and other liabilities.................... 18,002 14,818
Operating liabilities for owned properties................ 14,744 12,063
--------- ----------
Total Liabilities....................................... 484,138 581,650
Shareholders' equity:
Preferred Stock $1.00 par value:
Authorized--10,000 shares Issued and outstanding--2,300
shares Class A with an aggregate liquidation
preference of $57,500................................. 57,500 57,500
Issued and outstanding--2,000 shares Class B with an
aggregate liquidation preference of $50,000........... 50,000 50,000
Issued and outstanding--1,000 shares Class C with an
aggregate liquidation preference of $100,000.......... 100,000 --
Common stock $.10 par value:
Authorized--100,000 shares Issued and
outstanding--20,038 shares in 2000 and 19,877 shares
in 1999............................................... 2,004 1,988
Additional paid-in capital................................ 438,552 447,304
Cumulative net earnings................................... 182,548 232,105
Cumulative dividends paid................................. (365,654) (331,341)
Stock option loans........................................ -- (2,499)
Unamortized restricted stock awards....................... (607) (526)
Accumulated other comprehensive income (loss)............. (30) 2,550
--------- ----------
Total Shareholders' Equity.............................. 464,313 457,081
--------- ----------
Total Liabilities and Shareholders' Equity.............. $ 948,451 $1,038,731
========= ==========

See accompanying notes.

F-3

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

YEAR ENDED DECEMBER 31,
------------------------------
2000 1999 1998
-------- -------- --------

Revenues
Rental income............................................. $ 67,308 $ 76,389 $ 72,072
Mortgage interest income.................................. 24,126 36,369 30,399
Other investment income--net.............................. 6,594 6,814 5,971
Nursing home revenues of owned and operated assets........ 175,559 26,223 --
Miscellaneous............................................. 2,206 2,334 872
-------- -------- --------
275,793 148,129 109,314
Expenses
Depreciation and amortization............................. 23,265 24,211 21,542
Interest.................................................. 42,400 42,947 32,436
General and administrative................................ 6,425 5,231 4,852
Legal..................................................... 2,467 386 155
State taxes............................................... 195 503 358
Severance and consulting agreement costs.................. 4,665 -- --
Provision for loss on mortgages and notes receivable...... 15,257 -- --
Provision for impairment.................................. 61,690 19,500 6,800
Nursing home expenses of owned and operated assets........ 178,975 25,173 --
-------- -------- --------
335,339 117,951 66,143
-------- -------- --------
(Loss) earnings before gain (loss) on assets sold........... (59,546) 30,178 43,171
Gain (loss)on assets sold--net.............................. 9,989 (10,507) 2,798
Gain on distribution of Omega Worldwide, Inc................ -- -- 30,240
-------- -------- --------
Net (loss) earnings......................................... (49,557) 19,671 76,209
Preferred stock dividends................................... (16,928) (9,631) (8,194)
-------- -------- --------
Net (loss) earnings available to common..................... $(66,485) $ 10,040 $ 68,015
======== ======== ========
(Loss) earnings per common share:
Net (loss) earnings per share--basic...................... $ (3.32) $ 0.51 $ 3.39
======== ======== ========
Net (loss) earnings per share--diluted.................... $ (3.32) $ 0.51 $ 3.39
======== ======== ========
Dividends declared and paid per common share................ $ 1.00 $ 2.80 $ 2.68
======== ======== ========
Weighted Average Shares Outstanding, Basic.................. 20,052 19,877 20,034
======== ======== ========
Weighted Average Shares Outstanding, Diluted................ 20,052 19,877 20,041
======== ======== ========
Other comprehensive income (loss):
Unrealized Gain (Loss) on Omega Worldwide, Inc............ $ (2,580) $ 1,789 $ 761
======== ======== ========
Total comprehensive (loss) income........................... $(52,137) $ 21,460 $ 76,970
======== ======== ========

See accompanying notes.

F-4

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

COMMON CUMULATIVE
STOCK ADDITIONAL PREFERRED NET
PAR VALUE PAID-IN CAPITAL STOCK EARNINGS
--------- --------------- --------- ----------

Balance at December 31, 1997 (19,475 shares)............... $1,947 $439,214 $ 57,500 $136,225
Issuance of common stock:
Grant of restricted stock (3 shares at an average of
$38.112 per share) and amortization of deferred stock
compensation......................................... 42
Dividend Reinvestment Plan (58 shares)................. 6 1,826
Conversion of debentures, net of issue costs (522 52
shares).............................................. 13,810
Stock options exercised (151 shares)................... 15 3,780
Acquisition of real estate (8 shares).................. 1 282
Stock option loans from directors, officers and
employees............................................
Shares purchased and retired (156 shares).............. (15) (4,515)
Issuance of preferred stock.............................. (2,000) 50,000
Net earnings for 1998.................................... 76,209
Distribution of common shares of Omega Worldwide, Inc....
Common dividends paid ($2.68 per share)..................
Preferred dividends paid (Series A of $2.313 per share
and Series B of $1.078 per share)......................
Unrealized Gain on Omega Worldwide, Inc..................
------ -------- -------- --------
Balance at December 31, 1998 (20,057 shares)............... 2,006 452,439 107,500 212,434
Issuance of common stock:
Grant of restricted stock (1 share at an average of
$29.709 per share) and amortization of deferred stock
compensation......................................... 270
Dividend Reinvestment Plan (113 shares) 11 2,370
Acquisition of real estate (8 shares) 1 301
Payments on stock option loans from directors, officers
and employees........................................
Shares purchased and retired (320 shares).............. (30) (8,076)
Net earnings for 1999.................................. 19,671
Common dividends paid ($2.80 per share)................
Preferred dividends paid (Series A of $2.313 per share
and Series B of $2.156 per share)....................
Unrealized Gain on Omega Worldwide, Inc................
------ -------- -------- --------
Balance at December 31, 1999 (19,877 shares)............... 1,988 447,304 107,500 232,105
Issuance of common stock:
Grant of restricted stock (187 shares at an average of 19
$6.378 per share) and amortization of deferred stock
compensation......................................... 1,179
Dividend Reinvestment Plan (74 shares)................. 7 487
Shares surrendered for stock option loan cancellation (10)
(100 shares)......................................... (579)
Issuance of preferred stock............................ (9,839) 100,000
Net loss for 2000...................................... (49,557)
Common dividends paid ($1.000 per share)...............
Preferred dividends paid and/or declared (Series A of
$2.313 per share, Series B of $2.156 per share and
Series C of $0.25 per share).........................
Unrealized Gain on Omega Worldwide, Inc..................
------ -------- -------- --------
Balance at December 31, 2000 (20,038 shares)............... $2,004 $438,552 $207,500 $182,548
====== ======== ======== ========

See accompanying notes.

F-5

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

ACCUMULATED
UNAMORTIZED STOCK OTHER
CUMULATIVE RESTRICTED OPTION COMPREHENSIVE
DIVIDENDS STOCK AWARDS LOANS INCOME
---------- ------------ -------- -------------

Balance at December 31, 1997 (19,475 shares)............. $(165,824) $ (841)
Issuance of common stock:
Grant of restricted stock (3 shares at an average of
$38.112 per share) and amortization of deferred
stock compensation................................. 380
Dividend Reinvestment Plan (58 shares)...............
Conversion of debentures, net of issue costs (522
shares)............................................
Stock options exercised (151 shares).................
Acquisition of real estate (8 shares)................
Stock option loans from directors, officers and
employees.......................................... $(2,863)
Shares purchased and retired (156 shares)............
Issuance of preferred stock............................
Net earnings for 1998..................................
Distribution of common shares of Omega Worldwide, (39,062)
Inc..................................................
Common dividends paid ($2.68 per share)................ (53,693)
Preferred dividends paid (Series A of $2.313 per share (7,475)
and Series B of $1.078 per share)....................
Unrealized Gain on Omega Worldwide, Inc................ $ 761
--------- ------- ------- ------
Balance at December 31, 1998 (20,057 shares)............. (266,054) (461) (2,863) 761
Issuance of common stock:
Grant of restricted stock (1 share at an average of
$29.709 per share) and amortization of deferred
stock compensation................................. (65)
Dividend Reinvestment Plan (113 shares)
Acquisition of real estate (8 shares)
Payments on stock option loans from directors,
officers and employees............................. 67
Shares purchased and retired (320 shares)............ 297
Net earnings for 1999................................
Common dividends paid ($2.80 per share).............. (55,655)
Preferred dividends paid (Series A of $2.313 per (9,632)
share and Series B of $2.156 per share)............
Unrealized Gain on Omega Worldwide, Inc.............. 1,789
--------- ------- ------- ------
Balance at December 31, 1999 (19,877 shares)............. (331,341) (526) (2,499) 2,550
Issuance of common stock:
Grant of restricted stock (187 shares at an average
of $6.378 per share) and amortization of deferred
stock compensation................................. (81)
Dividend Reinvestment Plan (74 shares)...............
Shares surrendered for stock option loan cancellation
(100 shares)....................................... 2,499
Issuance of preferred stock..........................
Net loss for 2000....................................
Common dividends paid ($1.000 per share)............. (20,015)
Preferred dividends paid and/or declared (Series A of (14,298)
$2.313 per share, Series B of $2.156 per share and
Series C of $0.25 per share).......................
Unrealized Gain on Omega Worldwide, Inc................ (2,580)
--------- ------- ------- ------
Balance at December 31, 2000 (20,038 shares)............. $(365,654) $ (607) $ -- $ (30)
========= ======= ======= ======

See accompanying notes.

F-6

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)

YEAR ENDED DECEMBER 31,
2000 1999 1998
---------- --------- ----------
(IN THOUSANDS)

OPERATING ACTIVITIES
Net (loss) earnings..................................... $ (49,557) $ 19,671 $ 76,209
Adjustment to reconcile net (loss) earnings to cash
provided by operating activities:
Depreciation and amortization....................... 23,265 24,211 21,543
Provision for impairment............................ 61,690 19,500 6,800
Provision for loss on notes and mortgages
receivable........................................ 15,257 -- --
(Gain)/loss on assets sold--net..................... (9,989) 10,507 (2,798)
Gain on distribution of Omega Worldwide............. -- -- (30,240)
Other............................................... 3,283 3,538 2,179
Net change in accounts receivable for Owned & Operated
assets--net............................................. (20,442) (9,588) --
Net change in accounts payable for Owned & Operated
assets.................................................. 4,674 3,962 --
Net change in other Owned & Operated assets and
liabilities............................................. (8,709) 8,040 --
Net change in operating assets and liabilities............ 20 (5,529) (3,980)
---------- --------- ----------
Net cash provided by operating activities................. 19,492 74,312 69,713

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds of revolving lines of credit--net................ 19,041 43,600 64,700
Proceeds from unsecured note offering..................... -- -- 125,000
Payments of long-term borrowings.......................... (122,418) (1,078) (612)
Receipts from Dividend Reinvestment Plan.................. 495 2,381 1,832
Dividends paid............................................ (29,646) (65,287) (61,168)
Proceeds from preferred stock offering.................... 100,000 -- 50,000
Costs of raising capital.................................. (9,839) -- (3,290)
Purchase of Company common stock.......................... -- (8,106) (3,545)
Deferred financing costs paid............................. (5,071) -- --
Other..................................................... -- (957) 356
---------- --------- ----------
Net cash (used in) provided by financing activities....... (47,438) (29,447) 173,273

CASH FLOW FROM INVESTING ACTIVITIES
Acquisition of real estate................................ -- (79,844) (157,474)
Placement of mortgage loans............................... -- (22,987) (125,850)
Proceeds from sale of real estate investments--net........ 35,792 18,198 37,771
Net proceeds from sale of Omega Worldwide shares.......... -- -- 16,938
Fundings of other investments--net........................ (6,815) (14,714) (17,488)
Collection of mortgage principal.......................... 2,036 54,749 3,748
Other..................................................... -- 1,961 746
---------- --------- ----------
Net cash provided by (used in) investing activities....... 31,013 (42,637) (241,609)
---------- --------- ----------
Increase in cash and cash equivalents..................... 3,067 2,228 1,377
Cash and cash equivalents at beginning of year............ 4,105 1,877 500
---------- --------- ----------
Cash and cash equivalents at end of year.................. $ 7,172 $ 4,105 $ 1,877
========== ========= ==========

See accompanying notes.

F-7

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1--ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

ORGANIZATION

Omega Healthcare Investors, Inc., a Maryland corporation ("the Company"), is
a self-administered real estate investment trust (REIT). From the date the
Company commenced operations in 1992, it has invested primarily in long-term
care facilities, which include nursing homes, assisted living facilities and
rehabilitation hospitals. The Company currently has investments in 264
healthcare facilities located in the United States.

CONSOLIDATION

The consolidated financial statements include the accounts of our Company
and our wholly-owned subsidiaries after elimination of all material intercompany
accounts and transactions. Due to changes in the market conditions affecting the
long-term care industry, we have begun to operate a portfolio of our foreclosure
assets for our own account until such time as these facilities' operations are
stabilized and are re-leasable or saleable at lease rates or sales prices that
maximize the value of these assets to the Company. As a result, these facilities
and their respective operations are presented on a consolidated basis in the
Company's financial statements. Certain reclassifications have been made to the
1999 and 1998 financial statements for consistency with the presentation adopted
for 2000. Such reclassifications have no effect on previously reported earnings
or equity.

REAL ESTATE INVESTMENTS

Investments in leased real estate properties and mortgage notes are recorded
at cost and original mortgage amount, respectively. The cost of the properties
acquired is allocated between land and buildings based generally upon
independent appraisals. Depreciation for buildings is recorded on the
straight-line basis, using estimated useful lives ranging from 20 to 39 years.
Leasehold interests are amortized over the initial term of the lease, with lives
ranging from four to seven years.

OWNED & OPERATED ASSETS AND ASSETS HELD FOR SALE

In the ordinary course of our business activities, our Company periodically
evaluates investment opportunities and extends credit to customers. It also is
regularly engaged in lease and loan extensions and modifications. Additionally,
the Company monitors and manages its investment portfolio with the objectives of
improving credit quality and increasing returns. In connection with portfolio
management, it engages in various collection and foreclosure activities. When
the Company acquires real estate pursuant to a foreclosure proceeding, it is
designated as "owned and operated assets" and is recorded at the lower of cost
or fair value. Such amounts are included in real estate properties on the
Company's Consolidated Balance Sheet. Operating assets and operating liabilities
for the owned and operated properties are shown separately on the face of the
Company's Consolidated Balance Sheet and are detailed in Note 18--Segment
Information.

When a formal plan to sell real estate is adopted, the real estate is
classified as "assets held for sale," with the net carrying amount adjusted to
the lower of cost or estimated fair value, less cost of disposal. Depreciation
of the facilities is excluded from operations after management has committed to
a plan to sell the asset.

F-8

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
IMPAIRMENT OF ASSETS

Provisions for impairment losses related to long-lived assets are recognized
when expected future cash flows are less than the carrying values of the assets.
If indicators of impairment are present, the Company evaluates the carrying
value of the related real estate investments in relationship to the future
undiscounted cash flows of the underlying facilities and, if impaired, the
Company then adjusts the net carrying value of leased properties and other
long-lived assets to the lower of discounted present value of its expected
future cash flows or fair value, if the sum of the expected future cash flow or
sales proceeds is less than carrying value.

LOAN IMPAIRMENT POLICY

When management identifies an indication of potential loan impairment, such
as non-payment under the loan documents or impairment of the underlying
collateral, the loan is written down to the present value of the expected future
cash flows. In cases where expected future cash flows cannot be estimated, the
loan is written down to the fair value of that collateral.

CASH EQUIVALENTS

Cash equivalents consist of highly liquid investments with a maturity date
of three months or less when purchased. These investments are stated at cost,
which approximates fair value.

ACCOUNTS RECEIVABLE--OWNED AND OPERATED ASSETS

Accounts Receivable from Owned and Operated Assets consist primarily of
amounts due from Medicare and Medicaid programs, other government programs,
managed care health plans, commercial insurance companies and individual
patients. Amounts recorded include estimated provisions for loss related to
uncollectible accounts and disputed items.

INVESTMENTS IN EQUITY SECURITIES

Marketable securities held as available-for-sale are stated at fair value
with unrealized gains and losses for the securities reported in accumulated
other comprehensive income. Realized gains and losses and declines in value
judged to be other-than-temporary on securities held as available-for-sale are
included in investment income. The cost of securities sold is based on the
specific identification method. Interest and dividends on securities
available-for-sale are included in investment income.

DEFERRED FINANCING COSTS

Deferred financing costs are amortized on a straight-line basis over the
terms of the related borrowings. Amortization of financing costs totaling
$1,930,000, $1,342,000 and $1,042,000 in 2000, 1999 and 1998, respectively, is
classified as interest expense in the Consolidated Statements of Operations.
Unamortized deferred financing costs applicable to debt which is converted to
common stock are charged to paid-in capital at the date of conversion.

NON-COMPETE AGREEMENTS AND GOODWILL

Non-compete agreements and the excess of the purchase price over the value
of tangible net assets acquired (i.e., goodwill) are amortized on a
straight-line basis over periods ranging from five to ten

F-9

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
years. Non-compete agreements, which have cost of $4,982,000 became fully
amortized and were eliminated in 1999 by a charge to accumulated amortization.
Due to the diminished value of the related real estate assets, management has
determined that the goodwill is entirely impaired and has written off the
balance of $2,356,000 in 2000. Accumulated amortization was $-0- and $3,363,000
at December 31, 2000 and 1999, respectively.

REVENUE RECOGNITION

Rental income and mortgage interest income is recognized as earned over the
terms of the related master leases and mortgage notes, respectively. Such income
includes periodic increases based on pre-determined formulas (i.e. such as
increases in the Consumer Price Index) as defined in the master leases and
mortgage loan agreements. Reserves are taken against earned revenues from leases
and mortgages when collection of amounts due become questionable or when
negotiations for restructurings of troubled operators lead to lower expectations
regarding ultimate collection. When collection is uncertain, lease revenues are
recorded as received, after taking into account application of security
deposits. Interest income on impaired mortgage loans is recognized as received
after taking into account application of security deposits.

Nursing home revenues from owned and operated assets (primarily Medicare,
Medicaid and other third party insurance) are recognized as patient services are
provided.

FEDERAL AND STATE INCOME TAXES

As a qualified real estate investment trust, the Company will not be subject
to Federal income taxes on its income, and no provisions for Federal income
taxes have been made. To the extent that we have foreclosure income from our
owned and operated assets we will incur federal tax at a rate of 35%. To date
our owned and operated assets have generated losses, and therefore, no provision
for federal income tax is necessary. The reported amounts of the Company's
assets and liabilities as of December 31, 2000 are less than the tax basis of
assets by approximately $21 million.

STOCK BASED COMPENSATION

The Company grants stock options to employees and directors with an exercise
price equal to the fair value of the shares at the date of the grant. In
accordance with the provisions of APB Opinion No. 25, Accounting for Stock
Issued to Employees, compensation expense is not recognized for these stock
option grants.

Expense related to Dividend Equivalent Rights is recognized as dividends are
declared, based on anticipated vesting.

ACCOUNTING ESTIMATES

The preparation of financial statements in conformity with accounting
principles generally accepted in the United States requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities, the disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.

F-10

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 1--ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
RISKS AND UNCERTAINTIES

The Company is subject to certain risks and uncertainties affecting the
healthcare industry as a result of healthcare legislation and growing regulation
by federal, state and local governments. Additionally, the Company is subject to
risks and uncertainties as a result of changes affecting operators of nursing
home facilities due to the actions of governmental agencies and insurers to
limit the growth in cost of healthcare services. (See Note 5--Concentration of
Risk).

NOTE 2--PROPERTIES

LEASED PROPERTY

The Company's leased real estate properties, represented by 130 long-term
care facilities and 2 rehabilitation hospitals at December 31, 2000, are leased
under provisions of master leases with initial terms ranging from 10 to
16 years, plus renewal options. Substantially all of the master leases provide
for minimum annual rentals which are subject to annual increases based upon
increases in the Consumer Price Index or increases in revenues of the underlying
properties, with certain maximum limits. Under the terms of the leases, the
lessee is responsible for all maintenance, repairs, taxes and insurance on the
leased properties.

A summary of the Company's investment in leased real estate properties is as
follows:

DECEMBER 31,
-----------------------
2000 1999
-------- --------
(IN THOUSANDS)

Buildings............................................ $553,183 $655,588
Land................................................. 26,758 30,517
-------- --------
579,941 686,105
Less accumulated depreciation........................ (72,190) (67,115)
-------- --------
Total.............................................. $507,751 $618,990
======== ========

The future minimum contractual rentals for the remainder of the initial
terms of the leases are as follows:

(IN THOUSANDS)
--------------

2001........................................................ $ 65,212
2002........................................................ 65,194
2003........................................................ 64,186
2004........................................................ 62,816
2005........................................................ 62,405
Thereafter.................................................. 310,569
--------
$630,382
========

F-11

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 2--PROPERTIES (CONTINUED)
OWNED AND OPERATED PROPERTY

The Company's owned and operated real estate properties include 69 long-term
care facilities at December 31, 2000, of which 57 are owned directly by the
Company and 12 are subject to third-party leases. An impairment charge of
$41.3 million was taken on these assets during the year ended December 31, 2000.

A summary of the Company's investment in the 57 owned and operated real
estate properties is as follows:

DECEMBER 31,
-----------------------
2000 1999
-------- --------
(IN THOUSANDS)

Buildings............................................. $124,452 $57,637
Land.................................................. 6,149 3,173
-------- -------
130,601 60,810
Less accumulated depreciation......................... (17,680) (814)
-------- -------
Total............................................... $112,921 $59,996
======== =======

A summary of the Company's investment in the 12 facilities subject to
third-party leases is as follows:

DECEMBER 31, 2000
-----------------

Leasehold interest.......................................... $1,771
Less accumulated amortization............................... (92)
------
Total..................................................... $1,679
======

Future minimum operating lease payments on the 12 facilities are as follows:

2001........................................................ $ 4,318
2002........................................................ 4,318
2003........................................................ 4,318
2004........................................................ 3,335
2005........................................................ 2,221
Thereafter.................................................. 855
-------
$19,365
=======

ASSETS SOLD OR HELD FOR SALE

During 1998, management initiated a plan to dispose of certain properties
judged to have limited long-term potential and to re-deploy the proceeds.
Following a review of the portfolio, assets identified for sale in 1998 had a
cost of $95 million, a net carrying value of $83 million, and annualized
revenues of approximately $11.4 million. In 1998, the Company recorded a
provision for impairment of $6.8 million to adjust the carrying value of certain
assets to their fair value, less cost of disposal. During

F-12

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 2--PROPERTIES (CONTINUED)
1998, the Company completed sales of two groups of assets, yielding sales
proceeds of $42.0 million. Gains realized in 1998 from the dispositions
approximated $2.8 million.

During 1999, the Company completed sales yielding net proceeds of
$18.2 million, realizing losses of $10.5 million. In addition, management
initiated a plan for additional asset sales to be completed in 2000. The
additional assets identified as assets held for sale had a cost of
$33.8 million, a net carrying amount of $28.6 million and annualized revenue of
approximately $3.4 million. As a result of this review, the Company recorded a
provision for impairment of $19.5 million to adjust the carrying value of assets
held for sale to their fair value, less cost of disposal.

During 2000, the Company recorded a $14.4 million provision for impairment
related to assets held for sale and reclassified $24.3 million of assets held
for sale to "owned and operated assets" as the timing and strategy for sale or,
alternatively, re-leasing were revised in light of prevailing marketing
conditions. During 2000, the Company realized disposition proceeds of
$1.1 million on assets held for sale. Additionally, the Company received
proceeds of $34.7 million from sales of certain of its core and other assets,
resulting in a gain of $9.9 million.

Following is a summary of the impairment reserve:

Beginning Impairment at January 1, 1998..................... $ 0
Provision charged........................................... 6,800
Provision applied........................................... --
--------
Impairment Balance at December 31, 1998..................... 6,800
Provision charged........................................... 19,500
Provision applied........................................... (4,567)
--------
Impairment Balance at December 31, 1999..................... 21,733
Provision charged........................................... 14,415
Converted to Owned and Operated............................. (17,339)
Provision applied........................................... (10,060)
--------
Impairment Balance at December 31, 2000..................... $ 8,749
========

F-13

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 3--MORTGAGE NOTES RECEIVABLE

The following table summarizes the mortgage notes balances for the years
ended December 31, 2000 and 1999:

2000 1999
-------- --------
(IN THOUSANDS)

Gross mortgage notes--unimpaired........................ $204,550 $213,617

Gross mortgage notes--impaired.......................... 7,031 --

Reserve for uncollectable loans......................... (4,871) --
-------- --------

Net mortgage notes at December 31....................... $206,710 $213,617
======== ========

Mortgage notes receivable relate to 63 long-term care facilities. The
mortgage notes are secured by first mortgage liens on the borrowers' underlying
real estate and personal property. The mortgage notes receivable relate to
facilities located in 13 states, operated by 12 independent healthcare operating
companies.

The Company monitors compliance with mortgages and when necessary has
initiated collection, foreclosure and other proceedings with respect to certain
outstanding loans.

During 2000, the Company determined that a certain mortgage loan was
impaired and accordingly recorded an impairment provision of $4.9 million to
reduce the carrying value of the mortgage loan to its net realizable value. No
other activity has been reflected in such reserve during the three-year period
ended December 31, 2000. The impaired mortgage was collateralized by three
skilled nursing facilities, one of which was to be returned to us and included
in a master lease with the same operator. The other two properties were to be
sold, with the proceeds applied to the mortgage loan. The loan was written down
to the sum of the value of the facility to be leased plus the estimated
proceeds, net of cost to dispose, from the sale of the other two facilities.
Income recognized on the mortgage was $745,000, $966,000, and $951,000 for the
years ended December 31, 2000, 1999 and 1998, respectively. No income was
recognized after the mortgage loan was impaired.

The following are the three primary mortgage structures currently used by
the Company:

CONVERTIBLE PARTICIPATING MORTGAGES are secured by first mortgage liens on
the underlying real estate and personal property of the mortgagor. Interest
rates are usually subject to annual increases based upon increases in the CPI or
increases in revenues of the underlying long-term care facilities, with certain
maximum limits. Convertible Participating Mortgages afford the Company an option
to convert its mortgage into direct ownership of the property, generally at a
point six to nine years from inception; they are then subject to a leaseback to
the operator for the balance of the original agreed term and for the original
agreed participation in revenues or CPI adjustments. This allows the Company to
capture a portion of the potential appreciation in value of the real estate. The
operator has the right to buy out the Company's option at formula prices.

PARTICIPATING MORTGAGES are secured by first mortgage liens on the
underlying real estate and personal property of the mortgagor. Interest rates
are usually subject to annual increases based upon increases in the CPI or
increases in revenues of the underlying long-term care facilities, with certain
maximum limits.

F-14

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 3--MORTGAGE NOTES RECEIVABLE (CONTINUED)
FIXED-RATE MORTGAGES, with a fixed interest rate for the mortgage term, are
also secured by first mortgage liens on the underlying real estate and personal
property of the mortgagor.

The outstanding principal amount of mortgage notes receivable, net of
allowances, are as follows:

DECEMBER 31,
-------------------
2000 1999
-------- --------
(IN THOUSANDS)

Participating mortgage note due 2007; interest at 16.00%
payable monthly (excluding 1.0% deferred interest)........ $ 58,800 $ 58,800

Participating mortgage note due 2003; interest at 10.55%
payable monthly........................................... 37,500 37,500

Participating mortgage note due 2008; interest at 10.08%
payable monthly........................................... 12,000 12,000

Convertible participating mortgage note due 2001; monthly
interest payments at 16.16% with principal due at
maturity.................................................. 8,932 8,932

Convertible participating mortgage note due 2016, monthly
interest payments at 13.50%............................... 8,114 8,127

Mortgage notes due 2015; monthly payments of $189,004,
including interest at 11.01%.............................. 16,199 16,656

Mortgage note due 2010; monthly payment of $124,826,
including interest at 11.50%.............................. 12,805 12,825

Mortgage note due 2006; monthly payment of $107,382,
including interest at 11.50%.............................. 11,025 11,035

Other mortgage notes........................................ 19,527 20,975

Other convertible participating mortgage notes.............. 15,287 15,297

Other participating mortgage notes.......................... 6,521 11,470
-------- --------

Total mortgages--net.................................... $206,710 $213,617
======== ========

Mortgage notes are shown net of allowances of $4,871,000 in 2000. There were
no provisions recorded prior to 2000.

On December 30, 1999, the Company provided notice as to an Event of Default
and acceleration of the due date to the mortgagor of the $58.8 million
participating mortgage note. The total obligation outstanding at that time,
including deferred interest, was $63.3 million. At that date the mortgagor was
current with respect to principal and interest payments due on the loan but had
failed to fully comply with certain covenants and to pay certain property taxes.
On January 13, 2000, the Company offset security deposits of $2.4 million
against unpaid current and deferred interest. On January 18, 2000 the mortgagor
filed with the Bankruptcy Court of Wilmington, Delaware for protection under
Chapter 11 of the Bankruptcy Code. While the Company's collection actions have
been stayed as a result of the bankruptcy filing by the mortgagor, the Company
believes the security for its loan will be adequate for collection of amounts
due. During 2000, the Company recorded interest on this mortgage note at a rate
equal to the results expected from negotiations with the operator, and continues
to accrue interest at

F-15

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 3--MORTGAGE NOTES RECEIVABLE (CONTINUED)
this reduced rate. On February 1, 2001, four facilities that were collateral for
this mortgage were sold to a third-party, and the Company received a separate
mortgage note in the amount of $4.5 million, which is secured by liens on the
underlying real estate. The Company reduced the amount of the participating
mortgage note by $4.5 million.

The estimated fair value of the Company's mortgage loans at December 31,
2000 is approximately $230.6 million. Fair value is based on the estimates by
management using rates currently prevailing for comparable loans.

NOTE 4--OTHER INVESTMENTS

A summary of the Company's other investments is as follows:

AT DECEMBER 31,
-------------------
2000 1999
-------- --------

Assets leased by United States Postal Service-net......... $22,416 $22,672
Notes Receivable.......................................... 24,550 27,548
Allowance for loss on notes receivable.................... (8,995) (1,460)
Equity Securities of Omega Worldwide Inc.................. 5,435 8,015
Equity Securities of Principal Healthcare Finance
Limited................................................. 1,615 1,615
Equity Securities of Principal Healthcare Finance Trust... 1,266 1,266
Other..................................................... 6,955 15,804
------- -------
Total Other Investments............................... $53,242 $75,460
======= =======

NOTE 5--CONCENTRATION OF RISK

As of December 31, 2000, 92% of the Company's real estate investments are
related to long-term care facilities. The Company's facilities are located in 29
states and are operated by 27 independent healthcare operating companies.

Investing in long-term healthcare facilities involves certain risks stemming
from government legislation and regulation of operators of the facilities. The
Company's tenants/mortgagors depend on reimbursement legislation which will
provide them adequate payments for services because a significant portion of
their revenue is derived from government programs funded under Medicare and
Medicaid. The Medicare program recently implemented a Prospective Payment System
for skilled nursing facilities, which replaced cost-based reimbursements and
significantly reduced payments for services provided. Additionally, certain
State Medicaid programs have implemented similar prospective payment systems.
The reduction in payments to nursing home operators pursuant to the Medicare and
Medicaid payment changes has negatively affected the revenues of the Company's
nursing home facilities.

Most of the Company's nursing home investments were designed exclusively to
provide long-term healthcare services. These facilities are also subject to
detailed and complex specifications for the physical characteristics as mandated
by various governmental authorities. If the facilities cannot be operated as
long-term care facilities, finding alternative uses may be difficult. The
Company's triple-net leases require its tenants to comply with regulations
affecting its facilities, and the Company regularly monitors compliance by
tenants with healthcare facilities' regulations. Nevertheless, if tenants fail
to

F-16

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 5--CONCENTRATION OF RISK (Continued)
perform their obligations, the Company may be required to do so in order to
maintain the value of its investments.

Approximately 77% of the Company's real estate investments are operated by 7
public companies, including Sun Healthcare Group, Inc. (26.1%), Integrated
Health Services, Inc. (17.5%), Advocat, Inc. (11.6%), Vencor Operating, Inc.
(5.8%), Mariner Post-Acute Network (6.4%), Genesis Health Ventures, Inc. (5.3%)
and Alterra Healthcare Corporation (formerly Alternative Living Services)
(3.7%). Of the remaining 20 operators, none operate investments in facilities
representing more than 3.4% of the total real estate investments.

Many of the nursing home companies operating the Company's facilities have
reported significant operating losses in the last two years. The Company has
initiated discussions with all operators who are experiencing financial
difficulties, as well as state officials who regulate its properties. It also
has initiated various other actions to protect its interest under its leases and
mortgages.

NOTE 6--LEASE AND MORTGAGE DEPOSITS

The Company obtains liquidity deposits and letters of credit from most
operators pursuant to its leases and mortgages. These generally represent the
monthly rental and mortgage interest income for periods ranging from three to
six months with respect to certain of its investments. At December 31, 2000, the
Company held $7.6 million in such liquidity deposits and $9.6 million in letters
of credit. Additional security for rental and mortgage interest revenue from
operators is provided by covenants regarding minimum working capital and net
worth, liens on accounts receivable and other operating assets of the operators,
provisions for cross default, provisions for cross-collateralization and by
corporate/personal guarantees.

NOTE 7--BORROWING ARRANGEMENTS

On July 17, 2000, the Company replaced its $200 million unsecured revolving
line of credit facility with a new $175 million secured revolving line of credit
facility that expires on December 31, 2002. Borrowings bear interest at 2.5% to
3.25% over LIBOR, based on the Company's leverage ratio. Borrowings of
approximately $129 million are outstanding at December 31, 2000. LIBOR based
borrowings under this facility bear interest at a weighted-average rate of
10.00% at December 31, 2000 and 7.30% at December 31, 1999. Real estate
Investments with a gross book value of approximately $240 million are pledged as
collateral for this revolving line of credit facility.

On August 16, 2000, the Company replaced its $50 million secured revolving
line of credit facility with a new $75 million secured revolving line of credit
facility that expires on March 31, 2002 as to $10 million and June 30, 2005 as
to $65 million. Borrowings under the facility bear interest at 2.5% to 3.75%
over LIBOR, based on the Company's leverage ratio and collateral assigned. LIBOR
based borrowings under this facility bear interest at a weighted-average rate of
9.77% at December 31, 2000 and 8.44% at December 31, 1999. Real estate
Investments with a gross book value of approximately $90 million are currently
pledged as collateral for this revolving line of credit facility.

The Company is required to meet certain financial covenants, including
prescribed leverage and interest coverage ratios on its long-term borrowings.

F-17

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 7--BORROWING ARRANGEMENTS (CONTINUED)
The following is a summary of the Company's long-term borrowings:

DECEMBER 31,
-------------------
2000 1999
-------- --------
(IN THOUSANDS)

Unsecured borrowings:
6.95% Notes due June 2002................................. $125,000 $125,000
6.95% Notes due August 2007............................... 100,000 100,000
Subordinated Convertible Debentures due 2001.............. 16,590 48,405
Unsecured Notes due July 2000............................. -- 81,381
Other..................................................... 4,455 4,615
-------- --------
246,045 359,401

Secured borrowings:
Revolving lines of credit................................. 185,641 166,600
Industrial Development Revenue Bonds...................... 8,375 8,595
Mortgage notes payable to banks........................... 6,112 14,844
HUD loans................................................. 5,219 5,329
-------- --------
205,347 195,368
-------- --------
$451,392 $554,769
======== ========

The Subordinated Convertible Debentures ("Debentures") are convertible at
any time into shares of Common Stock at a conversion price of $26.962 per share.
The Debentures are unsecured obligations of the Company and are subordinate in
right and payment to the Company's senior unsecured indebtedness. The balance of
the Debentures was repaid in full on February 1, 2001 principally utilizing
borrowings under the Company's revolving lines of credit. (See Note 15--
Subsequent Events).

On July 15, 2000 the Company repaid the 10% and 7.4% Unsecured Notes issued
in 1995. The effective interest rate for the unsecured notes was 8.8%, with
interest-only payments due semi-annually through July 2000.

Real estate investments with a gross book value of approximately
$41 million are pledged as collateral for outstanding secured borrowings.
Long-term secured borrowings are payable in aggregate monthly installments of
approximately $282,300, including interest at rates ranging from 7.0% to 10.0%.

F-18

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 7--BORROWING ARRANGEMENTS (CONTINUED)
Assuming none of the Company's borrowing arrangements are refinanced,
converted or prepaid prior to maturity, required principal payments for each of
the five years following December 31, 2000 and the aggregate due thereafter are
set forth below:

2001........................................................ $ 18,882

2002........................................................ 263,429

2003........................................................ 2,026

2004........................................................ 2,176

2005........................................................ 50,036

Thereafter.................................................. 114,843
--------

$451,392
========

The estimated fair values of the Company's long-term borrowings is
approximately $415.0 million at December 31, 2000 and $508.5 million at
December 31, 1999. Fair values are based on the estimates by management using
rates currently prevailing for comparable loans.

F-19

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 8--FINANCIAL INSTRUMENTS

At December 31, 2000 and 1999, the carrying amounts and fair values of the
Company's financial instruments are as follows:

2000 1999
------------------- -------------------
CARRYING FAIR CARRYING FAIR
AMOUNT VALUE AMOUNT VALUE
-------- -------- -------- --------

ASSETS:
Cash and cash equivalents......................... $ 7,172 $ 7,172 $ 4,105 $ 4,105
Mortgage notes receivable......................... 206,710 230,590 213,617 230,781
Other investments................................. 53,242 53,675 75,460 74,610
-------- -------- -------- --------
Totals.......................................... $267,124 $291,437 293,182 309,496
======== ======== ======== ========
LIABILITIES:
Revolving lines of credit......................... $185,641 $185,641 $166,600 $166,600
6.95% Notes....................................... 225,000 190,177 225,000 181,832
Senior Unsecured Notes............................ -- -- 81,381 81,054
Subordinated Convertible Debentures............... 16,590 17,101 48,405 47,402
Other long-term borrowings........................ 24,161 22,121 33,383 31,620
-------- -------- -------- --------
Totals.......................................... $451,392 $415,040 $554,769 $508,508
======== ======== ======== ========

Fair value estimates are subjective in nature and are dependent on a number
of important assumptions, including estimates of future cash flows, risks,
discount rates and relevant comparable market information associated with each
financial instrument (See Note 1--Risks and Uncertainties). The use of different
market assumptions and estimation methodologies may have a material effect on
the reported estimated fair value amounts. Accordingly, the estimates presented
above are not necessarily indicative of the amounts the Company would realize in
a current market exchange.

The Company utilizes interest rate swaps to fix interest rates on variable
rate debt and reduce certain exposures to interest rate fluctuations. At
December 31, 2000, the Company had an interest rate cap with a notional amount
of $100 million and an interest rate swap with a notional amount of
$32 million, based on 30-day London Interbank Offered Rates (LIBOR). Under the
$100 million agreement, the Company's LIBOR base interest rate cannot exceed
7.5%. This agreement expires in March, 2001. Under the $32 million agreement,
the Company receives payments when LIBOR interest rates exceed 6.35% and pays
the counterparties when LIBOR rates are under 6.35%. The amounts exchanged are
based on the notional amounts. The $32 million agreement expires on
December 17, 2001. The combined fair value of the interest rate swaps at
December 31, 2000 was a deficit of $351,344.

In June 1998, the Financial Accounting Standards Board issued Statement
No. 133, ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES, which is
required to be adopted in years beginning after June 15, 2000. The Company
expects to adopt the new Statement effective January 1, 2001. The Statement will
require the Company to recognize all derivatives on the balance sheet at fair
value. Derivatives that are not hedges must be adjusted to fair value through
income. If the derivative is a hedge, depending on the nature of the hedge,
changes in the fair value of derivatives will either be offset against the
change in fair value of the hedged assets, liabilities, or firm commitments
through

F-20

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 8--FINANCIAL INSTRUMENTS (CONTINUED)
earnings or recognized in other comprehensive income until the hedge item is
recognized in earnings. The ineffective portion of a derivative's change in fair
value will be immediately recognized in earnings.

Based on the Company's derivative positions at December 31, 2000, the
Company estimates that upon adoption it will record a loss from the cumulative
effect of an accounting change of approximately $400,000 in the consolidated
statement of operations.

NOTE 9--RETIREMENT ARRANGEMENTS

The Company has a 401(k) Profit Sharing Plan covering all eligible
employees. Under the Plan, employees are eligible to make contributions, and the
Company, at its discretion, may match contributions and make a profit sharing
contribution.

In 1993, the Company adopted the 1993 Deferred Compensation Plan, which
covered all eligible employees and members of our Board of Directors.
Participation by the directors in the Deferred Compensation Plan was terminated
effective December 31, 1997, and accumulated benefits to the Directors under the
plan were settled and paid in 1998.

The Deferred Compensation Plan is an unfunded plan under which the Company
may award units that result in participation in the dividends and future growth
in the value of the Company's common stock. The total number of units permitted
by the plan is 200,000, of which 90,850 units have been awarded and 20,050 are
outstanding at December 31, 2000. Units awarded to eligible participants vest
over a period of five years based on the participant's initial service date.

Provisions charged to operations with respect to these retirement
arrangements totaled $181,000, $123,000 and $346,000, in 2000, 1999, and 1998,
respectively.

NOTE 10--STOCKHOLDERS' EQUITY AND STOCK OPTIONS

SERIES C PREFERRED STOCK

On July 14, 2000, Explorer Holdings, L.P. ("Explorer"), an affiliate of
Hampstead Investment Partners III, L.P. ("Hampstead"), a private equity
investor, completed an investment (the "Equity Investment") of $100.0 million in
the Company in exchange for 1,000,000 shares of the Company's Series C Preferred
Stock Stock. The Company used a portion of the proceeds from the Equity
Investment to repay $81 million of maturing debt on July 17, 2000.

Shares of the Series C Preferred Stock are convertible into Common Stock at
any time by the holder at an initial conversion price of $6.25 per share of
Common Stock. The shares of Series C Preferred Stock are entitled to receive
dividends at the greater of 10% per annum or the dividend payable on shares of
Common Stock, with the Series C Preferred Stock participating on an "as
converted" basis. Dividends on the Series C Preferred Stock are cumulative from
the date of original issue and are payable quarterly commencing on November 15,
2000. Explorer agreed to defer until April 2, 2001, the accrued dividend of
$4,666,667 payable on November 15, 2000 with respect to the Series C Preferred
Stock Stock. (See Note 15--Subsequent Events).

The Series C Preferred Stock will vote (on an "as converted" basis) together
with our common stock on all matters submitted to stockholders. However, without
the consent of our Board of Directors, no holder of Series C Preferred Stock may
vote or convert shares of Series C Preferred Stock if the effect thereof would
be to cause such holder to beneficially own more than 49.9% of the

F-21

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 10--STOCKHOLDERS' EQUITY AND STOCK OPTIONS (CONTINUED)
Company's Voting Securities. If dividends on the Series C Preferred Stock are in
arrears for four quarters, the holders of the Series C Preferred Stock, voting
separately as a class (and together with the holder of Series A and Series B
preferred if and when dividends on such series are in arrears for six or more
quarters and special class voting rights are in effect with respect to the
Series A and Series B preferred), will be entitled to elect directors who,
together with the other directors designated by the holders of Series C
Preferred Stock, would constitute a majority of the Company's Board of
Directors.

The general terms of the Equity Investment are set forth in the Investment
Agreement. In addition to setting forth the terms on which Explorer has acquired
the initial $100.0 million of Series C Preferred Stock, the Investment Agreement
also contains provisions pursuant to which Explorer will make available, upon
satisfaction of certain conditions up to $50.0 million to fund growth (the
"Growth Equity Commitment"). Draws under the Growth Equity Commitment will be
evidenced by Common Stock issued at the then fair market value less a discount
agreed to by Explorer and the Company representing the customary discount
applied in rights offerings to an Issuer's existing security holders, or, if not
agreed, 6%. Following the drawing in full of the Growth Equity Commitment or
upon expiration of the Initial Growth Equity Commitment, Explorer will have the
option to provide up to an additional $50.0 million to fund growth for an
additional twelve month period (the "Increased Growth Equity Commitment"). Draws
under the Increased Growth Equity Commitment will be subject to the same
conditions as applied to the Growth Equity Commitment and the common stock so
issued will be priced in the same manner described above.

If Explorer exercises its option to fund the Increased Growth Equity
Commitment, the Company will have the option to engage in a Rights Offering to
all common stockholders other than Explorer and its affiliates. In the Rights
Offering, stockholders will be entitled to acquire their proper share of our
common stock issued in connection with the Growth Equity Commitment at the same
price paid by Explorer. Proceeds received from the Rights Offering will be used
to repurchase Common Stock issued to Explorer under the Growth Commitment.

Upon the first to occur of the drawing in full of the Increased Growth
Equity Commitment or the expiration of the Increased Growth Equity Commitment,
the Company again will have the option to engage in a second Rights Offering,
Stockholders (other than Explorer and its affiliates) will be entitled to
acquire their proportionate share of the common stock issued in connection with
the Increased Growth Equity Commitment at the same price paid by Explorer.
Proceeds received in connection with the second Rights Offering will be used to
repurchase Common Stock issued to Explorer under the increased Growth
Commitment.

In connection with Explorer's Equity Investment, the Company entered into a
Stockholders Agreement with Explorer dated July 14, 2000 (the "Stockholders'
Agreement") pursuant to which Explorer is entitled to designate up to four
members of the Company's Board of Directors depending on the percentage of total
voting securities (consisting of Common Stock and Series C Preferred Stock)
acquired from time to time by Explorer pursuant to the documentation entered
into by Explorer in connection with the Equity Investment. Explorer is entitled
to designate at least one director of the Company's Board of Directors as long
as it owns at least five percent (5%) of the total voting power of the Company
and to approve one "independent director" as long as it owns at least
twenty-five percent (25%) of the shares it acquired at the time it completed the
Equity Investment (or Common Stock issued upon the conversion of the Series C
Preferred Stock acquired by Explorer at such time). Explorer's director
designations terminate upon the tenth anniversary of the Stockholders'
Agreement.

F-22

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 10--STOCKHOLDERS' EQUITY AND STOCK OPTIONS (CONTINUED)
The Company has amended its Stockholders' Right Plan to exempt Explorer and
any of its transferees that become parties to the standstill as Acquiring
Persons under such plan. Subsequent acquisitions of voting securities by a
transferee of more than 9.9% of voting securities from Explorer are limited to
not more than 2% of the total amount of outstanding voting securities in any
twelve-month period.

The Company has agreed to indemnify Explorer, its affiliates and the
individuals that will serve as directors of the Company against any losses and
expenses that may be incurred as a result of the assertion of certain claims,
provided that the conduct of the indemnified parties meets certain required
standards. In addition, the Company has agreed to pay Explorer an advisory fee
if Explorer provides assistance to the Company in connection with evaluating
growth opportunities or other financing matters. The amount of the advisory fee
will be mutually determined by the Company and Explorer at the time the services
are rendered based upon the nature and extent of the services provided. The
Company will also reimburse Explorer for Explorer's out-of-pocket expenses, up
to a maximum of $2.5 million, incurred in connection with the Equity Investment.
To date, the Company has reimbursed Explorer approximately $964,000 of such
expenses.

SERIES A AND SERIES B CUMULATIVE PREFERRED STOCK

On April 28, 1998, the Company received gross proceeds of $50 million from
the issuance of 2 million shares of 8.625% Series B Cumulative Preferred Stock
("Series B Preferred Stock") at $25 per share. Dividends on the Series B
Preferred Stock are cumulative from the date of original issue and are payable
quarterly commencing on August 15, 1998. On April 7, 1997, the Company received
gross proceeds of $57.5 million from the issuance of 2.3 million shares of 9.25%
Series A Cumulative Preferred Stock ("Series A Preferred Stock") at $25 per
share. Dividends on the Series A Preferred Stock are cumulative from the date of
original issue and are payable quarterly. At December 31, 2000, the aggregate
liquidation preference of Series A and Series B preferred stock issued is
$107,500,000.

STOCKHOLDER RIGHTS PLAN

On May 12, 1999, the Company's Board of Directors authorized the adoption of
a stockholder rights plan. The plan is designed to require a person or group
seeking to gain control of the Company to offer a fair price to all the
Company's stockholders. The rights plan will not interfere with any merger,
acquisition or business combination that the Company's Board of Directors finds
is in the best interest of the Company and its stockholders.

In connection with the adoption of the rights plan, the board declared a
dividend distribution of one right for each common share outstanding on May 24,
1999. The rights will not become exercisable unless a person acquires 10% or
more of the Company's common stock, or begins a tender offer that would result
in the person owning 10% or more of the Company's common stock. At that time,
each right would entitle each stockholder other than the person who triggered
the rights plan to purchase either the Company's common stock or stock of an
acquiring entity at a discount to the then market price. The plan was not
adopted in response to any specific attempt to acquire control of the Company.

The Company amended its Stockholders' Right Plan to exempt Explorer and any
of its transferees that become parties to the standstill as Acquiring Persons
under such plan. Subsequent acquisitions of voting securities by a transferee of
more than 9.9% of voting securities from Explorer are limited to not more than
2% of the total amount of outstanding voting securities in any 12 month period.

F-23

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 10--STOCKHOLDERS' EQUITY AND STOCK OPTIONS (CONTINUED)
STOCK OPTIONS AND STOCK PURCHASE ASSISTANCE PLAN

In January 1998, the Company adopted a stock purchase assistance plan,
whereby the Company extended credit to directors and employees to purchase the
Company's stock through the exercise of stock options. During 2000, the Company
terminated this borrowing program and forgave the outstanding stock option loans
in exchange for the surrender of the underlying stock certificates and payment
of all outstanding interest on the loans. The Company recorded a charge of
$1.9 million related to these loans, which is included in the provision for loss
on mortgages and notes receivable in the Company's Consolidated Statements of
Operations.

Under the terms of the 2000 Stock Incentive Plan, the Company reserved
3,500,000 shares of common stock for grants to be issued during a period of up
to 10 years. Options are exercisable at the market price at the date of grant,
expire five years after date of grant for over 10% owners and 10 years from the
date of grant for less than 10% owners. Directors' shares vest over three years
while other grants vest over five years. Directors, officers and employees are
eligible to participate in the Plan. Options for 1,346,953 shares have been
granted to 22 eligible participants. Additionally, 275,052 shares of restricted
stock have been granted under the provisions of the Plan. The market value of
the restricted shares on the date of the award was recorded as unearned
compensation-restricted stock, with the unamortized balance shown as a separate
component of stockholders' equity. Unearned compensation is amortized to expense
generally over the vesting period, with charges to operations of $535,000,
$635,000, and $612,000 in 2000, 1999, and 1998, respectively.

During 2000, 1,005,000 Dividend Equivalent Rights were granted to eligible
employees. A Dividend Equivalent Right entitles the participant to receive
payments from the Company in an amount determined by reference to any cash
dividends paid on a specified number of shares of stock to the Company
stockholders of record during the period such rights are effective. The Company
recorded $502,500 of expense related to the Dividend Equivalent Rights in 2000.

At December 31, 2000, options currently exercisable (49,562) have a weighted
average exercise price of $25.677, with exercise prices ranging from $24.45 to
$37.20. There are 1,877,995 shares available for future grants as of
December 31, 2000.

F-24

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 10--STOCKHOLDERS' EQUITY AND STOCK OPTIONS (CONTINUED)
The following is a summary of activity under the plan. Exercise prices and
all other option data for grants prior to April 2, 1998 have been adjusted based
on a formula reflecting the per share value of the distribution of Omega
Worldwide, Inc.

STOCK OPTIONS
------------------------------------- WEIGHTED
NUMBER OF AVERAGE
SHARES EXERCISE PRICE PRICE
--------- ------------------------- --------

Outstanding at December 31, 1997...................... 710,726 $ 19.866 - $34.795 $29.265
Granted during 1998................................. 84,000 28.938 - 37.205 35.342
Exercised........................................... (151,200) 19.866 - 30.210 23.605
Canceled............................................ (67,599) 24.215 - 35.500 33.462
--------- ------------------------- -------
Outstanding at December 31, 1998...................... 575,927 19.866 - 37.205 31.144
Granted during 1999................................. 101,500 15.250 - 30.188 27.483
Canceled............................................ (312,164) 28.938 - 36.676 33.099
--------- ------------------------- -------
Outstanding at December 31, 1999...................... 365,263 15.250 - 37.205 28.542
Granted during 2000................................. 1,109,500 5.688 - 7.750 6.268
Canceled............................................ (307,699) 6.125 - 37.205 28.885
--------- ------------------------- -------
Outstanding at December 31, 2000...................... 1,167,064 $ 5.688 - 37.205 $ 7.276
========= ========================= =======

During 1999, the Company offered holders of options the opportunity to
accelerate the expiration date of options in consideration of a cash payment.
Twenty-two employees who were holders of options for 431,830 shares accepted the
offer and were paid a total of $38,000. Options for 157,000 shares granted in
1999 and canceled in 1999 under this arrangement are excluded from the above
table for 1999 and from the calculation for the weighted average fair value of
options granted in 1999.

In 1995, the Financial Accounting Standards Board issued the Statement of
Financial Accounting Standards (SFAS) No. 123, "Accounting for Stock-Based
Compensation." This standard prescribes a fair value-based method of accounting
for employee stock options or similar equity instruments and requires certain
pro forma disclosures. For purposes of the pro forma disclosures required under
Statement 123, the estimated fair value of the options is amortized to expense
over the option's vesting period. Based on the Company's option activity, net
earnings would have increased in 2000 and 1999 by approximately $1,064,000 and
$618,000, respectively and decreased in 1998 by approximately $2.2 million. Net
earnings per basic and diluted common share on a pro forma basis would have
increased in 2000 and 1999 by approximately $.06 and $.03, respectively, and
decreased in 1998 by $.11 under APB 25. The estimated weighted average fair
value of options granted in 2000, 1999, and 1998 was $407,000, $168,000 and
$220,000, respectively. In determining the estimated fair value of the Company's
stock options as of the date of grant, a Black-Scholes option pricing model was
used with the following weighted-average assumptions: risk-free interest rates
of 5.2% in 2000, 6.5% in 1999 and 6% in 1998; a dividend yield of 10% in 2000
and 1999 and 6.75% in 1998; volatility factors of the expected market price of
the Company's common stock based on 30.0% volatility in 2000, 22.7% in 1999 and
15.0% in 1998; and a weighted-average expected life of the options of eight
years for each of the three years.

The Black-Scholes options valuation model was developed for use in
estimating the fair value of traded options which have no vesting restrictions
and are fully transferable. In addition, option

F-25

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 10--STOCKHOLDERS' EQUITY AND STOCK OPTIONS (CONTINUED)
valuation models require the input of highly subjective assumptions, including
the expected stock price volatility. Because the Company's employee stock
options have characteristics significantly different from those of traded
options, and because changes in the subjective input assumptions can materially
affect the fair value estimate, in management's opinion, the existing models do
not necessarily provide a reliable single measure of the fair value of its
employee stock options.

NOTE 11--RELATED PARTY TRANSACTIONS

The Company has agreed to pay Explorer an advisory fee if Explorer provides
assistance to the Company in connection with the evaluating growth opportunities
or other financing matters. The amount of the advisory fee will be mutually
determined by the Company and Explorer, based upon the nature and the extent of
the services provided and the results achieved. The Company will also reimburse
Explorer for Explorer's out-of-pocket expenses, up to a maximum of
$2.5 million, incurred in connection with the Equity Investment. To date, the
Company has reimbursed Explorer for approximately $964,000 of such expenses.

Explorer agreed to defer until April 2, 2001, the accrued dividend of
$4,666,667 payable on November 15, 2000 with respect to the Series C Preferred
Stock stock. In exchange for this deferral, the Company agreed to pay Explorer a
waiver fee equal to 10% per annum of the unpaid dividend from November 15, 2000
until the October dividend is paid. (See note 15--Subsequent Events)

In 1995, the Company sponsored the organization of Principal Healthcare
Finance Limited ("Principal"), an Isle of Jersey company, whose purpose is to
invest in nursing homes and long-term care facilities in the United Kingdom.
Prior to the April 2, 1998 contribution to Omega Worldwide, Inc. ("Worldwide")
as explained below, the Company had invested $30.7 million in Principal, of
which $23.8 million was represented by a L15 million subordinated note due
December 31, 2000, and $6.9 million was represented by an equity investment. The
Company had also provided investment advisory and management services to
Principal and had advanced temporary loans to Principal from time to time.

In November 1997, the Company formed Worldwide, a company which provides
asset management services and management advisory services, as well as equity
and debt capital to the healthcare industry, particularly residential healthcare
services to the elderly. On April 2, 1998, the Company contributed substantially
all of its Principal assets to Worldwide in exchange for approximately
8.5 million shares of Worldwide common stock and 260,000 shares of Series B
preferred stock. Of the 8,500,000 shares of Worldwide received by the Company,
approximately 5,200,000 were distributed on April 2, 1998 to the Company's
stockholders on the basis of one Worldwide share for every 3.77 common shares of
the Company held by stockholders of the Company on the record date of
February 1, 1998. Of the remaining 3,300,000 shares of Worldwide received by the
Company, 2,300,000 shares were sold by the Company on April 3, 1998 for net
proceeds of approximately $16,250,000 in a secondary offering pursuant to a
registration statement of Worldwide. The market value of the distribution to
stockholders approximated $39 million or $1.99 per share. The Company recorded a
non-recurring gain of $30.2 million on the distribution and secondary offerings
of Worldwide common shares during 1998. In April 1999, in conjunction with a
similar acquisition by Worldwide, the Company acquired an interest in Principal
Healthcare Finance Trust ("the Trust"), an Australian Unit Trust, which owns 44
nursing home facilities and 483 assisted living units in Australia and New
Zealand.

F-26

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 11--RELATED PARTY TRANSACTIONS (CONTINUED)
As of December 31, 2000, the Company holds 1,163,000 shares of Worldwide
common stock and 260,000 shares of its preferred stock. The carrying value of
the Company's investment in Worldwide is $5,435,000, including the market value
of its common stock and its cost basis in its preferred stock. The Company also
holds a $1,615,000 investment in Principal, represented by 990,000 ordinary
shares of Principal, and a $1,266,000 investment in the Trust.

The Company has guaranteed repayment of Worldwide borrowings pursuant to a
revolving credit facility in exchange for an initial 1% fee and an annual
facility fee of 25 basis points. At December 31, 2000 borrowings of $2,850,000
were outstanding under Worldwide's revolving credit facility. Worldwide's credit
agreement calls for scheduled payments to be made until fully repaid in
June 2001. Under this agreement, no further borrowings may be made by Worldwide
under its revolving credit facility. The Company is required to provide
collateral in the amount of $8.8 million related to the guarantee of Worldwide's
obligations. Upon repayment by Worldwide of the remaining outstanding balance
under its revolving credit facility, the subject collateral will be released in
connection with the termination of the Company's guarantee.

Additionally, the Company had a Services Agreement with Worldwide that
provided for the allocation of indirect costs incurred by the Company to
Worldwide. The allocation of indirect costs has been based on the relationship
of assets under the Company's management to the combined total of those assets
and assets under Worldwide's management. Upon expiration of this agreement on
June 30, 2000, the Company entered into a new agreement requiring quarterly
payments from Worldwide of $37,500 for the use of offices and certain
administrative and financial services provided by the Company. Upon the
reduction of the Company's accounting staff, the Service Agreement was
renegotiated again on November 1, requiring quarterly payments from Worldwide of
$32,500. Costs allocated to Worldwide for 2000 and 1999 were $404,000 and
$754,000, respectively.

NOTE 12--DIVIDENDS

In order to qualify as a real estate investment trust, the Company must,
among other requirements, distribute at least 95% of its real estate investment
trust taxable income to its

F-27

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 12--DIVIDENDS (CONTINUED)
stockholders. Per share distributions by the Company were characterized in the
following manner for income tax purposes:

2000 1999 1998
-------- -------- --------

COMMON
Ordinary income..................................... $ -- $2.100 $2.275
------ ------ ------
Return of capital................................... 1.000 0.700 0.191
Long-term capital gain.............................. -- -- 0.214
------ ------ ------
Total dividends paid.............................. $1.000 $2.800 $2.680
====== ====== ======
COMMON NON-CASH
Return of capital................................... $ -- $ -- $0.461
Long-term capital gain.............................. -- -- 1.529
------ ------ ------
Total non-cash distribution....................... $ -- $ -- $1.990
====== ====== ======
SERIES A PREFERRED
Ordinary income..................................... $2.313 $2.313 $2.313
====== ====== ======
SERIES B PREFERRED
Ordinary income..................................... $2.156 $2.156 $1.078
====== ====== ======

F-28

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 13--SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Following are details of changes in operating assets and liabilities
(excluding the effects of non-cash expenses), and other non-cash transactions:

FOR THE YEAR ENDED DECEMBER 31,
---------------------------------
2000 1999 1998
--------- --------- ---------
(IN THOUSANDS)

Increase (decrease) in cash from changes in operating assets
and liabilities:
Operating assets, including $517 and $2,896 transferred
to held for sale in 1999 and 1998, respectively....... $1,306 $ (568) $(8,183)
Accrued interest........................................ (3,751) 589 (70)
Other liabilities....................................... 2,465 (5,550) 4,273
------ ------- -------
$ 20 $(5,529) $(3,980)
====== ======= =======
Other non-cash investing and financing transactions:
Acquisition of real estate:
Value of real estate acquired........................... $ -- $ 302 $ 283
Common stock issued..................................... -- (302) (283)
Common stock issued for conversion of debentures.......... -- -- 13,862
Interest paid during the period............................. 44,221 41,015 31,464

NOTE 14--LITIGATION

The Company is subject to various legal proceedings, claims and other
actions arising out of the normal course of business. While any legal proceeding
or claim has an element of uncertainty, management believes that the outcome of
each lawsuit claim or legal proceeding that is pending or threatened, or all of
them combined, will not have a material adverse effect on its consolidated
financial position or results of operations.

On June 20, 2000, the Company and its chief executive officer, chief
financial officer and chief operating officer were named as defendants in
certain litigation brought by Ronald M. Dickerman, in his individual capacity,
in the United States District Court for the Southern District of New York. In
the complaint, Mr. Dickerman contends that the Company and the named executive
officers violated Section 10(b) and 20(a) of the Securities Exchange Act of 1934
and Rule 10b-5 promulgated thereunder. Mr. Dickerman subsequently amended the
complaint to assert his claims on behalf of an unnamed class of plaintiffs. On
July 28, 2000, Benjamin LeBorys commenced a class action lawsuit making similar
allegations against the Company and certain of its officers and directors in the
United States District Court for the Southern District of New York. The cases
have been consolidated, and Mr. LeBorys has been named lead plaintiff. The
plaintiffs seek unspecified damages. The Company has reported the litigation to
its directors and officers liability insurer. The Company believes that the
litigation is without merit and is defending vigorously. The Company's Motion to
Dismiss was filed with the Court on February 16, 2001.

F-29

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 14--LITIGATION (CONTINUED)
and is a guarantor of Madison's obligations to the Company. Madison claims
damages as a result of the alleged breach of approximately $700,000. Madison
seeks damages as a result of the claimed anticipatory breach in the amount of
$15 million or, in the alternative, Madison seeks specific performance of the
contract as modified by a course of conduct that Madison alleges developed
between Madison and the Company. The Company contends that Madison is in default
under the contract in question. The Company believes that the litigation is
meritless. The Company is defending vigorously and on December 5, 2000, filed
counterclaims against Madison and the guarantors, including Mr. Dickerman,
seeking repayment of approximately $8.5 million that Madison owes the Company.

Karrington Health, Inc. brought suit against the Company alleging that the
Company repudiated and ultimately breached a financing contract to provide
$95,000,000 of financing for the development of 13 assisted living facilities.
Karrington seeks recovery of approximately $20,000,000 in damages it alleges to
have incurred as a result of the breach. The Company denies that it entered into
a valid and binding contract with Karrington and is vigorously defending the
litigation.

NOTE 15--SUBSEQUENT EVENTS

On February 1, 2001, the Company repaid the outstanding balance of its 8.5%
Subordinated Convertible Debentures due February 1, 2001 from cash and revolving
credit line availability.

On February 1, 2001, the Company also announced suspension of payments of
common and preferred dividends to strengthen the Company's Balance Sheet while
it pursues alternatives for extending or repaying its 2002 debt maturities. The
Company can give no assurance as to when the dividends will be reinstated or the
amount of the dividends, if and when such payments are recommenced. All accrued
and unpaid dividends on the Company's outstanding shares of Series A, B and C
Preferred Stock must be paid in full before dividends on our common stock can be
resumed.

On March 30, 2001, the Company exercised its option to pay the accrued
$4,666,667 Series C dividend from November 15, 2000 and the associated waiver
fee by issuing 48,420 Series C Preferred Stock shares to Explorer, which are
convertible into 774,722 shares of the Company's common stock at $6.25 per
share. (See "Note 11--Related Party Transactions" for information regarding the
dividend deferral).

In March 2001, the Company announced that it continues its discussions with
several of its lessees to resolve payment issues, including Alterra Healthcare
Corp., Lyric Healthcare, Alden Management Services Inc., and TLC
Healthcare Inc. Alterra has recently issued a press release stating that it had
informed certain of its lenders and landlords in March, 2001 that they will not
be paying their March rents and debt service and are seeking relief as to these
payments. The Company has a master lease with Alterra relating to ten assisted
living facilities representing an investment of $34.1 million which provides for
annual rental payments of $3.6 million. Alterra has not made its March rental
payment to the Company, and while discussions are ongoing, the Company has sent
Alterra a notice of default.

Additionally, during the first quarter of 2001, pursuant to a forbearance
agreement between the Company and Lyric through April 30, 2001, the Company
began receiving 60% of the approximately $860,000 of monthly rent due under the
Lyric leases. Discussions are continuing with Lyric to reach a permanent
restructuring agreement. The Company's total original investment in the ten
nursing homes covered under the leases is $95.4 million, and annual rent is
$10.3 million.

F-30

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 15--SUBSEQUENT EVENTS (CONTINUED)
Affiliates of Alden Management, Inc., Chicago, IL, are delinquent in paying
their lease, loan and escrow payments on the four facilities it leases from the
Company. These facilities represent an initial investment by the Company of
$31.3 million, with annual rent of approximately $3.2 million. Discussions with
Alden are ongoing.

TLC Healthcare of Illinois, Inc. has made only partial payments under its
master lease with the Company, based on the shut down of one of its facilities
having an annual rent payment of approximately $732,000, and has notified the
Company that it may not be able to make its April payment on its other seven
facilities or otherwise fund operations with annual rent and mortgage payments
totaling approximately $2.8 million. The Company has funded $623,000 for payroll
at the facilities to facilitate continued operations and is taking steps to
transition the operations of the facilities to qualified operators through new
lease or management structures.

In several instances the Company holds security deposits that can be applied
in the event of lease and loan defaults, subject to applicable limitations under
bankruptcy law with respect to operators seeking protection under Chapter 11 of
the Bankruptcy Code.

NOTE 16--SUMMARY OF QUARTERLY RESULTS (UNAUDITED)

The following summarizes quarterly results of operations for the years ended

MARCH 31 JUNE 30 SEPTEMBER 30 DECEMBER 31
-------- -------- ------------ -----------
(IN THOUSANDS, EXCEPT PER SHARE)

2000
Revenues.......................................... $57,214 $70,448 $74,010 $74,121
(Loss) earnings before gain (loss) on assets
sold............................................ 3,018 4,637 (64,984) (2,217)
Net (loss) earnings available to common........... 610 12,680 (70,797) (8,978)
(Loss) earnings before gain (loss) on assets sold
per share:
Basic (loss) earnings before gain (loss) on
asset dispositions............................ $ 0.15 $ 0.23 $ (3.24) $ (0.11)
Diluted (loss) earnings before gain (loss) on
asset dispositions............................ 0.15 0.23 (3.24) (0.11)
Net (Loss) Earnings Available to Common per share:
Basic net (loss) earnings....................... $ 0.03 $ 0.63 $ (3.53) $ (0.45)
Diluted net (loss) earnings..................... 0.03 0.63 (3.53) (0.45)
Cash dividends paid on common stock............... 0.50 -- 0.25 0.25

F-31

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 16--SUMMARY OF QUARTERLY RESULTS (UNAUDITED) (CONTINUED)

MARCH 31 JUNE 30 SEPTEMBER 30 DECEMBER 31
-------- -------- ------------ -----------
(IN THOUSANDS, EXCEPT PER SHARE)

1999
Revenues.......................................... $30,177 $30,914 $40,971 $46,067
(Loss) earnings before gain (loss) on assets
sold............................................ 12,825 13,010 12,355 (8,012)
Net (loss) earnings available to common........... 10,417 10,602 9,947 (20,926)
(Loss) earnings before gain (loss) on assets sold
per share:
Basic (loss) earnings before gain (loss) on
asset dispositions............................ $ 0.64 $ 0.66 $ 0.62 $ (0.40)
Diluted (loss) earnings before gain (loss) on
asset dispositions............................ 0.64 0.65 0.62 (0.40)
Net (Loss) Earnings Available to Common per share:
Basic net (loss) earnings....................... $ 0.52 $ 0.53 $ 0.50 $ (1.05)
Diluted net (loss) earnings..................... 0.52 0.53 0.50 (1.05)
Cash dividends paid on common stock............... 0.70 0.70 0.70 0.70

------------------------

Note: During the three-month periods ended March 31, 2000, September 30, 2000
and December 31, 2000, the Company recognized a provision for impairment
of assets of $4,500, $49,849 and $7,341 respectively. Additionally, during
the three-month period ended June 30, 2000, the Company recognized a gain
of $10,451 related to assets sold during the period. During the
three-month period ended December 31, 1999, the Company recognized a loss
of $30,000 related to assets sold during the period and a provision for
impairment of assets held for sale (See Note 2--Properties).

NOTE 17--CONSULTING AND SEVERANCE AGREEMENTS

On July 18, 2000, the Company entered into a Consulting and Severance
Agreement with Essel W. Bailey, Jr. (The "Bailey Severance Agreement"), pursuant
to which Mr. Bailey resigned as an officer of the Company. Mr. Bailey's
resignation and the Bailey Severance Agreement became effective on July 14,
2000.

Pursuant to the Bailey Severance Agreement, Mr. Bailey received payment of
his regular salary through the effective date of his resignation and a lump-sum
severance payment equal to $1,555,000. The Bailey Severance Agreement provides
that Mr. Bailey is fully vested in his deferred compensation plan and in 59,708
shares of his restricted stock. Pursuant to the Bailey Severance Agreement,
Mr. Bailey will provide consulting services to the Company for twelve months
following his resignation. In exchange for consulting services and his agreement
not to compete with the Company or solicit its customers or employees,
Mr. Bailey will receive compensation equal to $147,500 per month for twelve
months.

The costs incurred related to the Bailey Severance Agreement, along with
costs incurred in connection with a similar agreement with the Company's former
Chief Financial Officer, total approximately $4.7 million and have been included
in the Company's Consolidated Statements of Operations in 2000.

F-32

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 18--SEGMENT INFORMATION

The following tables set forth the reconciliation of operating results and
total assets for the Company's reportable segments for the years ended
December 31, 2000, 1999 and 1998.

FOR THE YEAR ENDED DECEMBER 31, 2000
----------------------------------------------------
OWNED AND
OPERATED AND CORPORATE
CORE ASSETS HELD AND
OPERATIONS FOR SALE OTHER CONSOLIDATED
---------- ------------ --------- ------------
(IN THOUSANDS)

Operating Revenues....................................... $ 91,434 $ 175,559 $ -- $ 266,993
Operating Expenses....................................... -- (178,975) -- (178,975)
-------- --------- -------- ---------
Net operating income................................... 91,434 (3,416) -- 88,018
Adjustments to arrive at net income:
Other revenues......................................... -- -- 8,800 8,800
Interest expense....................................... -- -- (42,400) (42,400)
Depreciation and amortization.......................... (17,978) (3,797) (1,490) (23,265)
General and administrative............................. -- -- (6,425) (6,425)
Legal.................................................. -- -- (2,467) (2,467)
State Taxes............................................ -- -- (195) (195)
Severance and consulting agreement costs............... -- -- (4,665) (4,665)
Provision for uncollectable mortgages and notes
receivable........................................... (4,871) -- (10,386) (15,257)
-------- --------- -------- ---------
(22,849) (3,797) (59,228) (85,874)
-------- --------- -------- ---------
Income before gain on assets sold and impairment
charges................................................ 68,585 (7,213) (59,228) 2,144
Provision for impairment................................. (1,939) (57,395) (2,356) (61,690)
Gain on assets sold--net................................. 9,989 -- -- 9,989
Preferred dividends...................................... -- -- (16,928) (16,928)
-------- --------- -------- ---------
Net loss available to common............................. $ 76,635 $ (64,608) $(78,512) $ (66,485)
======== ========= ======== =========
Total Assets............................................. $724,338 $ 159,105 $ 65,008 $ 948,451
======== ========= ======== =========

Operating Revenues....................................... $112,758 $ 26,223 $ -- $ 138,981
Operating Expenses....................................... -- (25,173) -- (25,173)
-------- --------- -------- ----------
Net operating income................................... 112,758 1,050 -- 113,808
Adjustments to arrive at net income:
Other revenues......................................... -- -- 9,148 9,148
Interest expense....................................... -- -- (42,947) (42,947)
Depreciation and amortization.......................... (21,204) (814) (2,193) (24,211)
General and administrative............................. -- -- (5,231) (5,231)
Legal.................................................. -- -- (386) (386)
State Taxes............................................ -- -- (503) (503)
Severance and consulting agreement costs............... -- -- -- --
Provision for uncollectable mortgages and notes
receivable........................................... -- -- -- --
-------- --------- -------- ----------
(21,204) (814) (42,112) (64,130)
-------- --------- -------- ----------
Income before gain on assets sold and impairment
charges................................................ 91,554 236 (42,112) 49,678
Provision for impairment................................. -- (19,500) -- (19,500)
Loss on assets sold--net................................. -- (10,507) -- (10,507)
Preferred dividends...................................... -- -- (9,631) (9,631)
-------- --------- -------- ----------
Net loss available to common............................. $ 91,554 $ (29,771) $(51,743) $ 10,040
======== ========= ======== ==========
Total Assets............................................. $841,558 $ 106,050 $ 91,123 $1,038,731
======== ========= ======== ==========

F-33

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 18--SEGMENT INFORMATION (CONTINUED)

FOR THE YEAR ENDED DECEMBER 31, 1998
----------------------------------------------------
OWNED AND
OPERATED AND CORPORATE
CORE ASSETS HELD AND
OPERATIONS FOR SALE OTHER CONSOLIDATED
---------- ------------ --------- ------------
(IN THOUSANDS)

Operating Revenues.................................... $102,471 $ -- $ -- $ 102,471
Operating Expenses.................................... -- -- -- --
-------- --------- -------- ----------
Net operating income................................ 102,471 -- -- 102,471
Adjustments to arrive at net income:
Other revenues...................................... -- -- 6,843 6,843
Interest expense.................................... -- -- (32,436) (32,436)
Depreciation and amortization....................... (19,838) -- (1,704) (21,542)
General and administrative.......................... -- -- (4,852) (4,852)
Legal............................................... -- -- (155) (155)
State Taxes......................................... -- -- (358) (358)
Severance and consulting agreement costs............ -- -- -- --
Provision for uncollectable mortgages and notes
receivable........................................ -- -- -- --
-------- --------- -------- ----------
(19,838) -- (32,662) (52,500)
-------- --------- -------- ----------
Income before gain on assets sold and impairment
charges............................................. 82,633 -- (32,662) 49,971
Provision for impairment.............................. -- (6,800) -- (6,800)
Gain on assets sold--net.............................. 2,798 -- -- 2,798
Gain on distribution of Omega Worldwide, Inc.......... -- -- 30,240 30,240
Preferred dividends................................... -- -- (8,194) (8,194)
-------- --------- -------- ----------
Net loss available to common.......................... $ 85,431 $ (6,800) $(10,616) $ 68,015
======== ========= ======== ==========
Total Assets.......................................... $936,414 $ 35,289 $ 65,504 $1,037,207
======== ========= ======== ==========

F-34

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 18--SEGMENT INFORMATION (CONTINUED)
The revenues, expenses, assets and liabilities in the Company's consolidated
financial statements which related to owned and operated assets are as follows:

YEAR ENDED DECEMBER 31,
-----------------------
2000 1999
-------- --------
(IN THOUSANDS)

REVENUES(1)
Medicaid.............................................. $108,082 $16,636
Medicare.............................................. 31,459 4,861
Private & Other....................................... 36,018 4,726
-------- -------
Total Revenues...................................... 175,559 26,223
EXPENSES
Administration........................................ 34,264 4,925
Property & Related.................................... 11,701 1,675
Patient Care Expenses................................. 120,444 17,393
-------- -------
Total Expenses...................................... 166,409 23,993
Contribution Margin................................... 9,150 2,230
Management Fees....................................... 8,778 1,180
Rent.................................................. 3,788 --
-------- -------
EBITDA(2)............................................. $ (3,416) $ 1,050
======== =======

------------------------

(1) Nursing home revenues from these owned and operated assets are recognized as
services are provided.

(2) EBITDA represents earnings before interest, income taxes, depreciation and
amortization. It is considered by the Company to be a meaningful measure of
performance of its Owned and Operated Assets. EBITDA in and of itself does
not represent cash generated from operating activities in accordance with
GAAP and therefore should not be considered an alternative to net earnings
as an indication of operating performance or to net cash flow from operating
activities as

F-35

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 18--SEGMENT INFORMATION (CONTINUED)
determined by GAAP as a measure of liquidity and is not necessarily
indicative of cash available to fund cash needs.

DECEMBER 31,
-------------------
2000 1999
-------- --------
(IN THOUSANDS)

ASSETS
Cash $ 5,364 $ --
Accounts Receivable...................................... 30,030 9,588
Other Current Assets..................................... 5,098 60
-------- -------
Total Current Assets................................... 40,492 9,648
Investment in leasehold.................................. 1,679 --
Land and Buildings....................................... 130,601 60,810
Less Accumulated Depreciation............................ (17,680) (814)
-------- -------
Land and Buildings--Net.................................. 112,921 59,996
-------- -------
TOTAL ASSETS............................................. $155,092 $69,644
======== =======
LIABILITIES
Accounts Payable......................................... $ 8,636 $ 3,962
Other Current Liabilities................................ 6,108 8,101
-------- -------
Total Current Liabilities.............................. 14,744 12,063
-------- -------
TOTAL LIABILITIES........................................ $ 14,744 $12,063
======== =======

Accounts receivable for owned and operated assets is net of an allowance for
doubtful accounts of approximately $7 million in 2000 and $0.2 million in 1999.

F-36

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

NOTE 19--EARNINGS PER SHARE

The following tables set forth the computation of basic and diluted earnings
per share:

YEAR ENDED DECEMBER 31,
-----------------------------------------
2000 1999 1998
--------- --------- ---------
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

Numerator:
(Loss) earnings before gain (loss) on assets sold........ $(59,546) $ 30,178 $43,171
Preferred stock dividends................................ (16,928) (9,631) (8,194)
-------- -------- -------
Numerator for (loss) earnings available to common before
gain (loss) on assets sold--basic and diluted.......... (76,474) 20,547 34,977
Gain (loss) on assets sold--net.......................... 9,989 (10,507) 2,798
Gain on distribution of Omega Worldwide, Inc............. -- -- 30,240
-------- -------- -------
Numerator for net loss (earnings) per share--basic and
diluted.................................................. (66,485) 10,040 68,015
======== ======== =======
Denominator:
Denominator for net loss (earnings) per share--basic..... 20,052 19,877 20,034
Effect of dilutive securities:
Stock option incremental shares........................ -- -- 7
-------- -------- -------
Denominator for net loss (earnings) per share--diluted... 20,052 19,877 20,041
======== ======== =======

YEAR ENDED DECEMBER 31,
--------------------------------------
2000 1999 1998
-------- -------- --------

Net (loss) earnings per share--basic:
(Loss) earnings before gain (loss) on assets sold.......... $ (3.82) $ 1.04 $ 1.74
(Loss) gain on assets sold--net............................ 0.50 (0.53) 1.65
-------- -------- -------
Net (loss) earnings per share--basic....................... $ (3.32) $ 0.51 $ 3.39
======== ======== =======
Net (loss) earnings per share--diluted:
(Loss) earnings before gain (loss) on assets sold.......... $ (3.82) $ 1.04 $ 1.74
(Loss) gain on assets sold--net............................ 0.50 (0.53) 1.65
-------- -------- -------
Net (loss) earnings per share--diluted $ (3.32) $ 0.51 $ 3.39
======== ======== =======

The effect of converting the Series C Preferred Stock for the year 2000 and
the effects of converting the 1996 convertible debentures have been excluded as
all such effects are antidilutive.

F-37

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION
OMEGA HEALTHCARE INVESTORS, INC.
DECEMBER 31, 2000

GROSS AMOUNT AT
WHICH CARRIED AT
CLOSE OF PERIOD(6)
INITIAL COST ------------------
TO COMPANY
------------- COST CAPITALIZED
SUBSEQUENT TO BUILDINGS
BUILDINGS ACQUISITION AND LAND
AND LAND ---------------------------- IMPROVEMENTS
DESCRIPTION(1) ENCUMBRANCES IMPROVEMENTS IMPROVEMENTS IMPAIRMENT TOTAL
-------------- ------------- ------------- ------------- ------------ ------------------

Sun Healthcare Group, Inc.:
Alabama (LTC)................... $ 23,584,957 $ 23,584,957
California (LTC, RH)............ (4)(5) 65,912,924 65,912,924
Florida (LTC)................... 10,796,688 10,796,688
Florida (LTC)................... 10,700,000 10,700,000
Idaho (LTC)..................... 600,000 600,000
Illinois (LTC).................. 4,900,000 4,900,000
Illinois (LTC).................. 3,942,726 3,942,726
Indiana (LTC)................... 3,000,000 3,000,000
Louisiana (LTC)................. 4,602,574 4,602,574
Massachusetts (LTC)............. 8,300,000 8,300,000
North Carolina (LTC)............ (4) 19,970,418 19,970,418
North Carolina (LTC)............ (5) 2,739,021 2,739,021
Ohio (LTC)...................... (4)(5) 11,884,567 11,884,567
Tennessee (LTC)................. (2) 7,942,374 7,942,374
Texas (LTC)..................... 9,415,056 9,415,056
Washington (LTC)................ (4) 5,900,000 5,900,000
West Virginia (LTC)............. (4)(5) 24,793,444 24,793,444
------------ ---------- ------------ ------------
218,984,749 218,984,749
Integrated Health Services, Inc.:
Florida (LTC)................... (5) 10,000,000 10,000,000
Florida (LTC)................... 29,000,000 29,000,000
Illinois (LTC).................. (5) 14,700,000 14,700,000
New Hampshire (LTC)............. (5) 5,800,000 5,800,000
Ohio (LTC)...................... (5) 16,000,000 16,000,000
Pennsylvania (LTC).............. (5) 14,400,000 14,400,000
Pennsylvania (LTC).............. 5,500,000 5,500,000
Washington (LTC)................ 10,000,000 10,000,000
------------ ---------- ------------ ------------
105,400,000 105,400,000
Advocat, Inc.:
Alabama (LTC)................... (4) 11,638,797 707,998 12,346,795
Arkansas (LTC).................. (4) 37,887,832 1,473,599 39,361,431
Kentucky (LTC).................. (4) 14,897,402 1,816,000 16,713,402
Ohio (LTC)...................... (4) 5,854,186 5,854,186
Tennessee (LTC)................. (2) 9,542,121 9,542,121
West Virginia (LTC)............. (4) 5,283,525 502,338 5,785,863
------------ ---------- ------------ ------------
85,103,863 4,499,935 89,603,798

LIFE ON WHICH
DEPRECIATION IN
(7) LATEST INCOME
ACCUMULATED DATE OF DATE STATEMENTS
DESCRIPTION(1) DEPRECIATION RENOVATION ACQUIRED IS COMPUTED
-------------- ------------ ---------- ------------------ ---------------

Sun Healthcare Group, Inc.: 1964-1995
Alabama (LTC)................... $ 2,549,186 March 31, 1997 33 years
California (LTC, RH)............ 5,913,927 October 8, 1997 33 years
Florida (LTC)................... 1,166,963 March 31, 1997 33 years
Florida (LTC)................... 1,182,106 February 28, 1997 33 years
Idaho (LTC)..................... 66,286 February 28, 1997 33 years
Illinois (LTC).................. 673,130 August 30, 1996 30 years
Illinois (LTC).................. 426,151 March 31, 1997 33 years
Indiana (LTC)................... 412,120 August 30, 1996 30 years
Louisiana (LTC)................. 497,470 March 31, 1997 33 years
Massachusetts (LTC)............. 916,961 February 28, 1997 33 years
North Carolina (LTC)............ 3,936,793 June 4, 1994 39 years
North Carolina (LTC)............ 250,496 October 8, 1997 33 years
Ohio (LTC)...................... 1,070,766 October 8, 1997 33 years
Tennessee (LTC)................. 1,569,783 September 30, 1994 30 years
Texas (LTC)..................... 1,017,629 March 31, 1997 33 years
Washington (LTC)................ 650,949 March 31, 1997 33 years
West Virginia (LTC)............. 2,196,026 October 8, 1997 33 years
-----------
24,496,742
Integrated Health Services, Inc.: 1979-1993
Florida (LTC)................... 792,958 January 13, 1998 33 years
Florida (LTC)................... 2,361,040 March 31, 1998 33 years
Illinois (LTC).................. 1,221,821 January 13, 1998 33 years
New Hampshire (LTC)............. 495,564 January 13, 1998 33 years
Ohio (LTC)...................... 1,268,733 March 31, 1998 33 years
Pennsylvania (LTC).............. 1,230,365 January 13, 1998 33 years
Pennsylvania (LTC).............. 436,127 March 31, 1998 33 years
Washington (LTC)................ 2,118,746 September 1, 1996 20 years
-----------
9,925,354
Advocat, Inc.: 1972-1994
Alabama (LTC)................... 3,015,242 August 14, 1992 31.5 years
Arkansas (LTC).................. 9,842,102 August 14, 1992 31.5 years
Kentucky (LTC).................. 2,798,615 July 1, 1994 33 years
Ohio (LTC)...................... 970,874 July 1, 1994 33 years
Tennessee (LTC)................. 2,449,079 August 14, 1992 31.5 years
West Virginia (LTC)............. 975,555 July 1, 1994 33 years
-----------
20,051,467

F-38

Vencor Operating, Inc.:
Arizona (LTC)................... 24,029,032 44,924 (6,603,745) 17,470,211
Indiana (LTC)................... 8,383,671 100,914 (1,820,624) 6,663,961
Texas (LTC)..................... 27,141,483 84,323 27,225,806
------------ ---------- ------------ ------------
59,554,186 230,161 (8,424,369) 51,359,978
Genesis Health Ventures, Inc.:
Connecticut (LTC)............... 28,483,164 185,670 (4,787,084) 23,881,750
Massachusetts (LTC)............. 34,559,901 421,567 (10,506,822) 24,474,646
------------ ---------- ------------ ------------
63,043,065 607,237 (15,293,906) 48,356,396
Alterra Healthcare Corporation:
Colorado (AL)................... 2,583,440 2,583,440
Indiana (AL).................... 11,641,805 11,641,805
Kansas (AL)..................... 3,418,670 3,418,670
Ohio (AL)....................... 3,520,747 3,520,747
Oklahoma (AL)................... 3,177,993 3,177,993
Tennessee (AL).................. 4,068,652 4,068,652
Washington (AL)................. 5,673,693 5,673,693
------------ ---------- ------------ ------------
34,085,000 34,085,000
Alden Management Services, Inc.:
Illinois (LTC).................. 31,000,000 305,756 31,305,756

Atrium Living Centers, Inc.:
Indiana (LTC)................... 25,693,563 47,216 (12,846,628) 12,894,151
Indiana (LTC)................... 6,456,391 26,464 (2,773,242) 3,709,613
------------ ---------- ------------ ------------
32,149,954 73,680 (15,619,870) 16,603,764
TLC Healthcare, Inc.:
Illinois (LTC).................. (5) 1,274,703 1,274,703
Illinois (LTC).................. (5) 5,118,775 5,118,775
Ohio (LTC)...................... (5) 2,804,347 2,804,347
Texas (LTC)..................... (5) 4,942,000 4,942,000
Texas (LTC)..................... (5) 6,557,143 6,557,143
Texas (LTC)..................... (5) 2,442,858 2,442,858
------------ ---------- ------------ ------------
23,139,826 23,139,826
USA Healthcare, Inc.:
Iowa(LTC)....................... 14,344,797 168,000 14,512,797
Iowa(LTC)....................... 2,700,000 2,700,000
------------ ---------- ------------ ------------
17,044,797 168,000 17,212,797

Vencor Operating, Inc.: 1980-1994
Arizona (LTC)................... 1,327,091 December 31, 1998 33 years
Indiana (LTC)................... 1,997,691 December 23, 1992 31.5 years
Texas (LTC)..................... 3,165,920 December 1, 1993 39 years
-----------
6,490,702
Genesis Health Ventures, Inc.:
Connecticut (LTC)............... 1,143,510 July 14, 1999 33 years
Massachusetts (LTC)............. 1,373,516 July 14, 1999 33 years
-----------
2,517,026
Alterra Healthcare Corporation:
Colorado (AL)................... 115,241 June 14, 1999 33 years
Indiana (AL).................... 519,313 June 14, 1999 33 years
Kansas (AL)..................... 152,499 June 14, 1999 33 years
Ohio (AL)....................... 157,052 June 14, 1999 33 years
Oklahoma (AL)................... 141,763 June 14, 1999 33 years
Tennessee (AL).................. 181,493 June 14, 1999 33 years
Washington (AL)................. 253,090 June 14, 1999 33 years
-----------
1,520,451
Alden Management Services, Inc.: 1978
Illinois (LTC).................. 6,378,152 September 30, 1994 30 years
Atrium Living Centers, Inc.:
Indiana (LTC)................... 5,621,697 September 30, 1994 25 years
Indiana (LTC)................... 2,233,127 November 1, 1992 31.5 years
-----------
7,854,824
TLC Healthcare, Inc.: 1972-1996
Illinois (LTC).................. 72,217 January 7, 1999 33 years
Illinois (LTC).................. 228,336 June 1, 1999 33 years
Ohio (LTC)...................... 154,298 January 7, 1999 33 years
Texas (LTC)..................... 220,451 June 30, 1999 33 years
Texas (LTC)..................... 627,086 September 5, 1997 33 years
Texas (LTC)..................... 198,479 March 4, 1998 33 years
-----------
1,500,867
USA Healthcare, Inc.: 1974-1997
Iowa(LTC)....................... 1,267,902 October 7, 1997 33 years
Iowa(LTC)....................... 370,908 August 30, 1996 30 years
-----------
1,638,810

F-39

Pinon Management, Inc.:
Colorado (LTC).................. 14,170,968 109,931 14,280,899
Washington N & R, LLC.:
Missouri (LTC).................. (5) 12,152,174 12,152,174
Peak Medical of Idaho, Inc.:
Idaho (LTC)..................... (5) 10,500,000 10,500,000
HQM of Floyd County, Inc.:
Kentucky (LTC).................. (5) 10,250,000 10,250,000
Safe Harbor Florida Health Care
Properties, Inc.:
Florida (LTC)................... 8,150,000 866 8,150,866
Meadowbrook Healthcare of North
Carolina:
North Carolina (AL)............. (3) 7,500,000 (1,939,476) 5,560,524
Liberty Assisted Living Center:
Florida (AL).................... 5,994,730 760 5,995,490
Eldorado Care Center, Inc. &
Magnolia Manor, Inc.:
Illinois (LTC).................. 5,100,000 5,100,000
Kansas & Missouri, Inc.:
Kansas (LTC).................... 2,500,000 2,500,000
------------ ---------- ------------ ------------
$745,823,312 $5,996,326 ($41,277,621) $710,542,017
============ ========== ============ ============

Pinon Management, Inc.:
Colorado (LTC).................. 817,633 December 31, 1998 33 years
Washington N & R, LLC.:
Missouri (LTC).................. 690,758 January 7, 1999 33 years
Peak Medical of Idaho, Inc.:
Idaho (LTC)..................... 544,512 March 26, 1999 33 years
HQM of Floyd County, Inc.:
Kentucky (LTC).................. 358,673 June 30, 1997 33 years
Safe Harbor Florida Health Care
Properties, Inc.: 1984
Florida (LTC)................... 1,384,872 September 13, 1993 39 years
Meadowbrook Healthcare of North
Carolina:
North Carolina (AL)............. 1,444,027 September 30, 1994 31.5 years
Liberty Assisted Living Center:
Florida (AL).................... 1,464,958 September 30, 1994 27 years
Eldorado Care Center, Inc. &
Magnolia Manor, Inc.: 1995-1998
Illinois (LTC).................. 276,157 February 1, 1999 33 years
Kansas & Missouri, Inc.:
Kansas (LTC).................... 513,922 September 30, 1994 30 years
-----------
$89,869,907
===========

F-40

(1) All of the real estate included in this schedule are being used in either
the operation of long-term care facilities (LTC), assisted living facilities
(AL), or rehabilitation hospitals (RH) located in the states indicated.

(2) Certain of the real estate indicated are security for Industrial Development
Revenue bonds totaling $8,375,000 at December 31, 2000.

(3) Certain of the real estate indicated are security for HUD loans totaling
$5,218,497 at December 31, 2000.

(4) Certain of the real estate indicated are security for the Provident line of
credit borrowings totaling $56,641,232 at December 31, 2000.

(5) Certain of the real estate indicated are security for the Fleet line of
credit borrowings totaling $129,000,000 at December 31, 2000.

YEAR ENDED DECEMBER 31,
------------------------------------------
1998 1999 2000
(6) ------------ ------------ ------------

Balance at beginning of period.................... $561,054,194 $643,378,340 $746,914,941
Additions during period:
Acquisitions................................... 157,474,363 79,676,000 --
Conversion from mortgage....................... -- 79,431,597 --
Impairment(a).................................. -- -- (37,456,499)
Improvements................................... -- 168,000 1,302,828
Disposals/other................................ (75,150,217) (55,738,996) (219,253)
------------ ------------ ------------
Balance at close of period....................... $643,378,340 $746,914,941 $710,542,017
============ ============ ============

(a) The variance in impairment in the table shown above relates to assets
previously classified as held for sale which were reclassified to owned
and operated assets during 2000.

1998 1999 2000
(7) ------------ ----------- -----------

Balance at beginning of period...................... $ 48,147,275 $56,385,853 $67,929,407
Additions during period:
Provisions for depreciation....................... 19,749,781 21,119,252 21,683,180
Dispositions/other................................ (11,511,203) (9,575,698) 257,320
------------ ----------- -----------
Balance at close of period.......................... $ 56,385,853 $67,929,407 $89,869,907
============ =========== ===========

F-41

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE
OMEGA HEALTHCARE INVESTORS, INC.
DECEMBER 31, 2000

FACE
FINAL PERIODIC PRIOR AMOUNT OF
DESCRIPTION (1) INTEREST RATE MATURITY DATE PAYMENT TERMS LIENS MORTGAGES
--------------- ---------------- ------------------ ------------------------- -------- ------------

Michigan Interest payable at
(13 LTC facilities)............. 17.00% August 13, 2007 16.00% payable monthly None $ 58,800,000
North Carolina
(3 LTC facilities).............. Deferred interest at 1%
accrues monthly and is
payable at maturity of
the note
Florida
(4 LTC facilities).............. 11.50% February 28, 2010 Interest plus $2,200 of None 12,891,500
principal payable monthly
Florida
(2 LTC facilities).............. 11.50% June 4, 2006 Interest payable monthly None 11,090,000
Texas
(6 LTC facilities).............. 9.00% to 10.00% various Interest plus $57,000 of None 8,106,487
principal payable monthly
Tennessee
(2 LTC facilities).............. 16.16% April 29, 2001 Interest payable monthly None 8,932,000
Tennessee
(2 LTC facilities).............. 11.56% to 13.50% August 1, 2016 Interest payable monthly None 12,650,000
Ohio
(6 LTC facilities).............. 11.01% January 1, 2015 Interest plus $42,500 of None 18,238,752
principal payable monthly
Georgia
(2 LTC facilities).............. 10.08% March 13, 2008 Interest payable monthly None 12,000,000
Florida
(5 LTC facilities)
Texas
(2 LTC facilities).............. 10.55% December 3, 2003 Interest payable monthly None 37,500,000
Other Mortgage Notes:
Various........................... 9.00% to 14.14% 2002 to 2012 Interest payable monthly None 37,503,181
Quarterly amortization of
$50,000 commencing in the
year 2002
------------
$217,711,920
============

PRINCIPAL AMOUNT
CARRYING OF LOANS
AMOUNT OF SUBJECT TO
MORTGAGES(2) DELINQUENT
DESCRIPTION (1) (3) INTEREST
--------------- ------------ ----------------

Michigan
(13 LTC facilities)............. $58,800,000 $58,800,000(4)
North Carolina
(3 LTC facilities)..............
Florida
(4 LTC facilities).............. 12,804,956
Florida
(2 LTC facilities).............. 11,024,884
Texas
(6 LTC facilities).............. 5,951,566
Tennessee
(2 LTC facilities).............. 8,932,000
Tennessee
(2 LTC facilities).............. 12,613,539
Ohio
(6 LTC facilities).............. 16,198,689
Georgia
(2 LTC facilities).............. 12,000,000
Florida
(5 LTC facilities)
Texas
(2 LTC facilities).............. 37,500,000
Other Mortgage Notes:
Various........................... 30,883,936 $ 5,882,009(5)
------------
$206,709,570
============

(1) The mortgage loans included in this schedule represent first mortgages on
facilities used in the delivery of long-term healthcare, such facilities are
located in the states indicated.

(2) The aggregate cost for federal income tax purposes is equal to the carrying
amount.

YEAR ENDED DECEMBER 31,
------------------------------------------
1998 1999 2000
(3) ------------ ------------ ------------

Balance at beginning of period..................... $218,353,007 $340,455,332 $213,616,645
Additions during period -- Placements.............. 125,850,000 22,986,500 --
Deductions during period -- Collection of
principal........................................ (3,747,675) (54,748,620) (2,035,825)
Allowance for loss on mortgage loans............... -- -- (4,871,250)
Conversion to purchase leaseback/other changes..... -- (95,076,567) --
------------ ------------ ------------
Balance at close of period......................... $340,455,332 $213,616,645 $206,709,570
============ ============ ============

(4) On January 18, 2000, the mortgagor filed for protection under Chapter 11 of
the Bankruptcy Code. On February 1 2001, four facilities that were
collateral for this mortgage were taken back in exchange for a reduction in
principal of $4.5 million.

(5) A mortgagor with a mortgage on two facilities in Florida declared bankruptcy
on July 8, 1999. The bankruptcy court has ordered that all amounts owed to
the Company (including default rate interest, late charges, attorney's fees
and court costs), bear interest at an annual rate of 10% and that the
mortgagor make monthly payments of $40,000 on a timely basis. As of
December 31, 2000, the mortgagor had complied with the court order.

F-42

OMEGA HEALTHCARE INVESTORS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

SEPTEMBER 30, DECEMBER 31,
2001 2000
------------- ------------
(UNAUDITE(SEE NOTE)

ASSETS
Real estate properties
Land and buildings at cost................................ $ 701,370 $710,542
Less accumulated depreciation............................. (101,861) (89,870)
--------- --------
Real estate properties--net............................. 599,509 620,672
Mortgage notes receivable--net............................ 185,861 206,710
--------- --------
785,370 827,382
Other investments........................................... 47,818 53,242
--------- --------
833,188 880,624
Assets held for sale--net................................... 7,377 4,013
--------- --------
Total Investments....................................... 840,565 884,637
Cash and cash equivalents................................... 14,145 7,172
Accounts receivable......................................... 6,881 10,497
Other assets................................................ 3,789 9,338
Operating assets for owned properties....................... 45,885 36,807
--------- --------
Total Assets............................................ $ 911,265 $948,451
========= ========
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving lines of credit................................... $ 203,641 $185,641
Unsecured borrowings........................................ 199,641 225,000
Other long-term borrowings.................................. 22,755 24,161
Subordinated convertible debentures......................... -- 16,590
Accrued expenses and other liabilities...................... 16,708 18,002
Operating liabilities for owned properties.................. 11,861 14,744
--------- --------
Total Liabilities....................................... 454,606 484,138

Preferred Stock............................................. 212,342 207,500
Common stock and additional paid-in capital................. 440,392 440,556
Cumulative net earnings..................................... 171,272 182,548
Cumulative dividends paid................................... (365,654) (365,654)
Unamortized restricted stock awards......................... (202) (607)
Accumulated other comprehensive loss........................ (1,491) (30)
--------- --------
Total Stockholders' Equity.............................. 456,659 464,313
--------- --------
Total Liabilities and Stockholders' Equity.............. $ 911,265 $948,451
========= ========

--------------------------

Note--The balance sheet at December 31, 2000, has been derived from the audited
consolidated financial statements at that date but does not include all of the
information and footnotes required by generally accepted accounting principles
in the United States for complete financial statements.

See notes to condensed consolidated financial statements.

F-43

OMEGA HEALTHCARE INVESTORS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

UNAUDITED

(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

THREE MONTHS NINE MONTHS
ENDED ENDED
SEPTEMBER 30, SEPTEMBER 30,
------------------- -------------------
2001 2000 2001 2000
-------- -------- -------- --------

REVENUES
Rental income............................................. $ 14,936 $ 15,503 $ 45,686 $ 49,652
Mortgage interest income.................................. 5,130 5,888 16,343 17,800
Other investment income--net.............................. 1,374 534 3,640 4,277
Nursing home revenues of owned and operated assets........ 43,820 45,960 133,613 123,461
Miscellaneous............................................. 1,575 126 2,384 483
-------- -------- -------- --------
66,835 68,011 201,666 195,673
EXPENSES
Nursing home expenses of owned and operated assets........ 44,439 48,552 134,565 126,436
Depreciation and amortization............................. 5,515 5,657 16,560 17,385
Interest.................................................. 9,124 9,846 28,039 32,221
General and administrative................................ 2,203 1,830 7,707 4,631
Legal..................................................... 1,145 481 2,862 974
State taxes............................................... 126 15 339 241
Litigation settlement expense............................. -- -- 10,000 --
Provision for impairment.................................. -- 49,849 8,381 54,349
Provision for uncollectable accounts...................... 19 12,100 700 12,100
Severance, moving and consulting agreement costs.......... 4,300 4,665 4,766 4,665
Charges for derivative accounting......................... 561 -- 1,113 --
-------- -------- -------- --------
67,432 132,995 215,032 253,002
-------- -------- -------- --------
Loss before (loss) gain on assets sold and gain on early
extinguishment of debt.................................... (597) (64,984) (13,366) (57,329)
(Loss) gain on assets sold--net (1,485) (109) (873) 10,342
Gain on early extinguishment of debt........................ 226 -- 2,963 --
-------- -------- -------- --------
Net loss.................................................... (1,856) (65,093) (11,276) (46,987)
Preferred stock dividends................................... (5,029) (5,705) (14,966) (10,520)
-------- -------- -------- --------
Net loss available to common................................ $ (6,885) $(70,798) $(26,242) $(57,507)
======== ======== ======== ========
Loss per common share:
Net loss per share--basic................................. $ (0.34) $ (3.53) $ (1.31) $ (2.87)
======== ======== ======== ========
Net loss per share--diluted............................... $ (0.34) $ (3.53) $ (1.31) $ (2.87)
======== ======== ======== ========
Net loss per common share before gain on early
extinguishment of debt:
Net loss per share--basic................................. $ (0.35) $ (3.53) $ (1.46) $ (2.87)
Net loss per share--diluted............................... $ (0.35) $ (3.53) $ (1.46) $ (2.87)
Dividends declared and paid per common share................ $ -- $ 0.25 $ -- $ 0.75
======== ======== ======== ========
Weighted Average Shares Outstanding, Basic.................. 20,071 20,064 20,032 20,058
======== ======== ======== ========
Weighted Average Shares Outstanding, Diluted................ 20,071 20,064 20,032 20,058
======== ======== ======== ========
Other comprehensive loss:
Unrealized Loss on Omega Worldwide, Inc................... $ (814) $ (1,745) $ (567) $ (2,944)
======== ======== ======== ========
Unrealized Loss on Hedging Contracts...................... $ (458) $ -- $ (894) $ --
======== ======== ======== ========
Total comprehensive loss.................................... $ (3,128) $(66,838) $(12,737) $(49,931)
======== ======== ======== ========

See notes to condensed consolidated financial statements.

F-44

OMEGA HEALTHCARE INVESTORS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

UNAUDITED

(IN THOUSANDS)

NINE MONTHS ENDED
SEPTEMBER 30,
-------------------
2001 2000
-------- --------

OPERATING ACTIVITIES
Net loss.................................................. $(11,276) $(46,987)
Adjustment to reconcile net loss to cash provided by
operating activities:
Depreciation and amortization........................... 16,560 17,385
Provision for impairment................................ 8,381 54,349
Provision for collection losses......................... 700 12,100
Loss (Gain) on assets sold--net......................... 873 (10,342)
Gain on early extinguishment of debt.................... (2,963) --
Other................................................... 3,291 2,078
Net change in accounts receivable for Owned & Operated
assets--net............................................... (8,120) (17,087)
Net change in accounts payable for Owned & Operated
assets.................................................... (3,776) 5,421
Net change in other Owned & Operated assets and
liabilities............................................... (97) (12,723)
Net change in operating assets and liabilities.............. 3,875 (3,383)
-------- --------

Net cash provided by operating activities................... 7,448 811

CASH FLOW FROM FINANCING ACTIVITIES
Proceeds of revolving lines of credit--net.................. 18,000 25,041
Payments of long-term borrowings............................ (43,355) (121,447)
Receipts from Dividend Reinvestment Plan.................... 29 430
Dividends paid.............................................. -- (22,253)
Proceeds from preferred stock offering...................... -- 100,000
Deferred financing costs paid............................... (852) (4,976)
Other....................................................... (45) (9,339)
-------- --------
Net cash used in financing activities....................... (26,223) (32,544)

CASH FLOW FROM INVESTING ACTIVITIES
Proceeds from sale of real estate investments--net.......... 1,514 35,793
Fundings of other investments--net.......................... 1,444 (5,507)
Collection of mortgage principal............................ 22,790 1,632
-------- --------
Net cash provided by investing activities................... 25,748 31,918
-------- --------
Increase in cash and cash equivalents....................... 6,973 185
Cash and cash equivalents at beginning of period............ 7,172 4,105
-------- --------
Cash and cash equivalents at end of period.................. $ 14,145 $ 4,290
======== ========

See notes to condensed consolidated financial statements.

F-45

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE A--BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements for
Omega Healthcare Investors, Inc. (the "Company") have been prepared in
accordance with generally accepted accounting principles in the United States
for interim financial information and with the instructions to Form 10-Q and
Article 10 of Regulation S-X. Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting principles
for complete financial statements. In the opinion of management, all adjustments
(consisting of normal recurring accruals and impairment provisions to adjust the
carrying value of assets) considered necessary for a fair presentation have been
included. Certain reclassifications have been made to the 2000 financial
statements for consistency with the current presentation. Such reclassifications
have no effect on previously reported earnings or equity. Operating results for
the three-month and nine-month periods ended September 30, 2001 are not
necessarily indicative of the results that may be expected for the year ending
December 31, 2001. For further information, refer to the financial statements
and footnotes thereto included in the Company's annual report on Form 10-K for
the year ended December 31, 2000.

NOTE B--PROPERTIES

In the ordinary course of its business activities, the Company periodically
evaluates investment opportunities and extends credit to customers. It also
regularly engages in lease and loan extensions and modifications. Additionally,
the Company actively monitors and manages its investment portfolio with the
objectives of improving credit quality and increasing returns. In connection
with portfolio management, the Company engages in various collection and
foreclosure activities.

When the Company acquires real estate pursuant to a foreclosure, lease
termination or bankruptcy proceeding, and does not immediately re-lease the
properties to new operators, the assets are included on the balance sheet as
"real estate properties," and the value of such assets is reported at the lower
of cost or fair value. (See "Owned and Operated Assets" below). Additionally,
when a formal plan to sell real estate is adopted, the real estate is classified
as "Assets Held for Sale," with the net carrying amount adjusted to the lower of
cost or fair value, less cost of disposal.

Based on management's current review of the Company's portfolio, a provision
for impairment on the value of assets held for sale of $8.4 million was recorded
for the nine-month period ended September 30, 2001. This provision relates to
additional properties that were added to Assets Held for Sale during the
three-month period ended June 30, 2001 as a result of the foreclosure of assets
leased by a defaulting customer during that quarter.

F-46

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE B--PROPERTIES (CONTINUED)
A summary of the number of properties by category for the quarter ended
September 30, 2001 follows:

TOTAL
PURCHASE / OWNED & HEALTHCARE
FACILITY COUNT LEASEBACK MORTGAGES OPERATED FACILITIES HELD FOR SALE TOTAL
-------------- ---------- --------- -------- ---------- ------------- --------

Balance at June 30, 2001............. 129 57 63 249 9 258
Properties transferred to Held for
Sale............................... -- -- (2) (2) 2 --
Properties transferred to Owned &
Operated........................... -- -- -- -- -- --
Properties Sold / Mortgages Paid..... -- -- (1) (1) (1) (2)
Properties Leased / Mortgages
Placed............................. -- -- -- -- -- --
Properties transferred to Purchase/
Leaseback.......................... 2 (2) -- -- -- --
-------- -------- -------- -------- ------- --------
Balance at September 30, 2001........ 131 55 60 246 10 256
======== ======== ======== ======== ======= ========

GROSS INVESTMENT ($000'S)
-------------------------
Balance at June 30, 2001. $ 581,468 $ 180,768 $121,368 $ 883,604 $ 5,698 $889,302

Properties transferred to Held for
Sale............................... -- -- (2,230) (2,230) 2,230 --
Properties transferred to Owned &
Operated........................... -- -- -- -- -- --
Properties Sold / Mortgages Paid..... -- -- (3,404) (3,404) (149) (3,553)
Properties Leased / Mortgages
Placed............................. -- 9,360 -- 9,360 -- 9,360
Properties transferred to Purchase /
Leaseback.......................... 3,900 (3,900) -- -- -- --
Capex and other...................... -- (367) 268 (99) (402) (501)
-------- -------- -------- -------- ------- --------
Balance at September 30, 2001........ $585,368 $185,861 $116,002 $887,231 $ 7,377 $894,608
======== ======== ======== ======== ======= ========

REAL ESTATE DISPOSITIONS

The Company disposed of two facilities during the three-month period ended
September 30, 2001. One facility, located in Texas, had a total of 120 beds and
was classified as Owned & Operated Assets. The Company recognized a loss on
disposition of this facility of $1.5 million. The other facility, located in
Indiana, was classified as Assets Held for Sale. The Company recognized a net
gain on disposition of assets during the nine-month period ended September 30,
2000 of $10.3 million. The net gain was comprised of a $10.9 million gain on the
sale of four facilities previously leased to Tenet Healthsystem
Philadelphia, Inc., offset by a loss of $0.6 million on the sale of a 57 bed
facility in Colorado.

NOTES AND MORTGAGES RECEIVABLE

Income on notes and mortgages that are impaired will be recognized as cash
is received. During the nine-month period ended September 30, 2000 the Company
recorded a charge of $12.1 million to provision for loss on mortgages
($4.9 million) and notes receivable ($7.2 million).

F-47

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE B--PROPERTIES (CONTINUED)
OWNED AND OPERATED ASSETS

The Company owns 60 facilities that were recovered from customers and are
operated for the Company's own account. These facilities have 4,701 beds and are
located in nine states. During the three-month period ended September 30, 2001,
one of the Company's previously Owned and Operated facilities was sold and two
were closed and reclassified to Assets Held for Sale.

The Company intends to operate these owned and operated assets for its own
account until such time as these facilities' operations are stabilized and are
re-leasable or saleable at lease rates or sale prices that maximize the value of
these assets to the Company. As a result, these facilities and their respective
operations are presented on a consolidated basis in the Company's financial
statements. See Note J--"Subsequent Events."

The revenues, expenses, assets and liabilities included in the Company's
condensed consolidated financial statements which relate to such owned and
operated assets are set forth in the table below. Nursing home revenues from
these owned and operated assets are recognized as services are provided. The
amounts shown in the condensed consolidated financial statements are not
comparable, as the number of Owned and Operated facilities and the timing of the
foreclosures and re-leasing activities have occurred at different times during
the periods presented.

THREE MONTHS NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
------------------- -------------------
2001 2000 2001 2000
-------- -------- -------- --------
UNAUDITED
(IN THOUSANDS)

Revenues (1)
Medicaid.............................................. $27,084 $29,176 $ 80,645 $ 75,535
Medicare.............................................. 10,074 8,646 32,588 21,896
Private & Other....................................... 6,662 8,138 20,380 26,030
------- ------- -------- --------
Total Revenues...................................... 43,820 45,960 133,613 123,461
Expenses
Patient Care Expenses................................. 30,917 28,782 93,638 78,885
Administration........................................ 7,246 13,171 21,423 30,613
Property & Related.................................... 3,092 3,084 9,052 7,955
------- ------- -------- --------
Total Expenses...................................... 41,255 45,037 124,113 117,453
Contribution Margin................................... 2,565 923 9,500 6,008
Management Fees....................................... 2,217 2,337 7,084 6,235
Rent.................................................. 967 1,178 3,368 2,748
------- ------- -------- --------
Net Operating Loss.................................... $ (619) $(2,592) $ (952) $ (2,975)
======= ======= ======== ========

F-48

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE B--PROPERTIES (CONTINUED)

SEPTEMBER 30, DECEMBER 31,
2001 2000
------------- ------------
UNAUDITED
(IN THOUSANDS)

ASSETS
Cash........................................................ $ 8,826 $ 5,364
Accounts Receivable--Net.................................... 38,150 30,030
Other Current Assets........................................ 6,013 5,098
-------- --------
Total Current Assets........................................ 52,989 40,492
Investment in leasehold..................................... 1,722 1,679
Land and Buildings.......................................... 116,002 130,601
Less Accumulated Depreciation............................... (17,043) (17,680)
-------- --------
Land and Buildings--Net..................................... 98,959 112,921
-------- --------
TOTAL ASSETS................................................ $153,670 $155,092
======== ========
LIABILITIES
Accounts Payable............................................ $ 4,861 $ 8,636
Other Current Liabilities................................... 6,967 6,108
-------- --------
Total Current Liabilities................................... 11,828 14,744
-------- --------
TOTAL LIABILITIES........................................... $ 11,828 $ 14,744
======== ========

ASSETS HELD FOR SALE

At September 30, 2001, the carrying value of assets held for sale totals
$7.4 million (net of impairment reserves of $15.9 million). The Company intends
to sell the remaining facilities as soon as practicable. There can be no
assurance if or when such sales will be completed or whether such sales will be
completed on terms that allow the Company to realize the carrying value of the
assets.

F-49

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE B--PROPERTIES (CONTINUED)

SEGMENT INFORMATION

The following tables set forth the reconciliation of operating results and
total assets for the Company's reportable segments for the three and nine-month
periods ended September 30, 2001 and 2000.

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2001
----------------------------------------------------
OWNED AND
OPERATED AND
CORE ASSETS HELD CORPORATE
OPERATIONS FOR SALE AND OTHER CONSOLIDATED
---------- ------------ --------- ------------
(IN THOUSANDS)

Operating Revenues.......................................... $ 20,066 $ 43,820 $ -- $ 63,886
Operating Expenses.......................................... -- (44,439) -- (44,439)
-------- -------- -------- ----------
Net operating income (loss)............................... 20,066 (619) -- 19,447
Adjustments to arrive at net income (loss):
Other revenues............................................ -- -- 2,949 2,949
Depreciation and amortization............................. (4,273) (1,018) (224) (5,515)
Interest expense.......................................... -- -- (9,124) (9,124)
General and administrative................................ -- -- (2,203) (2,203)
Legal..................................................... -- -- (1,145) (1,145)
State Taxes............................................... -- -- (126) (126)
Litigation settlement expense............................. -- -- -- --
Provision for impairment.................................. -- -- -- --
Provision for uncollectable accounts...................... (19) -- -- (19)
Severance, moving and consulting agreement costs.......... -- -- (4,300) (4,300)
Charges for derivative accounting......................... -- -- (561) (561)
-------- -------- -------- ----------
(4,292) (1,018) (14,734) (20,044)
-------- -------- -------- ----------
Income (loss) before net loss on assets sold and gain on
early extinguishment of debt.............................. 15,774 (1,637) (14,734) (597)
Loss on assets sold--net.................................... -- (1,485) -- (1,485)
Gain on early extinguishment of debt........................ -- -- 226 226
Preferred dividends......................................... -- -- (5,029) (5,029)
-------- -------- -------- ----------
Net income (loss) available to common....................... $ 15,774 $ (3,122) $(19,537) $ (6,885)
======== ======== ======== ==========
Total Assets................................................ $686,411 $161,047 $ 63,807 $ 911,265
======== ======== ======== ==========

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2000
----------------------------------------------------
OWNED AND
OPERATED AND
CORE ASSETS HELD CORPORATE
OPERATIONS FOR SALE AND OTHER CONSOLIDATED
---------- ------------ --------- ------------
(IN THOUSANDS)

Operating Revenues.......................................... $ 21,391 $ 45,960 $ -- $ 67,351
Operating Expenses.......................................... -- (48,552) -- (48,552)
-------- -------- -------- ----------
Net operating income (loss)............................... 21,391 (2,592) -- 18,799
Adjustments to arrive at net income (loss):
Other revenues............................................ -- -- 660 660
Depreciation and amortization............................. (4,302) (967) (388) (5,657)
Interest expense.......................................... -- -- (9,846) (9,846)
General and administrative................................ -- -- (1,830) (1,830)
Legal..................................................... -- -- (481) (481)
State Taxes............................................... -- -- (15) (15)
Provision for impairment.................................. (1,940) (47,909) -- (49,849)
Provision for uncollectable accounts...................... (12,100) -- -- (12,100)
Severance and consulting agreement costs.................. -- -- (4,665) (4,665)
-------- -------- -------- ----------
(18,342) (48,876) (16,565) (83,783)
-------- -------- -------- ----------

F-50

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE B--PROPERTIES (CONTINUED)

Income (loss) before net loss on assets sold................ 3,049 (51,468) (16,565) (64,984)
Loss on assets sold--net.................................... (109) -- -- (109)
Preferred dividends......................................... -- -- (5,705) (5,705)
-------- -------- -------- ----------
Net income (loss) available to common....................... $ 2,940 $(51,468) $(22,270) $ (70,798)
======== ======== ======== ==========
Total Assets................................................ $719,848 $166,038 $ 78,803 $ 964,689
======== ======== ======== ==========

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2001
----------------------------------------------------
OWNED AND
OPERATED AND CORPORATE
CORE ASSETS HELD AND
OPERATIONS FOR SALE OTHER CONSOLIDATED
---------- ------------ --------- ------------
(IN THOUSANDS)

Operating Revenues.................................... $ 62,029 $133,613 $ -- $ 195,642
Operating Expenses.................................... -- (134,565) -- (134,565)
-------- -------- -------- ----------
Net operating income (loss)......................... 62,029 (952) -- 61,077
Adjustments to arrive at net income (loss):
Other revenues...................................... -- -- 6,024 6,024
Depreciation and amortization....................... (12,941) (2,950) (669) (16,560)
Interest expense.................................... -- -- (28,039) (28,039)
General and administrative.......................... -- -- (7,707) (7,707)
Legal............................................... -- -- (2,862) (2,862)
State Taxes......................................... -- -- (339) (339)
Litigation settlement expense....................... -- -- (10,000) (10,000)
Provision for impairment............................ -- -- (8,381) (8,381)
Provision for uncollectable accounts................ (700) -- -- (700)
Severance, moving and consulting agreement costs.... -- -- (4,766) (4,766)
Charges for derivative accounting................... -- -- (1,113) (1,113)
-------- -------- -------- ----------
(13,641) (2,950) (57,852) (74,443)
-------- -------- -------- ----------
Income (loss) before net loss on assets sold and gain
on early extinguishment of debt..................... 48,388 (3,902) (57,852) (13,366)
Loss on assets sold--net.............................. -- (873) -- (873)
Gain on early extinguishment of debt.................. -- -- 2,963 2,963
Preferred dividends................................... -- -- (14,966) (14,966)
-------- -------- -------- ----------
Net income (loss) available to common................. $ 48,388 $ (4,775) $(69,855) $ (26,242)
======== ======== ======== ==========
Total Assets.......................................... $686,411 $161,047 $ 63,807 $ 911,265
======== ======== ======== ==========

F-51

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE B--PROPERTIES (CONTINUED)

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000
----------------------------------------------------
OWNED AND
OPERATED AND CORPORATE
CORE ASSETS HELD AND
OPERATIONS FOR SALE OTHER CONSOLIDATED
---------- ------------ --------- ------------
(IN THOUSANDS)

Operating Revenues.................................... $ 67,452 $123,461 $ -- $ 190,913
Operating Expenses.................................... -- (126,436) -- (126,436)
-------- -------- -------- ----------
Net operating income (loss)......................... 67,452 (2,975) -- 64,477
Adjustments to arrive at net income (loss):
Other revenues...................................... -- -- 4,760 4,760
Depreciation and amortization....................... (13,723) (2,545) (1,117) (17,385)
Interest expense.................................... -- -- (32,221) (32,221)
General and administrative.......................... -- -- (4,631) (4,631)
Legal............................................... -- -- (974) (974)
State Taxes......................................... -- -- (241) (241)
Provision for impairment............................ (1,940) (52,409) -- (54,349)
Provision for uncollectable accounts................ (12,100) -- -- (12,100)
Severance and consulting agreement costs............ -- -- (4,665) (4,665)
-------- -------- -------- ----------
(27,763) (54,954) (39,089) (121,806)
-------- -------- -------- ----------
Income (loss) before gain on assets sold.............. 39,689 (57,929) (39,089) (57,329)
Gain on assets sold--net.............................. 10,342 -- -- 10,342
Preferred dividends................................... -- -- (10,520) (10,520)
-------- -------- -------- ----------
Net income (loss) available to common................. $ 50,031 $(57,929) $(49,609) $ (57,507)
======== ======== ======== ==========
Total Assets.......................................... $719,848 $166,038 $ 78,803 $ 964,689
======== ======== ======== ==========

NOTE C--CONCENTRATION OF RISK AND RELATED ISSUES

As of September 30, 2001, the Company's portfolio of domestic investments
consisted of 246 healthcare facilities, located in 29 states and operated by 32
third-party operators. The Company's gross investments in these facilities
totaled $887.2 million at September 30, 2001. This portfolio is made up of 129
long-term healthcare facilities and 2 rehabilitation hospitals owned and leased
to third parties, fixed rate, participating and convertible participating
mortgages on 55 long-term healthcare facilities and 48 long-term healthcare
facilities that were recovered from customers and are currently operated through
third-party management contracts for the Company's own account. In addition, 12
facilities subject to third-party leasehold interests are included in Other
Investments. The Company also holds miscellaneous investments and closed
healthcare facilities held for sale of approximately $55.2 million at
September 30, 2001, including $22.3 million related to two non-healthcare
facilities leased by the United States Postal Service, a $7.7 million investment
in Omega Worldwide, Inc., Principal Healthcare Finance Limited, an Isle of
Jersey (United Kingdom) company and Principal Healthcare Finance Trust, an
Australian Unit Trust, and $14.3 million of notes receivable.

Seven public companies operate approximately 73.7% of the Company's
investments, including Sun Healthcare Group, Inc. (24.6%), Integrated Health
Services, Inc. (18.1%, including 10.7% as the manager for and 50% owner of Lyric
Health Care LLC), Advocat, Inc. (12.0%), Mariner Post-Acute

F-52

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE C--CONCENTRATION OF RISK AND RELATED ISSUES (CONTINUED)

Network (6.7%), Kindred Healthcare, Inc. (formerly known as Vencor
Operating, Inc.) (5.7%), Alterra Healthcare Corporation (3.8%), and Genesis
Health Ventures, Inc. (2.8%). Kindred and Genesis manage facilities for the
Company's own account, included in Owned & Operated Assets. The two largest
private operators represent 3.5% and 2.5%, respectively, of investments. No
other operator represents more than 2.5% of investments. The three states in
which the Company has its highest concentration of investments are Florida
(16.0%), California (7.5%) and Illinois (7.5%).

GOVERNMENT HEALTHCARE REGULATION, REIMBURSEMENTS AND INDUSTRY CONCENTRATION
RISKS

Nearly all of the Company's properties are used as healthcare facilities,
therefore, the Company is directly affected by the risk associated with the
healthcare industry. The Company's lessees and mortgagors, as well as the
facilities owned and operated for the Company's account, derive a substantial
portion of their net operating revenues from third-party payers, including the
Medicare and Medicaid programs. Such programs are highly regulated and subject
to frequent and substantial changes. In addition, private payers, including
managed care payers, are increasingly demanding discounted fee structures and
the assumption by healthcare providers of all or a portion of the financial risk
of operating a healthcare facility. Any changes in reimbursement policies that
reduce reimbursement levels could adversely affect revenues of the Company's
lessees and borrowers and thereby adversely affect those lessees' and borrowers'
abilities to make their monthly lease or debt payments to the Company.

The possibility that the healthcare facilities will not generate income
sufficient to meet operating expenses or will yield returns lower than those
available through investments in comparable real estate or other investments are
additional risks of investing in healthcare-related real estate. Income from
properties and yields from investments in such properties may be affected by
many factors, including changes in governmental regulation (such as zoning
laws), general or local economic conditions (such as fluctuations in interest
rates and employment conditions), the available local supply and demand for
improved real estate, a reduction in rental income as the result of an inability
to maintain occupancy levels, natural disasters (such as earthquakes and floods)
or similar factors.

Real estate investments are relatively illiquid and, therefore, tend to
limit the ability of the Company to vary its portfolio promptly in response to
changes in economic or other conditions. Thus, if the operation of any of the
Company's properties becomes unprofitable due to competition, age of
improvements or other factors such that the lessee or borrower becomes unable to
meet its obligations on the lease or mortgage loan, the liquidation value of the
property may be substantially less, particularly relative to the amount owing on
any related mortgage loan, than would be the case if the property were readily
adaptable to other uses.

POTENTIAL RISKS FROM BANKRUPTCIES

Generally, the Company's lease arrangements with a single operator who
operates more than one of the Company's facilities is designed pursuant to a
single master lease (a "Master Lease" or collectively, the "Master Leases").
Although each lease or Master Lease provides that the Company may terminate the
Master Lease upon the bankruptcy or insolvency of the tenant, the Bankruptcy

F-53

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE C--CONCENTRATION OF RISK AND RELATED ISSUES (CONTINUED)
Reform Act of 1978 ("Bankruptcy Code") provides that a trustee in a bankruptcy
or reorganization proceeding under the Bankruptcy Code (or debtor-in-possession
in a reorganization under the Bankruptcy Code) has the power and the option to
assume or reject the unexpired lease obligations of a debtor-lessee. In the
event that the unexpired lease is assumed on behalf of the debtor-lessee, all
the rental obligations thereunder generally would be entitled to a priority over
other unsecured claims. However, the court also has the power to modify a lease
if a debtor-lessee in a reorganization were required to perform certain
provisions of a lease that the court determined to be unduly burdensome. It is
not possible at this time to determine whether or not a court would hold that
any lease or Master Lease contains any such provisions. If a lease is rejected,
the lessor has a general unsecured claim limited to any unpaid rent already due
plus an amount equal to the rent reserved under the lease, without acceleration,
for the greater of one year or 15% of the remaining term of such lease, not to
exceed the rent obligation for three years.

Generally, with respect to the Company's mortgage loans, the imposition of
an automatic stay under the Bankruptcy Code precludes the Company from
exercising foreclosure or other remedies against the debtor. A mortgagee also is
treated differently from a landlord in three key respects. First, the mortgage
loan is not subject to assumption or rejection because it is not an executory
contract or a lease. Second, the mortgagee's loan may be divided into (1) a
secured loan for the portion of the mortgage debt that does not exceed the value
of the property and (2) a general unsecured loan for the portion of the mortgage
debt that exceeds the value of the property. A secured creditor such as the
Company is entitled to the recovery of interest and costs only if and to the
extent that the value of the collateral exceeds the amount owed. If the value of
the collateral is less than the debt, a lender such as the Company would not
receive or be entitled to any interest for the time period between the filing of
the case and confirmation. If the value of the collateral does exceed the debt,
interest and allowed costs may not be paid during the bankruptcy proceeding but
accrue until confirmation of a plan or reorganization or some other time as the
court orders. Finally, while a lease generally would either be rejected or
assumed with all of its benefits and burdens intact, the terms of a mortgage,
including the rate of interest and timing of principal payments, may be modified
if the debtor is able to effect a "cramdown" under the Bankruptcy Code.

The receipt of liquidation proceeds or the replacement of an operator that
has defaulted on its lease or loan could be delayed by the approval process of
any federal, state or local agency necessary for the transfer of the property or
the replacement of the operator licensed to manage the facility. In addition,
certain significant expenditures associated with real estate investment (such as
real estate taxes and maintenance costs) are generally not reduced when
circumstances cause a reduction in income from the investment. In order to
protect its investments, the Company may take possession of a property or even
become licensed as an operator, which might expose the Company to successorship
liability to government programs or require the Company to indemnify subsequent
operators to whom it might transfer the operating rights and licenses. Third
party payors may also suspend payments to the Company following foreclosure
until the Company receives the required licenses to operate the facilities.
Should such events occur, the Company's income and cash flows from operations
would be adversely affected.

F-54

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE C--CONCENTRATION OF RISK AND RELATED ISSUES (CONTINUED)
RISKS RELATED TO OWNED AND OPERATED ASSETS

As a consequence of the financial difficulties encountered by a number of
the Company's operators, the Company has recovered various long-term care
assets, pledged as collateral for the operators' obligations, either in
connection with a restructuring or settlement with certain operators or pursuant
to foreclosure proceedings. Under normal circumstances, the Company would
classify such assets as "Assets Held for Sale" and seek to re-lease or otherwise
dispose of such assets as promptly as practicable. During 2000, a number of
companies were actively marketing portfolios of similar assets and, in light of
market conditions in the long-term care industry generally, it had become more
difficult both to sell such properties and for potential buyers to obtain
financing to acquire such properties. During 2000, $24.3 million of assets
previously classified as held for sale were reclassified to "Owned and Operated
Assets" as the timing and strategy for sale or, alternatively, re-leasing, were
revised in light of prevailing market conditions.

The Company is typically required to hold applicable leases and is
responsible for the regulatory compliance at its owned and operated facilities.
The Company's management contracts with third-party operators for such
properties provide that the third-party operator is responsible for regulatory
compliance, but the Company could be sanctioned for violation of regulatory
requirements. In addition, the risk of third-party claims such as patient care
and personal injury claims may be higher with respect to Company owned and
operated properties as compared to the Company's leased and mortgaged assets.

RECENT DEVELOPMENTS

In Note 15 to our Form 10-K for the year ended December 31, 2000, we
announced continuing discussions with several of our lessees to resolve payment
issues, including Alterra Healthcare Corp., Lyric Healthcare LLC, Alden
Management Services, Inc. and TLC Healthcare Inc.

F-55

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE C--CONCENTRATION OF RISK AND RELATED ISSUES (CONTINUED)
Georgia; and a $4.9 million mortgage collateralized by one facility located in
Florida. Annual contractual interest income on each of the mortgages is
approximately $3.96 million, $1.25 million and $0.55 million, respectively. We
also have a lease with IHS for one property in the state of Washington,
representing an investment of $10 million and annualized contractual revenue of
$1.45 million. IHS rejected this lease on November 9, 2001.

We are currently negotiating with IHS to reach a permanent restructuring
agreement or to transition the facilities to a new operator or operators. Rent
under the lease was paid for November, but no payments were made on the October
mortgage interest due November 1. As of the date of this filing, no further
payments have been made. Accordingly, no revenue was recorded for the mortgage
for October through December. Current appraisals of the properties underlying
the mortgage loans indicate collateral value in excess of the mortgage loan
balances. Accordingly, we do not expect to record any reserves relative to these
loans at this time.

F-56

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE C--CONCENTRATION OF RISK AND RELATED ISSUES (CONTINUED)
In several instances we hold security deposits that can be applied in the
event of lease and loan defaults, subject to applicable limitations under
bankruptcy law with respect to operators seeking protection under Chapter 11 of
the Bankruptcy Act.

NOTE D--DIVIDENDS

On February 1, 2001, the Company announced the suspension of all common and
preferred dividends. This action is intended to preserve cash to facilitate the
Company's ability to obtain financing to fund its 2002 maturing indebtedness.
Prior to recommencing the payment of dividends on the Company's Common stock,
all accrued and unpaid dividends on the Company's Series A, B and C preferred
stock must be paid in full. The Company has made sufficient distributions to
satisfy the distribution requirements under the REIT rules to maintain its REIT
status for 2000 and intends to satisfy such requirements under the REIT rules
for 2001. The accumulated and unpaid dividends relating to all series of the
preferred stock, excluding the November 15, 2000 Series C dividends described
below, total $14.9 million as of September 30, 2001.

On March 30, 2001, the Company exercised its option to pay the accrued
$4,666,667 Series C dividend from November 15, 2000 and the associated waiver
fee by issuing 48,420 Series C preferred shares to Explorer on April 2, 2001,
which are convertible into 774,722 shares of the Company's common stock at $6.25
per share. Such election resulted in an increase in the aggregate liquidation
preference of Series C Preferred Stock as of April 2, 2001 to $104,842,000,
including accrued dividends through that date.

During the nine-month period ended September 30, 2000 the Company paid
dividends of $4.0 million on its 9.25% Series A Cumulative Preferred Stock and
8.625% Series B Cumulative Preferred Stock.

NOTE E--EARNINGS PER SHARE

The computation of basic earnings per share is determined based on the
weighted average number of common shares outstanding during the respective
periods. Diluted earnings per share reflect the dilutive effect, if any, of
stock options and, beginning in the third quarter of 2000, the assumed
conversion of the Series C Preferred Stock.

NOTE F--OMEGA WORLDWIDE, INC.

As of September 30, 2001 the Company holds a $4.9 million investment in
Omega Worldwide, Inc. ("Worldwide"), represented by 1,163,000 shares of common
stock and 260,000 shares of preferred stock. The Company also holds a
$1.6 million investment in Principal Healthcare Finance Limited, an Isle of
Jersey (United Kingdom) company, and a $1.3 million investment in Principal
Healthcare Finance Trust, an Australian Unit Trust. The Company had guaranteed
repayment of Worldwide borrowings pursuant to a revolving credit facility in
exchange for an initial 1% fee and an annual facility fee of 25 basis points.
The Company was required to provide collateral in the amount of $8.8 million
related to the guarantee of Worldwide's obligations. Worldwide repaid all
borrowings

F-57

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE F--OMEGA WORLDWIDE, INC. (CONTINUED)
under the revolving credit facility in June 2001. The Company's guarantee was
terminated and the subject collateral was released.

Additionally, the Company had a Services Agreement with Worldwide that
provided for the allocation of indirect costs incurred by the Company to
Worldwide. The allocation of indirect costs has been based on the relationship
of assets under the Company's management to the combined total of those assets
and assets under Worldwide's management. Upon expiration of this agreement on
June 30, 2000, the Company entered into a new agreement requiring quarterly
payments from Worldwide of $37,500 for the use of offices and certain
administrative and financial services provided by the Company. Upon the
reduction of the Company's accounting staff, the Service Agreement was
renegotiated again on November 1, 2000 requiring quarterly payments from
Worldwide of $32,500. Costs allocated to Worldwide for the three-month and
nine-month periods ended September 30, 2001 were $32,500 and $97,500,
respectively, compared with ($19,000) and $370,000 for the same periods in 2000.

NOTE G--LITIGATION

On June 21, 2000, the Company was named as a defendant in certain litigation
brought against it by Madison/OHI Liquidity Investors, LLC ("Madison"), a
customer that claims that the Company has breached and/or anticipatorily
breached a commercial contract. Ronald M. Dickerman and Bryan Gordon are
partners in Madison and limited guarantors of Madison's obligations to the
Company. Madison claims damages as a result of the alleged breach of
approximately $700,000. Madison seeks damages as a result of the claimed
anticipatory breach in the amount of $15 million or, in the alternative, Madison
seeks specific performance of the contract as modified by a course of conduct
that Madison alleges developed between Madison and the Company. The Company
contends that Madison is in default under the contract in question. The Company
believes that the litigation is meritless. The Company continues to vigorously
defend the case and has filed counterclaims against Madison and the guarantors,
seeking repayment of approximately $9.4 million, excluding default interest,
that Madison owes the Company. The Company's Motion for Summary Judgment seeking
dismissal of Madison's anticipatory breach claim is scheduled for November 19,
2001. The trial in this matter is set for February 2002.

On December 29, 1998, Karrington Health, Inc. brought suit against the
Company in the Franklin County, Ohio, Common Pleas Court (subsequently removed
to the U.S. District Court for the Southern District of Ohio, Eastern Division)
alleging that the Company repudiated and ultimately breached a financing
contract to provide $95 million of financing for the development of 13 assisted
living facilities. Karrington was seeking recovery of approximately $34 million
in damages it alleged to have incurred as a result of the breach. On August 13,
2001, the Company paid Karrington $10 million to settle all

F-58

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE G--LITIGATION (CONTINUED)
claims arising from the suit, but without admission of any liability or fault by
the Company, which liability is expressly denied. Based on the settlement, the
suit has been dismissed with prejudice. The settlement was recorded in the
quarter ended June 30, 2001.

NOTE H--BORROWING ARRANGEMENTS

The Company has a $175 million secured revolving credit facility that
expires on December 31, 2002. Borrowings under the facility bear interest at
2.5% to 3.25% over London Interbank Offered Rates ("LIBOR"), based on the
Company's leverage ratio. Borrowings of approximately $129 million are
outstanding at September 30, 2001. Investments with a gross book value of
approximately $240 million are pledged as collateral for this credit facility.

The Company has a $75 million secured revolving credit facility that expires
on March 31, 2002 as to $10 million and June 30, 2005 as to $65 million.
Borrowings under the facility bear interest at 2.5% to 3.75% over LIBOR, based
on the Company's leverage ratio and collateral assigned. Borrowings of
approximately $74.6 million are outstanding at September 30, 2001. Real estate
investments with a gross book value of approximately $95 million are pledged as
collateral for this credit facility.

During the three-month and nine-month periods ended September 30, 2001, the
Company repurchased $3.9 million and $25.4 million, respectively, of its 6.95%
Notes maturing in June 2002. At September 30, 2001, $99.6 million of these notes
remain outstanding.

As of September 30, 2001, the Company had an aggregate of $238.6 million of
outstanding debt that matures in 2002, including $99.6 million of 6.95% Notes
due June 2002 and $139 million on credit facilities expiring in 2002.

The recognition of $10 million of expense associated with the settlement of
the lawsuit with Karrington Health, Inc. described in Note G above resulted in a
violation of certain financial covenants in the loan agreements relating to the
Company's secured credit facilities as of June 30, 2001. For the quarter ended
June 30, 2001, we were not in compliance with the maximum leverage covenant
ratio of funded indebtedness to earnings before interest, taxes, depreciation
and amortization, or EBITDA, in each of our credit facilities. For the quarter
ended September 30, 2001, we were not in compliance with the maximum leverage
covenant and the minimum EBITDA to interest expense covenants in each of our
credit facilities. The Company previously obtained a waiver from the lenders
under both credit facilities through September 14, 2001. The lenders under the
Company's $175 million secured credit facility have extended their waiver
through December 13, 2001 and the lenders under our $75 million secured credit
facility extended their waiver through December 15, 2001. These covenant
violations have been waived pursuant to the agreements described below, but
currently prevent the Company from drawing upon the otherwise remaining
availability under both credit facilities until a permanent resolution is
attained.

On December 21, 2001, we reached agreements with the lenders under both of
our revolving credit facilities which include modifications and waivers to
certain financial covenants including those with which we were not in
compliance. In addition, certain other financial covenants will be either
modified as eliminated going forward. As part of these agreements, the lenders
extended their waivers through

F-59

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE H--BORROWING ARRANGEMENTS (CONTINUED)
February 28, 2002. The effectiveness of these agreements is subject to the
completion of the rights offering and private placement to Explorer. Explorer
has approved the amendments, and therefore the effectiveness of the amendments
will satisfy the conditions to the rights offering and Explorer investment
related to our credit facilities. See "The Rights Offering--Closing Conditions."

- Minimum EBITDA / interest expense covenant will be increased from 200% to
225% beginning in the second quarter of 2002, 250% in the fourth quarter
of 2002 and 275% thereafter.

- The requirement for no loss in a fiscal year beginning December 31, 2001
has been removed.

- The maximum leverage ratio covenant has been reduced to 5.0 times EBITDA
in the second quarter of 2002 and 4.75 times EBITDA thereafter.

In addition, adjusted EBITDA under the loan agreements has been redefined to
exclude certain one-time charges including, but not limited to, the $10 million
litigation settlement recognized in June 2001 and associated legal fees up to
$1 million, up to $5 million for relocation of our corporate headquarters to
Maryland, for which we recognized a charge of $4.3 million in September 2001.

At September 30, 2001 the Company would have had $14.5 million available
under its secured revolving credit facilities if it were in compliance with the
applicable financial covenants. Certain assets that served as collateral for one
of the credit facilities were recovered from a customer during the June 30, 2001
quarter. These assets are no longer eligible to serve as collateral, resulting
in reduced availability under the credit facility. The Company has the ability
to replace this collateral and increase the availability under the line by up to
an additional $18.1 million subject to compliance with the applicable financial
covenants. (See Management's Discussion and Analysis of Financial Condition and
Results of Operations--Liquidity and Capital Resources)

F-60

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE I--EFFECT OF NEW ACCOUNTING PRONOUNCEMENTS

The Company utilizes interest rate swaps to fix interest rates on variable
rate debt and reduce certain exposures to interest rate fluctuations. In
June 1998, the Financial Accounting Standards Board issued Statement No. 133,
ACCOUNTING FOR DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES, which is required
to be adopted in years beginning after June 15, 2000. The Company adopted the
new Statement effective January 1, 2001. The Statement requires the Company to
recognize all derivatives on the balance sheet at fair value. Derivatives that
are not hedges must be adjusted to fair value through income. If the derivative
is a hedge, depending on the nature of the hedge, changes in the fair value of
derivatives will either be offset against the change in fair value of the hedged
assets, liabilities, or firm commitments through earnings or recognized in other
comprehensive income until the hedge item is recognized in earnings. The
ineffective portion of a derivative's change in fair value will be immediately
recognized in earnings.

At September 30, 2001, the Company had two interest rate swaps with notional
amounts of $32 million each, based on 30-day LIBOR. Under the terms of the first
agreement, which expires in December 2001, the Company receives payments when
LIBOR exceeds 6.35% and pays the counterparty when LIBOR is less than 6.35%. At
September 30, 2001, 30-day LIBOR was 2.63%. This interest rate swap may be
extended for an additional twelve months at the option of the counterparty and
therefore does not qualify for hedge accounting under FASB No. 133. The fair
value of this swap at January 1, and September 30, 2001 was a liability of
$351,344 and $1,200,369, respectively. The liability at January 1 was recorded
as a transition adjustment in other comprehensive income and is being amortized
over the initial term of the swap. Such amortization for the three-month and
nine-month periods ended September 30, 2001 of $87,836 and $263,508,
respectively, together with the change in fair value of the swap of $472,544 and
$849,025, respectively, is included in charges for derivative accounting in the
Company's Condensed Consolidated Statement of Operations.

Under the second agreement, which expires December 31, 2002, the Company
receives payments when LIBOR exceeds 4.89% and pays the counterparty when LIBOR
is less than 4.89%. The fair value of this interest rate swap at September 30,
2001 was a liability of $805,928, which is included in other comprehensive
income as required under FASB No. 133 for fully effective cash flow hedges.

The fair values of these interest rate swaps are included in accrued
expenses and other liabilities in the Company's Condensed Consolidated Balance
Sheet at September 30, 2001.

FASB 144 ACCOUNTING FOR THE IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS

The Financial Accounting Standards Board recently issued SFAS 144,
ACCOUNTING FOR THE IMPAIRMENT OR DISPOSAL OF LONG-LIVED ASSETS, which is
applicable to financial statements issued for fiscal years beginning after
December 15, 2001. The Company expects to adopt the new pronouncement effective
January 1, 2002. This pronouncement supersedes FASB Statement No. 121,
ACCOUNTING FOR THE IMPAIRMENT OF LONG-LIVED ASSETS AND FOR LONG-LIVED ASSETS TO
BE DISPOSED. The Company has not yet evaluated the impact of this pronouncement
on its financial condition or results of operations.

F-61

OMEGA HEALTHCARE INVESTORS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

SEPTEMBER 30, 2001

NOTE J--SUBSEQUENT EVENTS

On October 30, 2001, the Company announced that it has reached an agreement
with Explorer Holdings, L.P. ("Explorer") to facilitate Omega's ability to raise
$50.0 million in new equity capital. Explorer has committed to invest
approximately $22.8 million in a private placement and has agreed to "backstop"
Omega's proposal to engage in a fixed price rights offering of Omega Common
Stock to raise approximately $27.2 million from existing holders of Omega's
Common Stock. Holders of Omega Common Stock (other than Explorer) will receive a
non-transferable right to purchase at an exercise price of $2.92 per share, one
full share of Omega Common Stock for every 2.15 shares of Omega Common Stock
they hold as of the close of business on November 8, 2001 or such later date as
the Registration Statement filed with the Securities and Exchange Commission to
register the shares of Common Stock to be offered in the rights offering becomes
effective. The Company intends to use the proceeds of the rights offering and
Explorer's investment will be used to repay certain indebtedness maturing in
2002 and for general working capital purposes.

Explorer, which beneficially owns 1,048,420 shares of Omega's Series C
Convertible Preferred Stock constituting approximately 45.5% of Omega's issued
and outstanding Common Stock on an as converted basis, will not receive rights
in the rights offering. Instead, the amount of Explorer's private placement is
equal to Explorer's percentage interest in the aggregate amount of the proposed
$50.0 million offering. In addition, to the extent the Company's stockholders do
not fully exercise their rights to purchase Common Stock in the rights offering,
Explorer has committed to invest an additional amount equal to the exercise
price of the unexercised rights.

In exchange for its investment in the Company, Explorer will receive shares
of the Company's Common Stock if stockholders have approved its issuance to
Explorer at the closing of its investment. If the issuance of Common Stock to
Explorer has not been approved by stockholders at the time of closing, Explorer
will receive shares of a newly created series of non-voting convertible
preferred stock which will automatically convert into Common Stock upon receipt
of stockholder approval. Omega will call a special meeting of stockholders to
seek approval of the issuance of Common Stock to Explorer among other matters.

The closing of the rights offering and Explorer's investment will occur
simultaneously no later than 10 days following the expiration of the
subscription period for the rights offering. The closing is subject to the
fulfillment or waiver of customary closing conditions as well as the amendment
of Omega's two secured bank credit facilities and permanent waiver of Omega's
current non-compliance with certain covenants on terms acceptable to Omega and
Explorer. There can be no assurance that the proposed offering will be
consummated.

A registration statement relating to the rights and the underlying Common
Stock to be offered in the rights offering has not yet been filed with the U.S.
Securities and Exchange Commission ("SEC"). These securities, if registered, may
not be sold nor may offers to buy be accepted prior to the time the proposed
registration statement becomes effective.

On November 1, 2001 seventeen properties previously classified as Owned and
Operated Assets were sold to Hickory Creek Foundation, Inc., subject to a
mortgage provided by us in the amount of $10.5 million. The initial term of the
mortgage is three years and the initial yield is 7.6%.

F-62

ANNEX A

[LOGO]

October 29, 2001

The Committee of Independent Directors and
The Board of Directors
Omega Healthcare Investors, Inc.
900 Victors Way
Ann Arbor, MI 48108

Members of the Committee of Independent Directors and the Board of Directors:

We understand that Omega Healthcare Investors, Inc. ("OHI") has entered into an
Investment Agreement (including the exhibits attached thereto), dated as of
October 29, 2001 (the "Investment Agreement"), with Explorer Holdings, L.P.
("Explorer"). Explorer currently owns, and its only investment in OHI is,
1,048,420 shares of OHI's Series C Preferred Stock, constituting all the shares
of that class presently outstanding (the "Preferred C") and representing
approximately 45.5% of OHI's common stock on an as converted basis. Pursuant to
the Investment Agreement as described in more detail below, among other things,
Explorer will commit to invest, subject to certain conditions being satisfied or
waived, up to $50.0 million (the "Capital Infusion Amount") in payment for OHI
common stock or a newly created security, Series D Preferred stock of OHI
("Preferred D") (the "Explorer Investment"). The actual amount of the Explorer
Investment will be equal to the difference between the Capital Infusion Amount
and the gross proceeds received by OHI through a Rights Offering (the "Rights
Offering") to OHI common stockholders other than Explorer (the "Unsubscribed
Purchase Amount"). If all rights offered in the Rights Offering were exercised,
we understand that the proportional ownership of OHI by stockholders other than
Explorer and by Explorer on an as converted basis would, upon Explorer's payment
of the Unsubscribed Purchase Amount and the issuance to it of shares of OHI
common stock, remain approximately the same as such ownership on the date of
this letter.

We understand that the price per common OHI share in the Rights Offering and the
price per common OHI share or the conversion price of the Preferred D to be paid
by Explorer will be the same; i.e., not to exceed $2.92 per share as determined
in accordance with the provisions of the Investment Agreement. Explorer's
commitment to fund the Unsubscribed Purchase Amount is irrespective of the
actual price per OHI common share at the time of the expiration of the Rights
Offering.

This opinion to the Committee of Independent Directors and the Board of
Directors of OHI addresses the fairness, from a financial point of view, to OHI
of the financial terms of the Investment Agreement taken as a whole (the
"Financial Terms of the Investment Agreement").

[LOGO]

The Committee of Independent Directors and
The Board of Directors
Omega Healthcare Investors, Inc.
October 29, 2001
Page 2

We further understand that the Investment Agreement, among other things,
includes the following Financial Terms which are more fully set forth in the
Investment Agreement:

- DISTRIBUTION OF RIGHTS: OHI will undertake a Rights Offering whereby each
OHI common stockholder other than Explorer will receive a dividend of one
right ("Right") for every 2.15 shares of OHI common stock owned by such
stockholder on the record date. An OHI stockholder who exercises all of
the Rights issued to him or her will maintain their proportional interest
in OHI common stock on an as converted basis. Each Right will entitle the
holder to purchase one share of OHI common stock at the Exercise Price as
described below;

- EXPLORER INVESTMENT: Explorer will not receive any Rights pursuant to the
Rights Offering. Explorer commits within ten days after the expiration
date of the Rights Offering to purchase either OHI common stock or
Preferred D shares for an aggregate amount equal to the Unsubscribed
Purchase Amount. In this regard, if the issuance of OHI common stock has
not been approved by OHI's stockholders at the time of the Explorer
Investment, the Explorer Investment will be in the form of Preferred D
shares which will be substantially the same as the Preferred C and which
will be automatically converted into OHI common stock upon the earlier of
receipt of stockholder approval for the issuance of OHI common stock to
Explorer and the date the New York Stock Exchange waives any requirement
under its rules and policies for stockholder approval of the conversion of
the Preferred D into OHI common stock. We understand that Explorer has
agreed to vote its Preferred C shares in favor of stockholder approval;

- OVER-SUBSCRIPTION RIGHT: There will be no over-subscription right for
unexercised Rights;

- TRANSFERABILITY AND TRADING OF RIGHTS: The Rights will not be
transferable or assignable and will not trade as a separate security;

- EXERCISE PRICE: The exercise price of each Right (the "Exercise Price")
is $2.92 determined in accordance with the terms of the Investment
Agreement;

- CLOSING CONDITION: The closing of the Rights Offering and the Explorer
Investment will be conditioned upon Fleet Bank, NA ("Fleet") and The
Provident Bank: (i) amending their loan agreements with OHI in a manner
and on terms and conditions satisfactory to each of OHI and Explorer in
their respective sole discretion; (ii) waiving any then existing defaults
as well as the right to assert a default based on OHI's current
non-compliance with certain covenants; and (iii) with respect to Fleet,
extending the current maturity date of its loan by no less than
12 months;

- TERMINATION: OHI will have the right to amend the terms of or terminate
the Rights Offering at any time prior to the expiration of the
subscription period in the Rights Offering;

- CONTROL OF OHI: In the event that upon consummation of the Rights
Offering and the transactions contemplated by the Investment Agreement,
Explorer holds more than 50% of the voting securities of OHI, Explorer
will have voting control of OHI, the unrestricted right to vote the OHI
voting securities which it holds and the power to designate a majority of
the Directors of OHI subject to the following restrictions imposed by the
Investment Agreement and any other limitation or restriction imposed by
law: (i) a limitation on the number of Directors of OHI which Explorer can
designate; (ii) so long as Explorer holds at least 15% of the voting
securities of OHI, a commitment by Explorer to vote in favor of the
election of three directors who are "independent" under the rules of the
New York Stock Exchange and otherwise

The Committee of Independent Directors and
The Board of Directors
Omega Healthcare Investors, Inc.
October 29, 2001
Page 3

unaffiliated with Explorer and, upon the increase in the number of
directors to ten, one additional person who is unaffiliated with Explorer;
and (iii) except in a transaction approved by a committee of the Board of
OHI comprised entirely of independent directors and under certain limited
circumstances, a prohibition against Explorer's acquiring beneficial
ownership of more than 80% of the voting securities of OHI then issued and
outstanding; and

- TRANSFERABILITY OF VOTING SECURITIES OWNED BY EXPLORER: Transfers by
Explorer of its voting securities that cause the transferee's beneficial
ownership to exceed 9.9% of OHI's total voting securities are subject to
the transferee agreeing to be bound by certain provisions of the Amended
and Restated Stockholders Agreement to be executed in connection with the
closing of the Rights Offering (the "Amended and Restated Stockholders
Agreement").

For the purposes of this opinion, we have:

(i) Reviewed the Investment Agreement (including the exhibits attached
thereto) between OHI and Explorer, dated as of October 29, 2001;

(ii) Reviewed the Investment Agreement between OHI and Explorer, dated as
of May 11, 2000 and the First Amendment thereto, dated June 2, 2000;

(iii) Reviewed the Stockholders Agreement between OHI and Explorer, dated
July 14, 2000, which will be superceded by the Amended and Restated
Stockholders Agreement;

(iv) Reviewed the following documents filed by OHI with the Securities and
Exchange Commission: Form 10-K for OHI for the year ended
December 31, 2000; Forms 10-Q for the quarters ended March 31, and
June 30, 2001; 2000 Annual Report; and Proxy Statement for the Annual
Meeting of Stockholders, dated as of April 18, 2001;

(v) Reviewed various reports and analyses prepared by OHI management;

(vi) Discussed the business, operations, projections, capital structure and
prospects of OHI with OHI's management;

(vii) Reviewed financial projections and other financial information
prepared by OHI management for the years ending December 31, 2001 and
2002;

(viii) Reviewed Explorer's pro forma ownership of OHI under various
assumptions related to the Rights Offering. With regard to this
review, we noted that Explorer's current ownership in OHI common stock
on an as converted basis is approximately 45.5% and based on various
assumptions concerning the number of shares of OHI common stock which
are purchased in the Rights Offering, Explorer's ownership of OHI's
voting securities on as converted basis could exceed 50%;

(ix) Discussed with management of OHI (a) OHI's efforts to negotiate with
its banks; (b) the financial implications for OHI if agreement for
covenant waivers and a term extension were not reached with OHI's
banks; (c) the importance to OHI of securing an equity or junior
capital investment in order to potentially obtain such waivers and
extensions; and (d) OHI's efforts to access alternative sources of
capital including the timing and risk of closing associated with such
alternative investments;

(x) Discussed with a principal of Explorer, among other things Explorer's:
(a) timing of the Explorer Investment; (b) additional due diligence
requirements; (c) definitive agreement

The Committee of Independent Directors and
The Board of Directors
Omega Healthcare Investors, Inc.
October 29, 2001
Page 4

requirements; and (d) ability to make the investment contemplated in the
Investment Agreement without any additional approvals by Explorer's
partners;

(xi) Reviewed publicly available financial and stock market data with
respect to publicly-traded companies in lines of business we believe
to be generally comparable to those of OHI;

(xii) Reviewed over a five year, twelve month and three month period ending
October 26, 2001 the trading price history of OHI's common stock;

(xiii) Reviewed over the twelve month and three month period ending
October 26, 2001 the trading price history of OHI's Series A Preferred
Stock and Series B Preferred Stock;

(xiv) Reviewed the price and yield to maturity of OHI's senior unsecured
debt;

(xv) Reviewed the trading performance and other data of selected
publicly-traded companies which have undertaken a rights offering since
January 1, 2001;

(xvi) Reviewed the draft dated October 25, 2001 of OHI's Registration
Statement on Form S-1; and

(xvii) Conducted such other studies, analyses, investigations and inquiries,
and considered such other information, as we deemed relevant.

In rendering our opinion, we have assumed and relied upon the accuracy and
completeness of all documents and other information supplied or otherwise made
available to us by OHI or obtained by us from other sources, and we have relied
upon the assurances of the management of OHI that they are unaware of any
information or facts that would make the information provided to us incomplete
or misleading. We have further assumed that the Investment Agreement, including
but not limited to the Rights Offering, will not be amended after the date
hereof. While we have discussed the information provided to us with management
of OHI, we have not independently verified such information, undertaken an
independent appraisal of the assets or liabilities (contingent or otherwise) of
OHI or been furnished with any such appraisals of OHI. With respect to financial
forecasts furnished to us by OHI, we have been advised by the management of OHI,
and we have assumed, that they have been reasonably prepared and reflect
management's best currently available estimates and judgment as to the expected
future financial performance of such entities. The terms of our engagement did
not include soliciting interest in an investment transaction from investors, and
we have made no such solicitation.

Our opinion is necessarily based upon market, economic and other conditions that
exist and can be evaluated as of the date of this letter, and on information
available to us as of the date hereof. We disclaim any undertaking or obligation
to advise any person of any change in any fact or matter affecting the opinion
expressed herein that may come or be brought to our attention after the date
hereof.

As part of its investment banking business, Shattuck Hammond Partners LLC is
continually engaged in the valuation of businesses and their securities in
connection with mergers and acquisitions, negotiated underwritings, secondary
distributions of securities, private placements and other purposes. We have
acted as financial advisor to the Committee of Independent Directors in
connection with a review of other financing alternatives that might be available
to OHI and a review of any proposals related to Explorer and will receive from
OHI a fee for such services and an additional fee upon the delivery of this
opinion.

The opinion expressed herein does not constitute a recommendation as to any
action the Committee of Independent Directors, the Board of Directors or any
stockholder of OHI should take in connection

The Committee of Independent Directors and
The Board of Directors
Omega Healthcare Investors, Inc.
October 29, 2001
Page 5

with the Investment Agreement. This opinion addresses only the fairness, from a
financial point of view, of the Financial Terms of the Investment Agreement
taken as a whole. Further, we express no opinion herein as to the structure,
terms (other than the Financial Terms) or effect of any other aspect of the
investment by Explorer or the Rights Offering, including, without limitation,
the tax consequences thereof or the corporate governance changes occurring in
connection therewith except to the extent that such changes constitute Financial
Terms of the Investment Agreement.

Based upon and subject to the foregoing, it is our opinion, as investment
bankers, that, as of the date hereof, the Financial Terms of the Investment
Agreement taken as a whole are fair to OHI from a financial point of view.

Very truly yours,
/s/ Shattuck Hammond Partners LLC
Shattuck Hammond Partners LLC

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

RIGHTS TO PURCHASE UP TO 9,350,000 SHARES

[LOGO]

COMMON STOCK

--------------

PROSPECTUS
--------------

JANUARY 24, 2002

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 31. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

The following table sets forth the estimated expenses in connection with
this offering.

SEC Registration Fee........................................ $ 6,810
NYSE Listing Fee............................................ 60,550
Subscription Agent Fee...................................... 37,500
Escrow Agent Fee............................................ 4,000
Legal Fees and Expenses..................................... 562,000
Accounting Fees and Expenses................................ 50,000
Financial Adviser Fees...................................... 400,000
Printing Fees............................................... 300,000
Miscellaneous............................................... 25,000
----------
Total................................................. 1,445,860
==========

ITEM 32. SALES TO SPECIAL PARTIES.

Not Applicable.

ITEM 33. RECENT SALES OF UNREGISTERED SECURITIES.

On July 17, 2000, the Company received gross proceeds of $100 million from
the issuance of 1,000,000 shares of Series C convertible preferred stock to
Explorer, which were initially convertible into 16,000,000 shares of common
stock. On April 2, 2001 the Company issued an additional 48,420 shares of
Series C convertible preferred stock to Explorer, which are convertible into
774,722 shares of the Company's common stock, to satisfy accrued and unpaid
dividends on the Series C preferred stock issued in July 2000 and the associated
waiver fee, which had been deferred by agreement with Explorer from
November 15, 2000 through April 2, 2001. The conversion price of the Series C
convertible preferred stock is currently $6.25 per share. The shares of
Series C preferred stock issued to Explorer on July 17, 2000 were sold in
reliance upon the exemption from the registration provided by Section 4(2) of
the Securities Act. The shares of Series C convertible preferred stock issued on
April 2, 2001 were issued without registration under the Securities Act, because
the issuance did not involve a sale within the meaning of the Securities Act
and/or in reliance upon the exemption from registration provided by
Section 4(2) of the Securities Act. For more information about the terms of
conversion see "Business" set forth in the Prospectus.

Proceeds from the July 17, 2001 issuance were used to repay outstanding
debt.

ITEM 34. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

The Articles of Incorporation and Bylaws of the Registrant provide for
indemnification of directors and officers to the full extent permitted by
Maryland law.

Section 2-418 of the General Corporation Law of the State of Maryland
generally permits indemnification of any director or officer with respect to any
proceedings unless it is established that (a) the act or omission of the
director or officer was material to the matter giving rise to the proceeding and
was either committed in bad faith or the result of active or deliberate
dishonesty; (b) the director or officer actually received an improper personal
benefit in money, property or services, or; (c) in the case of criminal
proceedings, the director or officer had reasonable cause to

II-1

believe that the act or omission was unlawful. The indemnity may include
judgments, penalties, fines, settlements, and reasonable expenses actually
incurred by the director or officer in connection with the proceedings;
provided, however, that if the proceeding is one by, or in the right of, the
corporation, indemnity is permitted only for reasonable expenses and not with
respect to any proceeding in which the director shall have been adjudged to be
liable to the corporation. The termination of any proceeding by judgment, order
or settlement does not create a presumption that the director did not meet the
requisite standard of conduct required for permitted indemnification. The
termination of any proceeding by conviction, or plea of nolo contendere or its
equivalent, or an entry of an order of probation prior to judgment, creates a
rebuttable presumption that the director or officer did not meet that standard
of conduct.

The Company has entered into indemnity agreements with the officers and
directors of the Company that provide that the Company will, subject to certain
conditions, pay on behalf of the indemnified party any amount which the
indemnified party is or becomes legally obligated to pay because of any act or
omission or neglect or breach of duty, including any actual or alleged error or
misstatement or misleading statement, which the indemnified party commits or
suffers while acting in the capacity as an officer or director of the Company.

Insofar as indemnification for liabilities arising under the Securities Act
is permitted to directors and officers of the Registrant pursuant to the
above-described provisions, the Registrant understands that the Commission is of
the opinion that such indemnification contravenes federal public policy as
expressed in said act and therefore is unenforceable.

ITEM 35. TREATMENT OF PROCEEDS FROM STOCK BEING REGISTERED.

Not Applicable.

ITEM 36. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

INDEX TO EXHIBITS

EXHIBIT
NUMBER DESCRIPTION
------- -----------

II-2

EXHIBIT
NUMBER DESCRIPTION
------- -----------

4.7 Form of Supplemental Indenture No. 1 dated as of June 1,
1998 relating to the 6.95% Notes due 2002 (Incorporated by
reference to Exhibit 4 to the Company's Form 8-K dated June
9, 1998)
4.8 Rights Agreement, dated as of May 12, 1999, between Omega
Healthcare Investors, Inc. and First Chicago Trust Company,
as Rights Agent, including Exhibit A thereto (Form of
Articles Supplementary relating to the Series A Junior
Participating Preferred stock) and Exhibit B thereto (Form
of Rights Certificate) (Incorporated by reference to Exhibit
4 to the Company's Form 8-K dated April 20, 1999)
4.9 Amendment No. 1, dated May 11, 2000 to Rights Agreement,
dated as of May 12, 1999, between Omega Healthcare
Investors, Inc. and First Chicago Trust Company, as Rights
Agent (Incorporated by reference to Exhibit 4.1 to the
Company's Form 10-Q for the quarterly period ended March 31,
2000)
4.10 Articles Supplementary for Series C Convertible Preferred
Stock (Incorporated by reference to Exhibit 4.1 to the
Company's Form 10-Q for the quarterly period ended June 30,
2000)
4.11 Stockholders Agreement between Explorer Holdings, L.P. and
Omega Healthcare Investors, Inc. (Incorporated by reference
to Exhibit 4.2 to the Company's Form 10-Q for the quarterly
period ended June 30, 2000)
4.12 Registration Rights Agreement between Explorer Holdings,
L.P. and Omega Healthcare Investors, Inc. (Incorporated by
reference to Exhibit 4.3 to the Company's Form 10-Q for the
quarterly period ended June 30, 2000)
4.13 Form of Amended and Restated Articles Supplementary for
Series C Convertible Preferred Stock (Incorporated by
reference to Exhibit B to the Schedule 13D filed by Explorer
Holdings, L.P. on October 30, 2001 on behalf of the Company)
4.14 Form of Articles Supplementary for Series D Convertible
Preferred Stock (Incorporated by reference to Exhibit C to
the Schedule 13D filed by Explorer Holdings, L.P. on
October 30, 2001 on behalf of the Company)
5.1+ Opinion of Powell, Goldstein, Frazer & Murphy LLP
8.1+ Opinion of Powell, Goldstein, Frazer & Murphy LLP with
respect to certain tax matters
8.2+ Opinion of Argue Pearson Harbison & Myers, LLP with respect
to certain tax matters
10.1 1993 Deferred Compensation Plan, effective March 2, 1993
(Incorporated by reference to Exhibit 10.16 to the Company's
Form 10-K for the year ended December 31, 1992)**
10.2 Form of Note Exchange Agreement--10% Senior Notes due July
15, 2000 (Incorporated by reference to Exhibit 10.1 to the
Company's Form 10-Q for the quarterly period ended September
30, 1995)
10.3 Form of Note Exchange Agreement--7.4% Senior Notes due July
15, 2000 (Incorporated by reference to Exhibit 10.2 to the
Company's Form 10-Q for the quarterly period ended September
30, 1995)
10.4 Form of Note Exchange Agreement--7.4% Senior Notes due July
15, 2000 (Incorporated by reference to Exhibit 10.25 to the
Company's Form 10-K for the year ended December 31, 1995)
10.5 First Amendment of Purchase Agreement, Master Lease
Agreement, Facility Leases and Guaranty between Delta
Investors I, LLC and Sun Healthcare Group, Inc. and Delta
Investors II, LLC and Sun Healthcare Group, Inc.
(Incorporated by reference to Exhibits 99.1 and 99.2 to the
Company's Form 8-K dated April 30, 1998)
10.6 Agreement of Sale and Purchase dated May 12, 2000, by and
between Omega Healthcare Investors, Inc. and Tenet
Healthsystem Philadelphia, Inc. (Incorporated by reference
to Exhibit 10.3 to the Company's Form 10-Q for the quarterly
period ended March 31, 2000)
10.7 Amended and Restated Investment Agreement, by and among
Omega Healthcare Investors, Inc. and Explorer Holdings, L.P.
(Incorporated by reference to Exhibit A of the Company's
Proxy Statement dated June 16, 2000)
10.8 Indemnification Agreement between Omega Healthcare
Investors, Inc. and Explorer Holdings, L.P. (Incorporated by
reference to Exhibit 10.12 to the Company's Form 10-Q for
the quarterly period ended June 30, 2000)

II-3

EXHIBIT
NUMBER DESCRIPTION
------- -----------

10.9 Amended and Restated Advisory Agreement between Omega
Healthcare Investors, Inc. and The Hampstead Group, L.L.C.,
dated October 4, 2000 (Incorporated by reference to
Exhibit 10.1 to the Company's Form 10-Q for the quarterly
period ended September 30, 2000)
10.10 Loan Agreement by and among Omega Healthcare Investors, Inc.
and certain of its subsidiaries, the banks signatory hereto
and Fleet Bank, N.A., as agent for such banks, dated June
15, 2000 (Incorporated by reference to Exhibit 10.2 to the
Company's Form 10-Q for the quarterly period ended June 30,
2000)
10.11 Amendment No. 1 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory hereto and Fleet Bank, N.A., as agent
for such banks (Incorporated by reference to Exhibit 10.11
of the Company's Form 10-k for the year ended December 31,
2000)
10.12 Amendment No. 2 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory hereto and Fleet Bank, N.A., as agent
for such banks (Incorporated by reference to Exhibit 10.12
of the Company's Form 10-k for the year ended December 31,
2000)
10.13 Amendment No. 3 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory hereto and Fleet Bank, N.A., as agent
for such banks** (Incorporated by reference to
Exhibit 10.13 of the Company's Form 10-k for the year ended
December 31, 2000)
10.14 2000 Stock Incentive Plan (Incorporated by reference to
Exhibit 10.5 to the Company's Form 10-Q for the quarterly
period ended June 30, 2000)**
10.15 Amendment to 2000 Stock Incentive Plan (Incorporated by
reference to Exhibit 10.6 to the Company's Form 10-Q for the
quarterly period ended June 30, 2000)**
10.16 Consulting and Severance Agreement with Essel W. Bailey, Jr.
(Incorporated by reference to Exhibit 10.7 to the Company's
Form 10-Q for the quarterly period ended June 30, 2000)**
10.17 Compensation Agreement with F. Scott Kellman (Incorporated
by reference to Exhibit 10.8 to the Company's Form 10-Q for
the quarterly period ended June 30, 2000)**
10.18 Compensation Agreement with Susan Kovach (Incorporated by
reference to Exhibit 10.9 to the Company's Form 10-Q for the
quarterly period ended June 30, 2000)**
10.19 Compensation Agreement with Laurence Rich (Incorporated by
reference to Exhibit 10.10 to the Company's Form 10-Q for
the quarterly period ended June 30, 2000)**
10.20 Form of Directors and Officers Indemnification Agreement
(Incorporated by reference to Exhibit 10.11 to the Company's
Form 10-Q for the quarterly period ended June 30, 2000)
10.21 Loan Agreement by and among Omega Healthcare Investors,
Inc., Sterling Acquisition Corp. and Delta Investors I, LLC,
The Provident Bank, Agent and Various Lenders Described
Herein, dated August 16, 2000 (Incorporated by reference to
Exhibit 10.2 to the Company's Form 10-Q for the quarterly
period ended September 30, 2000)
10.22 Amendment No. 1 to Loan Agreement by and among Omega
Healthcare Investors, Inc., Sterling Acquisition Corp. and
Delta Investors I, LLC, The Provident Bank, Agent and
Various Lenders Described Herein (Incorporated by reference
to Exhibit 10.22 to the Company's Form 10-K for the year
ended December 31, 2000)
10.23 Amendment No. 2 to Loan Agreement by and among Omega
Healthcare Investors, Inc., Sterling Acquisition Corp. and
Delta Investors I, LLC, The Provident Bank, Agent and
Various Lenders Described Herein (Incorporated by reference
to Exhibit 10.23 to the Company's Form 10-K for the year
ended December 31, 2000)
10.24 Settlement and Restructuring Agreement by and among Omega
Healthcare Investors, Inc. and Sterling Acquisition Corp,
and Advocat, Inc., Diversicare Leasing Corp., Sterling
Health Care Management Inc., Diversicare Management Services
Co. and Advocat Finance, Inc. dated October 1, 2000
(Incorporated by reference to Exhibit 10.3 to the Company's
Form 10-Q for the quarterly period ended September 30, 2000)

II-4

EXHIBIT
NUMBER DESCRIPTION
------- -----------

10.25 Consolidated Amended and Restated Master Lease by and among
Sterling Acquisition Corp. and Diversicare Leasing
Corporation, effective October 1, 2000 and dated November 8,
2000 (Incorporated by reference to Exhibit 10.4 to the
Company's Form 10-Q for the quarterly period ended September
30, 2000)
10.26 Letter Agreement between Omega Healthcare Investors, Inc.
and Explorer Holdings, L.P. regarding deferral of dividends
and waiver of certain provisions of Articles Supplementary
pertaining to Series C Preferred Stock (Incorporated by
reference to Exhibit 10.5 to the Company's Form 10-Q/A for
the quarterly period ended September 30, 2000)
10.27 Management Services Agreement by and among Omega Healthcare
Investors, Inc., Erickson Capital Group, Inc. and Thomas
Erickson dated October 1, 2000 (Incorporated by reference to
Exhibit 10.27 to the Company's Form 10-K for the year ended
December 31, 2000)**
10.28 Agreement of Sale and Purchase between Omega Healthcare
Investors, Inc. and Tenet Healthsystem Philadelphia, Inc.
dated May 12, 2000 (Incorporated by reference to Exhibit
10.3 to the Company's Form 10-Q for the quarterly period
ended March 31, 2000)
10.29 Letter Agreement between Omega Healthcare Investors, Inc.
and The Hampstead Group, L.L.C. dated as of June 1, 2001
(Incorporated by reference to Exhibit 10.1 to the Company's
Form 10-Q for the quarterly period ended June 30, 2001)
10.30 Employment Agreement between Omega Healthcare Investors,
Inc. and C. Taylor Pickett, dated June 12, 2001
(Incorporated by reference to Exhibit 10.2 to the Company's
Form 10-Q for the quarterly period ended June 30, 2001)
10.31 Investment Agreement, dated as of October 29, 2001, by and
between Omega Healthcare Investors, Inc. and Explorer
Holdings, L.P. (Incorporated by reference to Exhibit A to
the Schedule 13D filed by Explorer Holdings, L.P. on
October 30, 2001 on behalf of the Company)
10.32 Form of Amended and Restated Stockholders Agreement
(Incorporated by reference to Exhibit D to the Schedule 13D
filed by Explorer Holdings, L.P. on October 30, 2001 on
behalf of the Company)
10.33 Form of Amended and Restated Registration Rights Agreement
(Incorporated by reference to Exhibit E to the Schedule 13D
filed by Explorer Holdings, L.P. on October 30, 2001 on
behalf of the Company)
10.34 Amendment No. 2 to Rights Agreement (Incorporated by
reference to Exhibit F to the Schedule 13D filed by Explorer
Holdings, L.P. on October 30, 2001 on behalf of the Company)
10.35 Employment Agreement between Omega Healthcare Investors,
Inc. and R. Lee Crabill, Jr., dated July 30, 2001
(Incorporated by reference to Exhibit 10.1 to the Company's
Form 10-Q for the quarterly period ended September 30, 2001)
10.36 Employment Agreement between Omega Healthcare Investors,
Inc. and Robert O. Stephenson, dated August 30, 2001
(Incorporated by reference to Exhibit 10.2 to the Company's
Form 10-Q for the quarterly period ended September 30, 2001)
10.37 Employment Agreement between Omega Healthcare Investors,
Inc. and Daniel J. Booth, dated October 15, 2001
(Incorporated by reference to Exhibit 10.3 to the Company's
Form 10-Q for the quarterly period ended September 30, 2001)
10.38 Retention, Severance and Release Agreement between Omega
Healthcare Investors, Inc. and F. Scott Kellman, dated
October 9, 2001 (Incorporated by reference to Exhibit 10.4
to the Company's Form 10-Q for the quarterly period ended
September 30, 2001)
10.39 Retention, Severance and Release Agreement between Omega
Healthcare Investors, Inc. and Laurence D. Rich, Dated
August 1, 2001 (Incorporated by reference to Exhibit 10.5 to
the Company's Form 10-Q for the quarterly period ended
September 30, 2001)
10.40 Amended and Restated Secured Promissory Note between Omega
Healthcare Investors, Inc. and Professional Health Care
Management, Inc. dated as of September 1, 2001 (Incorporated
by reference to Exhibit 10.6 to the Company's 10-Q for the
quarterly period ended September 30, 2001)

II-5

EXHIBIT
NUMBER DESCRIPTION
------- -----------

10.41 Settlement Agreement between Omega Healthcare Investors,
Inc. Professional Health Care Management, Inc., Living
Centers - PHCM, Inc., GranCare, Inc., and Mariner Post-Acute
Network, Inc. dated as of September 1, 2001 (Incorporated by
reference to Exhibit 10.7 to the Company's 10-Q for the
quarterly period ended September 30, 2001)
10.42+ Amendment No. 4 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory thereto and Fleet Bank, N.A., as agent
for such banks
10.43+ Amendment No. 3 to Loan Agreement by and among Omega
Healthcare Investors, Inc., Sterling Acquisition Corp. and
Delta Investors I, LLC, The Provident Bank, Agent and
Various Lenders Described Herein
10.44+ Letter Agreement between Omega Healthcare Investors, Inc.
and Explorer Holdings, L.P. dated January 15, 2002 amending
the Investment Agreement dated October 30, 2001 by and
between Omega Healthcare Investors, Inc. and Explorer
Holdings, L.P.
21 Subsidiaries of the Registrant (Incorporated by reference to
Exhibit 21 to the Company's Form 10-K for the year ended
December 31, 2000)
23.1+ Consent of Ernst & Young LLP
23.2 Consent of Powell, Goldstein, Frazer & Murphy LLP (included
in Exhibits 5.1 and 8.1)
23.3 Consent of Argue Pearson Harbison & Myers, LLP (included in
Exhibit 8.2)
99.1+ Form of Subscription Agreement
99.2+ Form of Letter to Stockholders
99.3+ Form of Letter to Brokers, Dealers, Commercial Banks, Trust
Companies and Other Nominees
99.4+ Form of Letter to Clients for use by Brokers, Dealers,
Commercial Banks, Trust Company and Other Nominees

------------------------

+ Previously filed.

* Filed herewith.

** Management contract or compensatory plan, contract or arrangement.

ITEM 37. UNDERTAKINGS.

(a) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this Registration Statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities
Act of 1933, as amended (the "Securities Act");

(ii) To reflect in the prospectus any facts or events arising after the
effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth
in the Registration Statement. Notwithstanding the foregoing, any
increase or decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that which was
registered) and any deviation from the low or high and of the estimated
maximum offering range may be reflected in the form of prospectus filed
with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than 20 percent change in
the maximum aggregate offering price set forth in the "Calculation of
Registration Fee" table in the effective registration statement;

(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the Registration Statement or
any material change to such information in the Registration Statement;

II-6

(2) That, for the purpose of determining any liability under the Securities
Act of 1933, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be
deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any
of the securities being registered which remain unsold at the termination of the
offering.

(a) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions,
or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public
policy as expressed in the Act and is, therefore, unenforceable. In the
event that a claim for indemnification against such liabilities (other than
the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered the
registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Act and will be governed by the final
adjudication of such issue.

II-7

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this Post-Effective Amendment No. 2 to the Form S-11
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Timonium, State of Maryland, on January 25,
2002.

OMEGA HEALTHCARE INVESTORS, INC.

By: /s/ C. TAYLOR PICKETT_____________
C. Taylor Pickett
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on January 25, 2002.

SIGNATURE TITLE
--------- -----

/s/ C. TAYLOR PICKETT
------------------------------------------- Chief Executive Officer
C. Taylor Pickett (Principal Executive Officer)

/s/ ROBERT O. STEPHENSON Chief Financial Officer
------------------------------------------- (Principal Financial and
Robert O. Stephenson Accounting Officer)

*
------------------------------------------- Director
Daniel A. Decker

*
------------------------------------------- Director
Thomas W. Erickson

*
------------------------------------------- Director
Thomas F. Franke

*
------------------------------------------- Director
Harold J. Kloosterman

*
------------------------------------------- Director
Bernard J. Korman

II-8

SIGNATURE TITLE
--------- -----

*
------------------------------------------- Director
Edward Lowenthal

*
------------------------------------------- Director
Christopher W. Mahowald

*
------------------------------------------- Director
Donald J. McNamara

*
------------------------------------------- Director
Stephen D. Plavin

*By: /s/ C. TAYLOR PICKETT
--------------------------------------
ATTORNEY-IN-FACT

II-9

EXHIBIT INDEX

EXHIBIT
NUMBER DESCRIPTION
--------------------- ------------------------------------------------------------

3.1 Articles of Incorporation, as amended (Incorporated by
reference to the Registrant's Form 10-Q for the quarterly
period ended March 31, 1995)
3.2 Articles of Amendment to the Company's Articles of
Incorporation, as amended (Incorporated by reference to the
Company's Form 10-Q for the quarterly period ended September
30, 1999)
3.3 Amended and Restated Bylaws, as amended April 20, 1999
(Incorporated by reference to Exhibit 3.1 to the Company's
Form 8-K dated April 20, 1999)
4.1 Indenture dated December 27, 1993 (Incorporated by reference
to Exhibit 4.2 to the Company's Form S-3 dated December 29,
1993)
4.2 First Supplemental Indenture dated January 23, 1996
(Incorporated by reference to Exhibit 4 to the Company's
Form 8-K dated January 19, 1996)
4.3 Form of Convertible Debenture (Incorporated by reference to
Exhibit 4.2 to the Company's Form S-3 dated February 3,
1997)
4.4 Form of Indenture (Incorporated by reference to Exhibit 4.2
to the Company's Form S-3 dated February 3, 1997)
4.5 Form of Articles Supplementary for Series A Preferred Stock
(Incorporated by reference to Exhibit 4.1 of the Company's
Form 10-Q for the quarterly period ended March 31, 1997)
4.6 Articles Supplementary for Series B Preferred Stock
(Incorporated by reference to Exhibit 4 to the Company's
Form 8-K dated April 27, 1998)
4.7 Form of Supplemental Indenture No. 1 dated as of June 1,
1998 relating to the 6.95% Notes due 2002 (Incorporated by
reference to Exhibit 4 to the Company's Form 8-K dated June
9, 1998)
4.8 Rights Agreement, dated as of May 12, 1999, between Omega
Healthcare Investors, Inc. and First Chicago Trust Company,
as Rights Agent, including Exhibit A thereto (Form of
Articles Supplementary relating to the Series A Junior
Participating Preferred stock) and Exhibit B thereto (Form
of Rights Certificate) (Incorporated by reference to Exhibit
4 to the Company's Form 8-K dated April 20, 1999)
4.9 Amendment No. 1, dated May 11, 2000 to Rights Agreement,
dated as of May 12, 1999, between Omega Healthcare
Investors, Inc. and First Chicago Trust Company, as Rights
Agent (Incorporated by reference to Exhibit 4.1 to the
Company's Form 10-Q for the quarterly period ended March 31,
2000)
4.10 Articles Supplementary for Series C Convertible Preferred
Stock (Incorporated by reference to Exhibit 4.1 to the
Company's Form 10-Q for the quarterly period ended June 30,
2000)
4.11 Stockholders Agreement between Explorer Holdings, L.P. and
Omega Healthcare Investors, Inc. (Incorporated by reference
to Exhibit 4.2 to the Company's Form 10-Q for the quarterly
period ended June 30, 2000)
4.12 Registration Rights Agreement between Explorer Holdings,
L.P. and Omega Healthcare Investors, Inc. (Incorporated by
reference to Exhibit 4.3 to the Company's Form 10-Q for the
quarterly period ended June 30, 2000)
4.13 Form of Amended and Restated Articles Supplementary for
Series C Convertible Preferred Stock (Incorporated by
reference to Exhibit B to the Schedule 13D filed by Explorer
Holdings, L.P. on October 30, 2001 on behalf of the Company)
4.14 Form of Articles Supplementary for Series D Convertible
Preferred Stock (Incorporated by reference to Exhibit C to
the Schedule 13D filed by Explorer Holdings, L.P. on
October 30, 2001 on behalf of the Company)
5.1+ Opinion of Powell, Goldstein, Frazer & Murphy LLP
8.1+ Opinion of Powell, Goldstein, Frazer & Murphy LLP with
respect to certain tax matters
8.2+ Form of Opinion of Argue Pearson Harbison & Myers, LLP with
respect to certain tax matters

EXHIBIT
NUMBER DESCRIPTION
--------------------- ------------------------------------------------------------

10.1 1993 Deferred Compensation Plan, effective March 2, 1993
(Incorporated by reference to Exhibit 10.16 to the Company's
Form 10-K for the year ended December 31, 1992)**
10.2 Form of Note Exchange Agreement--10% Senior Notes due July
15, 2000 (Incorporated by reference to Exhibit 10.1 to the
Company's Form 10-Q for the quarterly period ended September
30, 1995)
10.3 Form of Note Exchange Agreement--7.4% Senior Notes due July
15, 2000 (Incorporated by reference to Exhibit 10.2 to the
Company's Form 10-Q for the quarterly period ended September
30, 1995)
10.4 Form of Note Exchange Agreement--7.4% Senior Notes due July
15, 2000 (Incorporated by reference to Exhibit 10.25 to the
Company's Form 10-K for the year ended December 31, 1995)
10.5 First Amendment of Purchase Agreement, Master Lease
Agreement, Facility Leases and Guaranty between Delta
Investors I, LLC and Sun Healthcare Group, Inc. and Delta
Investors II, LLC and Sun Healthcare Group, Inc.
(Incorporated by reference to Exhibits 99.1 and 99.2 to the
Company's Form 8-K dated April 30, 1998)
10.6 Agreement of Sale and Purchase dated May 12, 2000, by and
between Omega Healthcare Investors, Inc. and Tenet
Healthsystem Philadelphia, Inc. (Incorporated by reference
to Exhibit 10.3 to the Company's Form 10-Q for the quarterly
period ended March 31, 2000)
10.7 Amended and Restated Investment Agreement, by and among
Omega Healthcare Investors, Inc. and Explorer Holdings, L.P.
(Incorporated by reference to Exhibit A of the Company's
Proxy Statement dated June 16, 2000)
10.8 Indemnification Agreement between Omega Healthcare
Investors, Inc. and Explorer Holdings, L.P. (Incorporated by
reference to Exhibit 10.12 to the Company's Form 10-Q for
the quarterly period ended June 30, 2000)
10.9 Amended and Restated Advisory Agreement between Omega
Healthcare Investors, Inc. and The Hampstead Group, L.L.C.,
dated October 4, 2000 (Incorporated by reference to
Exhibit 10.1 to the Company's Form 10-Q for the quarterly
period ended September 30, 2000)
10.10 Loan Agreement by and among Omega Healthcare Investors, Inc.
and certain of its subsidiaries, the banks signatory hereto
and Fleet Bank, N.A., as agent for such banks, dated June
15, 2000 (Incorporated by reference to Exhibit 10.2 to the
Company's Form 10-Q for the quarterly period ended June 30,
2000)
10.11 Amendment No. 1 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory hereto and Fleet Bank, N.A., as agent
for such banks (Incorporated by reference to Exhibit 10.11
of the Company's Form 10-k for the year ended December 31,
2000)
10.12 Amendment No. 2 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory hereto and Fleet Bank, N.A., as agent
for such banks (Incorporated by reference to Exhibit 10.12
of the Company's Form 10-k for the year ended December 31,
2000)
10.13 Amendment No. 3 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory hereto and Fleet Bank, N.A., as agent
for such banks** (Incorporated by reference to
Exhibit 10.13 of the Company's Form 10-k for the year ended
December 31, 2000)
10.14 2000 Stock Incentive Plan (Incorporated by reference to
Exhibit 10.5 to the Company's Form 10-Q for the quarterly
period ended June 30, 2000)**
10.15 Amendment to 2000 Stock Incentive Plan (Incorporated by
reference to Exhibit 10.6 to the Company's Form 10-Q for the
quarterly period ended June 30, 2000)**
10.16 Consulting and Severance Agreement with Essel W. Bailey, Jr.
(Incorporated by reference to Exhibit 10.7 to the Company's
Form 10-Q for the quarterly period ended June 30, 2000)**
10.17 Compensation Agreement with F. Scott Kellman (Incorporated
by reference to Exhibit 10.8 to the Company's Form 10-Q for
the quarterly period ended June 30, 2000)**

EXHIBIT
NUMBER DESCRIPTION
--------------------- ------------------------------------------------------------

10.18 Compensation Agreement with Susan Kovach (Incorporated by
reference to Exhibit 10.9 to the Company's Form 10-Q for the
quarterly period ended June 30, 2000)**
10.19 Compensation Agreement with Laurence Rich (Incorporated by
reference to Exhibit 10.10 to the Company's Form 10-Q for
the quarterly period ended June 30, 2000)**
10.20 Form of Directors and Officers Indemnification Agreement
(Incorporated by reference to Exhibit 10.11 to the Company's
Form 10-Q for the quarterly period ended June 30, 2000)
10.21 Loan Agreement by and among Omega Healthcare Investors,
Inc., Sterling Acquisition Corp. and Delta Investors I, LLC,
The Provident Bank, Agent and Various Lenders Described
Herein, dated August 16, 2000 (Incorporated by reference to
Exhibit 10.2 to the Company's Form 10-Q for the quarterly
period ended September 30, 2000)
10.22 Amendment No. 1 to Loan Agreement by and among Omega
Healthcare Investors, Inc., Sterling Acquisition Corp. and
Delta Investors I, LLC, The Provident Bank, Agent and
Various Lenders Described Herein (Incorporated by reference
to Exhibit 10.22 to the Company's Form 10-K for the year
ended December 31, 2000)
10.23 Amendment No. 2 to Loan Agreement by and among Omega
Healthcare Investors, Inc., Sterling Acquisition Corp. and
Delta Investors I, LLC, The Provident Bank, Agent and
Various Lenders Described Herein (Incorporated by reference
to Exhibit 10.23 to the Company's Form 10-K for the year
ended December 31, 2000)
10.24 Settlement and Restructuring Agreement by and among Omega
Healthcare Investors, Inc. and Sterling Acquisition Corp,
and Advocat, Inc., Diversicare Leasing Corp., Sterling
Health Care Management Inc., Diversicare Management Services
Co. and Advocat Finance, Inc. dated October 1, 2000
(Incorporated by reference to Exhibit 10.3 to the Company's
Form 10-Q for the quarterly period ended September 30, 2000)
10.25 Consolidated Amended and Restated Master Lease by and among
Sterling Acquisition Corp. and Diversicare Leasing
Corporation, effective October 1, 2000 and dated November 8,
2000 (Incorporated by reference to Exhibit 10.4 to the
Company's Form 10-Q for the quarterly period ended September
30, 2000)
10.26 Letter Agreement between Omega Healthcare Investors, Inc.
and Explorer Holdings, L.P. regarding deferral of dividends
and waiver of certain provisions of Articles Supplementary
pertaining to Series C Preferred Stock (Incorporated by
reference to Exhibit 10.5 to the Company's Form 10-Q/A for
the quarterly period ended September 30, 2000)
10.27 Management Services Agreement by and among Omega Healthcare
Investors, Inc., Erickson Capital Group, Inc. and Thomas
Erickson dated October 1, 2000 (Incorporated by reference to
Exhibit 10.27 to the Company's Form 10-K for the year ended
December 31, 2000)**
10.28 Agreement of Sale and Purchase between Omega Healthcare
Investors, Inc. and Tenet Healthsystem Philadelphia, Inc.
dated May 12, 2000 (Incorporated by reference to Exhibit
10.3 to the Company's Form 10-Q for the quarterly period
ended March 31, 2000)
10.29 Letter Agreement between Omega Healthcare Investors, Inc.
and The Hampstead Group, L.L.C. dated as of June 1, 2001
(Incorporated by reference to Exhibit 10.1 to the Company's
Form 10-Q for the quarterly period ended June 30, 2001)
10.30 Employment Agreement between Omega Healthcare Investors,
Inc. and C. Taylor Pickett, dated June 12, 2001
(Incorporated by reference to Exhibit 10.2 to the Company's
Form 10-Q for the quarterly period ended June 30, 2001)
10.31 Investment Agreement, dated as of October 30, 2001, by and
between Omega Healthcare Investors, Inc. and Explorer
Holdings, L.P. (Incorporated by reference to Exhibit A to
the Schedule 13D filed by Explorer Holdings, L.P. on
October 30, 2001 on behalf of the Company)
10.32 Form of Amended and Restated Stockholders Agreement
(Incorporated by reference to Exhibit D to the Schedule 13D
filed by Explorer Holdings, L.P. on October 30, 2001 on
behalf of the Company)

EXHIBIT
NUMBER DESCRIPTION
--------------------- ------------------------------------------------------------

10.33 Form of Amended and Restated Registration Rights Agreement
(Incorporated by reference to Exhibit E to the Schedule 13D
filed by Explorer Holdings, L.P. on October 30, 2001 on
behalf of the Company)
10.34 Amendment No. 2 to Rights Agreement (Incorporated by
reference to Exhibit F to the Schedule 13D filed by Explorer
Holdings, L.P. on October 30, 2001 on behalf of the Company)
10.35 Employment Agreement between Omega Healthcare Investors,
Inc. and R. Lee Crabill, Jr., dated July 30, 2001
(Incorporated by reference to Exhibit 10.1 to the Company's
Form 10-Q for the quarterly period ended September 30, 2001)
10.36 Employment Agreement between Omega Healthcare Investors,
Inc. and Robert O. Stephenson, dated August 30, 2001
(Incorporated by reference to Exhibit 10.2 to the Company's
Form 10-Q for the quarterly period ended September 30, 2001)
10.37 Employment Agreement between Omega Healthcare Investors,
Inc. and Daniel J. Booth, dated October 15, 2001
(Incorporated by reference to Exhibit 10.3 to the Company's
Form 10-Q for the quarterly period ended September 30, 2001)
10.38 Retention, Severance and Release Agreement between Omega
Healthcare Investors, Inc. and F. Scott Kellman, dated
October 9, 2001 (Incorporated by reference to Exhibit 10.4
to the Company's Form 10-Q for the quarterly period ended
September 30, 2001)
10.39 Retention, Severance and Release Agreement between Omega
Healthcare Investors, Inc. and Laurence D. Rich, Dated
August 1, 2001 (Incorporated by reference to Exhibit 10.5 to
the Company's Form 10-Q for the quarterly period ended
September 30, 2001)
10.40 Amended and Restated Secured Promissory Note between Omega
Healthcare Investors, Inc. and Professional Health Care
Management, Inc. dated as of September 1, 2001 (Incorporated
by reference to Exhibit 10.6 to the Company's 10-Q for the
quarterly period ended September 30, 2001)
10.41 Settlement Agreement between Omega Healthcare Investors,
Inc. Professional Health Care Management, Inc., Living
Centers - PHCM, Inc. GranCare, Inc., and Mariner Post-Acute
Network, Inc. dated as of September 1, 2001 (Incorporated by
reference to Exhibit 10.7 to the Company's 10-Q for the
quarterly period ended September 30, 2001)
10.42+ Amendment No. 4 to Loan Agreement by and among Omega
Healthcare Investors, Inc. and certain of its subsidiaries,
the banks signatory thereto and Fleet Bank, N.A., as agent
for such banks
10.43+ Amendment No. 3 to Loan Agreement by and among Omega
Healthcare Investors, Inc., Sterling Acquisition Corp. and
Delta Investors I, LLC, The Provident Bank, Agent and
Various Lenders Described Herein
10.44+ Letter Agreement between Omega Healthcare Investors, Inc.
and Explorer Holdings, L.P. dated January 15, 2002 amending
the Investment Agreement dated October 30, 2001 by and
between Omega Healthcare Investors, Inc. and Explorer
Holdings, L.P.
21 Subsidiaries of the Registrant (Incorporated by reference to
Exhibit 21 to the Company's Form 10-K for the year ended
December 31, 2000)
23.1+ Consent of Ernst & Young LLP
23.2 Consent of Powell, Goldstein, Frazer & Murphy LLP (included
in Exhibits 5.1 and 8.1)
23.3 Consent of Argue Pearson Harbison & Myers, LLP (included in
Exhibit 8.2)
99.1+ Form of Subscription Agreement
99.2+ Form of Letter to Stockholders
99.3+ Form of Letter to Brokers, Dealers, Commercial Banks, Trust
Companies and Other Nominees
99.4+ Form of Letter to Clients for use by Brokers, Dealers,
Commercial Banks, Trust Company and Other Nominees

------------------------

+ Previously filed.

* Filed herewith.

** Management contract or compensatory plan, contract or arrangement.

*** To be filed by amendment.